01121000000000421000450099100020000070000020000270600020000470100020000609100090
00081300042000171510024000590350010000834800059000930300021001529300005001731170
00600178085000300184935001000187031000200197032000200199036000600201042000200207
20000020020906500090021112200030022004800140022304800140023704800240025104900330
02750490033003080490025003410490031003660490068003970490051004650430061005160430
06100577043006100638#1#0#i#1#20110401#Revista Brasileira de Medicina do Esporte#
Rev. bras. med. esporte#1517-8692#Sociedade Brasileira de Medicina do Exercício 
e do Esporte#Rev Bras Med Esporte#RBME#other#nd#1517-8692#5#4#19994#1#0#19990800
#08#^les^hSumario#^lpt^hSumário#^len^hTable of Contents#^lpt^cRBME090^tArtigo de
 Opinião#^lpt^cRBME120^tArtigo de Revisão#^lpt^cRBME150^tEditorial#^lpt^cRBME180
^tArtigo Original#^les^cRBME240^tArchivos de Medicina del Deporte (Artigo de Rev
isão)#^len^cRBME260^tAmerican College of Sports Medicine#^les^tRev Bras Med Espo
rte^vvol.5^nno.4^cNiterói^mago.^a1999#^lpt^tRev Bras Med Esporte^vvol.5^nno.4^cN
iterói^mago.^a1999#^len^tRev Bras Med Esporte^vvol.5^nno.4^cNiterói^mAug.^a1999#
#
00267000000000169000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640910009000660920007000750020012000827030
00300094#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#o#1#1#text#1#20110
405#115543#v5n4a01.htm#64##
00627000000000361000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640710003000660400003000690010006000720420
00200078120000400080038000300084121000300087049000800090158000300098030002100101
03100020012203200020012406500090012601400110013503500100014612300020015601200860
0158117000600244072000300250002001200253#v5n4#V:\SciELO\serial\rbme\v5n4\markup\
v5n4a01.htm#S#h#2#1#text#1#ed#pt#br1.1#1#4.0#ND#01#RBME150#nd#Rev Bras Med Espor
te#5#4#19990800#^f127^l129#1517-8692#1#O exercício na insuficiência cardíaca: da
 contra-indicação à evidência científica^lpt#other#14#v5n4a01.htm##
00641000000000361000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640710003000660400003000690010006000720420
00200078120000400080038000300084121000300087049000800090158000300098030002100101
03100020012203200020012406500090012601400110013503500100014612300020015601201000
0158117000600258072000300264002001200267#v5n4#V:\SciELO\serial\rbme\v5n4\markup\
v5n4a01.htm#S#f#3#1#text#1#ed#pt#br1.1#1#4.0#ND#01#RBME150#nd#Rev Bras Med Espor
te#5#4#19990800#^f127^l129#1517-8692#1#<b>O exercício na insuficiência cardíaca<
/b>: <b>da contra-indicação à evidência científica</b>^lpt#other#14#v5n4a01.htm#
#
00741000000000373000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640640013000660710003000790400003000820010
00600085042000200091120000400093121000300097049000800100158000300108030002400111
03100020013503200020013706500090013901400110014803500100015912300020016901200860
0171117000600257072000300263002001200266008008900278#v5n4#V:\SciELO\serial\rbme\
v5n4\markup\v5n4a01.htm#S#l#4#1#text#1#^mago.^a1999#ed#pt#br1.1#1#4.0#01#RBME150
#nd#Rev. bras. med. esporte#5#4#19990800#^f127^l129#1517-8692#1#O exercício na i
nsuficiência cardíaca: da contra-indicação à evidência científica^lpt#other#14#v
5n4a01.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S151
7-86921999000400001##
00308000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704008300067002001200150#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#5#1#text#46#<P align="right"><font face=
"Verdana" size="2"><b>EDITORIAL</b></font></p>     ^cY#v5n4a01.htm##
00247000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704002200067002001200089#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#6#2#text#46#<p>&nbsp;</p>     ^cY#v5n4a0
1.htm##
00426000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704020100067002001200268#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#7#3#text#46#<P><font face="Verdana" size
="4"><b>O exerc&iacute;cio na insufici&ecirc;ncia    card&iacute;aca: da contra-
indica&ccedil;&atilde;o &agrave; evid&ecirc;ncia    cient&iacute;fica</b></font>
</p>     ^cY#v5n4a01.htm##
00247000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704002200067002001200089#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#8#4#text#46#<p>&nbsp;</p>     ^cY#v5n4a0
1.htm##
00247000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704002200067002001200089#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#9#5#text#46#<p>&nbsp;</p>     ^cY#v5n4a0
1.htm##
01473000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704124700068002001201315#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#10#6#text#46#<P><font face="Verdana" siz
e="2">A insufici&ecirc;ncia card&iacute;aca cr&ocirc;nica    (ICC) pode ser defi
nida como uma situa&ccedil;&atilde;o cl&iacute;nica na qual    o d&eacute;bito c
ard&iacute;aco &eacute; incapaz de satisfazer a demanda metab&oacute;lica    dos
 tecidos da periferia. Esta anormalidade desencadeia uma s&eacute;rie de    meca
nismos compensat&oacute;rios e, desta forma, a insufici&ecirc;ncia card&iacute;a
ca    n&atilde;o &eacute; mais vista simplesmente como um d&eacute;ficit da fun&
ccedil;&atilde;o    sist&oacute;lica ou diast&oacute;lica, mas tamb&eacute;m com
o uma s&iacute;ndrome    neurohumoral. Em uma fase mais avan&ccedil;ada, estas a
ltera&ccedil;&otilde;es    se tornam delet&eacute;rias e o progn&oacute;stico &e
acute; inversamente proporcional    ao grau de ativa&ccedil;&atilde;o neuroend&o
acute;crina<SUP>1</SUP>. A ICC apresenta    uma incid&ecirc;ncia anual nos Estad
os Unidos de aproximadamente 2.000.000 casos.    &Eacute; o diagn&oacute;stico d
e alta hospitalar mais comum nos indiv&iacute;duos    acima de 65 anos de idade 
e a taxa de mortalidade em cinco anos &eacute; freq&uuml;entemente    superior &
agrave; de pacientes portadores de diversos tipos de neoplasias<SUP>2</SUP>.    
</font></p>     ^cY#v5n4a01.htm##
01107000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704088100068002001200949#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#11#7#text#46#<P><font face="Verdana" siz
e="2">A intoler&acirc;ncia ao esfor&ccedil;o e &agrave;s    atividades do cotidi
ano e a dispn&eacute;ia s&atilde;o os sintomas mais freq&uuml;entes    e debilit
antes nos pacientes com ICC leve a moderada. Tradicionalmente, sempre    houve u
ma recomenda&ccedil;&atilde;o para que os pacientes com ICC se mantivessem    ta
nto quanto poss&iacute;vel em repouso, evitando a realiza&ccedil;&atilde;o    de
 qualquer tipo de atividade f&iacute;sica que fosse capaz de desencadear sintoma
s.    Assim, sempre se evitou submeter estes pacientes a um teste de esfor&ccedi
l;o    ou recomendar atividade f&iacute;sica ou reabilita&ccedil;&atilde;o<SUP>3
</SUP>.    De fato, at&eacute; recentemente a atividade f&iacute;sica regular n&
atilde;o    fazia parte das recomenda&ccedil;&otilde;es para o tratamento dos pa
cientes    com ICC<SUP>4,5</SUP>. </font></p>     ^cY#v5n4a01.htm##
01578000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704135200068002001201420#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#12#8#text#46#<P><font face="Verdana" siz
e="2">Os pacientes com ICC representam um grupo um    tanto quanto heterog&ecirc
;neo em rela&ccedil;&atilde;o &agrave;s anormalidades    que determinam a redu&c
cedil;&atilde;o da sua capacidade funcional. H&aacute;    v&aacute;rios subgrupo
s de anormalidades musculares e hemodin&acirc;micas, que    podem se superpor em
 cada paciente. H&aacute; pacientes com fluxo muscular normal    ou alterado dur
ante o exerc&iacute;cio; nos pacientes com altera&ccedil;&otilde;es    de fluxo,
 parece haver algum grau de disfun&ccedil;&atilde;o endotelial. H&aacute;    pac
ientes que possuem uma atrofia muscular por altera&ccedil;&otilde;es intr&iacute
;nsecas    das fibras musculares &#150; neste caso uma prov&aacute;vel etiologia
 seria    o <I>drive</I> simp&aacute;tico cronicamente aumentado; em outros paci
entes,    a atrofia muscular seria meramente por inatividade f&iacute;sica, com 
altera&ccedil;&otilde;es    comuns a indiv&iacute;duos sedent&aacute;rios sem do
en&ccedil;a; em alguns outros    pacientes, a desnutri&ccedil;&atilde;o contribu
iria para a atrofia muscular.    De qualquer forma, o elemento comum a todos os 
pacientes &eacute; uma insufici&ecirc;ncia    muscular esquel&eacute;tica<SUP>6,
7</SUP>, que seria o principal respons&aacute;vel    pela redu&ccedil;&atilde;o 
da capacidade funcional. </font></p>     ^cY#v5n4a01.htm##
01412000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704118600068002001201254#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#13#9#text#46#<P><font face="Verdana" siz
e="2">A atividade f&iacute;sica regular induz v&aacute;rias    adapta&ccedil;&ot
ilde;es morfofuncionais nos pacientes com ICC. Estas adapta&ccedil;&otilde;es,  
  do ponto de vista qualitativo, s&atilde;o semelhantes &agrave;s observadas em 
   indiv&iacute;duos aparentemente saud&aacute;veis e atletas. Os estudos da lit
eratura,    com algumas &oacute;bvias varia&ccedil;&otilde;es conforme o foco da
 avalia&ccedil;&atilde;o,    mostram achados at&eacute; certo ponto semelhantes,
 que incluem: aumentos vari&aacute;veis    no consumo m&aacute;ximo de oxig&ecir
c;nio, no consumo de oxig&ecirc;nio e na    carga de trabalho nos quais se ating
e o limiar anaer&oacute;bico, na capacidade    de realizar e manter um determina
do trabalho mec&acirc;nico; redu&ccedil;&atilde;o    da FC em repouso e para esf
or&ccedil;os subm&aacute;ximos; aumento no tamanho    das fibras musculares, na 
quantidade e no volume das mitoc&ocirc;ndrias, bem    como na atividade das enzi
mas oxidativas<SUP>8-10</SUP>. O aumento da capacidade    funcional induzido pel
o exerc&iacute;cio regular est&aacute; associado com um    melhor progn&oacute;s
tico<SUP>11</SUP>. </font></p>     ^cY#v5n4a01.htm##
01230000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704100300069002001201072#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#14#10#text#46#<P><font face="Verdana" si
ze="2">Al&eacute;m disso, dois achados particularmente    interessantes nos paci
entes com ICC e recentemente demonstrados s&atilde;o a    melhora da disfun&cced
il;&atilde;o auton&ocirc;mica, com redu&ccedil;&atilde;o    do t&ocirc;nus simp&
aacute;tico e aumento do t&ocirc;nus vagal card&iacute;aco<SUP>12</SUP>,    e a 
revers&atilde;o da disfun&ccedil;&atilde;o endotelial presente em muitos    dess
es pacientes<SUP>13</SUP>. Todos esses achados dispon&iacute;veis na literatura 
   at&eacute; o ano passado, aliados &agrave; experi&ecirc;ncia de servi&ccedil;
os    de reabilita&ccedil;&atilde;o card&iacute;aca em todo o mundo, n&atilde;o 
deixavam    d&uacute;vida que o exerc&iacute;cio f&iacute;sico se constitu&iacut
e;a em uma    interven&ccedil;&atilde;o extremamente ben&eacute;fica para o paci
ente portador    de ICC sob v&aacute;rios pontos de vista e que presumivelmente 
tamb&eacute;m    traria um impacto positivo em termos de progn&oacute;stico. </f
ont></p>     ^cY#v5n4a01.htm##
01063000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704083600069002001200905#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#15#11#text#46#<P><font face="Verdana" si
ze="2">As t&atilde;o esperadas evid&ecirc;ncias vieram    neste ano, com um inte
ressante estudo randomizado e controlado<SUP>14</SUP>,    no qual 50 pacientes c
om ICC foram submetidos a um programa de 14 meses de dura&ccedil;&atilde;o    qu
e incluiu exerc&iacute;cios em cicloerg&ocirc;metro a 60% do VO<SUB>2</SUB>    m
&aacute;ximo; os resultados foram comparados com os de um grupo controle com    
49 pacientes, que n&atilde;o foram submetidos a programas formais de exerc&iacut
e;cios.    Os autores demonstraram uma redu&ccedil;&atilde;o importante e inequ&
iacute;voca    na mortalidade e na freq&uuml;&ecirc;ncia de reinterna&ccedil;&ot
ilde;es, al&eacute;m    de uma melhora expressiva da qualidade de vida e de outr
os par&acirc;metros    j&aacute; demonstrados por estudos anteriores. </font></p
>     ^cY#v5n4a01.htm##
00877000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704065000069002001200719#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#16#12#text#46#<P><font face="Verdana" si
ze="2">Este artigo certamente &eacute; o primeiro de    uma s&eacute;rie e vem c
orroborar uma conduta j&aacute; preconizada por muitos    j&aacute; h&aacute; mu
ito tempo. Desta forma, h&aacute; agora um irrefut&aacute;vel    argumento cient
&iacute;fico a favor da pr&aacute;tica regular de exerc&iacute;cios    no pacien
te portador de ICC. Ali&aacute;s, esses pacientes est&atilde;o entre    os que m
ais se beneficiam de programas formais de reabilita&ccedil;&atilde;o    card&iac
ute;aca e ignorar esse aspecto equivale cientificamente a negligenciar    o pr&o
acute;prio tratamento farmacol&oacute;gico. </font></p>     ^cY#v5n4a01.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002200069002001200091#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#17#13#text#46#<p>&nbsp;</p>     ^cY#v5n4
a01.htm##
00304000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704007700069002001200146#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#18#14#text#46#<P><font face="Verdana" si
ze="3"><B>REFER&Ecirc;NCIAS</B></font></p>     ^cY#v5n4a01.htm##
00400000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704015900071002001200230#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#p#19#15#text#46#1#<P><font fac
e="Verdana" size="2">1. Cohn JN, Rector TS. Prognosis of congestive    heart fai
lure and predictors of mortality. Am J Cardiol 1988;62:25A.    ^cY#v5n4a01.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#20#16#text#46# </font></p>     ^cY#v5n4a
01.htm##
00461000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704022000071002001200291#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#p#21#17#text#46#2#<P><font fac
e="Verdana" size="2">2. Minotti JR, Dudley G. Pathophysiology of exercise    int
olerance and the role of exercise training in congestive heart failure. Current 
   Opinion in Cardiology 1993;8:397-403.    ^cY#v5n4a01.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#22#18#text#46# </font></p>     ^cY#v5n4a
01.htm##
00387000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704014600071002001200217#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#p#23#19#text#46#3#<P><font fac
e="Verdana" size="2">3. Pi&ntilde;a IL, Fitzpatrick JT. Exercise and    heart fa
ilure &#150; a review. Chest 1996;110:1317-27.    ^cY#v5n4a01.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#24#20#text#46# </font></p>     ^cY#v5n4a
01.htm##
00493000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704025200071002001200323#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#p#25#21#text#46#4#<P><font fac
e="Verdana" size="2">4. Smith TW, Braunwald E, Kelly RA. The management    of he
art failure. In: Braunwald E. Heart disease &#150; a textbook of cardiovascular 
   medicine. 4<SUP>th</SUP> ed. Philadelphia: WB Saunders, 1992:464-519.    ^cY#
v5n4a01.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#26#22#text#46# </font></p>     ^cY#v5n4a
01.htm##
00615000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704037400071002001200445#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#p#27#23#text#46#5#<P><font fac
e="Verdana" size="2">5. ACC/AHA Task Force Report on Practice Guidelines.    Gui
delines for the evaluation and management of heart failure &#150; report    of t
he American College of Cardiology/American Heart Association Task Force    on Pr
actice Guidelines (Committee on Evaluation and Management of Heart Failure).    
J Am Coll Cardiol 1995;26:1376-98.    ^cY#v5n4a01.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#28#24#text#46# </font></p>     ^cY#v5n4a
01.htm##
00368000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704012700071002001200198#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#p#29#25#text#46#6#<P><font fac
e="Verdana" size="2">6. Drexler H. Skeletal muscle failure in heart    failure. 
Circulation 1992;85:1621-3.    ^cY#v5n4a01.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#30#26#text#46# </font></p>     ^cY#v5n4a
01.htm##
00470000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704022900071002001200300#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#p#31#27#text#46#7#<P><font fac
e="Verdana" size="2">7. Minotti JR, Johnson EC, Hudson TL, Zuroske    G, Murata 
G, Fukushima E, et al. Skeletal muscle response to exercise training    in conge
stive heart failure. J Clin Invest 1990;86:751-8.    ^cY#v5n4a01.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#32#28#text#46# </font></p>     ^cY#v5n4a
01.htm##
00470000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704022900071002001200300#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#p#33#29#text#46#8#<P><font fac
e="Verdana" size="2">8. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise    train
ing in patients with severe left ventricular dysfunction &#150; hemodynamic    a
nd metabolic effects. Circulation 1988;78:506-15.    ^cY#v5n4a01.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#34#30#text#46# </font></p>     ^cY#v5n4a
01.htm##
00545000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704030400071002001200375#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#p#35#31#text#46#9#<P><font fac
e="Verdana" size="2">9. Belardinelli R, Georgiou D, Cianci G, Purcaro    A. Effe
cts of exercise training on left ventricular filling at rest and during    exerc
ise in patients with ischemic cardiomyopathy and severe left ventricular    syst
olic dysfunction. Am Heart J 1996;132:61-70.    ^cY#v5n4a01.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#36#32#text#46# </font></p>     ^cY#v5n4a
01.htm##
00552000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000300069704031000072002001200382#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#p#37#33#text#46#10#<P><font fa
ce="Verdana" size="2">10. Meyer K, Schwaibold M, Westbrook S, Beneke    R, Hajri
c R, G&ouml;rnandt L, et al. Effects of short-term exercise training    and acti
vity restriction on functional capacity in patients with severe chronic    conge
stive heart failure. Am J Cardiol 1996;78: 1017-22.    ^cY#v5n4a01.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#38#34#text#46# </font></p>     ^cY#v5n4a
01.htm##
00518000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000300069704027600072002001200348#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#p#39#35#text#46#11#<P><font fa
ce="Verdana" size="2">11. Mancini DM, Eisen H, Kussmaul W, Mull R,    Edmunds LH
, Wilson JR. Value of peak exercise oxygen consumption for optimal    timing of 
cardiac transplantation in ambulatory patients with heart failure.    Circulatio
n 1991;83:778-86.    ^cY#v5n4a01.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#40#36#text#46# </font></p>     ^cY#v5n4a
01.htm##
00546000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000300069704030400072002001200376#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#p#41#37#text#46#12#<P><font fa
ce="Verdana" size="2">12. Coats AJS, Adamopoulos S, Radaelli A, McCance    A, Me
yer TE, Bernardi L, et al. Controlled trial of physical training in chronic    h
eart failure &#150; exercise performance, hemodynamics, ventilation, and autonom
ic    function. Circulation 1992;85: 2119-31.    ^cY#v5n4a01.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#42#38#text#46# </font></p>     ^cY#v5n4a
01.htm##
00522000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000300069704028000072002001200352#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#p#43#39#text#46#13#<P><font fa
ce="Verdana" size="2">13. Hambrecht R, Fiehn E, Weigl C, Gielen S,    Hamann C, 
Kaiser R, et al. Regular physical exercise corrects endothelial dysfunction    a
nd improves exercise capacity in patients with chronic heart failure. Circulatio
n    1998;98:2709-15.    ^cY#v5n4a01.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#44#40#text#46# </font></p>     ^cY#v5n4a
01.htm##
00545000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000300069704030300072002001200375#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#p#45#41#text#46#14#<P><font fa
ce="Verdana" size="2">14. Belardinelli R, Georgiou D, Cianci G, Purcaro    A. Ra
ndomized, controlled trial of long-term moderate exercise training in chronic   
 heart failure &#150; effects on functional capacity, quality of life, and clini
cal    outcome. Circulation 1999;99:1173-82.    ^cY#v5n4a01.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#46#42#text#46# </font></p>     ^cY#v5n4a
01.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002200069002001200091#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#47#43#text#46#<P>&nbsp;</p>     ^cY#v5n4
a01.htm##
00316000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704008900069002001200158#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#48#44#text#46#<P align="center"><font fa
ce="Verdana" size="2"><B><I>Jos&eacute; Kawazoe Lazzoli    ^cY#v5n4a01.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002800069002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#49#45#text#46#<br>   Editor-Chefe,    ^c
Y#v5n4a01.htm##
00303000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704007600069002001200145#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a01.htm#S#p#50#46#text#46#<BR>   Revista Brasileira 
de Medicina do Esporte</I></B></font></p>     ^cY#v5n4a01.htm##
00529000000000277000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100015000700100018000850120
07000103030001300173065000900186064000500195031000300200020000400203865000900207
002001200216035001000228801001300238#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a01.htm#S#c#51#1#text#14#1#^rND^sCohn^nJN#^rND^sRector^nTS.#Prognosis of congest
ive heart failure and predictors of mortality^len#Am J Cardiol#19880000#1988#62#
25A#19990800#v5n4a01.htm#0002-9149#Am J Cardiol##
00604000000000277000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100018000700100017000880120
10600105030003000211065000900241064000500250031000200255014000800257865000900265
002001200274035001000286801003000296#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a01.htm#S#c#52#2#text#14#2#^rND^sMinotti^nJR#^rND^sDudley^nG.#Pathophysiology of
 exercise intolerance and the role of exercise training in congestive heart fail
ure^len#Current Opinion in Cardiology#19930000#1993#8#397-403#19990800#v5n4a01.h
tm#0268-4705#Current opinion in cardiology##
00497000000000277000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100015000700100023000850120
04200108030000600150065000900156064000500165031000400170014000800174865000900182
002001200191035001000203801000600213#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a01.htm#S#c#53#3#text#14#3#^rND^sPiña^nIL#^rND^sFitzpatrick^nJT.#Exercise and he
art failure - a review^len#Chest#19960000#1996#110#1317-27#19990800#v5n4a01.htm#
0012-3692#Chest##
00608000000000301000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100016000700100019000860100
01700105012003600122016002000158018005800178063000200236066001300238062001200251
065000900263064000500272014000800277865000900285002001200294#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a01.htm#S#c#54#4#text#14#4#^rND^sSmith^nTW#^rND^sBraunwa
ld^nE#^rND^sKelly^nRA.#The management of heart failure^len#^rND^sBraunwald^nE.#H
eart disease - a textbook of cardiovascular medicine^len#4#Philadelphia#WB Saund
ers#19920000#1992#464-519#19990800#v5n4a01.htm##
00711000000000265000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680110009000700120274000790300
01800353065000900371064000500380031000300385014000800388865000900396002001200405
035001000417801001800427#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#c#
55#5#text#14#5#AHA^dACC#Task Force Report on Practice Guidelines. Guidelines for
 the evaluation and management of heart failure - report of the American College
 of Cardiology/American Heart Association Task Force on Practice Guidelines (Com
mittee on Evaluation and Management of Heart Failure)^len#J Am Coll Cardiol#1995
0000#1995#26#1376-98#19990800#v5n4a01.htm#0735-1097#J Am Coll Cardiol##
00478000000000265000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100018000700120045000880300
01200133065000900145064000500154031000300159014000700162865000900169002001200178
035001000190801001200200#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#c#
56#6#text#14#6#^rND^sDrexler^nH.#Skeletal muscle failure in heart failure^len#Ci
rculation#19920000#1992#85#1621-3#19990800#v5n4a01.htm#0009-7322#Circulation##
00680000000000337000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100018000700100018000880100
01700106010001700123010001600140010001900156810000700175012007800182030001400260
06500090027406400050028303100030028801400060029186500090029700200120030603500100
0318801001400328#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#c#57#7#tex
t#14#7#^rND^sMinotti^nJR#^rND^sJohnson^nEC#^rND^sHudson^nTL#^rND^sZuroske^nG#^rN
D^sMurata^nG#^rND^sFukushima^nE#et al.#Skeletal muscle response to exercise trai
ning in congestive heart failure^len#J Clin Invest#19900000#1990#86#751-8#199908
00#v5n4a01.htm#0021-9738#J Clin Invest##
00608000000000289000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100019000700100023000890100
01600112012011100128030001200239065000900251064000500260031000300265014000700268
865000900275002001200284035001000296801001200306#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a01.htm#S#c#58#8#text#14#8#^rND^sSullivan^nMJ#^rND^sHigginbotham^nMB
#^rND^sCobb^nFR.#Exercise training in patients with severe left ventricular dysf
unction - hemodynamic and metabolic effects^len#Circulation#19880000#1988#78#506
-15#19990800#v5n4a01.htm#0009-7322#Circulation##
00702000000000301000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100022000700100018000920100
01600110010001800126012017900144030001100323065000900334064000500343031000400348
014000600352865000900358002001200367035001000379801001100389#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a01.htm#S#c#59#9#text#14#9#^rND^sBelardinelli^nR#^rND^sG
eorgiou^nD#^rND^sCianci^nG#^rND^sPurcaro^nA.#Effects of exercise training on lef
t ventricular filling at rest and during exercise in patients with ischemic card
iomyopathy and severe left ventricular systolic dysfunction^len#Am Heart J#19960
000#1996#132#61-70#19990800#v5n4a01.htm#0002-8703#Am Heart J##
00752000000000337000450000400050000070200460000570500020005170600020005370000030
00557010003000587090005000617080003000661180003000690100015000720100020000870100
01900107010001600126010001600142010001800158810000700176012014900183030001300332
06500090034506400050035403100030035901400080036286500090037000200120037903500100
0391801001300401#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#c#60#10#te
xt#14#10#^rND^sMeyer^nK#^rND^sSchwaibold^nM#^rND^sWestbrook^nS#^rND^sBeneke^nR#^
rND^sHajric^nR#^rND^sGörnandt^nL#et al.#Effects of short-term exercise training 
and activity restriction on functional capacity in patients with severe chronic 
congestive heart failure^len#Am J Cardiol#19960000#1996#78#1017-22#19990800#v5n4
a01.htm#0002-9149#Am J Cardiol##
00712000000000325000450000400050000070200460000570500020005170600020005370000030
00557010003000587090005000617080003000661180003000690100018000720100015000900100
01800105010001400123010001800137010001800155012013400173030001200307065000900319
06400050032803100030033301400070033686500090034300200120035203500100036480100120
0374#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#c#61#11#text#14#11#^rN
D^sMancini^nDM#^rND^sEisen^nH#^rND^sKussmaul^nW#^rND^sMull^nR#^rND^sEdmunds^nLH#
^rND^sWilson^nJR.#Value of peak exercise oxygen consumption for optimal timing o
f cardiac transplantation in ambulatory patients with heart failure^len#Circulat
ion#19910000#1991#83#778-86#19990800#v5n4a01.htm#0009-7322#Circulation##
00745000000000337000450000400050000070200460000570500020005170600020005370000030
00557010003000587090005000617080003000661180003000690100017000720100021000890100
01800110010001700128010001600145010001800161810000700179012014100186030001200327
06500090033906400050034803100030035301400080035686500090036400200120037303500100
0385801001200395#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#c#62#12#te
xt#14#12#^rND^sCoats^nAJS#^rND^sAdamopoulos^nS#^rND^sRadaelli^nA#^rND^sMcCance^n
A#^rND^sMeyer^nTE#^rND^sBernardi^nL#et al.#Controlled trial of physical training
 in chronic heart failure - exercise performance, hemodynamics, ventilation, and
 autonomic function^len#Circulation#19920000#1992#85#2119-31#19990800#v5n4a01.ht
m#0009-7322#Circulation##
00727000000000337000450000400050000070200460000570500020005170600020005370000030
00557010003000587090005000617080003000661180003000690100019000720100015000910100
01500106010001600121010001600137010001600153810000700169012013300176030001200309
06500090032106400050033003100030033501400080033886500090034600200120035503500100
0367801001200377#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a01.htm#S#c#63#13#te
xt#14#13#^rND^sHambrecht^nR#^rND^sFiehn^nE#^rND^sWeigl^nC#^rND^sGielen^nS#^rND^s
Hamann^nC#^rND^sKaiser^nR#et al.#Regular physical exercise corrects endothelial 
dysfunction and improves exercise capacity in patients with chronic heart failur
e^len#Circulation#19980000#1998#98#2709-15#19990800#v5n4a01.htm#0009-7322#Circul
ation##
00698000000000301000450000400050000070200460000570500020005170600020005370000030
00557010003000587090005000617080003000661180003000690100022000720100018000940100
01600112010001800128012017000146030001200316065000900328064000500337031000300342
014000800345865000900353002001200362035001000374801001200384#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a01.htm#S#c#64#14#text#14#14#^rND^sBelardinelli^nR#^rND^
sGeorgiou^nD#^rND^sCianci^nG#^rND^sPurcaro^nA.#Randomized, controlled trial of l
ong-term moderate exercise training in chronic heart failure - effects on functi
onal capacity, quality of life, and clinical outcome^len#Circulation#19990000#19
99#99#1173-82#19990800#v5n4a01.htm#0009-7322#Circulation##
00267000000000169000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640910009000660920007000750020012000827030
00300094#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a02.htm#S#o#1#1#text#1#20110
405#115545#v5n4a02.htm#35##
00731000000000361000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640710003000660400003000690010006000720420
00200078120000400080038000300084121000300087049000800090158000300098030002100101
03100020012203200020012406500090012601400110013503500100014612300020015601200700
0158010003600228070009300264002001200357#v5n4#V:\SciELO\serial\rbme\v5n4\markup\
v5n4a02.htm#S#h#2#1#text#1#oa#pt#br1.1#1#4.0#ND#02#RBME090#nd#Rev Bras Med Espor
te#5#4#19990800#^f120^l131#1517-8692#1#Posicionamentos e orientações institucion
ais: uma nota de cautela^lpt#^rND^nClaudio Gil Soares de^sAraújo#Sociedade Brasi
leira de Cardiologia^iA01^1Departamento de Ergometria e Reabilitação Cardíaca#v5
n4a02.htm##
00745000000000361000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640710003000660400003000690010006000720420
00200078120000400080038000300084121000300087049000800090158000300098030002100101
03100020012203200020012406500090012601400110013503500100014612300020015601200840
0158010003600242070009300278002001200371#v5n4#V:\SciELO\serial\rbme\v5n4\markup\
v5n4a02.htm#S#f#3#1#text#1#oa#pt#br1.1#1#4.0#ND#02#RBME090#nd#Rev Bras Med Espor
te#5#4#19990800#^f120^l131#1517-8692#1#<b>Posicionamentos e orientações instituc
ionais</b>: <b>uma nota de cautela</b>^lpt#^rND^nClaudio Gil Soares de^sAraújo#S
ociedade Brasileira de Cardiologia^iA01^1Departamento de Ergometria e Reabilitaç
ão Cardíaca#v5n4a02.htm##
00847000000000373000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640640013000660710003000790400003000820010
00600085042000200091120000400093121000300097049000800100158000300108030002400111
03100020013503200020013706500090013901400110014803500100015912300020016901200700
0171010003600241070009500277002001200372008008900384#v5n4#V:\SciELO\serial\rbme\
v5n4\markup\v5n4a02.htm#S#l#4#1#text#1#^mago.^a1999#oa#pt#br1.1#1#4.0#02#RBME090
#nd#Rev. bras. med. esporte#5#4#19990800#^f120^l131#1517-8692#1#Posicionamentos 
e orientações institucionais: uma nota de cautela^lpt#^rND^nClaudio Gil Soares d
e^sAraújo#^iA01^1Sociedade Brasileira de Cardiologia^2Departamento de Ergometria
 e Reabilitação Cardíaca#v5n4a02.htm#Internet^ihttp://www.scielo.br/scielo.php?s
cript=sci_arttext&pid=S1517-86921999000400002##
00323000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704009800067002001200165#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#5#1#text#31#<p align="right"><font face=
"Verdana" size="2"><b>ARTIGO DE OPINI&Atilde;O</b></font></p>     ^cY#v5n4a02.ht
m##
00247000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704002200067002001200089#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#6#2#text#31#<p>&nbsp;</p>     ^cY#v5n4a0
2.htm##
00398000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704017300067002001200240#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#7#3#text#31#<p><font face="Verdana" size
="4"><b><a name="topo"></a>Posicionamentos e orienta&ccedil;&otilde;es    instit
ucionais: uma nota de cautela<SUP>*</SUP></b></font></p>     ^cY#v5n4a02.htm##
00247000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704002200067002001200089#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#8#4#text#31#<p>&nbsp;</p>     ^cY#v5n4a0
2.htm##
00247000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704002200067002001200089#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#9#5#text#31#<p>&nbsp;</p>     ^cY#v5n4a0
2.htm##
00321000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704009500068002001200163#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#10#6#text#31#<p><font face="Verdana" siz
e="2"><b>Claudio Gil Soares de Ara&uacute;jo</b></font></p>     ^cY#v5n4a02.htm#
#
00943000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704071700068002001200785#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#11#7#text#31#<p><font face="Verdana" siz
e="2">Programa de P&oacute;s-Gradua&ccedil;&atilde;o    &#150; Educa&ccedil;&ati
lde;o F&iacute;sica &#150; UGF, Servi&ccedil;o de Medicina    do Exerc&iacute;ci
o e do Esporte 3 HUCFF/UFRJ e Departamento de Fisiologia &#150;    UFF, Rio de J
aneiro, Brasil. <I>Fellow</I> do Col&eacute;gio Americano de Medicina    Desport
iva; Coordenador do Curso de Especializa&ccedil;&atilde;o em Medicina    do Exer
c&iacute;cio e do Esporte &#150; Universidade Est&aacute;cio de S&aacute;/Clinim
ex;    Vice-Presidente de Reabilita&ccedil;&atilde;o Card&iacute;aca do Departam
ento    de Ergometria e Reabilita&ccedil;&atilde;o Card&iacute;aca da Sociedade 
Brasileira    de Cardiologia. </font></p>     ^cY#v5n4a02.htm##
00341000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704011500068002001200183#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#12#8#text#31#<P><font face="Verdana" siz
e="2"><a href="#send">Endere&ccedil;o para correspond&ecirc;ncia</a></font></p> 
    ^cY#v5n4a02.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704002200068002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#13#9#text#31#<p>&nbsp;</p>     ^cY#v5n4a
02.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002200069002001200091#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#14#10#text#31#<P>&nbsp;</p>     ^cY#v5n4
a02.htm##
02700000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704247300069002001202542#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#15#11#text#31#<P><font face="Verdana" si
ze="2">Organiza&ccedil;&otilde;es cient&iacute;ficas    respeitadas s&atilde;o m
elhor reconhecidas atrav&eacute;s do n&iacute;vel acad&ecirc;mico    de seus mem
bros e pelo impacto cient&iacute;fico e tradi&ccedil;&atilde;o de    suas public
a&ccedil;&otilde;es peri&oacute;dicas e de seus congressos. Nas &uacute;ltimas  
  duas d&eacute;cadas e, mais especificamente, nos &uacute;ltimos anos, a produ&
ccedil;&atilde;o    de documentos institucionais pelas organiza&ccedil;&otilde;e
s cient&iacute;ficas    tem-se tornado bastante freq&uuml;ente. Mais apropriadam
ente chamados de documentos    institucionais, esses artigos recebem diferentes 
denomina&ccedil;&otilde;es,    tais como posicionamentos, orienta&ccedil;&otilde
;es ou consensos. Tipicamente,    especialistas ou pesquisadores ilustres em cer
ta &aacute;rea ou sub&aacute;rea    do conhecimento s&atilde;o convidados para u
tilizar sua experi&ecirc;ncia t&eacute;cnico-cient&iacute;fica    na prepara&cce
dil;&atilde;o dos documentos, os quais s&atilde;o, muitas vezes,    posteriormen
te revisados por outros especialistas internos e/ou externos &agrave;    institu
i&ccedil;&atilde;o. Em determinados casos, ainda h&aacute; o endosso    do docum
ento final por uma comiss&atilde;o ou da diretoria da referida institui&ccedil;&
atilde;o.    Em determinados casos, outras organiza&ccedil;&otilde;es cient&iacu
te;ficas    afins tamb&eacute;m podem associar-se e subscrever e endossar o docu
mento final.    Considerando esses aspectos, documentos institucionais passam a 
merecer elevada    prioridade em termos de aceitabilidade e respeitabilidade aca
d&ecirc;mica, desde    que eles presumivelmente refletem o estado-da-arte em um 
dado t&oacute;pico    e teriam sido, obrigatoriamente, alvo de meticulosa revis&
atilde;o antes da    publica&ccedil;&atilde;o. Em adendo, esses documentos s&ati
lde;o freq&uuml;entemente    empregados como refer&ecirc;ncias ou padr&otilde;es
 para a implanta&ccedil;&atilde;o    de rotinas laboratoriais, para a prepara&cc
edil;&atilde;o de algoritmos de decis&atilde;o    cl&iacute;nica e at&eacute; me
smo para definir crit&eacute;rios e padr&otilde;es    de conduta apropriada, com
 implica&ccedil;&otilde;es legais e profissionais.    Em um esfor&ccedil;o para 
manter o n&iacute;vel de estado-da-arte, os documentos    institucionais mais re
levantes s&atilde;o periodicamente revisados e novas vers&otilde;es    ou edi&cc
edil;&otilde;es publicadas.</font></p>     ^cY#v5n4a02.htm##
02053000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704182600069002001201895#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#16#12#text#31#<P><font face="Verdana" si
ze="2">Certamente, considerando o fato de que &eacute;    imposs&iacute;vel para
 qualquer indiv&iacute;duo ou pequeno grupo de indiv&iacute;duos    lidar com a 
enorme e crescente quantidade de dados cient&iacute;ficos dispon&iacute;veis,   
 &eacute; natural esperar algum vi&eacute;s no processo redacional que reflita  
  as concep&ccedil;&otilde;es, opini&otilde;es e, at&eacute; mesmo, as intui&cce
dil;&otilde;es    dos especialistas envolvidos no processo de prepara&ccedil;&at
ilde;o do documento.    Muitas vezes, quando os documentos s&atilde;o preparados
 em reuni&otilde;es    com v&aacute;rios especialistas participantes, a capacida
de de argumentar no    momento correto e de forma apropriada tende a direcionar 
o formato e o conte&uacute;do    final do documento, em detrimento de outras boa
s id&eacute;ias, que, todavia,    n&atilde;o teriam sido t&atilde;o bem defendid
as. Um leitor experiente e conhecedor    profundo da literatura no t&oacute;pico
 do documento &eacute; freq&uuml;entemente    capaz de reconhecer, dentre a list
a de especialistas autores, o respons&aacute;vel    por determinada senten&ccedi
l;a, tabela ou coment&aacute;rio. Enquanto isso    n&atilde;o deve ser considera
do uma fraqueza importante, dever&aacute;, por    outro lado, ser colocado dentr
o de uma perspectiva apropriada, na qual se inclui    n&atilde;o concluir que to
dos os participantes do documento, ou at&eacute; mesmo    a maioria dos membros 
dessa organiza&ccedil;&atilde;o, aprovam completamente    as recomenda&ccedil;&o
tilde;es expressas no texto final. Desde que consenso    completo &eacute; muito
 raro em ci&ecirc;ncias biol&oacute;gicas e sociais,    os leitores devem sempre
 considerar esta limita&ccedil;&atilde;o crucial e relevante    em qualquer docu
mento institucional.</font></p>     ^cY#v5n4a02.htm##
00760000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704053300069002001200602#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#17#13#text#31#<P><font face="Verdana" si
ze="2">Enquanto discuss&otilde;es ou argumenta&ccedil;&otilde;es    te&oacute;ri
cas podem ser tecidas com rela&ccedil;&atilde;o a muitos aspectos    desses docu
mentos, &eacute; apropriado esperar que grandes erros n&atilde;o    dever&atilde
;o ser encontrados. Infelizmente, isso &eacute; raramente verdadeiro.    Apresen
tamos, a seguir, exemplos de equ&iacute;vocos e erros importantes em    quatro d
ocumentos relevantes e recentes do Col&eacute;gio Americano de Medicina    Despo
rtiva. </font></p>     ^cY#v5n4a02.htm##
00377000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704015000069002001200219#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#18#14#text#31#<P><font face="Verdana" si
ze="2"><B>1)ACSM's Guidelines for Exercise Testing and    Prescription &#150; 5<
SUP>th</SUP> edition</B></font></p>     ^cY#v5n4a02.htm##
00712000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704048500069002001200554#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#19#15#text#31#<P><font face="Verdana" si
ze="2">P. 138: A figura 6-3 apresenta crit&eacute;rios    padr&otilde;es para a 
identifica&ccedil;&atilde;o de isquemia mioc&aacute;rdica    em tra&ccedil;ados 
de eletrocardiograma. No primeiro diagrama, descrevendo como    cl&aacute;ssico,
 existe um erro &oacute;bvio: o posicionamento das express&otilde;es    "anormal
" e "normal" foi invertido, modificando completamente o significado    e a inter
preta&ccedil;&atilde;o cl&iacute;nica. </font></p>     ^cY#v5n4a02.htm##
00470000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704024300069002001200312#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#20#16#text#31#<P><font face="Verdana" si
ze="2"><B>2)AHA/ACSM Joint Statement: Recommendations    for Cardiovascular Scre
ening, Staffing, and Emergency Policies at Health/Fitness    Facilities (Med Sci
 Sports Exerc 1998;30:1009-1018)</B> </font></p>     ^cY#v5n4a02.htm##
01768000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704154100069002001201610#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#21#17#text#31#<P><font face="Verdana" si
ze="2">P. 1014: A figura 5 apresenta um diagrama muito    interessante para clas
sifica&ccedil;&atilde;o das instala&ccedil;&otilde;es    voltadas para a pr&aacu
te;tica de atividade f&iacute;sica. Categorias mutuamente    exclusivas s&atilde
;o propostas de acordo com certos crit&eacute;rios predefinidos,    tais como id
ade, g&ecirc;nero e n&uacute;mero de fatores de risco cardiovascular.    Todavia
, o exame cuidadoso dos crit&eacute;rios de inclus&atilde;o para as categorias  
  A-2 (sem fatores de risco) e A-3 (dois ou mais fatores de risco) coloca claram
ente    um problema classificat&oacute;rio para um homem de 50 anos de idade com
 apenas    um fator de risco coronariano, desde que ele n&atilde;o poderia ser c
lassificado    em nenhuma das categorias propostas. Na realidade, uma inspe&cced
il;&atilde;o    mais detalhada mostra que n&atilde;o h&aacute; nenhuma raz&atild
e;o pr&aacute;tica    para separar A-2 e A-3, j&aacute; que os indiv&iacute;duos
 classificados em    ambas as categorias poderiam fazer uso do mesmo tipo de ins
tala&ccedil;&otilde;es    para sua pr&aacute;tica regular de exerc&iacute;cio. U
m modo simples de corrigir    o erro seria colocar todos os homens com mais de 4
5 anos de idade e as mulheres    com mais de 55 anos de idade, sem doen&ccedil;a
 cardiovascular conhecida, em    uma &uacute;nica categoria, talvez denominada A
-2 e A-3, para permitir a consist&ecirc;ncia    com documentos anteriores, indep
endentemente do n&uacute;mero de fatores de    risco. </font> </p>     ^cY#v5n4a
02.htm##
00400000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704017300069002001200242#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#22#18#text#31#<P><font face="Verdana" si
ze="2"><B>3)ACSM Position Stand: Exercise and Physical    Activity for Older Adu
lts (Med Sci Sports Exerc 1998;30:992-1008)</B></font></p>     ^cY#v5n4a02.htm##
01681000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704145400069002001201523#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#23#19#text#31#<P><font face="Verdana" si
ze="2">P. 997: A inclus&atilde;o de uma se&ccedil;&atilde;o    sobre flexibilida
de deve ser reputada como um dos avan&ccedil;os significativos    do documento. 
Contudo, existem erros &oacute;bvios no texto. Por exemplo, o    segundo par&aac
ute;grafo dessa se&ccedil;&atilde;o inicia-se com "It is evident    that flexibi
lity declines with age, with the maximum range of motion occurring    in the mid
- to late twenties for men e for women, respectively". Nesse aspecto,    bastari
a o senso comum para nos informar que a flexibilidade &eacute; muito    maior em
 crian&ccedil;as do que em adultos jovens e que, portanto, n&atilde;o    alcan&c
cedil;a seus n&iacute;veis m&aacute;ximos ao redor dos 25 ou 30 anos    de idade
, conforme &eacute; afirmado no documento. Duas das tr&ecirc;s refer&ecirc;ncias
    citadas para substanciar a informa&ccedil;&atilde;o apresentada prov&ecirc;m
    de disserta&ccedil;&otilde;es de p&oacute;s-gradua&ccedil;&atilde;o apresent
adas,    respectivamente, em 1955 e 1961, ambas incluindo somente dados de adult
os. Na    realidade, vale destacar o fato de que, das 248 refer&ecirc;ncias list
adas no    documento, apenas uma pequena minoria possui mais do que 20 anos, inc
luindo    as mencionadas acima. Seria provavelmente muito mais apropriado refras
ear a    senten&ccedil;a, afirmando que a flexibilidade nitidamente diminui com 
a idade,    tanto nos homens como nas mulheres. </font></p>     ^cY#v5n4a02.htm#
#
00509000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704028200069002001200351#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#24#20#text#31#<P><font face="Verdana" si
ze="2"><B>4)ACSM Position Stand: The Recommended Quantity    and Quality of Exer
cise for Developing and Maintaining Cardiorespiratory and    Muscular Fitness, a
nd Flexibility Healthy Adults (Med Sci Sports Exerc 1998;30:975-991)</B>    </fo
nt></p>     ^cY#v5n4a02.htm##
01630000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704140300069002001201472#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#25#21#text#31#<P><font face="Verdana" si
ze="2">P. 983: No &uacute;ltimo par&aacute;grafo da    primeira coluna dessa p&a
acute;gina do documento existe uma senten&ccedil;a    que informa "... a minimum
 of 1 set of 8-12 RM or to near fatigue should be    completed by most participa
nts; however, for older and more frail persons (approximately    50-60 yr of age
 and above), 10-15 repetitions may be more appropriate". Em adendo,    se examin
amos a tabela 1 (p. 978), o conceito de intensidade relativa para exerc&iacute;c
ios    de sobrecarga muscular &eacute; baseado em 8-12 repeti&ccedil;&otilde;es 
para    os adultos e 10-15 repeti&ccedil;&otilde;es para os idosos na mesma perc
entagem    da contra&ccedil;&atilde;o volunt&aacute;ria m&aacute;xima. Se a inte
n&ccedil;&atilde;o    &eacute; proteger os indiv&iacute;duos mais velhos de um e
sfor&ccedil;o desnecess&aacute;rio,    tanto a senten&ccedil;a e a tabela tal co
mo s&atilde;o atualmente apresentadas    podem ser confusas e de dif&iacute;cil 
interpreta&ccedil;&atilde;o. Seria provavelmente    mais apropriado explicitar q
ue os indiv&iacute;duos idosos devem realizar exerc&iacute;cios    de sobrecarga
 muscular com cargas mais baixas e com menores velocidades, ao    inv&eacute;s d
e propor um aumento no n&uacute;mero de repeti&ccedil;&otilde;es    por s&eacute
;rie no mesmo percentual da for&ccedil;a volunt&aacute;ria m&aacute;xima.    </f
ont></p>     ^cY#v5n4a02.htm##
02312000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704208500069002001202154#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#26#22#text#31#<P><font face="Verdana" si
ze="2">A tabela 1 tamb&eacute;m apresenta v&aacute;rios    outros erros &oacute;
bvios. A tentativa de classificar a intensidade do esfor&ccedil;o    em termos p
ercentuais de uma dada vari&aacute;vel &eacute; interessante, mas    provavelmen
te incorreta na maioria das vezes. Pegando como exemplo um homem    idoso com um
a freq&uuml;&ecirc;ncia card&iacute;aca m&aacute;xima de 160bpm,    dificilmente
 pode ser imaginado que ele possa exercitar-se a 35% de sua freq&uuml;&ecirc;nci
a    card&iacute;aca m&aacute;xima, isto &eacute; 56bpm, por menos intenso e lev
e    que seja a atividade f&iacute;sica realizada, j&aacute; que a maioria desse
s    indiv&iacute;duos possui freq&uuml;&ecirc;ncia card&iacute;aca de repouso n
a    posi&ccedil;&atilde;o ortost&aacute;tica superior a esse valor. Em adendo, 
qual    &eacute; o significado de propor como um exerc&iacute;cio muito leve aqu
ele    cuja intensidade absoluta n&atilde;o excede 1 MET em um homem muito idoso
, j&aacute;    que, por defini&ccedil;&atilde;o, 1 MET representa o consumo de o
xig&ecirc;nio    basal e, portanto, n&atilde;o se pode consumir menos oxig&ecirc
;nio do que isso,    especialmente durante um exerc&iacute;cio f&iacute;sico. Ta
lvez um equ&iacute;voco    ainda mais evidente &eacute; feito na afirma&ccedil;&
atilde;o "mean values for    women are approximately 1-2 METs lower than those f
or men", o que, em alguns    casos, resultaria em consumos de oxig&ecirc;nio neg
ativos para mulheres idosas    realizando exerc&iacute;cios leves ou muito leves
. Se alguma corre&ccedil;&atilde;o    deve ser feita para comparar a intensidade
 de exerc&iacute;cios em homens e    mulheres, o que &eacute; question&aacute;ve
l em princ&iacute;pio, ela deve ser    realizada em termos percentuais, isto &ea
cute;, relativos, e n&atilde;o em termos    absolutos, ou seja, em METs. Por &ua
cute;ltimo, mas n&atilde;o menos importante,    dever&aacute; destacar-se o efei
to multiplicador desses erros, pois eles s&atilde;o    tamb&eacute;m reproduzido
s em outro documento da AHA/ACSM (2). </font> </p>     ^cY#v5n4a02.htm##
00985000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704075800069002001200827#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#27#23#text#31#<P><font face="Verdana" si
ze="2">Concluindo, &eacute; nossa inten&ccedil;&atilde;o,    de forma bastante s
imples, desmistificar os documentos institucionais como b&iacute;blias    profis
sionais ou legais. &Eacute; certamente verdadeiro que eles s&atilde;o    normalm
ente muito bem redigidos e representam documentos relevantes, mas feitos    por 
seres humanos normais e, portanto, fal&iacute;veis, dever&atilde;o ser alvo    d
e leitura cr&iacute;tica e estudados cuidadosamente, antes que suas recomenda&cc
edil;&otilde;es    possam ser aceitas, adotadas ou implementadas. Estas observa&
ccedil;&otilde;es    podem ainda ser &uacute;teis para todos aqueles que vierem 
a participar da reda&ccedil;&atilde;o    de documentos institucionais. </font> <
/p>     ^cY#v5n4a02.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#28#24#text#31#<P>&nbsp; </p>     ^cY#v5n
4a02.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#29#25#text#31#<P>&nbsp; </p>     ^cY#v5n
4a02.htm##
00415000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704018800069002001200257#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#30#26#text#31#<p><font face="Verdana" si
ze="2"><b><a name="send"></a><a href="#topo"><img src="/img/revistas/rbme/v5n4/s
eta.gif" border="0"></a>    Endere&ccedil;o para correspond&ecirc;ncia</b>    ^c
Y#v5n4a02.htm##
00288000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704006100069002001200130#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#31#27#text#31#<br>   Cl&iacute;nica de M
edicina do Exerc&iacute;cio    ^cY#v5n4a02.htm##
00269000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704004200069002001200111#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#32#28#text#31#<br>   Rua Siqueira Campos
, 93/102    ^cY#v5n4a02.htm##
00277000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704005000069002001200119#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#33#29#text#31#<br>   22031-070 &#150; Ri
o de Janeiro, RJ    ^cY#v5n4a02.htm##
00261000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704003400069002001200103#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#34#30#text#31#<br>   Tel. (021) 256-7183
    ^cY#v5n4a02.htm##
00324000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704009700069002001200166#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a02.htm#S#p#35#31#text#31#<br>   E-mail: <a href="ma
ilto:cgaraujo@iis.com.br">cgaraujo@iis.com.br</a></font>  </p>     ^cY#v5n4a02.h
tm##
00271000000000169000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670910009000690920007000780020012000857030
00400097#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#o#1#1#article#1#20
110405#115550#v5n4a03.htm#213##
04242000000000637000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000400087121000300091049000800094158000300102030002100105
03100020012603200020012806500090013001400110013903500100015001201240016001201070
02840100034003910100023004250100028004480100026004760100031005020100030005330100
03200563010003300595010003000628010002900658083135800687085000802045085003502053
08500400208808500350212808500310216308312070219408500080340108500350340908500310
3444085003403475085002803509058004603537117000603583072000303589002001203592#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#h#2#1#article#1#oa#pt#br1.1#1#
4.0#TAB#03#RBME180#nd#Rev Bras Med Esporte#5#4#19990800#^f132^l137#1517-8692#Per
fil de limiares ventilatórios durante o exercício e o consumo de oxigênio de pic
o verificado em jogadoras de futebol^lpt#Ventilatory threshold profile during ex
ercise and peak oxygen uptake verified in female soccer players^len#^rND^nPaulo 
Roberto Santos^sSilva#^rND^nAdilson^sAndrade#^rND^nWilson Oliveira^sRiça#^rND^nA
na Maria^sVisconti#^rND^nFernando Miele da^sPonte#^rND^nAlbertina Fontana^sRosa#
^rND^nSolange Basílio da^sCosta#^rND^nCarla Dal Maso Nunes^sRoxo#^rND^nGilberto 
Silva^sMachado#^rND^nJorge Mendes de^sSousa#^lpt^aForam avaliadas 37 jogadoras d
e futebol, com média de idade de 21,5 ± 5,9 anos, peso de 57,0 ± 8,3kg, estatura
 de 161 ± 7cm e índice de massa corpórea de 21,8 ± 2,1kg/m². Todas as atletas fo
ram submetidas à avaliação espirométrica e metabólica, por meio de um sistema co
mputadorizado de análise de gases expirados (modelo Vmax 29c, SensorMedics, EUA)
. A resposta cardiovascular foi verificada por meio de um eletrocardiógrafo comp
utadorizado (modelo 6.4, HeartWare, BRA). A capacidade física máxima foi avaliad
a por meio de teste de esforço realizado em esteira rolante (modelo ATL-10.100, 
Inbramed, BRA) utilizando-se protocolo escalonado contínuo. Os seguintes parâmet
ros e os resultados encontrados foram: no limiar ventilatório 1 (LV1): VO2 = 30,
5 ± 3,7ml O2.kg-1.min-1; % VO2 = 64 ± 7%; velocidade de corrida = 8,1 ± 0,3km.h-
1; FC = 154 ± 9bpm. No limiar ventilatório 2 (LV2): VO2 = 40,9 ± 4,5ml O2.kg-1.m
in-1; % VO2 = 85,7 ± 4,9%; velocidade de corrida = 11,4 ± 1,1km.h-1; FC = 179 ± 
7bpm. O VO2 de pico foi de 47,4 ± 4,1ml O2.kg-1.min-1. CONCLUSÃO: A verificação 
de limiares ventilatórios e a potência aeróbia em jogadoras de futebol são parâm
etros fisiológicos de grande importância, pois permitem ampliar suas aplicações 
práticas, qualificando, controlando e desenvolvendo de modo mais adequado e obje
tivo o treinamento físico dessas atletas.#^dnd^i1#^tm^lpt^kLimiares ventilatório
s^i1#^tm^lpt^kConsumo de oxigênio de pico^i1#^tm^lpt^kFutebolistas femininas^i1#
^tm^lpt^kMedicina esportiva^i1#^len^aThirty-seven female soccer players aged 21.
5 ± 5.9, weight 57.0 ± 8.3 kg, height 161 ± 7 cm and body mass index 21.8 ± 2.1 
kg/m² were submitted to spirometric and metabolic evaluation by a computerized a
nalysis system of expired gases (model Vmax 29c, SensorMedics, EUA). Cardiovascu
lar response was recorded by means of a computerized ECG (model 6.4, HeartWare, 
BRA). Maximum physical capacity was evaluated by a treadmill test (model ATL 10.
100, Inbramed, BRA), using incremental continuous protocol. The parameters and r
esults were: in ventilatory threshold 1 (VT1): VO2 = 30.5 ± 3.7 ml O2.kg-1.min-1
; %VO2 = 64 ± 7%; running velocity = 8.1 ± 0.3 km.h-1; HR = 154 ± 9 bpm; in vent
ilatory threshold 2 (VT2): VO2 = 40.9 ± 4.5 ml O2.kg-1.min-1; %VO2 = 85.7 ± 4.9%
; running velocity = 11.4 ± 1.1 km.h-1; HR = 179 ± 7 bpm. The peak VO2 was 47.4 
± 4.1 ml O2. kg-1.min-1. In conclusion, the ventilatory thresholds and the aerob
ic power verified in female soccer players are physiological parameters of great
 importance, as they make it possible to enlarge their practical application, qu
alifying, controlling and developing the physical training of such athletes in a
 more practical and objective manner.#^dnd^i2#^tm^len^kVentilatory thresholds^i2
#^tm^len^kPeak oxygen uptake^i2#^tm^len^kFemale soccer players^i2#^tm^len^kSport
s medicine^i2#professor de língua inglesa Humberto Blancato#other#33#v5n4a03.htm
##
04723000000000637000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000400087121000300091049000800094158000300102030002100105
03100020012603200020012806500090013001400110013903500100015001201310016001201140
02910100034004050100023004390100028004620100026004900100031005160100030005470100
03200577010003300609010003000642010002900672083159500701085000802296085003502304
08500400233908500350237908500310241408314370244508500080388208500350389008500310
3925085003403956085002803990058004604018117000604064072000304070002001204073#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#f#3#1#article#1#oa#pt#br1.1#1#
4.0#TAB#03#RBME180#nd#Rev Bras Med Esporte#5#4#19990800#^f132^l137#1517-8692#<b>
Perfil de limiares ventilatórios durante o exercício e o consumo de oxigênio de 
pico verificado em jogadoras de futebol</b>^lpt#<b>Ventilatory threshold profile
 during exercise and peak oxygen uptake verified in female soccer players</b>^le
n#^rND^nPaulo Roberto Santos^sSilva#^rND^nAdilson^sAndrade#^rND^nWilson Oliveira
^sRiça#^rND^nAna Maria^sVisconti#^rND^nFernando Miele da^sPonte#^rND^nAlbertina 
Fontana^sRosa#^rND^nSolange Basílio da^sCosta#^rND^nCarla Dal Maso Nunes^sRoxo#^
rND^nGilberto Silva^sMachado#^rND^nJorge Mendes de^sSousa#^lpt^aForam avaliadas 
37 jogadoras de futebol, com média de idade de 21,5 ± 5,9 anos, peso de 57,0 ± 8
,3kg, estatura de 161 ± 7cm e índice de massa corpórea de 21,8 ± 2,1kg/m<sup>2</
sup>. Todas as atletas foram submetidas à avaliação espirométrica e metabólica, 
por meio de um sistema computadorizado de análise de gases expirados (modelo Vma
x 29c, <i>SensorMedics</i>, EUA). A resposta cardiovascular foi verificada por m
eio de um eletrocardiógrafo computadorizado (modelo 6.4, <i>HeartWare</i>, BRA).
 A capacidade física máxima foi avaliada por meio de teste de esforço realizado 
em esteira rolante (modelo <i>ATL-10.100, Inbramed</i>, BRA) utilizando-se proto
colo escalonado contínuo. Os seguintes parâmetros e os resultados encontrados fo
ram: no limiar ventilatório 1 (LV<sub>1</sub>): VO<sub>2</sub> = 30,5 ± 3,7ml O<
sub>2</sub>.kg<sup>-1</sup>.min<sup>-1</sup>; % VO<sub>2</sub> = 64 ± 7%; veloci
dade de corrida = 8,1 ± 0,3km.h<sup>-1</sup>; FC = 154 ± 9bpm. No limiar ventila
tório 2 (LV<sub>2</sub>): VO<sub>2</sub> = 40,9 ± 4,5ml O<sub>2</sub>.kg<sup>-1<
/sup>.min<sup>-1</sup>; % VO<sub>2</sub> = 85,7 ± 4,9%; velocidade de corrida = 
11,4 ± 1,1km.h<sup>-1</sup>; FC = 179 ± 7bpm. O VO<sub>2</sub> de pico foi de 47
,4 ± 4,1ml O<sub>2</sub>.kg<sup>-1</sup>.min<sup>-1</sup>. <b>CONCLUSÃO:</b> A v
erificação de limiares ventilatórios e a potência aeróbia em jogadoras de futebo
l são parâmetros fisiológicos de grande importância, pois permitem ampliar suas 
aplicações práticas, qualificando, controlando e desenvolvendo de modo mais adeq
uado e objetivo o treinamento físico dessas atletas.#^dnd^i1#^tm^lpt^kLimiares v
entilatórios^i1#^tm^lpt^kConsumo de oxigênio de pico^i1#^tm^lpt^kFutebolistas fe
mininas^i1#^tm^lpt^kMedicina esportiva^i1#^len^aThirty-seven female soccer playe
rs aged 21.5 ± 5.9, weight 57.0 ± 8.3 kg, height 161 ± 7 cm and body mass index 
21.8 ± 2.1 kg/m<sup>2</sup> were submitted to spirometric and metabolic evaluati
on by a computerized analysis system of expired gases (model Vmax 29c, <i>Sensor
Medics</i>, EUA). Cardiovascular response was recorded by means of a computerize
d ECG (model 6.4, <i>HeartWare</i>, BRA). Maximum physical capacity was evaluate
d by a treadmill test (model <i>ATL 10.100, Inbramed</i>, BRA), using incrementa
l continuous protocol. The parameters and results were: in ventilatory threshold
 1 (VT<sub>1</sub>): VO<sub>2</sub> = 30.5 ± 3.7 ml O<sub>2</sub>.kg<sup>-1</sup
>.min<sup>-1</sup>; %VO<sub>2</sub> = 64 ± 7%; running velocity = 8.1 ± 0.3 km.h
<sup>-1</sup>; HR = 154 ± 9 bpm; in ventilatory threshold 2 (VT<sub>2</sub>): VO
<sub>2</sub> = 40.9 ± 4.5 ml O<sub>2</sub>.kg<sup>-1</sup>.min<sup>-1</sup>; %VO
<sub>2</sub> = 85.7 ± 4.9%; running velocity = 11.4 ± 1.1 km.h<sup>-1</sup>; HR 
= 179 ± 7 bpm. The peak VO<sub>2</sub> was 47.4 ± 4.1 ml O<sub>2</sub>. kg<sup>-
1</sup>.min<sup>-1</sup>. In conclusion, the ventilatory thresholds and the aero
bic power verified in female soccer players are physiological parameters of grea
t importance, as they make it possible to enlarge their practical application, q
ualifying, controlling and developing the physical training of such athletes in 
a more practical and objective manner.#^dnd^i2#^tm^len^kVentilatory thresholds^i
2#^tm^len^kPeak oxygen uptake^i2#^tm^len^kFemale soccer players^i2#^tm^len^kSpor
ts medicine^i2#professor de língua inglesa Humberto Blancato#other#33#v5n4a03.ht
m##
04435000000000661000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670640013000690710003000820400003000850010
00600088042000200094120000400096038000400100121000300104049000800107158000300115
03000240011803100020014203200020014406500090014601400110015503500100016601201240
01760120107003000100034004070100023004410100028004640100026004920100031005180100
03000549010003200579010003300611010003000644010002900674083139400703085000802097
08500350210508500400214008500350218008500310221508312350224608500080348108500350
34890850031035240850034035550850028035890580046036171170006036630720003036690020
01203672008008903684#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#l#4#1#
article#1#^mago.^a1999#oa#pt#br1.1#1#4.0#tab#03#RBME180#nd#Rev. bras. med. espor
te#5#4#19990800#^f132^l137#1517-8692#Perfil de limiares ventilatórios durante o 
exercício e o consumo de oxigênio de pico verificado em jogadoras de futebol^lpt
#Ventilatory threshold profile during exercise and peak oxygen uptake verified i
n female soccer players^len#^rND^nPaulo Roberto Santos^sSilva#^rND^nAdilson^sAnd
rade#^rND^nWilson Oliveira^sRiça#^rND^nAna Maria^sVisconti#^rND^nFernando Miele 
da^sPonte#^rND^nAlbertina Fontana^sRosa#^rND^nSolange Basílio da^sCosta#^rND^nCa
rla Dal Maso Nunes^sRoxo#^rND^nGilberto Silva^sMachado#^rND^nJorge Mendes de^sSo
usa#^lpt^aForam avaliadas 37 jogadoras de futebol, com média de idade de 21,5 ± 
5,9 anos, peso de 57,0 ± 8,3kg, estatura de 161 ± 7cm e índice de massa corpórea
 de 21,8 ± 2,1kg/m². Todas as atletas foram submetidas à avaliação espirométrica
 e metabólica, por meio de um sistema computadorizado de análise de gases expira
dos (modelo Vmax 29c, SensorMedics, EUA). A resposta cardiovascular foi verifica
da por meio de um eletrocardiógrafo computadorizado (modelo 6.4, HeartWare, BRA)
. A capacidade física máxima foi avaliada por meio de teste de esforço realizado
 em esteira rolante (modelo ATL-10.100, Inbramed, BRA) utilizando-se protocolo e
scalonado contínuo. Os seguintes parâmetros e os resultados encontrados foram: n
o limiar ventilatório 1 (LV1): VO2 = 30,5 ± 3,7ml O2.kg-1.min-1;  por cento VO2 
= 64 ± 7 por cento; velocidade de corrida = 8,1 ± 0,3km.h-1; FC = 154 ± 9bpm. No
 limiar ventilatório 2 (LV2): VO2 = 40,9 ± 4,5ml O2.kg-1.min-1;  por cento VO2 =
 85,7 ± 4,9 por cento; velocidade de corrida = 11,4 ± 1,1km.h-1; FC = 179 ± 7bpm
. O VO2 de pico foi de 47,4 ± 4,1ml O2.kg-1.min-1. CONCLUSÃO: A verificação de l
imiares ventilatórios e a potência aeróbia em jogadoras de futebol são parâmetro
s fisiológicos de grande importância, pois permitem ampliar suas aplicações prát
icas, qualificando, controlando e desenvolvendo de modo mais adequado e objetivo
 o treinamento físico dessas atletas.#^dnd^i1#^tm^lpt^kLimiares ventilatórios^i1
#^tm^lpt^kConsumo de oxigênio de pico^i1#^tm^lpt^kFutebolistas femininas^i1#^tm^
lpt^kMedicina esportiva^i1#^len^aThirty-seven female soccer players aged 21.5 ± 
5.9, weight 57.0 ± 8.3 kg, height 161 ± 7 cm and body mass index 21.8 ± 2.1 kg/m
² were submitted to spirometric and metabolic evaluation by a computerized analy
sis system of expired gases (model Vmax 29c, SensorMedics, EUA). Cardiovascular 
response was recorded by means of a computerized ECG (model 6.4, HeartWare, BRA)
. Maximum physical capacity was evaluated by a treadmill test (model ATL 10.100,
 Inbramed, BRA), using incremental continuous protocol. The parameters and resul
ts were: in ventilatory threshold 1 (VT1): VO2 = 30.5 ± 3.7 ml O2.kg-1.min-1;  p
ercentVO2 = 64 ± 7 percent; running velocity = 8.1 ± 0.3 km.h-1; HR = 154 ± 9 bp
m; in ventilatory threshold 2 (VT2): VO2 = 40.9 ± 4.5 ml O2.kg-1.min-1;  percent
VO2 = 85.7 ± 4.9 percent; running velocity = 11.4 ± 1.1 km.h-1; HR = 179 ± 7 bpm
. The peak VO2 was 47.4 ± 4.1 ml O2. kg-1.min-1. In conclusion, the ventilatory 
thresholds and the aerobic power verified in female soccer players are physiolog
ical parameters of great importance, as they make it possible to enlarge their p
ractical application, qualifying, controlling and developing the physical traini
ng of such athletes in a more practical and objective manner.#^dnd^i2#^tm^len^kV
entilatory thresholds^i2#^tm^len^kPeak oxygen uptake^i2#^tm^len^kFemale soccer p
layers^i2#^tm^len^kSports medicine^i2#professor de língua inglesa Humberto Blanc
ato#other#33#v5n4a03.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_ar
ttext&pid=S1517-86921999000400003##
00316000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704008700071002001200158#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#5#1#article#176#<P align="right"><font f
ace="Verdana" size="2"><b>ARTIGO ORIGINAL </b></font>      ^cY#v5n4a03.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704002200071002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#6#2#article#176#<p>&nbsp;</p>     ^cY#v5
n4a03.htm##
00454000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704022500071002001200296#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#7#3#article#176#<P><font face="Verdana" 
size="4"><b><a name="topo"></a>Perfil de limiares ventilat&oacute;rios    durant
e o exerc&iacute;cio e o consumo de oxig&ecirc;nio de pico verificado    em joga
doras de futebol </b></font></p>     ^cY#v5n4a03.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704002200071002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#8#4#article#176#<p>&nbsp;</p>     ^cY#v5
n4a03.htm##
00394000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704016500071002001200236#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#9#5#article#176#<P><font face="Verdana" 
size="3"><b>Ventilatory threshold profile during exercise    and peak oxygen upt
ake verified in female soccer players</b></font></p>     ^cY#v5n4a03.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704002200072002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#10#6#article#176#<p>&nbsp;</p>     ^cY#v
5n4a03.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704002200072002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#11#7#article#176#<p>&nbsp;</p>     ^cY#v
5n4a03.htm##
00683000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704045300072002001200525#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#12#8#article#176#<P><font face="Verdana"
 size="2"><b>Paulo Roberto Santos Silva<SUP>I</SUP>; Adilson    Andrade<sup>II</
sup>; Wilson Oliveira Ri&ccedil;a<sup>III</sup>; Ana Maria Visconti<sup>IV</sup>
;    Fernando Miele da Ponte<SUP>V</SUP>; Albertina Fontana Rosa<SUP>VI</SUP>; S
olange    Bas&iacute;lio da Costa<SUP>VI</SUP>; Carla Dal Maso Nunes Roxo<SUP>VI
I</SUP>;    Gilberto Silva Machado<SUP>VII</SUP>; Jorge Mendes de Sousa<SUP>VIII
</SUP></b></font></p>     ^cY#v5n4a03.htm##
00431000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704020100072002001200273#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#13#9#article#176#<P><font face="Verdana"
 size="2">Se&ccedil;&atilde;o de Fisiologia do Centro de    Medicina Integrada d
a Associa&ccedil;&atilde;o Portuguesa de Desportos, SP,    Brasil <sup>I</sup>Fi
siologista    ^cY#v5n4a03.htm##
00269000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003800073002001200111#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#14#10#article#176#<br>   <sup>II</sup>Fi
sicultor    ^cY#v5n4a03.htm##
00294000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704006300073002001200136#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#15#11#article#176#<br>   <sup>III</sup>T
&eacute;cnico de Futebol Feminino    ^cY#v5n4a03.htm##
00273000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704004200073002001200115#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#16#12#article#176#<br>   <sup>IV</sup>Cl
&iacute;nico    ^cY#v5n4a03.htm##
00269000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003800073002001200111#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#17#13#article#176#<br>   <sup>V</sup>Ort
opedista    ^cY#v5n4a03.htm##
00272000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704004100073002001200114#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#18#14#article#176#<br>   <sup>VI</sup>Od
ontologista    ^cY#v5n4a03.htm##
00274000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704004300073002001200116#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#19#15#article#176#<br>   <sup>VII</sup>F
isioterapeuta    ^cY#v5n4a03.htm##
00356000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704012500073002001200198#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#20#16#article#176#<br>   <sup>VIII</sup>
Vice-Presidente de Medicina da Associa&ccedil;&atilde;o Portuguesa    de Desport
os </font></p>     ^cY#v5n4a03.htm##
00346000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704011500073002001200188#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#21#17#article#176#<p><font face="Verdana
" size="2"><a href="#send">Endere&ccedil;o para correspond&ecirc;ncia</a></font>
</p>     ^cY#v5n4a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#22#18#article#176#<p>&nbsp;</p>     ^cY#
v5n4a03.htm##
00275000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704004400073002001200117#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#23#19#article#176#<p>&nbsp;</p> <hr size
="1" noshade>     ^cY#v5n4a03.htm##
00297000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704006600073002001200139#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#24#20#article#176#<P><font face="Verdana
" size="2"><B>RESUMO</B></font></p>     ^cY#v5n4a03.htm##
01817000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704158600073002001201659#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#25#21#article#176#<P><font face="Verdana
" size="2">Foram avaliadas 37 jogadoras de futebol, com    m&eacute;dia de idade
 de 21,5 &#177; 5,9 anos, peso de 57,0 &#177; 8,3kg, estatura    de 161 &#177; 7
cm e &iacute;ndice de massa corp&oacute;rea de 21,8 &#177; 2,1kg/m<SUP>2</SUP>. 
   Todas as atletas foram submetidas &agrave; avalia&ccedil;&atilde;o espirom&ea
cute;trica    e metab&oacute;lica, por meio de um sistema computadorizado de an&
aacute;lise    de gases expirados (modelo Vmax 29c, <I>SensorMedics</I>, EUA). A
 resposta cardiovascular    foi verificada por meio de um eletrocardi&oacute;gra
fo computadorizado (modelo    6.4, <I>HeartWare</I>, BRA). A capacidade f&iacute
;sica m&aacute;xima foi avaliada    por meio de teste de esfor&ccedil;o realizad
o em esteira rolante (modelo <I>ATL-10.100,    Inbramed</I>, BRA) utilizando-se 
protocolo escalonado cont&iacute;nuo. Os seguintes    par&acirc;metros e os resu
ltados encontrados foram: no limiar ventilat&oacute;rio    1 (LV<SUB>1</SUB>): V
O<SUB>2</SUB> = 30,5 &#177; 3,7ml O<SUB>2</SUB>.kg<SUP>&#150;1</SUP>.min<SUP>&#1
50;1</SUP>;    % VO<SUB>2</SUB> = 64 &#177; 7%; velocidade de corrida = 8,1 &#17
7; 0,3km.h<SUP>&#150;1</SUP>;    FC = 154 &#177; 9bpm. No limiar ventilat&oacute
;rio 2 (LV<SUB>2</SUB>): VO<SUB>2</SUB>    = 40,9 &#177; 4,5ml O<SUB>2</SUB>.kg<
SUP>&#150;1</SUP>.min<SUP>&#150;1</SUP>;    % VO<SUB>2</SUB> = 85,7 &#177; 4,9%;
 velocidade de corrida = 11,4 &#177; 1,1km.h<SUP>&#150;1</SUP>;    FC = 179 &#17
7; 7bpm. O VO<SUB>2</SUB> de pico foi de 47,4 &#177; 4,1ml O<SUB>2</SUB>.kg<SUP>
&#150;1</SUP>.min<SUP>&#150;1</SUP>.    ^cY#v5n4a03.htm##
00682000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704045100073002001200524#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#26#22#article#176#<br>   <B>CONCLUS&Atil
de;O:</B> A verifica&ccedil;&atilde;o de limiares ventilat&oacute;rios    e a po
t&ecirc;ncia aer&oacute;bia em jogadoras de futebol s&atilde;o par&acirc;metros 
   fisiol&oacute;gicos de grande import&acirc;ncia, pois permitem ampliar suas  
  aplica&ccedil;&otilde;es pr&aacute;ticas, qualificando, controlando e desenvol
vendo    de modo mais adequado e objetivo o treinamento f&iacute;sico dessas atl
etas.    </font></p>     ^cY#v5n4a03.htm##
00445000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704021400073002001200287#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#27#23#article#176#<P><font face="Verdana
" size="2"><B>Palavras-chave:</B> Limiares ventilat&oacute;rios.    Consumo de o
xig&ecirc;nio de pico. Futebolistas femininas. Medicina esportiva.    </font></p
> <hr size="1" noshade>     ^cY#v5n4a03.htm##
00299000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704006800073002001200141#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#28#24#article#176#<P><font face="Verdana
" size="2"><B>ABSTRACT</B></font></p>     ^cY#v5n4a03.htm##
01873000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704164200073002001201715#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#29#25#article#176#<P><font face="Verdana
" size="2">Thirty-seven female soccer players aged 21.5    &#177; 5.9, weight 57
.0 &#177; 8.3 kg, height 161 &#177; 7 cm and body mass    index 21.8 &#177; 2.1 
kg/m<SUP>2</SUP> were submitted to spirometric and metabolic    evaluation by a 
computerized analysis system of expired gases (model Vmax 29c,    <i>SensorMedic
s</i>, EUA). Cardiovascular response was recorded by means of    a computerized 
ECG (model 6.4, <i>HeartWare</I>, BRA). Maximum physical capacity    was evaluat
ed by a treadmill test (model <I>ATL 10.100, Inbramed</I>, BRA),    using increm
ental continuous protocol. The parameters and results were: in ventilatory    th
reshold 1 (VT<SUB>1</SUB>): VO<SUB>2</SUB> = 30.5 &#177; 3.7 ml O<SUB>2</SUB>.kg
<SUP>&#150;1</SUP>.min<SUP>&#150;1</SUP>;    %VO<SUB>2</SUB> = 64 &#177; 7%; run
ning velocity = 8.1 &#177; 0.3 km.h<SUP>&#150;1</SUP>;    HR = 154 &#177; 9 bpm;
 in ventilatory threshold 2 (VT<SUB>2</SUB>): VO<SUB>2</SUB>    = 40.9 &#177; 4.
5 ml O<SUB>2</SUB>.kg<SUP>&#150;1</SUP>.min<SUP>&#150;1</SUP>;    %VO<SUB>2</SUB
> = 85.7 &#177; 4.9%; running velocity = 11.4 &#177; 1.1 km.h<SUP>&#150;1</SUP>;
    HR = 179 &#177; 7 bpm. The peak VO<SUB>2</SUB> was 47.4 &#177; 4.1 ml O<SUB>
2</SUB>.    kg<SUP>&#150;1</SUP>.min<SUP>&#150;1</SUP>. In conclusion, the venti
latory thresholds    and the aerobic power verified in female soccer players are
 physiological parameters    of great importance, as they make it possible to en
large their practical application,    qualifying, controlling and developing the
 physical training of such athletes    in a more practical and objective manner.
</font></p>     ^cY#v5n4a03.htm##
00410000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704017900073002001200252#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#30#26#article#176#<P><font face="Verdana
" size="2"><b>Key words:</b> Ventilatory thresholds. Peak    oxygen uptake. Fema
le soccer players. Sports medicine.</font></p> <hr size="1" noshade>     ^cY#v5n
4a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#31#27#article#176#<p>&nbsp;</p>     ^cY#
v5n4a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#32#28#article#176#<p>&nbsp;</p>     ^cY#
v5n4a03.htm##
00317000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704008600073002001200159#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#33#29#article#176#<P><font face="Verdana
" size="3"><B>INTRODU&Ccedil;&Atilde;O</B> </font> </p>     ^cY#v5n4a03.htm##
00574000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704034300073002001200416#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#34#30#article#176#<P><font face="Verdana
" size="2">O futebol feminino para o mundo ainda n&atilde;o    &eacute; uma real
idade. Tradicionalmente, ele tem sido praticado por homens,    o que de certo mo
do tem inibido a coragem de muitas mulheres, pois ainda h&aacute;    um clima de
 hostilidade por muitos, principalmente do sexo masculino. </font>  </p>     ^cY
#v5n4a03.htm##
00506000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704027500073002001200348#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#35#31#article#176#<P><font face="Verdana
" size="2">Apesar das dificuldades, a hist&oacute;ria relata    que, desde 1900,
 as mulheres j&aacute; jogavam futebol na Inglaterra. Em 1993,    a Liga Naciona
l Inglesa tinha 11.000 jogadoras registradas com mais de 24 equipes.    </font> 
</p>     ^cY#v5n4a03.htm##
00442000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704021100073002001200284#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#36#32#article#176#<P><font face="Verdana
" size="2">Em 1988, no Jap&atilde;o, 9.647 futebolistas    foram inscritas na As
socia&ccedil;&atilde;o Japonesa de Futebol, com um total    de 470 equipes<SUP>1
</SUP>. </font> </p>     ^cY#v5n4a03.htm##
00598000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704036700073002001200440#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#37#33#article#176#<P><font face="Verdana
" size="2">Para promover o <I>status</I> dessa modalidade    praticada por mulhe
res, a <I>F&eacute;d&eacute;ration Internationale de Football    Association</I>
 (FIFA), &oacute;rg&atilde;o m&aacute;ximo e organizador desse    esporte, reali
zou o primeiro campeonato mundial em 1991, nos Estados Unidos    da Am&eacute;ri
ca. </font> </p>     ^cY#v5n4a03.htm##
00639000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704040800073002001200481#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#38#34#article#176#<P><font face="Verdana
" size="2">No Brasil o futebol feminino vem crescendo em    import&acirc;ncia, n
&uacute;mero de praticantes e desenvolvimento cient&iacute;fico.    Entretanto, 
h&aacute; ainda escassez muito grande de publica&ccedil;&otilde;es    sobre par&
acirc;metros fisiol&oacute;gicos verificados em jogadoras de futebol    no exter
ior e, principalmente, em nosso pa&iacute;s. </font> </p>     ^cY#v5n4a03.htm##
00631000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704040000073002001200473#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#39#35#article#176#<P><font face="Verdana
" size="2">Sabe-se que limiares ventilat&oacute;rios e a    pot&ecirc;ncia aer&o
acute;bia s&atilde;o par&acirc;metros fisiol&oacute;gicos    considerados import
antes preditores para definir a aptid&atilde;o de um indiv&iacute;duo    para to
lerar exerc&iacute;cio de intensidade subm&aacute;xima e de longa dura&ccedil;&a
tilde;o,    como &eacute; o futebol. </font> </p>     ^cY#v5n4a03.htm##
00534000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704030300073002001200376#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#40#36#article#176#<P><font face="Verdana
" size="2">Portanto, a verifica&ccedil;&atilde;o peri&oacute;dica    desses &iac
ute;ndices funcionais, al&eacute;m de controlar melhor a intensidade    do trein
amento, permite desenvolver de maneira mais precisa o objetivo-alvo    a ser ati
ngido pelos atletas. </font></p>     ^cY#v5n4a03.htm##
00547000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704031600073002001200389#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#41#37#article#176#<P><font face="Verdana
" size="2">O prop&oacute;sito do presente estudo foi mostrar    o perfil dos lim
iares ventilat&oacute;rios e o consumo de oxig&ecirc;nio de    pico, verificados
 em jogadoras de futebol, participantes de equipes que disputam    os campeonato
s oficiais em nosso pa&iacute;s. </font> </p>     ^cY#v5n4a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#42#38#article#176#<P>&nbsp;</P>     ^cY#
v5n4a03.htm##
00317000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704008600073002001200159#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#43#39#article#176#<P><font face="Verdana
" size="3"><B>MATERIAL E M&Eacute;TODOS</B></font> </p>     ^cY#v5n4a03.htm##
01097000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704086600073002001200939#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#44#40#article#176#<P><font face="Verdana
" size="2">Foram avaliadas 37 jogadoras de futebol, com    m&eacute;dia de idade
 de 21,5 &#177; 5,9 anos (14-34), peso de 57,0 &#177; 8,3kg    (45-79), estatura
 de 161 &#177; 7cm (146-179), &iacute;ndice de massa corp&oacute;rea    (IMC) de
 21,8 &#177; 2,1kg.m<SUP>2</SUP> (18,8-27,3). Suas caracter&iacute;sticas    car
diovasculares em repouso est&atilde;o listadas na <a href="/img/revistas/rbme/v5
n4/a03tab01.gif">tabela    1</a>. As condi&ccedil;&otilde;es meteorol&oacute;gic
as durante as realiza&ccedil;&otilde;es    dos testes foram as seguintes: temper
atura ambiente de 19,2 &#177; 1,6&#176;C    (16-22), press&atilde;o barom&eacute
;trica de 706,7 &#177; 2,7mmHg (703-710)    e umidade relativa percentual do ar 
de 66,6 &#177; 10,5% (45-76) &#91;<a href="/img/revistas/rbme/v5n4/a03tab01.gif"
>tabela    1</a>&#93;. </font> </p>     ^cY#v5n4a03.htm##
00989000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704075800073002001200831#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#45#41#article#176#<P><font face="Verdana
" size="2">Previamente &agrave; avalia&ccedil;&atilde;o    ergom&eacute;trica, t
odas as atletas foram submetidas a eletrocardiograma (ECG),    (modelo 6.4, <I>H
eart-Ware</I>, BRA) em repouso e durante teste de esfor&ccedil;o    por meio da 
monitora&ccedil;&atilde;o de 12 deriva&ccedil;&otilde;es, segundo    posi&ccedil
;&atilde;o preconizada por Mason &amp; Likar, com modifica&ccedil;&atilde;o    d
a deriva&ccedil;&atilde;o (D<SUB>1</SUB> para MC<SUB>5</SUB>) e registradas    p
or impressora a jato de tinta (modelo 680c, <I>HP DeskJet</I>). A press&atilde;o
    arterial (PA) foi medida por m&eacute;todo auscultat&oacute;rio indireto, ut
ilizando-se    esfigmoman&ocirc;metro aner&oacute;ide (<I>Tycos</I>, EUA). </fon
t> </p>     ^cY#v5n4a03.htm##
00872000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704064100073002001200714#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#46#42#article#176#<P><font face="Verdana
" size="2">A ventila&ccedil;&atilde;o pulmonar (V<SUB>E</SUB>    <SUB>BTPS</SUB>
), o consumo de oxig&ecirc;nio (VO<SUB>2 STPD</SUB>), a produ&ccedil;&atilde;o  
  de di&oacute;xido de carbono (VCO<SUB>2</SUB> <SUB>STPD</SUB>) e a raz&atilde;
o    de troca respirat&oacute;ria (RER) foram calculados a partir de valores med
idos    por um sistema computadorizado de an&aacute;lise de troca gasosa (respir
a&ccedil;&atilde;o-a-respira&ccedil;&atilde;o)    (modelo Vmax 29c, <I>SensorMed
ics</I>, EUA). O volume ventilat&oacute;rio foi    medido por um sensor de fluxo
 de massa (<I>SensorMedics</I>, EUA). </font> </p>     ^cY#v5n4a03.htm##
00879000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704064800073002001200721#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#47#43#article#176#<P><font face="Verdana
" size="2">A calibra&ccedil;&atilde;o foi feita antes da    realiza&ccedil;&atil
de;o de cada teste com uma seringa de tr&ecirc;s litros,    para ser empregado f
ator de corre&ccedil;&atilde;o que determinar&aacute; o    volume respirat&oacut
e;rio. As fra&ccedil;&otilde;es expiradas de oxig&ecirc;nio    (F<SUB>E</SUB>O<S
UB>2</SUB>) foram medidas por um sensor paramagn&eacute;tico    de resposta r&aa
cute;pida e elevada precis&atilde;o (<I>SensorMedics</I>, EUA)    e as fra&ccedi
l;&otilde;es expiradas de di&oacute;xido de carbono (F<SUB>E</SUB>CO<SUB>2</SUB>
)    pelo princ&iacute;pio do infravermelho. </font> </p>     ^cY#v5n4a03.htm##
00720000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704048900073002001200562#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#48#44#article#176#<P><font face="Verdana
" size="2">A calibra&ccedil;&atilde;o dos analisadores do    equipamento foi fei
ta antes e imediatamente ap&oacute;s a realiza&ccedil;&atilde;o    de cada teste
 com mistura gasosa conhecida de O<SUB>2</SUB> (12% e 26%), CO<SUB>2</SUB>    (4
%) e balanceada com nitrog&ecirc;nio (N<SUB>2</SUB>). As vari&aacute;veis    ven
tilat&oacute;rias foram registradas instantaneamente e posteriormente calculadas
    para o tempo m&eacute;dio de 10 segundos. </font> </p>     ^cY#v5n4a03.htm##
00663000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704043200073002001200505#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#49#45#article#176#<P><font face="Verdana
" size="2">A determina&ccedil;&atilde;o da capacidade f&iacute;sica    m&aacute;
xima foi verificada realizando-se um teste de esfor&ccedil;o em esteira    rolan
te (modelo ATL-10.100, <I>Inbramed</I>, BRA) de velocidade (km.h<SUP>&#150;1</SU
P>)    e inclina&ccedil;&atilde;o (%) vari&aacute;veis, utilizando-se protocolo 
escalonado    cont&iacute;nuo e inclina&ccedil;&atilde;o fixa de 3%. </font> </p
>     ^cY#v5n4a03.htm##
01003000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704077200073002001200845#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#50#46#article#176#<P><font face="Verdana
" size="2">Nesse protocolo, a atleta ficou dois minutos    em repouso, foi aquec
ida por quatro minutos nas velocidades de 4, 5, 6 e 7km.h<SUP>&#150;1    </SUP>d
urante um minuto em cada velocidade. Posteriormente, iniciou-se o teste    com 8
km.h<SUP>&#150;1</SUP> e incrementos de 1km.h<SUP>&#150;1</SUP> a cada    dois m
inutos at&eacute; a exaust&atilde;o da atleta. A fase de recupera&ccedil;&atilde
;o    durou quatro minutos e foi realizada com velocidades controladas a 60, 50,
 40    e 30% da velocidade m&aacute;xima atingida pela atleta no teste. A percep
&ccedil;&atilde;o    subjetiva ao esfor&ccedil;o foi verificada em cada est&aacu
te;gio do teste pela    escala linear gradual de 15 pontos (6 a 20) de Borg<SUP>
2</SUP>. </font> </p>     ^cY#v5n4a03.htm##
01255000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704102400073002001201097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#51#47#article#176#<P><font face="Verdana
" size="2">Os limiares ventilat&oacute;rios 1 (LV<SUB>1</SUB>)    e 2 (LV<SUB>2<
/SUB>) foram determinados, utilizando-se os seguintes crit&eacute;rios:    LV<SU
B>1</SUB> &#150; 1&#186;) menor valor do equivalente ventilat&oacute;rio    de o
xig&ecirc;nio (V<SUB>E</SUB>.VO<SUB>2</SUB><SUP>&#150;1</SUP>) e 2&#186;)    men
or valor da fra&ccedil;&atilde;o expirada de oxig&ecirc;nio (F<SUB>E</SUB>O<SUB>
2</SUB>),    ambos seguidos de inflex&atilde;o e crescimento ao longo do teste. 
LV<SUB>2</SUB>    &#150; 1&#186;) menor valor do equivalente ventilat&oacute;rio
 de di&oacute;xido    de carbono (V<SUB>E</SUB>.VCO<SUB>2</SUB><SUP>&#150;1</SUP
>) seguido de inflex&atilde;o    e incremento posterior e 2&#186;) maior valor d
a fra&ccedil;&atilde;o expirada    de di&oacute;xido de carbono (F<SUB>E</SUB>CO
<SUB>2</SUB>) seguido de diminui&ccedil;&atilde;o    at&eacute; o final do teste
. Ambos os limiares foram verificados em exerc&iacute;cio    de intensidade prog
ressiva<SUP>3</SUP>. </font> </p>     ^cY#v5n4a03.htm##
00488000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704025700073002001200330#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#52#48#article#176#<P><font face="Verdana
" size="2">A an&aacute;lise dos dados foi realizada calculando-se    a m&eacute;
dia, o desvio-padr&atilde;o e as varia&ccedil;&otilde;es m&iacute;nima    e m&aa
cute;xima dos par&acirc;metros avaliados<SUP>4</SUP>. </font> </p>     ^cY#v5n4a
03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#53#49#article#176#<P>&nbsp;</P>     ^cY#
v5n4a03.htm##
00303000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007200073002001200145#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#54#50#article#176#<P><font face="Verdana
" size="3"><B>RESULTADOS</B> </font> </p>     ^cY#v5n4a03.htm##
00452000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704022100073002001200294#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#55#51#article#176#<P><font face="Verdana
" size="2">Os resultados deste estudo est&atilde;o listados    nas <a href="/img
/revistas/rbme/v5n4/a03tab01.gif">tabelas 1</a>, <a href="#tab2">2</a>    e <a h
ref="#tab3">3</a>. </font></p>     ^cY#v5n4a03.htm##
00266000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003500073002001200108#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#56#52#article#176#<P><a name="tab2"></a>
</p>     ^cY#v5n4a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#57#53#article#176#<P>&nbsp;</p>     ^cY#
v5n4a03.htm##
00310000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007900073002001200152#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#58#54#article#176#<P align="center"><img
 src="/img/revistas/rbme/v5n4/a03tab02.gif"></p>     ^cY#v5n4a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#59#55#article#176#<P>&nbsp;</p>     ^cY#
v5n4a03.htm##
00267000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003600073002001200109#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#60#56#article#176#<P><a name="tab3"></a>
 </p>     ^cY#v5n4a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#61#57#article#176#<P>&nbsp;</p>     ^cY#
v5n4a03.htm##
00310000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007900073002001200152#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#62#58#article#176#<P align="center"><img
 src="/img/revistas/rbme/v5n4/a03tab03.gif"></P>     ^cY#v5n4a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#63#59#article#176#<P>&nbsp;</P>     ^cY#
v5n4a03.htm##
00309000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007800073002001200151#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#64#60#article#176#<P><font face="Verdana
" size="3"><B>DISCUSS&Atilde;O</B> </font> </p>     ^cY#v5n4a03.htm##
00592000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704036100073002001200434#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#65#61#article#176#<P><font face="Verdana
" size="2">Desde o aparecimento na literatura especializada    do termo limiar a
naer&oacute;bio, verificado por t&eacute;cnica n&atilde;o-invasiva    (an&aacute
;lise de gases expirados) em 1964 e que foi nomeado por Wasserman    &amp; McIlr
oy<SUP>5</SUP>, ele sofreu uma s&eacute;rie de modifica&ccedil;&otilde;es.    </
font> </p>     ^cY#v5n4a03.htm##
00691000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704046000073002001200533#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#66#62#article#176#<P><font face="Verdana
" size="2">Contudo, ele tem sido aceito e considerado por    diversos pesquisado
res como um dos par&acirc;metros-chave para definir a capacidade    de um indiv&
iacute;duo tolerar exerc&iacute;cio de intensidade subm&aacute;xima.    Entretan
to, ele tamb&eacute;m tem sido motivo de controv&eacute;rsia em v&aacute;rios   
 aspectos, como: origem, conceito, terminologia e crit&eacute;rios de detec&cced
il;&atilde;o.    </font> </p>     ^cY#v5n4a03.htm##
00834000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704060300073002001200676#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#67#63#article#176#<P><font face="Verdana
" size="2">A tend&ecirc;ncia mais recente da literatura    fisiol&oacute;gica no
rte-americana &eacute; a utiliza&ccedil;&atilde;o do termo    limiar anaer&oacut
e;bio. Al&eacute;m disso, a grande maioria das publica&ccedil;&otilde;es    refe
re-se apenas a um limiar, ou seja, o primeiro limiar ou limiar ventilat&oacute;r
io    1 (LV<SUB>1</SUB>), chamado pelos norte-americanos de limiar anaer&oacute;
bio<SUP>6</SUP>.    Ao contr&aacute;rio, os europeus geralmente preocupam-se com
 o segundo limiar,    ou seja, o limiar ventilat&oacute;rio 2 (LV<SUB>2</SUB>). 
</font> </p>     ^cY#v5n4a03.htm##
00707000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704047600073002001200549#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#68#64#article#176#<P><font face="Verdana
" size="2">Contudo, a orienta&ccedil;&atilde;o de Hughes    <I>et al.</I>, citad
os por Gomes<SUP>7</SUP>, sugere que, quando o limiar anaer&oacute;bio    for de
terminado por medidas de gases expirados, o termo limiar ventilat&oacute;rio    
deve ser o preferido. Portanto, optamos pela denomina&ccedil;&atilde;o de LV<SUB
>1</SUB>    e LV<SUB>2</SUB>, terminologia utilizada por Bhambhani &amp; Singh, 
do Canad&aacute;<SUP>3</SUP>.    </font> </p>     ^cY#v5n4a03.htm##
00559000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704032800073002001200401#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#69#65#article#176#<P><font face="Verdana
" size="2">&Eacute; importante lembrar que, em atletas,    o mais importante del
es para o desenvolvimento mais acentuado de sua aptid&atilde;o    aer&oacute;bia
 &eacute; treinar pr&oacute;ximo do LV<SUB>2</SUB>, pois a efici&ecirc;ncia    m
etab&oacute;lica neste ponto &eacute; maior. </font> </p>     ^cY#v5n4a03.htm##
00720000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704048900073002001200562#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#70#66#article#176#<P><font face="Verdana
" size="2">A determina&ccedil;&atilde;o dos limiares ventilat&oacute;rios    tem
 importante aplica&ccedil;&atilde;o pr&aacute;tica no controle da intensidade   
 e na avalia&ccedil;&atilde;o dos efeitos do treinamento. O consenso atual demon
stra    que um determinado par&acirc;metro fisiol&oacute;gico isolado n&atilde;o
 contribui    adequadamente para a compreens&atilde;o dos mecanismos que interfe
rem no rendimento    f&iacute;sico do atleta. </font> </p>     ^cY#v5n4a03.htm##
00567000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704033600073002001200409#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#71#67#article#176#<P><font face="Verdana
" size="2">Acredita-se que a detec&ccedil;&atilde;o de fases    metab&oacute;lic
as distintas ocorridas nos limiares ventilat&oacute;rios pode    identificar alt
era&ccedil;&otilde;es fisiol&oacute;gicas que expliquem a capacidade    para tol
erar o exerc&iacute;cio subm&aacute;ximo prolongado. </font> </p>     ^cY#v5n4a0
3.htm##
00723000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704049200073002001200565#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#72#68#article#176#<P><font face="Verdana
" size="2">Portanto, a detec&ccedil;&atilde;o desses momentos    metab&oacute;li
cos &eacute; importante em qualquer atividade de longa dura&ccedil;&atilde;o,   
 como &eacute; o futebol. Al&eacute;m disso, o referencial e a divis&atilde;o   
 dos limiares possibilitam o conhecimento de fases metab&oacute;licas distintas 
   e com elas a possibilidade de determinar a intensidade de trabalho f&iacute;s
ico    mais adequada para o objetivo pretendido. </font> </p>     ^cY#v5n4a03.ht
m##
00965000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704073400073002001200807#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#73#69#article#176#<P><font face="Verdana
" size="2">Assim, as caracter&iacute;sticas metab&oacute;licas    verificadas no
 LV<SUB>1</SUB> s&atilde;o provenientes basicamente de atividade    f&iacute;sic
a realizada em baixa intensidade. Em nosso estudo, as futebolistas    atingiram 
esse instante metab&oacute;lico numa intensidade m&eacute;dia de 64%    do consu
mo de oxig&ecirc;nio de pico (VO<SUB>2</SUB>pico) e com uma percep&ccedil;&atild
e;o    subjetiva de cansa&ccedil;o, segundo escala de Borg, atingindo valor 9 (f
&aacute;cil).    A m&eacute;dia de resposta da freq&uuml;&ecirc;ncia card&iacute
;aca (FC) atingida    no LV<SUB>1</SUB> foi de 156bpm, o que correspondeu a 81% 
da FC m&aacute;xima    atingida no final do teste. </font> </p>     ^cY#v5n4a03.
htm##
00588000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704035700073002001200430#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#74#70#article#176#<P><font face="Verdana
" size="2">O LV<SUB>1</SUB> ocorre numa intensidade de exerc&iacute;cio    na qu
al o n&iacute;vel de &aacute;cido l&aacute;tico no sangue aumenta acima    dos v
alores de repouso. Entretanto, nessa intensidade n&atilde;o se verifica    dimin
ui&ccedil;&atilde;o significante do pH sangu&iacute;neo<SUP>8,9</SUP>.    </font
> </p>     ^cY#v5n4a03.htm##
00594000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704036300073002001200436#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#75#71#article#176#<P><font face="Verdana
" size="2">Para eventos fisiol&oacute;gicos ocorridos nessa    intensidade de ex
erc&iacute;cio, a percentagem do consumo de oxig&ecirc;nio    de pico verificada
 no LV<SUB>1</SUB> ficou levemente acima da faixa de varia&ccedil;&atilde;o    d
o modelo hipot&eacute;tico proposto por Skinner &amp; McLellan<SUP>10</SUP>.    
</font> </p>     ^cY#v5n4a03.htm##
00725000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704049400073002001200567#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#76#72#article#176#<P><font face="Verdana
" size="2">Exerc&iacute;cio realizado nessa intensidade    estimula pouco a prod
u&ccedil;&atilde;o e o ac&uacute;mulo de &aacute;cido l&aacute;tico    no m&uacu
te;sculo, pois tem participa&ccedil;&atilde;o predominante das fibras    muscula
res do tipo I (oxidativas) ou de contra&ccedil;&atilde;o lenta (vermelhas)    e 
que t&ecirc;m grande afinidade pelo oxig&ecirc;nio, pois s&atilde;o cercadas    
por maior n&uacute;mero de capilares<SUP>11</SUP>. </font> </p>     ^cY#v5n4a03.
htm##
00580000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704034900073002001200422#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#77#73#article#176#<P><font face="Verdana
" size="2">Jorfeldt<SUP>12</SUP> sugere que as fibras do    tipo I, acionadas em
 exerc&iacute;cio de baixa intensidade, continuamente extraem    e oxidam o &aac
ute;cido l&aacute;tico do sangue proveniente das fibras do tipo    IIb (brancas)
 que possuem elevado teor glicol&iacute;tico anaer&oacute;bio.    </font> </p>  
   ^cY#v5n4a03.htm##
00825000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704059400073002001200667#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#78#74#article#176#<P><font face="Verdana
" size="2">Atividade f&iacute;sica realizada utilizando-se    a intensidade do e
xerc&iacute;cio no LV<SUB>1</SUB> &eacute; de grande utilidade    no desenvolvim
ento da capilariza&ccedil;&atilde;o muscular ap&oacute;s exerc&iacute;cios    in
tensos, como em jogos e/ou treinamentos, em indiv&iacute;duos que est&atilde;o  
  retornando de les&otilde;es musculares e que foram afastados de suas atividade
s    por um longo per&iacute;odo de tempo e/ou em indiv&iacute;duos sedent&aacut
e;rios    que querem iniciar um programa de treinamento f&iacute;sico. </font> <
/p>     ^cY#v5n4a03.htm##
00646000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704041500073002001200488#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#79#75#article#176#<P><font face="Verdana
" size="2">Dessa forma, a resposta metab&oacute;lica e ventilat&oacute;ria    ao
 exerc&iacute;cio em intensidade at&eacute; o LV<SUB>1</SUB>, medida pela    con
centra&ccedil;&atilde;o de &aacute;cido l&aacute;tico sangu&iacute;neo, varia   
 pouco em rela&ccedil;&atilde;o ao repouso, enquanto a ventila&ccedil;&atilde;o 
   se mant&eacute;m est&aacute;vel<SUP>13-15</SUP>. </font> </p>     ^cY#v5n4a03
.htm##
00509000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704027800073002001200351#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#80#76#article#176#<P><font face="Verdana
" size="2">Portanto, em futebolistas, o referencial de intensidade    do exerc&i
acute;cio realizado no LV<SUB>1</SUB> &eacute; de grande valor pr&aacute;tico   
 para o fisicultor, que pode utiliz&aacute;-lo de v&aacute;rias maneiras. </font
>  </p>     ^cY#v5n4a03.htm##
01034000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704080300073002001200876#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#81#77#article#176#<P><font face="Verdana
" size="2">Ao contr&aacute;rio, as respostas metab&oacute;licas    e ventilat&oa
cute;rias verificadas em intensidade acima do LV<SUB>2</SUB> s&atilde;o    mais 
exacerbadas do que as verificadas no LV<SUB>1</SUB>. Ao atingir e ultrapassar   
 essa fase, o exerc&iacute;cio f&iacute;sico &eacute; considerado de intensidade
    moderada e intensa, pois ocorre aumento na concentra&ccedil;&atilde;o de &aa
cute;cido    l&aacute;tico significantemente acima dos valores verificados no LV
<SUB>1</SUB>.    As fibras musculares do tipo I aer&oacute;bias e a participa&cc
edil;&atilde;o    das fibras do tipo IIa e IIb de padr&atilde;o glicol&iacute;ti
co misto e anaer&oacute;bio,    respectivamente, estimulam o aumento de &aacute;
cido l&aacute;tico sangu&iacute;neo.    </font> </p>     ^cY#v5n4a03.htm##
00867000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704063600073002001200709#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#82#78#article#176#<P><font face="Verdana
" size="2">Nesse segundo instante metab&oacute;lico, a resposta    ventilat&oacu
te;ria &eacute; aumentada progressivamente, como tentativa de compensar    a aci
dose metab&oacute;lica. Al&eacute;m deste momento, a capacidade tamp&atilde;o   
 do m&uacute;sculo &eacute; excedida e ocorre maior produ&ccedil;&atilde;o e    
ac&uacute;mulo de &aacute;cido l&aacute;tico sangu&iacute;neo. A partir da&iacut
e;,    se o exerc&iacute;cio for mantido nessa condi&ccedil;&atilde;o fisiol&oac
ute;gica,    por um longo per&iacute;odo de tempo, o atleta ser&aacute; acometid
o de fadiga    muscular intensa. </font> </p>     ^cY#v5n4a03.htm##
00507000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704027600073002001200349#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#83#79#article#176#<P><font face="Verdana
" size="2">Portanto, o LV<SUB>2</SUB> representa a intensidade    de esfor&ccedi
l;o acima da qual, durante um exerc&iacute;cio de carga crescente,    ocorre ac&
uacute;mulo de &aacute;cido l&aacute;tico no sangue e fadiga precoce.    </font>
 </p>     ^cY#v5n4a03.htm##
00726000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704049500073002001200568#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#84#80#article#176#<P><font face="Verdana
" size="2">No presente estudo, as atletas atingiram o LV<SUB>2</SUB>    a 86% do
 VO<SUB>2</SUB>pico, com m&eacute;dia de velocidade de 11,4km.h<SUP>&#150;1</SUP
>.    A m&eacute;dia de resposta da FC verificada foi de 179bpm, o que correspon
deu    a 93% da FC m&aacute;xima atingida ao final do teste e a percep&ccedil;&a
tilde;o    subjetiva de cansa&ccedil;o, medida pela escala de Borg, atingiu o va
lor m&eacute;dio    de 13 (ligeiramente cansativo). </font> </p>     ^cY#v5n4a03
.htm##
00865000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704063400073002001200707#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#85#81#article#176#<P><font face="Verdana
" size="2">Um LV<SUB>2</SUB> elevado, ou seja, uma fra&ccedil;&atilde;o    eleva
da do VO<SUB>2</SUB>pico sem que haja ac&uacute;mulo progressivo de &aacute;cido
    l&aacute;tico no sangue, tem importantes implica&ccedil;&otilde;es funcionai
s.    Basicamente, o atleta est&aacute; melhor preparado para realizar atividade
s    energ&eacute;ticas de maior intensidade por per&iacute;odos de tempo mais p
rolongados.    Conseq&uuml;entemente, &eacute;, sem d&uacute;vida, uma vantagem 
utilizar uma    percentagem alta de seu VO<SUB>2</SUB>pico sem entrar em acidose
 metab&oacute;lica    precoce. </font> </p>     ^cY#v5n4a03.htm##
00559000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704032800073002001200401#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#86#82#article#176#<P><font face="Verdana
" size="2">&Eacute; importante salientar que, em atletas,    o LV<SUB>2</SUB> &e
acute; fundamental quando se objetiva potencializar sua condi&ccedil;&atilde;o  
  aer&oacute;bia, pois o exerc&iacute;cio realizado nessa intensidade apresenta 
   maior efici&ecirc;ncia metab&oacute;lica. </font> </p>     ^cY#v5n4a03.htm##
00705000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704047400073002001200547#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#87#83#article#176#<P><font face="Verdana
" size="2">Os resultados demonstraram que a variabilidade    dos limiares ventil
at&oacute;rios pode ocorrer em diferentes percentagens do    VO<SUB>2</SUB>pico 
para atletas com valor semelhante dessa vari&aacute;vel<SUP>16,17</SUP>.    Port
anto, o exerc&iacute;cio realizado a uma determinada intensidade pode representa
r    graus variados de acidose metab&oacute;lica em atletas com n&iacute;veis de
    aptid&atilde;o diferentes. </font> </p>     ^cY#v5n4a03.htm##
00482000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704025100073002001200324#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#88#84#article#176#<P><font face="Verdana
" size="2">Essa condi&ccedil;&atilde;o pode ser uma fonte    de varia&ccedil;&at
ilde;o importante em determinar a capacidade de um indiv&iacute;duo    tolerar e
xerc&iacute;cio de longa dura&ccedil;&atilde;o. </font> </p>     ^cY#v5n4a03.htm
##
00548000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704031700073002001200390#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#89#85#article#176#<P><font face="Verdana
" size="2">Outro aspecto que valoriza esse &iacute;ndice    fisiol&oacute;gico e
m atletas &eacute; que eles se exercitam mais pr&oacute;ximos    do LV<SUB>2</SU
B> do que no LV<SUB>1</SUB>, assemelhando-se ao esfor&ccedil;o    realizado dura
nte as competi&ccedil;&otilde;es. </font> </p>     ^cY#v5n4a03.htm##
00582000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704035100073002001200424#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#90#86#article#176#<P><font face="Verdana
" size="2">Outra importante qualidade f&iacute;sica e o    seu desenvolvimento &
eacute; a pot&ecirc;ncia aer&oacute;bia em futebolistas.    Sabidamente, a solic
ita&ccedil;&atilde;o f&iacute;sica desse esporte &eacute;    caracterizada por e
xerc&iacute;cios intermitentes e de longa dura&ccedil;&atilde;o.    </font> </p>
     ^cY#v5n4a03.htm##
00824000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704059300073002001200666#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#91#87#article#176#<P><font face="Verdana
" size="2">Tradicionalmente, a pot&ecirc;ncia aer&oacute;bia    &eacute; conheci
da como VO<SUB>2</SUB>max. ou VO<SUB>2</SUB> pico e tem sido    aceita como um d
os par&acirc;metros fisiol&oacute;gicos, junto com LV<SUB>2</SUB>    e a economi
a de corrida, como os melhores indicadores da capacidade para o exerc&iacute;cio
    prolongado<SUP>18-20</SUP>. Entretanto, alguns estudos<SUP>21-23</SUP> demon
straram    que em indiv&iacute;duos saud&aacute;veis as diferen&ccedil;as gen&ea
cute;ticas    contribuem, significativamente, para sua variabilidade. </font> </
p>     ^cY#v5n4a03.htm##
00418000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704018700073002001200260#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#92#88#article#176#<P><font face="Verdana
" size="2">Portanto, a modifica&ccedil;&atilde;o dessa vari&aacute;vel    metab&
oacute;lica, pelo treinamento, tem um limite biol&oacute;gico. </font>  </p>    
 ^cY#v5n4a03.htm##
00890000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704065900073002001200732#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#93#89#article#176#<P><font face="Verdana
" size="2">S&atilde;o poucos os estudos que relatam valores    de VO<SUB>2</SUB>
max. ou VO<SUB>2</SUB>pico em jogadoras de futebol. Recentemente,    nosso labor
at&oacute;rio de fisiologia do exerc&iacute;cio publicou um estudo    relatando 
valor m&eacute;dio de 47,3 &#177; 4,5ml O<SUB>2</SUB>.kg<SUP>&#150;1</SUP>.min<S
UP>&#150;1</SUP>,    encontrado em um grupo de jogadoras que se sagraram campe&a
tilde;s do II Campeonato    Paulista de Futebol, em 1998<SUP>24</SUP>. Entretant
o, h&aacute; escassez significativa    de estudos no futebol feminino, enfocando
 esse e outros par&acirc;metros fisiol&oacute;gicos.    </font> </p>     ^cY#v5n
4a03.htm##
00690000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704045900073002001200532#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#94#90#article#176#<P><font face="Verdana
" size="2">Rhodes &amp; Mosher<SUP>25</SUP> verificaram,    em 12 jogadoras univ
ersit&aacute;rias canadenses de elite, valor m&eacute;dio    de 47,1ml O<SUB>2</
SUB>.kg<SUP>&#150;1</SUP>. min<SUP>&#150;1</SUP>. Resultado    semelhante foi en
contrado por Evangelista <I>et al.</I><SUP>26</SUP>, que verificaram    em futeb
olistas italianas valor de 49,75ml O<SUB>2</SUB>.kg<SUP>&#150;1</SUP>.min<SUP>&#
150;1</SUP>.    </font> </p>     ^cY#v5n4a03.htm##
00753000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704052200073002001200595#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#95#91#article#176#<P><font face="Verdana
" size="2">Contudo, Jensen &amp; Larsson<SUP>27</SUP> avaliaram    jogadoras da 
sele&ccedil;&atilde;o dinamarquesa e verificaram valor inicial    levemente supe
rior ao dos estudos acima citados, com valor m&eacute;dio de 53,3ml    O<SUB>2</
SUB>.kg<SUP>&#150;1</SUP>.min<SUP>&#150;1</SUP>. Ap&oacute;s 15 semanas    de tr
einamento, as mesmas atletas foram reavaliadas e o valor aumentou para    57,6ml
 O<SUB>2</SUB>. kg<SUP>&#150;1</SUP>.min<SUP>&#150;1</SUP>, um ganho de    8%. <
/font> </p>     ^cY#v5n4a03.htm##
00933000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704070200073002001200775#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#96#92#article#176#<P><font face="Verdana
" size="2">A import&acirc;ncia de elevada pot&ecirc;ncia    aer&oacute;bia est&a
acute; relacionada com v&aacute;rios aspectos. Alguns estudos<SUP>28-31</SUP>   
 verificaram que n&iacute;veis elevados de consumo de oxig&ecirc;nio exercem    
papel importante na recupera&ccedil;&atilde;o mais r&aacute;pida da energia    p
roveniente do sistema fosfag&ecirc;nio (ATP-CP), respons&aacute;vel por consider
&aacute;vel    fornecimento de energia durante per&iacute;odos de alta intensida
de, como tamb&eacute;m    atua na remo&ccedil;&atilde;o mais eficiente do lactat
o em momentos de repouso    ativo e/ou diminui&ccedil;&atilde;o da intensidade d
o exerc&iacute;cio. </font></p>     ^cY#v5n4a03.htm##
00652000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704042100073002001200494#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#97#93#article#176#<P><font face="Verdana
" size="2">Jacobs <I>et al.</I><SUP>32</SUP> afirmam que    futebolistas masculi
nos, com pot&ecirc;ncia aer&oacute;bia bem desenvolvida,    produzem menos lacta
to em qualquer intensidade de exerc&iacute;cio. O mesmo    pensamento pode ser d
irecionado para as jogadoras de futebol, pois o que determina    essa resposta f
isiol&oacute;gica &eacute; o metabolismo aer&oacute;bio. </font>  </p>     ^cY#v
5n4a03.htm##
00814000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704058300073002001200656#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#98#94#article#176#<P><font face="Verdana
" size="2">&Eacute; importante salientar que a m&eacute;dia    de dist&acirc;nci
a atingida ao final de uma partida, por jogadoras de futebol,    &eacute; por vo
lta de 8.500m<SUP>33</SUP>. Al&eacute;m disso, elas realizam    mais de 100 movi
mentos de <I>sprint</I> e sustentam uma resposta de freq&uuml;&ecirc;ncia    car
d&iacute;aca (FC) superior a 85% da FC m&aacute;xima predita para a idade,    po
r aproximadamente dois ter&ccedil;os do jogo e mantendo intensidade relativa    
ao redor de 70% do consumo m&aacute;ximo de oxig&ecirc;nio. </font> </p>     ^cY
#v5n4a03.htm##
00497000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704026600073002001200339#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#99#95#article#176#<P><font face="Verdana
" size="2">Portanto, a pot&ecirc;ncia aer&oacute;bia &eacute;    uma das qualida
de mais importantes a serem desenvolvidas em futebolistas femininas    com o obj
etivo de suportar a longa dura&ccedil;&atilde;o das partidas. </font>  </p>     
^cY#v5n4a03.htm##
00698000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704046600074002001200540#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#100#96#article#176#<P><font face="Verdan
a" size="2">Concluindo, a verifica&ccedil;&atilde;o de limiares    ventilat&oacu
te;rios e a pot&ecirc;ncia aer&oacute;bia em jogadoras de futebol    s&atilde;o 
par&acirc;metros fisiol&oacute;gicos de grande import&acirc;ncia,    pois permit
em expandir suas aplica&ccedil;&otilde;es pr&aacute;ticas, qualificando,    cont
rolando e desenvolvendo de modo mais adequado e objetivo o treinamento f&iacute;
sico    dessas atletas. </font> </p>     ^cY#v5n4a03.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704002200074002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#101#97#article#176#<P>&nbsp;</P>     ^cY
#v5n4a03.htm##
00308000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704007600074002001200150#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#102#98#article#176#<P><font face="Verdan
a" size="3"><B>AGRADECIMENTOS</B> </font> </p>     ^cY#v5n4a03.htm##
00419000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704018700074002001200261#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#103#99#article#176#<P><font face="Verdan
a" size="2">Agradecemos ao professor de l&iacute;ngua inglesa    Humberto Blanca
to pela corre&ccedil;&atilde;o gramatical do <I>Abstract</I>.    </font> </p>   
  ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#104#100#article#176#<P>&nbsp;</P>     ^c
Y#v5n4a03.htm##
00312000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704007900075002001200154#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#105#101#article#176#<P><font face="Verda
na" size="3"><B>REFER&Ecirc;NCIAS</B> </font> </p>     ^cY#v5n4a03.htm##
00530000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704028300077002001200360#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#106#102#article#176#1#<P><fo
nt face="Verdana" size="2">1. Kohno T, O'Hata N, Shirahata T, Hisatomi N,    End
o Y. Physical characteristics of Japan women's national team soccer players.    
Abstract PJ11. FIMS Proceedings of World Congress of Sports Medicine. Amsterdam,
    May, 27-June 1, 1990:195.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#107#103#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00385000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704013800077002001200215#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#108#104#article#176#2#<P><fo
nt face="Verdana" size="2">2. Borg G. Perceived exertion as an indicator    of s
omatic stress. Scan J Rehab Med 1970;2:92-6.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#109#105#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00396000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704014900077002001200226#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#110#106#article#176#3#<P><fo
nt face="Verdana" size="2">3. Bhambhani Y, Singh M. Ventilatory thresholds    du
ring a graded exercise test. Respiration 1985;47:120-8.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#111#107#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00366000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704011900077002001200196#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#112#108#article#176#4#<P><fo
nt face="Verdana" size="2">4. Glantz SA. Primer of biostatistics. 3rd ed.    New
 York: McGraw-Hill, 1992.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#113#109#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00396000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704014900077002001200226#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#114#110#article#176#5#<P><fo
nt face="Verdana" size="2">5. Wasserman K, McIlroy MB. Detecting the threshold  
  of anaerobic metabolism. Am J Cardiol 1964;14:844-52.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#115#111#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00524000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704027700077002001200354#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#116#112#article#176#6#<P><fo
nt face="Verdana" size="2">6. Ribeiro JP. Simp&oacute;sio ABC &#150; Cardiologia
    do Esporte. Limiares metab&oacute;licos e ventilat&oacute;rios durante o exe
rc&iacute;cio.    Aspectos fisiol&oacute;gicos e metodol&oacute;gicos. Arq Bras 
Cardiol 1995;64:171-81.    ^cY#v5n4a03.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#117#113#article#176#    </font> </p>    
 ^cY#v5n4a03.htm##
00488000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704024100077002001200318#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#118#114#article#176#7#<P><fo
nt face="Verdana" size="2">7. Gomes PSC. Effects of continuous and intermittent 
   training on body composition and selected physiological parameters. A thesis 
   for the degree of doctor of philosophy. Edmonton, Alberta, 1989.    ^cY#v5n4a
03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#119#115#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00455000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704020800077002001200285#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#120#116#article#176#8#<P><fo
nt face="Verdana" size="2">8. Hagberg JM, Coyle EF, Carroll JE, Miller JM,    Ma
rtin WH, Brooke MH. Exercise hyperventilation in patients with McArdle's disease
.    J Appl Physiol 1982;52:991-4.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#121#117#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00451000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704020400077002001200281#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#122#118#article#176#9#<P><fo
nt face="Verdana" size="2">9. Reinhard U, Muller PH, Schmulling RM. Determinatio
n    of anaerobic threshold by the ventilation equivalent in normal individuals.
    Respiration 1979;38:36-42.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#123#119#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00407000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015900078002001200237#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#124#120#article#176#10#<P><f
ont face="Verdana" size="2">10. Skinner JS, McLellan TM. The transition from    
aerobic to anaerobic metabolism. Res Q Exerc Sport 1980;51:234-48.    ^cY#v5n4a0
3.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#125#121#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00537000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704028900078002001200367#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#126#122#article#176#11#<P><f
ont face="Verdana" size="2">11. Saltin B, Gollnick P. Skeletal muscle adaptabili
ty:    significance for metabolism and performance. In: Peache LD, Adrian R, Gei
ger    SR, editors. Handbook of physiology &#150; Skeletal muscle. Baltimore: Wi
lliams    and Wilkins, 1983:555-631.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#127#123#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00412000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016400078002001200242#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#128#124#article#176#12#<P><f
ont face="Verdana" size="2">12. Jorfeldt L. Metabolism of L (+) lactate in    hu
man skeletal muscle during exercise. Acta Physiol Scand 1970:Suppl 338.    ^cY#v
5n4a03.htm##
00256000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002300075002001200098#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#129#125#article#176# </font>  </p>     ^
cY#v5n4a03.htm##
00440000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019200078002001200270#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#130#126#article#176#13#<P><f
ont face="Verdana" size="2">13. Mader A, Liesen H, Heck H. Zur Berteilung    der
 sportartspezifischen Ausdauerleistungsfahigkeit in labor. Sportarzt Sportmedizi
n    1976;27: 80-6.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#131#127#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00517000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704026900078002001200347#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#132#128#article#176#14#<P><f
ont face="Verdana" size="2">14. Rusko H, Luhtanen P, Rahkila P, Viitasalo    J, 
Rehunen S, Harkonen M. Muscle metabolism, blood lactate and oxygen uptake    in 
steady state exercise at aerobic and anaerobic thresholds. Eur J Appl Physiol   
 1986; 55:181-6.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#133#129#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00466000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704021800078002001200296#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#134#130#article#176#15#<P><f
ont face="Verdana" size="2">15. Casaburi R, Barstow TJ, Robinson T, Wasserman   
 K. Dynamic and steady-state ventilatory and gas exchange responses to arm exerc
ise.    Med Sci Sports Exerc 1992;24:1365-74.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#135#131#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00483000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704023500078002001200313#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#136#132#article#176#16#<P><f
ont face="Verdana" size="2">16. Davis JA, Frank MH, Whipp BJ, Wasserman K.    An
aerobic threshold alterations caused by endurance training in middle-aged    men
. J Appl Physiol Respir Environ Exerc Physiol 1979;46:1039-46.    ^cY#v5n4a03.ht
m##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#137#133#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00430000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704018200078002001200260#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#138#134#article#176#17#<P><f
ont face="Verdana" size="2">17. McLellan TM, Skinner JS. Blood lactate removal  
  during active recovery related to the aerobic threshold. Int J Sports Med 1982
;3:224-9.    ^cY#v5n4a03.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#139#135#article#176#    </font> </p>    
 ^cY#v5n4a03.htm##
00439000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019100078002001200269#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#140#136#article#176#18#<P><f
ont face="Verdana" size="2">18. Conley DL, Krahenbuhl GS. Running economy    and
 distance running performance of highly trained athletes. Med Sci Sports    Exer
c 1980;12: 357-60.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#141#137#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00450000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704020200078002001200280#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#142#138#article#176#19#<P><f
ont face="Verdana" size="2">19. Joyner MJ. Physiological limiting factors    and
 distance running: influence of gender and age on record performance. Exerc    S
ports Sci Rev 1993;21:103-29.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#143#139#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00371000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704012300078002001200201#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#144#140#article#176#20#<P><f
ont face="Verdana" size="2">20. Holmer I. Maximum oxygen uptake in athletes.    
J Appl Physiol 1967; 23:353-8.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#145#141#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00406000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015800078002001200236#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#146#142#article#176#21#<P><f
ont face="Verdana" size="2">21. Klissouras V. Prediction of athletic performance
:    genetic considerations. Can J Appl Sport Sci 1976;1:195-200.    ^cY#v5n4a03
.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#147#143#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00379000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704013100078002001200209#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#148#144#article#176#22#<P><f
ont face="Verdana" size="2">22. Bouchard C, Lortier G. Heredity and endurance   
 performance. Sports Med 1984;1:38-64.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#149#145#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00434000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704018600078002001200264#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#150#146#article#176#23#<P><f
ont face="Verdana" size="2">23. Bouchard C, Lortier G, Lesage R. Aerobic    perf
ormance in brothers, dizygotic and monozygotic twins. Med Sci Sports Exerc    19
86;18:639-46.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#151#147#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00588000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704034000078002001200418#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#152#148#article#176#24#<P><f
ont face="Verdana" size="2">24. Silva PRS, Romano A, Andrade A, Ri&ccedil;a    W
O, Cordeiro JR, et al. Caracter&iacute;sticas fisiol&oacute;gicas m&uacute;sculo
-esquel&eacute;ticas,    antropom&eacute;tricas e oftalmol&oacute;gicas em jogad
oras de futebol feminino    consideradas de elite. Acta Fisi&aacute;trica 1997;5
:18-26.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#153#149#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00549000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704030100078002001200379#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#154#150#article#176#25#<P><f
ont face="Verdana" size="2">25. Rhodes EC, Mosher RE. Aerobic and anaerobic    c
haracteristics of elite female university soccer players. Communications to    t
he Second World Congress of Science and Football. Eindoven, Nederlands 22-25,   
 May, 1991. J Sports Sci (abstract) 1992;10:143.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#155#151#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00578000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704033000078002001200408#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#156#152#article#176#26#<P><f
ont face="Verdana" size="2">26. Evangelista M, Pandolfi O, Fanton F, Faina    M.
 A functional model of female soccer players: Analysis of functional characteris
tics.    Communications to the Second World Congress of Science and Football. Ei
ndoven,    Nederlands 22-25, May, 1991. J Sports Sci (abstract) 1992;10: 165.   
 ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#157#153#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00592000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704034400078002001200422#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#158#154#article#176#27#<P><f
ont face="Verdana" size="2">27. Jensen K, Larsson B. Variations in physical    c
apacity among the Danish national soccer team for women during a period of    su
pplemental training. Communications to the Second World Congress of Science    a
nd Football. Eindoven, Nederlands 22-25, May, 1991. J Sports Sci (abstract)    1
992;10:145.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#159#155#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00419000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017100078002001200249#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#160#156#article#176#28#<P><f
ont face="Verdana" size="2">28. Donovan CM, Brooks GA. Endurance training    aff
ects lactate clearance, not lactate production. Am J Physiol 1983;244:E83-E92.  
  ^cY#v5n4a03.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#161#157#article#176#    </font> </p>    
 ^cY#v5n4a03.htm##
00426000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017800078002001200256#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#162#158#article#176#29#<P><f
ont face="Verdana" size="2">29. Donovan CM, Pagliassotti MJ. Endurance training 
   enhances lactate clearance during hyperlactatemia. Am J Physiol 1989;257:E782
-E89.    ^cY#v5n4a03.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#163#159#article#176#    </font> </p>    
 ^cY#v5n4a03.htm##
00419000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017100078002001200249#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#164#160#article#176#30#<P><f
ont face="Verdana" size="2">30. Donovan CM, Pagliassotti MJ. Enhance efficiency 
   of lactate removal after endurance training. J Appl Physiol 1990;68:1053-8.  
  ^cY#v5n4a03.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#165#161#article#176#    </font> </p>    
 ^cY#v5n4a03.htm##
00465000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704021700078002001200295#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#166#162#article#176#31#<P><f
ont face="Verdana" size="2">31. MacRae HSH, Denis SC, Bosh NA, Noakes TD.    Eff
ects of training in lactate production and removal during progressive exercise  
  in humans. J Appl Physiol 1992;72:1649-56.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#167#163#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00444000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019600078002001200274#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#168#164#article#176#32#<P><f
ont face="Verdana" size="2">32. Jacobs I, Westlin N, Karlsson J, Rasmousson    M
, Houghton B. Muscle glycogen and diet in elite soccer players. Eur J Appl    Ph
ysiol 1982;48: 297-302.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#169#165#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00374000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704012600078002001200204#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#p#170#166#article#176#33#<P><f
ont face="Verdana" size="2">33. Brewer J. Nutritional aspects of women's    socc
er. J Sports Sci 1994; 12:S35-S8.    ^cY#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#171#167#article#176# </font> </p>     ^c
Y#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#172#168#article#176#<P>&nbsp;</p>     ^c
Y#v5n4a03.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#173#169#article#176#<P>&nbsp;</p>     ^c
Y#v5n4a03.htm##
00417000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704018400075002001200259#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#174#170#article#176#<P><font face="Verda
na" size="2"><b><a name="send"></a><a href="#topo"><img src="/img/revistas/rbme/
v5n4/seta.gif" border="0"></a>    Endere&ccedil;o para correspond&ecirc;ncia    
^cY#v5n4a03.htm##
00279000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704004600075002001200121#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#175#171#article#176#<br>   </b>Paulo Rob
erto Santos Silva     ^cY#v5n4a03.htm##
00318000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704008500075002001200160#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#176#172#article#176#<br>   Centro de Med
icina Integrada &#150; Se&ccedil;&atilde;o de Fisiologia     ^cY#v5n4a03.htm##
00303000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704007000075002001200145#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#177#173#article#176#<br>   Rua Comendado
r Nestor Pereira, 33 &#150; Canind&eacute;    ^cY#v5n4a03.htm##
00285000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704005200075002001200127#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#178#174#article#176#<BR>   03034-070 &#1
50; S&atilde;o Paulo, SP    ^cY#v5n4a03.htm##
00282000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704004900075002001200124#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#179#175#article#176#<BR>   Tel. (011) 33
15-0400 &#150; R. 228    ^cY#v5n4a03.htm##
00279000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704004600075002001200121#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a03.htm#S#p#180#176#article#176#<BR>   Fax (011) 228
-2001 </font></p>     ^cY#v5n4a03.htm##
00652000000000289000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160015000740160016000890160
01900105016001800124016001400142018007500156053005700231056001300288055001200301
054002400313020000400337865000900341002001200350#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a03.htm#S#c#181#1#article#33#1#^rND^sKohno^nT#^rND^sO'Hata^nN#^rND^s
Shirahata^nT#^rND^sHisatomi^nN#^rND^sEndo^nY#Physical characteristics of Japan w
omen's national team soccer players^len#FIMS Proceedings of World Congress of Sp
orts Medicine^i1#Amsterdam^i1#19900601^i1#May, 27-June 1, 1990^i1#195#19990800#v
5n4a03.htm##
00461000000000253000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100015000740120057000890300
01700146710000200163065000900165064000500174031000200179014000500181865000900186
002001200195#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#c#182#2#articl
e#33#2#^rND^sBorg^nG.#Perceived exertion as an indicator of somatic stress^len#S
can J Rehab Med#2#19700000#1970#2#92-6#19990800#v5n4a03.htm##
00522000000000277000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100019000740100016000930120
05700109030001200166065000900178064000500187031000300192014000600195865000900201
002001200210035001000222801001200232#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a03.htm#S#c#183#3#article#33#3#^rND^sBhambhani^nY#^rND^sSingh^nM.#Ventilatory th
resholds during a graded exercise test^len#Respiration#19850000#1985#47#120-8#19
990800#v5n4a03.htm#0025-7931#Respiration##
00420000000000241000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160018000740180028000920630
00200120066000900122062001200131065000900143064000500152865000900157002001200166
#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#c#184#4#article#33#4#^rND^
sGlantz^nSA.#Primer of biostatistics^len#3#New York#McGraw-Hill#19920000#1992#19
990800#v5n4a03.htm##
00523000000000277000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100019000740100019000930120
05200112030001300164065000900177064000500186031000300191014000700194865000900201
002001200210035001000222801001300232#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a03.htm#S#c#185#5#article#33#5#^rND^sWasserman^nK#^rND^sMcIlroy^nMB.#Detecting t
he threshold of anaerobic metabolism^len#Am J Cardiol#19640000#1964#14#844-52#19
990800#v5n4a03.htm#0002-9149#Am J Cardiol##
00587000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100019000740120139000930300
01700232065000900249064000500258031000300263014000700266865000900273002001200282
035001000294801001700304#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#c#
186#6#article#33#6#^rND^sRibeiro^nJP.#Simpósio ABC - Cardiologia do Esporte. Lim
iares metabólicos e ventilatórios durante o exercício. Aspectos fisiológicos e m
etodológicos^lpt#Arq Bras Cardiol#19950000#1995#64#171-81#19990800#v5n4a03.htm#0
066-782X#Arq Bras Cardiol##
00482000000000229000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160017000740180110000910510
00700201046000900208045000900217044000500226865000900231002001200240#v5n4#V:\Sci
ELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#c#187#7#article#33#7#^rND^sGomes^nPSC#
Effects of continuous and intermittent training on body composition and selected
 physiological parameters^len#doctor#Edmonton#19890000#1989#19990800#v5n4a03.htm
##
00565000000000289000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100018000740100016000920100
01800108012006500126030001500191065000900206064000500215031000300220014000600223
865000900229002001200238035001000250801001500260#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a03.htm#S#c#188#8#article#33#8#^rND^sHagberg^nJM#^rND^sCoyle^nEF#^rN
D^sCarroll^nJE#Exercise hyperventilation in patients with McArdle's disease^len#
J Appl Physiol#19820000#1982#52#991-4#19990800#v5n4a03.htm#0021-8987#J Appl Phys
iol##
00592000000000289000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100018000740100017000920100
02200109012009300131030001200224065000900236064000500245031000300250014000600253
865000900259002001200268035001000280801001200290#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a03.htm#S#c#189#9#article#33#9#^rND^sReinhard^nU#^rND^sMuller^nPH#^r
ND^sSchmulling^nRM.#Determination of anaerobic threshold by the ventilation equi
valent in normal individuals^len#Respiration#19790000#1979#38#36-42#19990800#v5n
4a03.htm#0025-7931#Respiration##
00539000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100020000940120
05600114030001800170065000900188064000500197031000300202014000700205865000900212
002001200221035001000233801001800243#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a03.htm#S#c#190#10#article#33#10#^rND^sSkinner^nJS#^rND^sMcLellan^nTM.#The trans
ition from aerobic to anaerobic metabolism^len#Res Q Exerc Sport#19800000#1980#5
1#234-48#19990800#v5n4a03.htm#0270-1367#Res Q Exerc Sport##
00660000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100019000920120
07800111016001700189016001600206016001700222018004500239066001000284062002100294
065000900315064000500324014000800329865000900337002001200346#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a03.htm#S#c#191#11#article#33#11#^rND^sSaltin^nB#^rND^sG
ollnick^nP.#Skeletal muscle adaptability: significance for metabolism and perfor
mance^len#^rED^sPeache^nLD#^rED^sAdrian^nR#^rED^sGeiger^nSR#Handbook of physiolo
gy - Skeletal muscle^len#Baltimore#Williams and Wilkins#19830000#1983#555-631#19
990800#v5n4a03.htm##
00529000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760120073000950300
01900168065000900187064000500196032000800201020000400209865000900213002001200222
035001000234801001900244#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#c#
192#12#article#33#12#^rND^sJorfeldt^nL.#Metabolism of L (+) lactate in human ske
letal muscle during exercise^len#Acta Physiol Scand#19700000#1970#^sSuppl#338#19
990800#v5n4a03.htm#0001-6772#Acta Physiol Scand##
00548000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100015000760100016000910100
01500107012008000122030002300202710000200225065000900227064000500236031000300241
014000500244865000900249002001200258#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a03.htm#S#c#193#13#article#33#13#^rND^sMader^nA#^rND^sLiesen^nH#^rND^sHeck^nH.#Z
ur Berteilung der sportartspezifischen Ausdauerleistungsfahigkeit in labor^len#S
portarzt Sportmedizin#2#19760000#1976#27#80-6#19990800#v5n4a03.htm##
00715000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100015000760100018000910100
01700109010001900126010001700145010001900162012011600181030001900297065000900316
06400050032503100030033001400060033386500090033900200120034803500100036080100190
0370#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#c#194#14#article#33#14
#^rND^sRusko^nH#^rND^sLuhtanen^nP#^rND^sRahkila^nP#^rND^sViitasalo^nJ#^rND^sRehu
nen^nS#^rND^sHarkonen^nM.#Muscle metabolism, blood lactate and oxygen uptake in 
steady state exercise at aerobic and anaerobic thresholds^len#Eur J Appl Physiol
#19860000#1986#55#181-6#19990800#v5n4a03.htm#0301-5548#Eur J Appl Physiol##
00634000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100018000940100
01800112010002000130012008400150030002100234065000900255064000500264031000300269
014000800272865000900280002001200289035001000301801002100311#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a03.htm#S#c#195#15#article#33#15#^rND^sCasaburi^nR#^rND^
sBarstow^nTJ#^rND^sRobinson^nT#^rND^sWasserman^nK.#Dynamic and steady-state vent
ilatory and gas exchange responses to arm exercise^len#Med Sci Sports Exerc#1992
0000#1992#24#1365-74#19990800#v5n4a03.htm#0195-9131#Med Sci Sports Exerc##
00610000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100016000920100
01600108010002000124012008400144030004400228710000200272065000900274064000500283
031000300288014000800291865000900299002001200308#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a03.htm#S#c#196#16#article#33#16#^rND^sDavis^nJA#^rND^sFrank^nMH#^rN
D^sWhipp^nBJ#^rND^sWasserman^nK.#Anaerobic threshold alterations caused by endur
ance training in middle-aged men^len#J Appl Physiol Respir Environ Exerc Physiol
#2#19790000#1979#46#1039-46#19990800#v5n4a03.htm##
00561000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100019000950120
08200114030001700196065000900213064000500222031000200227014000600229865000900235
002001200244035001000256801001700266#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a03.htm#S#c#197#17#article#33#17#^rND^sMcLellan^nTM#^rND^sSkinner^nJS.#Blood lac
tate removal during active recovery related to the aerobic threshold^len#Int J S
ports Med#19820000#1982#3#224-9#19990800#v5n4a03.htm#0172-4622#Int J sports Med#
#
00570000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100022000930120
08000115030002100195065000900216064000500225031000300230014000700233865000900240
002001200249035001000261801002100271#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a03.htm#S#c#198#18#article#33#18#^rND^sConley^nDL#^rND^sKrahenbuhl^nGS.#Running 
economy and distance running performance of highly trained athletes^len#Med Sci 
Sports Exerc#19800000#1980#12#357-60#19990800#v5n4a03.htm#0195-9131#Med Sci Spor
ts Exerc##
00523000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760120107000940300
02100201710000200222065000900224064000500233031000300238014000700241865000900248
002001200257#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#c#199#19#artic
le#33#19#^rND^sJoyner^nMJ.#Physiological limiting factors and distance running: 
influence of gender and age on record performance^len#Exerc Sports Sci Rev#2#199
30000#1993#21#103-29#19990800#v5n4a03.htm##
00481000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760120038000930300
01500131065000900146064000500155031000300160014000600163865000900169002001200178
035001000190801001500200#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#c#
200#20#article#33#20#^rND^sHolmer^nI.#Maximum oxygen uptake in athletes^len#J Ap
pl Physiol#19670000#1967#23#353-8#19990800#v5n4a03.htm#0021-8987#J Appl Physiol#
#
00523000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100021000760120063000970300
02100160065000900181064000500190031000200195014000800197865000900205002001200214
035001000226801002100236#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#c#
201#21#article#33#21#^rND^sKlissouras^nV.#Prediction of athletic performance: ge
netic considerations^len#Can J Appl Sport Sci#19760000#1976#1#195-200#19990800#v
5n4a03.htm#0700-3978#Can J Appl Sport Sci##
00504000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100018000940120
03900112030001100151065000900162064000500171031000200176014000600178865000900184
002001200193035001000205801001100215#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a03.htm#S#c#202#22#article#33#22#^rND^sBouchard^nC#^rND^sLortier^nG.#Heredity an
d endurance performance^len#Sports Med#19840000#1984#1#38-64#19990800#v5n4a03.ht
m#0112-1642#Sports Med##
00584000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100017000940100
01700111012006900128030002100197065000900218064000500227031000300232014000700235
865000900242002001200251035001000263801002100273#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a03.htm#S#c#203#23#article#33#23#^rND^sBouchard^nC#^rND^sLortier^nG#
^rND^sLesage^nR.#Aerobic performance in brothers, dizygotic and monozygotic twin
s^len#Med Sci Sports Exerc#19860000#1986#18#639-46#19990800#v5n4a03.htm#0195-913
1#Med Sci Sports Exerc##
00684000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100016000930100
01700109010001500126010001900141810000600160012014300166030001600309710000200325
065000900327064000500336031000200341014000600343865000900349002001200358#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#c#204#24#article#33#24#^rND^sSilva
^nPRS#^rND^sRomano^nA#^rND^sAndrade^nA#^rND^sRiça^nWO#^rND^sCordeiro^nJR#et al#C
aracterísticas fisiológicas músculo-esqueléticas, antropométricas e oftalmológic
as em jogadoras de futebol feminino consideradas de elite^lpt#Acta Fisiátrica#2#
19970000#1997#5#18-26#19990800#v5n4a03.htm##
00659000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100018000930120
19200111030001300303065000900316064000500325031000300330020000400333865000900337
002001200346035001000358801001300368#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a03.htm#S#c#205#25#article#33#25#^rND^sRhodes^nEC#^rND^sMosher^nRE.#Aerobic and 
anaerobic characteristics of elite female university soccer players. Communicati
ons to the Second World Congress of Science and Football. Eindoven, Nederlands 2
2-25, May, 1991^len#J Sports Sci#19920000#1992#10#143#19990800#v5n4a03.htm#0264-
0414#J Sports Sci##
00723000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100021000760100018000970100
01600115010001600131012019600147030001300343065000900356064000500365031000300370
020000400373865000900377002001200386035001000398801001300408#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a03.htm#S#c#206#26#article#33#26#^rND^sEvangelista^nM#^r
ND^sPandolfi^nO#^rND^sFanton^nF#^rND^sFaina^nM.#A functional model of female soc
cer players: Analysis of functional characteristics. Communications to the Secon
d World Congress of Science and Football. Eindoven, Nederlands 22-25, May, 1991^
len#J Sports Sci#19920000#1992#10#165#19990800#v5n4a03.htm#0264-0414#J Sports Sc
i##
00668000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100018000920120
23300110030001300343065000900356064000500365865000900370002001200379035001000391
801001300401#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#c#207#27#artic
le#33#27#^rND^sJensen^nK#^rND^sLarsson^nB.#Variations in physical capacity among
 the Danish national soccer team for women during a period of supplemental train
ing. Communications to the Second World Congress of Science and Football. Eindov
en, Nederlands 22-25, May, 1991^len#J Sports Sci#19920000#1992#19990800#v5n4a03.
htm#0264-0414#J Sports Sci##
00546000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100018000940120
07300112030001300185065000900198064000500207031000400212014000800216865000900224
002001200233035001000245801001300255#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a03.htm#S#c#208#28#article#33#28#^rND^sDonovan^nCM#^rND^sBrooks^nGA.#Endurance t
raining affects lactate clearance, not lactate production^len#Am J Physiol#19830
000#1983#244#E83-E92#19990800#v5n4a03.htm#0002-9513#Am J Physiol##
00553000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100024000940120
07300118030001300191065000900204064000500213031000400218014000900222865000900231
002001200240035001000252801001300262#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a03.htm#S#c#209#29#article#33#29#^rND^sDonovan^nCM#^rND^sPagliassotti^nMJ.#Endur
ance training enhances lactate clearance during hyperlactatemia^len#Am J Physiol
#19890000#1989#257#E782-E89#19990800#v5n4a03.htm#0002-9513#Am J Physiol##
00548000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100024000940120
06700118030001500185065000900200064000500209031000300214014000700217865000900224
002001200233035001000245801001500255#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a03.htm#S#c#210#30#article#33#30#^rND^sDonovan^nCM#^rND^sPagliassotti^nMJ.#Enhan
ce efficiency of lactate removal after endurance training^len#J Appl Physiol#199
00000#1990#68#1053-8#19990800#v5n4a03.htm#0021-8987#J Appl Physiol##
00627000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100016000940100
01500110010001800125012009600143030001500239065000900254064000500263031000300268
014000800271865000900279002001200288035001000300801001500310#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a03.htm#S#c#211#31#article#33#31#^rND^sMacRae^nHSH#^rND^
sDenis^nSC#^rND^sBosh^nNA#^rND^sNoakes^nTD.#Effects of training in lactate produ
ction and removal during progressive exercise in humans^len#J Appl Physiol#19820
000#1992#72#1649-56#19990800#v5n4a03.htm#0021-8987#J Appl Physiol##
00627000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100017000920100
01800109010002000127010001900147012005300166030001900219065000900238064000500247
031000300252014000800255865000900263002001200272035001000284801001900294#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#c#212#32#article#33#32#^rND^sJacob
s^nI#^rND^sWestlin^nN#^rND^sKarlsson^nJ#^rND^sRasmousson^nM#^rND^sHoughton^nB.#M
uscle glycogen and diet in elite soccer players^len#Eur J Appl Physiol#19820000#
1982#48#297-302#19990800#v5n4a03.htm#0301-5548#Eur J Appl Physiol##
00482000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760120042000930300
01300135065000900148064000500157031000300162014000700165865000900172002001200181
035001000193801001300203#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a03.htm#S#c#
213#33#article#33#33#^rND^sBrewer^nJ.#Nutritional aspects of women's soccer^len#
J Sports Sci#19940000#1994#12#S35-S8#19990800#v5n4a03.htm#0264-0414#J Sports Sci
##
00271000000000169000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670910009000690920007000780020012000857030
00400097#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#o#1#1#article#1#20
110405#115553#v5n4a04.htm#144##
04658000000000673000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000400087121000300091049000800094158000300102030002100105
03100020012603200020012806500090013001400110013903500100015001201690016001201710
03290100030005000100022005300100025005520100026005770100029006030100031006320100
03200663010003200695083145100727085000802178085003002186085003102216085002802247
08500320227508500190230708500210232608500310234708313600237808500080373808500300
37460850027037760850026038030850033038290850027038620850028038890580046039171170
00603963072000303969002001203972#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.
htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#TAB#04#RBME180#nd#Rev Bras Med Esporte#5
#4#19990800#^f138^l143#1517-8692#Estudo descritivo da resposta de acuidade visua
l sem correção e pressão intra-ocular computadorizada de não contato em jogadore
s de futebol amadores e profissionais^lpt#Descriptive study on visual acuity res
ponse without correction and computerized non-contact intraocular pressure in am
ateur and professional (football) soccer players^len#^rND^nEmídio Valenti^sTavar
es#^rND^nBenny^sApelbaum#^rND^nLysia K.^sYukisaki#^rND^nYeda Maria^sRabboni#^rND
^nSérgio Barreto^sMendes#^rND^nOdibulho Naves^sOliveira#^rND^nSantos Pedro^sTana
ganelli#^rND^nFrancisco Oliveira^sRocha#^lpt^aO principal objetivo deste estudo 
foi verificar as possíveis alterações de acuidade visual e pressão intra-ocular 
em jogadores de futebol. A clínica Oftalmos e Cirurgia Oftalmológica submeteu à 
avaliação oftalmológica 127 atletas futebolistas provenientes de várias categori
as, incluindo mulheres, com idades variando de 14 a 33 anos. Todos foram submeti
dos a testes de acuidade visual sem correção, utilizando-se a tabela de Snellen 
e avaliando-se a pressão intra-ocular de não contato com um tonômetro computador
izado (modelo TX-10, Canon, EUA). Além disso, os atletas foram submetidos a exam
e de auto-refração, no equipamento auto-refrator (modelo R-30, Canon, EUA). Os s
eguintes parâmetros utilizados e os resultados encontrados foram: dos 127 atleta
s avaliados, 56 (44%) apresentaram alterações de auto-refração, consideradas de 
grau mais ou menos importante em um ou ambos os olhos. No teste de acuidade visu
al, 3% e 2,4% dos atletas apresentaram, no OD e OE, somente 20/100 e 20/200 pés 
de visão, respectivamente. Em uma jogadora, foi constatada catarata puntata cong
ênita. Os resultados da tonometria mostraram, em 5 atletas de cor negra, quadro 
suspeito de glaucoma (necessitando investigação mais apurada).Concluindo, o estu
do comprovou a importância da oftalmologia como medida preventiva e/ou corretiva
 na identificação de possíveis alterações oftalmológicas em atletas futebolistas
, devendo ser uma prática rotineira nesse esporte.#^dnd^i1#^tm^lpt^kEstudo descr
itivo^i1#^tm^lpt^kJogador de futebol^i1#^tm^lpt^kAcuidade visual^i1#^tm^lpt^kres
são intra-ocular^i1#^tm^lpt^kHomens^i1#^tm^lpt^kMulheres^i1#^tm^lpt^kMedicina es
portiva^i1#^len^aThe main purpose of this study was to verify possible visual ac
uity alterations and intraocular pressure in soccer players. An ophthalmological
 evaluation in 127 soccer athletes belonging to various categories, including fe
male (ages ranging from 14 to 33), was carried out by the Ophthalmologic Clinic 
Oftalmos. The athletes were all submitted to visual acuity tests without correct
ion, using the Snellen chart and the non-contact intraocular pressure by means o
f computerized tonometer (TX-model, Canon , USA). They were also submitted to a 
self-refraction examination using a self refractor (R-30 model, Canon, USA). The
 parameters used and the results obtained were the following: 56 (44%) of the 12
7 athletes submitted to evaluation presented self-refractions considered fairly 
important in one or both eyes. In the visual acuity test 3% and 2.4% of the athl
etes presented in the right and left eye only 20/100 and 20/200 feet of sight, r
espectively. The presence of a congenital punctate cataract was found in a femal
e player. Tonometry results in five black athletes showed signs of glaucoma, whi
ch, however, will require more detailed investigation. In conclusion, the study 
confirmed the importance of ophthalmology as a preventive and/or corrective meas
ure in order to identify possible ophthalmological alterations in soccer-playing
 athletes.#^dnd^i2#^tm^len^kDescriptive study^i2#^tm^len^kSoccer players^i2#^tm^
len^kVisual acuity^i2#^tm^len^kIntraocular pressure^i2#^tm^len^kMales. Females^i
2#^tm^len^kSports medicine^i2#professor de língua inglesa Humberto Blancato#othe
r#16#v5n4a04.htm##
04714000000000673000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000400087121000300091049000800094158000300102030002100105
03100020012603200020012806500090013001400110013903500100015001201760016001201780
03360100030005140100022005440100025005660100026005910100029006170100031006460100
03200677010003200709083147900741085000802220085003002228085003102258085002802289
08500320231708500190234908500210236808500310238908313740242008500080379408500300
38020850027038320850026038590850033038850850027039180850028039450580046039731170
00604019072000304025002001204028#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.
htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#TAB#04#RBME180#nd#Rev Bras Med Esporte#5
#4#19990800#^f138^l143#1517-8692#<b>Estudo descritivo da resposta de acuidade vi
sual sem correção e pressão intra-ocular computadorizada de não contato em jogad
ores de futebol amadores e profissionais</b>^lpt#<b>Descriptive study on visual 
acuity response without correction and computerized non-contact intraocular pres
sure in amateur and professional (football) soccer players</b>^len#^rND^nEmídio 
Valenti^sTavares#^rND^nBenny^sApelbaum#^rND^nLysia K.^sYukisaki#^rND^nYeda Maria
^sRabboni#^rND^nSérgio Barreto^sMendes#^rND^nOdibulho Naves^sOliveira#^rND^nSant
os Pedro^sTanaganelli#^rND^nFrancisco Oliveira^sRocha#^lpt^aO principal objetivo
 deste estudo foi verificar as possíveis alterações de acuidade visual e pressão
 intra-ocular em jogadores de futebol. A clínica Oftalmos e Cirurgia Oftalmológi
ca submeteu à avaliação oftalmológica 127 atletas futebolistas provenientes de v
árias categorias, incluindo mulheres, com idades variando de 14 a 33 anos. Todos
 foram submetidos a testes de acuidade visual sem correção, utilizando-se a tabe
la de Snellen e avaliando-se a pressão intra-ocular de não contato com um tonôme
tro computadorizado (modelo TX-10, <i>Canon</i>, EUA). Além disso, os atletas fo
ram submetidos a exame de auto-refração, no equipamento auto-refrator (modelo R-
30, <i>Canon</i>, EUA). Os seguintes parâmetros utilizados e os resultados encon
trados foram: dos 127 atletas avaliados, 56 (44%) apresentaram alterações de aut
o-refração, consideradas de grau mais ou menos importante em um ou ambos os olho
s. No teste de acuidade visual, 3% e 2,4% dos atletas apresentaram, no OD e OE, 
somente 20/100 e 20/200 pés de visão, respectivamente. Em uma jogadora, foi cons
tatada catarata <i>puntata</i> congênita. Os resultados da tonometria mostraram,
 em 5 atletas de cor negra, quadro suspeito de glaucoma (necessitando investigaç
ão mais apurada).<b>Concluindo</b>, o estudo comprovou a importância da oftalmol
ogia como medida preventiva e/ou corretiva na identificação de possíveis alteraç
ões oftalmológicas em atletas futebolistas, devendo ser uma prática rotineira ne
sse esporte.#^dnd^i1#^tm^lpt^kEstudo descritivo^i1#^tm^lpt^kJogador de futebol^i
1#^tm^lpt^kAcuidade visual^i1#^tm^lpt^kressão intra-ocular^i1#^tm^lpt^kHomens^i1
#^tm^lpt^kMulheres^i1#^tm^lpt^kMedicina esportiva^i1#^len^aThe main purpose of t
his study was to verify possible visual acuity alterations and intraocular press
ure in soccer players. An ophthalmological evaluation in 127 soccer athletes bel
onging to various categories, including female (ages ranging from 14 to 33), was
 carried out by the Ophthalmologic Clinic Oftalmos. The athletes were all submit
ted to visual acuity tests without correction, using the Snellen chart and the n
on-contact intraocular pressure by means of computerized tonometer (TX-model, <i
>Canon</i> , USA). They were also submitted to a self-refraction examination usi
ng a self refractor (R-30 model, <i>Canon</i>, USA). The parameters used and the
 results obtained were the following: 56 (44%) of the 127 athletes submitted to 
evaluation presented self-refractions considered fairly important in one or both
 eyes. In the visual acuity test 3% and 2.4% of the athletes presented in the ri
ght and left eye only 20/100 and 20/200 feet of sight, respectively. The presenc
e of a congenital punctate cataract was found in a female player. Tonometry resu
lts in five black athletes showed signs of glaucoma, which, however, will requir
e more detailed investigation. In conclusion, the study confirmed the importance
 of ophthalmology as a preventive and/or corrective measure in order to identify
 possible ophthalmological alterations in soccer-playing athletes.#^dnd^i2#^tm^l
en^kDescriptive study^i2#^tm^len^kSoccer players^i2#^tm^len^kVisual acuity^i2#^t
m^len^kIntraocular pressure^i2#^tm^len^kMales. Females^i2#^tm^len^kSports medici
ne^i2#professor de língua inglesa Humberto Blancato#other#16#v5n4a04.htm##
04834000000000697000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670640013000690710003000820400003000850010
00600088042000200094120000400096038000400100121000300104049000800107158000300115
03000240011803100020014203200020014406500090014601400110015503500100016601201690
01760120171003450100030005160100022005460100024005680100026005920100029006180100
03100647010003200678010003200710083147800742085000802220085003002228085003102258
08500280228908500320231708500190234908500210236808500310238908313810242008500080
38010850030038090850027038390850026038660850033038920850027039250850028039520580
04603980117000604026072000304032002001204035008008904047#v5n4#V:\SciELO\serial\r
bme\v5n4\markup\v5n4a04.htm#S#l#4#1#article#1#^mago.^a1999#oa#pt#br1.1#1#4.0#tab
#04#RBME180#nd#Rev. bras. med. esporte#5#4#19990800#^f138^l143#1517-8692#Estudo 
descritivo da resposta de acuidade visual sem correção e pressão intra-ocular co
mputadorizada de não contato em jogadores de futebol amadores e profissionais^lp
t#Descriptive study on visual acuity response without correction and computerize
d non-contact intraocular pressure in amateur and professional (football) soccer
 players^len#^rND^nEmídio Valenti^sTavares#^rND^nBenny^sApelbaum#^rND^nLysia K^s
Yukisaki#^rND^nYeda Maria^sRabboni#^rND^nSérgio Barreto^sMendes#^rND^nOdibulho N
aves^sOliveira#^rND^nSantos Pedro^sTanaganelli#^rND^nFrancisco Oliveira^sRocha#^
lpt^aO principal objetivo deste estudo foi verificar as possíveis alterações de 
acuidade visual e pressão intra-ocular em jogadores de futebol. A clínica Oftalm
os e Cirurgia Oftalmológica submeteu à avaliação oftalmológica 127 atletas futeb
olistas provenientes de várias categorias, incluindo mulheres, com idades varian
do de 14 a 33 anos. Todos foram submetidos a testes de acuidade visual sem corre
ção, utilizando-se a tabela de Snellen e avaliando-se a pressão intra-ocular de 
não contato com um tonômetro computadorizado (modelo TX-10, Canon, EUA). Além di
sso, os atletas foram submetidos a exame de auto-refração, no equipamento auto-r
efrator (modelo R-30, Canon, EUA). Os seguintes parâmetros utilizados e os resul
tados encontrados foram: dos 127 atletas avaliados, 56 (44 por cento) apresentar
am alterações de auto-refração, consideradas de grau mais ou menos importante em
 um ou ambos os olhos. No teste de acuidade visual, 3 por cento e 2,4 por cento 
dos atletas apresentaram, no OD e OE, somente 20/100 e 20/200 pés de visão, resp
ectivamente. Em uma jogadora, foi constatada catarata puntata congênita. Os resu
ltados da tonometria mostraram, em 5 atletas de cor negra, quadro suspeito de gl
aucoma (necessitando investigação mais apurada).Concluindo, o estudo comprovou a
 importância da oftalmologia como medida preventiva e/ou corretiva na identifica
ção de possíveis alterações oftalmológicas em atletas futebolistas, devendo ser 
uma prática rotineira nesse esporte.#^dnd^i1#^tm^lpt^kEstudo descritivo^i1#^tm^l
pt^kJogador de futebol^i1#^tm^lpt^kAcuidade visual^i1#^tm^lpt^kressão intra-ocul
ar^i1#^tm^lpt^kHomens^i1#^tm^lpt^kMulheres^i1#^tm^lpt^kMedicina esportiva^i1#^le
n^aThe main purpose of this study was to verify possible visual acuity alteratio
ns and intraocular pressure in soccer players. An ophthalmological evaluation in
 127 soccer athletes belonging to various categories, including female (ages ran
ging from 14 to 33), was carried out by the Ophthalmologic Clinic Oftalmos. The 
athletes were all submitted to visual acuity tests without correction, using the
 Snellen chart and the non-contact intraocular pressure by means of computerized
 tonometer (TX-model, Canon , USA). They were also submitted to a self-refractio
n examination using a self refractor (R-30 model, Canon, USA). The parameters us
ed and the results obtained were the following: 56 (44 percent) of the 127 athle
tes submitted to evaluation presented self-refractions considered fairly importa
nt in one or both eyes. In the visual acuity test 3 percent and 2.4 percent of t
he athletes presented in the right and left eye only 20/100 and 20/200 feet of s
ight, respectively. The presence of a congenital punctate cataract was found in 
a female player. Tonometry results in five black athletes showed signs of glauco
ma, which, however, will require more detailed investigation. In conclusion, the
 study confirmed the importance of ophthalmology as a preventive and/or correcti
ve measure in order to identify possible ophthalmological alterations in soccer-
playing athletes.#^dnd^i2#^tm^len^kDescriptive study^i2#^tm^len^kSoccer players^
i2#^tm^len^kVisual acuity^i2#^tm^len^kIntraocular pressure^i2#^tm^len^kMales. Fe
males^i2#^tm^len^kSports medicine^i2#professor de língua inglesa Humberto Blanca
to#other#16#v5n4a04.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_art
text&pid=S1517-86921999000400004##
00318000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704008900071002001200160#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#5#1#article#124#<p align="right"><font f
ace="Verdana" size="2"><b>ARTIGO ORIGINAL</b></font></p>     ^cY#v5n4a04.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704002300071002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#6#2#article#124#<p>&nbsp; </p>     ^cY#v
5n4a04.htm##
00510000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704028100071002001200352#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#7#3#article#124#<p><font face="Verdana" 
size="4"><b><a name="topo"></a>Estudo descritivo da resposta    de acuidade visu
al sem corre&ccedil;&atilde;o e press&atilde;o intra-ocular    computadorizada d
e n&atilde;o contato em jogadores de futebol amadores e profissionais    </b></f
ont></p>     ^cY#v5n4a04.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704002300071002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#8#4#article#124#<p>&nbsp; </p>     ^cY#v
5n4a04.htm##
00461000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704023200071002001200303#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#9#5#article#124#<p><font face="Verdana" 
size="3"><b>Descriptive study on visual acuity response    without correction an
d computerized non-contact intraocular pressure in amateur    and professional (
football) soccer players</b></font></p>     ^cY#v5n4a04.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704002200072002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#10#6#article#124#<p>&nbsp;</p>     ^cY#v
5n4a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704002300072002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#11#7#article#124#<p>&nbsp; </p>     ^cY#
v5n4a04.htm##
00587000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704035700072002001200429#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#12#8#article#124#<p><font face="Verdana"
 size="2"><b>Em&iacute;dio Valenti Tavares<SUP>I</SUP>;    Benny Apelbaum<SUP>I<
/SUP>; Lysia K. Yukisaki<SUP>I</SUP>; Yeda Maria Rabboni<SUP>I</SUP>;    S&eacut
e;rgio Barreto Mendes<SUP>I</SUP>; Odibulho Naves Oliveira<SUP>I</SUP>;    Santo
s Pedro Tanaganelli<SUP>I</SUP>; Francisco Oliveira Rocha<SUP>II</SUP></b></font
></p>     ^cY#v5n4a04.htm##
00330000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704010000072002001200172#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#13#9#article#124#<p><font face="Verdana"
 size="2">Cl&iacute;nica Oftalmos &amp; Cirurgia Oftalmol&oacute;gica    ^cY#v5n
4a04.htm##
00272000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704004100073002001200114#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#14#10#article#124#<br>   <sup>I</sup>Oft
almologista    ^cY#v5n4a04.htm##
00282000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704005100073002001200124#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#15#11#article#124#<br>   <sup>II</sup>An
estesista</font></p>     ^cY#v5n4a04.htm##
00346000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704011500073002001200188#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#16#12#article#124#<p><font face="Verdana
" size="2"><a href="#send">Endere&ccedil;o para correspond&ecirc;ncia</a></font>
</p>     ^cY#v5n4a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#17#13#article#124#<p>&nbsp;</p>     ^cY#
v5n4a04.htm##
00275000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704004400073002001200117#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#18#14#article#124#<p>&nbsp; </p> <hr siz
e="1"noshade>     ^cY#v5n4a04.htm##
00298000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704006700073002001200140#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#19#15#article#124#<p><font face="Verdana
" size="2"><B>RESUMO</B> </font></p>     ^cY#v5n4a04.htm##
02112000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704188100073002001201954#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#20#16#article#124#<p><font face="Verdana
" size="2">O principal objetivo deste estudo foi verificar    as poss&iacute;vei
s altera&ccedil;&otilde;es de acuidade visual e press&atilde;o    intra-ocular e
m jogadores de futebol. A cl&iacute;nica Oftalmos e Cirurgia Oftalmol&oacute;gic
a    submeteu &agrave; avalia&ccedil;&atilde;o oftalmol&oacute;gica 127 atletas 
futebolistas    provenientes de v&aacute;rias categorias, incluindo mulheres, co
m idades variando    de 14 a 33 anos. Todos foram submetidos a testes de acuidad
e visual sem corre&ccedil;&atilde;o,    utilizando-se a tabela de Snellen e aval
iando-se a press&atilde;o intra-ocular    de n&atilde;o contato com um ton&ocirc
;metro computadorizado (modelo TX-10,    <I>Canon</I>, EUA). Al&eacute;m disso, 
os atletas foram submetidos a exame de    auto-refra&ccedil;&atilde;o, no equipa
mento auto-refrator (modelo R-30, <I>Canon</I>,    EUA). Os seguintes par&acirc;
metros utilizados e os resultados encontrados foram:    dos 127 atletas avaliado
s, 56 (44%) apresentaram altera&ccedil;&otilde;es de    auto-refra&ccedil;&atild
e;o, consideradas de grau mais ou menos importante em    um ou ambos os olhos. N
o teste de acuidade visual, 3% e 2,4% dos atletas apresentaram,    no OD e OE, s
omente 20/100 e 20/200 p&eacute;s de vis&atilde;o, respectivamente.    Em uma jo
gadora, foi constatada catarata <I>puntata</I> cong&ecirc;nita. Os    resultados
 da tonometria mostraram, em 5 atletas de cor negra, quadro suspeito    de glauc
oma (necessitando investiga&ccedil;&atilde;o mais apurada).</font><font face="Ve
rdana" size="2"><B>Concluindo</B>,    o estudo comprovou a import&acirc;ncia da 
oftalmologia como medida preventiva    e/ou corretiva na identifica&ccedil;&atil
de;o de poss&iacute;veis altera&ccedil;&otilde;es    oftalmol&oacute;gicas em at
letas futebolistas, devendo ser uma pr&aacute;tica    rotineira nesse esporte. <
/font></p>     ^cY#v5n4a04.htm##
00457000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704022600073002001200299#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#21#17#article#124#<p><font face="Verdana
" size="2"><B>Palavras-chave:</B> Estudo descritivo. Jogador    de futebol. Acui
dade visual. Press&atilde;o intra-ocular. Homens. Mulheres.    Medicina esportiv
a. </font></p> <hr size="1"noshade>     ^cY#v5n4a04.htm##
00300000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704006900073002001200142#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#22#18#article#124#<p><font face="Verdana
" size="2"><B>ABSTRACT</B> </font></p>     ^cY#v5n4a04.htm##
01702000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704147100073002001201544#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#23#19#article#124#<p><font face="Verdana
" size="2">The main purpose of this study was to verify    possible visual acuit
y alterations and intraocular pressure in soccer players.    An ophthalmological
 evaluation in 127 soccer athletes belonging to various categories,    including
 female (ages ranging from 14 to 33), was carried out by the Ophthalmologic    C
linic Oftalmos. The athletes were all submitted to visual acuity tests without  
  correction, using the Snellen chart and the non-contact intraocular pressure  
  by means of computerized tonometer (TX-model, <I>Canon</I>, USA). They were   
 also submitted to a self-refraction examination using a self refractor (R-30   
 model, <I>Canon</I>, USA). The parameters used and the results obtained were   
 the following: 56 (44%) of the 127 athletes submitted to evaluation presented  
  self-refractions considered fairly important in one or both eyes. In the visua
l    acuity test 3% and 2.4% of the athletes presented in the right and left eye
    only 20/100 and 20/200 feet of sight, respectively. The presence of a congen
ital    punctate cataract was found in a female player. Tonometry results in fiv
e black    athletes showed signs of glaucoma, which, however, will require more 
detailed    investigation. In conclusion, the study confirmed the importance of 
ophthalmology    as a preventive and/or corrective measure in order to identify 
possible ophthalmological    alterations in soccer-playing athletes. </font></p>
     ^cY#v5n4a04.htm##
00431000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704020000073002001200273#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#24#20#article#124#<p><font face="Verdana
" size="2"><B>Key words:</B> Descriptive study. Soccer players.    Visual acuity
. Intraocular pressure. Males. Females. Sports medicine. </font></p> <hr size="1
"noshade>     ^cY#v5n4a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#25#21#article#124#<p>&nbsp;</p>     ^cY#
v5n4a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#26#22#article#124#<p>&nbsp;</p>     ^cY#
v5n4a04.htm##
00316000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704008500073002001200158#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#27#23#article#124#<p><font face="Verdana
" size="3"><B>INTRODU&Ccedil;&Atilde;O</B> </font></p>     ^cY#v5n4a04.htm##
00558000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704032700073002001200400#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#28#24#article#124#<p><font face="Verdana
" size="2">A import&acirc;ncia de vis&atilde;o dentro dos    padr&otilde;es norm
ais de acuidade &eacute; fundamental em atletas, como &eacute;    o caso de fute
bolistas, que precisam de reflexo r&aacute;pido para decidir uma    jogada duran
te o transcorrer de uma partida<SUP>1</SUP>. </font></p>     ^cY#v5n4a04.htm##
00601000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704037000073002001200443#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#29#25#article#124#<p><font face="Verdana
" size="2">Portanto, avaliar a capacidade de um atleta enxergar    o que est&aac
ute; &agrave; sua frente (vis&atilde;o central) ou dos lados (vis&atilde;o    la
teral) &eacute; de fundamental import&acirc;ncia, pois os olhos normais podem   
 reconhecer objetos em uma &aacute;rea de pelo menos 140&#186; (quase meio circu
lo).    </font></p>     ^cY#v5n4a04.htm##
00492000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704026100073002001200334#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#30#26#article#124#<p><font face="Verdana
" size="2">Se nenhum dos olhos pode ver melhor do que 20/60    p&eacute;s, sem m
elhora com o uso de &oacute;culos ou lentes corretivas, o atleta    pode ser con
siderado como portador de vis&atilde;o deficit&aacute;ria. </font></p>     ^cY#v
5n4a04.htm##
00540000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704030900073002001200382#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#31#27#article#124#<p><font face="Verdana
" size="2">A limita&ccedil;&atilde;o da vis&atilde;o lateral,    vis&atilde;o co
lorida anormal, vis&atilde;o dupla, vis&atilde;o deficiente &agrave;    noite e 
perda de vis&atilde;o em um dos olhos tamb&eacute;m podem ser consideradas    co
mo preju&iacute;zo visual. </font></p>     ^cY#v5n4a04.htm##
00673000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704044200073002001200515#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#32#28#article#124#<p><font face="Verdana
" size="2">Uma pessoa com faixa de vis&atilde;o lateral    mais estreita pode te
r problemas ao andar e reconhecer pessoas em uma sala ampla,    mesmo quando a v
is&atilde;o central &eacute; excelente. Agora, imagine-se um    atleta, que prec
isa decidir uma jogada em fra&ccedil;&atilde;o de segundo. Em    jogadores de fu
tebol, a vis&atilde;o lateral &eacute; decisiva em muitos lances    da partida. 
</font></p>     ^cY#v5n4a04.htm##
00687000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704045600073002001200529#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#33#29#article#124#<p><font face="Verdana
" size="2">Estudos cient&iacute;ficos prospectivos, publicados    sobre acuidade
 visual e press&atilde;o intra-ocular em atletas, s&atilde;o escassos,    princi
palmente em jogadores de futebol. Os poucos relatos observados na literatura    
especializada em medicina esportiva s&atilde;o, em sua grande maioria, sobre    
preven&ccedil;&atilde;o, tratamento, equipamentos e les&otilde;es oculares<SUP>1
-15</SUP>.    </font></p>     ^cY#v5n4a04.htm##
00558000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704032700073002001200400#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#34#30#article#124#<p><font face="Verdana
" size="2">Portanto, o principal objetivo deste estudo foi    mostrar em jogador
es de futebol, masculino e feminino, em v&aacute;rias faixas    et&aacute;rias, 
o perfil oftalmol&oacute;gico de acuidade visual sem corre&ccedil;&atilde;o    e
 press&atilde;o intra-ocular desses atletas. </font></p>     ^cY#v5n4a04.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#35#31#article#124#<p>&nbsp; </p>     ^cY
#v5n4a04.htm##
00317000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704008600073002001200159#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#36#32#article#124#<p><font face="Verdana
" size="3"><B>MATERIAL E M&Eacute;TODOS</B> </font></p>     ^cY#v5n4a04.htm##
00904000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704067300073002001200746#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#37#33#article#124#<p><font face="Verdana
" size="2">Foram submetidos &agrave; avalia&ccedil;&atilde;o    oftalmol&oacute;
gica 127 futebolistas, subdivididos em quatro categorias<B>:    </B>infantil (28
 jogadores), com m&eacute;dia de idade de 14,4 &#177; 0,5 anos;    juvenil (24 j
ogadores), com m&eacute;dia de idade de 15,9 &#177; 0,3 anos; juniores    (27 jo
gadores), com m&eacute;dia de idade de 18,4 &#177; 1,0 anos; futebolistas    fem
ininas (24 jogadoras), com m&eacute;dia de idade de 19,7 &#177; 4,4 anos    e jo
gadores profissionais (24 atletas), com m&eacute;dia de idade de 24,4 &#177;    
3,3 anos (<a href="/img/revistas/rbme/v5n4/a04tab01.gif">tabela 1</a>).</font></
p>     ^cY#v5n4a04.htm##
00473000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704024200073002001200315#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#38#34#article#124#<p><font face="Verdana
" size="2">A verifica&ccedil;&atilde;o da acuidade visual    sem corre&ccedil;&a
tilde;o, em enxergar objetos na dist&acirc;ncia longe, foi    realizada utilizan
do-se a escala de Snellen<SUP>14</SUP>. </font></p>     ^cY#v5n4a04.htm##
00652000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704042100073002001200494#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#39#35#article#124#<p><font face="Verdana
" size="2">O padr&atilde;o oftalmol&oacute;gico para quantificar    a dist&acirc
;ncia de enxergar perto &eacute; de 33cm e para longe, de 6m. Na    escala de Sn
ellen, o grau de acuidade visual &eacute; classificado em p&eacute;s    ou perce
ntagem (%). Indiv&iacute;duos com o resultado de 20/20 p&eacute;s t&ecirc;m    1
00% de vis&atilde;o normal para enxergar objetos de longe. </font></p>     ^cY#v
5n4a04.htm##
00703000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704047200073002001200545#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#40#36#article#124#<p><font face="Verdana
" size="2">Todos foram ainda submetidos &agrave; avalia&ccedil;&atilde;o    da p
ress&atilde;o intra-ocular de n&atilde;o contato, que mede a for&ccedil;a    exe
rcida pelo humor aquoso na c&acirc;mara anterior (espa&ccedil;o entre a face    
anterior da &iacute;ris e a face posterior da c&oacute;rnea) do globo ocular,   
 utilizando-se um ton&ocirc;metro computadorizado de n&atilde;o contato (modelo 
   TX-10, <I>Canon</I>, EUA). </font></p>     ^cY#v5n4a04.htm##
00527000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704029600073002001200369#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#41#37#article#124#<p><font face="Verdana
" size="2">Os atletas foram submetidos ao exame de auto-refra&ccedil;&atilde;o  
  (refra&ccedil;&atilde;o objetiva), para avaliar poss&iacute;veis erros refraci
onais,    utilizando-se um auto-refrator computadorizado (modelo R-30, <I>Canon<
/I>, EUA).    </font></p>     ^cY#v5n4a04.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#42#38#article#124#<p>&nbsp; </p>     ^cY
#v5n4a04.htm##
00302000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007100073002001200144#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#43#39#article#124#<p><font face="Verdana
" size="3"><B>RESULTADOS</B> </font></p>     ^cY#v5n4a04.htm##
00652000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704042100073002001200494#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#44#40#article#124#<p><font face="Verdana
" size="2">Os resultados observados neste estudo s&atilde;o    apresentados por 
categoria e dados individuais de cada atleta, listados nas    <a href="/img/revi
stas/rbme/v5n4/a04tab01.gif">tabelas 1</a>, <a href="#tab2">2</a>,    <a href="#
tab3">3</a>, <a href="#tab4">4</a>, <a href="#tab5">5</a>, <a href="#tab6">6</a>
    e <a href="/img/revistas/rbme/v5n4/a04tab07.gif">7</a>.</font></p>     ^cY#v
5n4a04.htm##
00266000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003500073002001200108#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#45#41#article#124#<p><a name="tab2"></a>
</p>     ^cY#v5n4a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#46#42#article#124#<p>&nbsp;</p>     ^cY#
v5n4a04.htm##
00310000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007900073002001200152#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#47#43#article#124#<p align="center"><img
 src="/img/revistas/rbme/v5n4/a04tab02.gif"></p>     ^cY#v5n4a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#48#44#article#124#<p>&nbsp;</p>     ^cY#
v5n4a04.htm##
00266000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003500073002001200108#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#49#45#article#124#<p><a name="tab3"></a>
</p>     ^cY#v5n4a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#50#46#article#124#<p>&nbsp;</p>     ^cY#
v5n4a04.htm##
00310000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007900073002001200152#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#51#47#article#124#<p align="center"><img
 src="/img/revistas/rbme/v5n4/a03tab03.gif"></p>     ^cY#v5n4a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#52#48#article#124#<p>&nbsp;</p>     ^cY#
v5n4a04.htm##
00266000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003500073002001200108#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#53#49#article#124#<p><a name="tab4"></a>
</p>     ^cY#v5n4a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#54#50#article#124#<p>&nbsp;</p>     ^cY#
v5n4a04.htm##
00310000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007900073002001200152#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#55#51#article#124#<p align="center"><img
 src="/img/revistas/rbme/v5n4/a04tab04.gif"></p>     ^cY#v5n4a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#56#52#article#124#<p>&nbsp;</p>     ^cY#
v5n4a04.htm##
00266000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003500073002001200108#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#57#53#article#124#<p><a name="tab5"></a>
</p>     ^cY#v5n4a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#58#54#article#124#<p>&nbsp;</p>     ^cY#
v5n4a04.htm##
00311000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704008000073002001200153#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#59#55#article#124#<p align="center"><img
 src="/img/revistas/rbme/v5n4/a04tab05.gif"> </p>     ^cY#v5n4a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#60#56#article#124#<p>&nbsp;</p>     ^cY#
v5n4a04.htm##
00266000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003500073002001200108#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#61#57#article#124#<p><a name="tab6"></a>
</p>     ^cY#v5n4a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#62#58#article#124#<p>&nbsp;</p>     ^cY#
v5n4a04.htm##
00310000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007900073002001200152#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#63#59#article#124#<p align="center"><img
 src="/img/revistas/rbme/v5n4/a04tab06.gif"></p>     ^cY#v5n4a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#64#60#article#124#<p>&nbsp;</p>     ^cY#
v5n4a04.htm##
00332000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704010100073002001200174#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#65#61#article#124#<p><font face="Verdana
" size="3"><B>DISCUSS&Atilde;O E COMENT&Aacute;RIOS</B>    </font></p>     ^cY#v
5n4a04.htm##
00707000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704047600073002001200549#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#66#62#article#124#<p><font face="Verdana
" size="2">A participa&ccedil;&atilde;o preventiva e investigativa    da oftalmo
logia na medicina do esporte e, especificamente, no futebol, em nosso    pa&iacu
te;s, tem sido escassa. &Eacute; dif&iacute;cil determinar raz&atilde;o    para 
tal fato. Entretanto, parece que a falta de esclarecimento sobre a import&acirc;
ncia    dos benef&iacute;cios dessa &aacute;rea para o esporte e, sobretudo, o a
tleta,    seja a causa principal. </font></p>     ^cY#v5n4a04.htm##
00556000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704032500073002001200398#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#67#63#article#124#<p><font face="Verdana
" size="2">A grande maioria dos estudos tem-se preocupado    em relatar les&otil
de;es oculares, relacionadas com v&aacute;rios tipos de esportes,    atividades 
recreativas, equipamentos, preven&ccedil;&atilde;o e com os aspectos    epidemio
l&oacute;gicos do problema<SUP>1-15</SUP>. </font></p>     ^cY#v5n4a04.htm##
00634000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704040300073002001200476#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#68#64#article#124#<p><font face="Verdana
" size="2">Recentemente, a Academia Americana de Oftalmologia<SUP>16</SUP>    cl
assificou algumas modalidades esportivas pela popularidade e a alta incid&ecirc;
ncia    de trauma ocular. Foi constatado que o beisebol e o basquetebol foram as
 modalidades    associadas ao maior n&uacute;mero de les&otilde;es em atletas en
tre 5 e 24 anos    de idade<SUP>9</SUP>. </font></p>     ^cY#v5n4a04.htm##
00449000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704021800073002001200291#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#69#65#article#124#<p><font face="Verdana
" size="2">O futebol (<I>soccer</I>) foi classificado em    s&eacute;timo lugar.
 Entretanto, essa entidade n&atilde;o informou sobre a gravidade    das les&otil
de;es oculares. </font></p>     ^cY#v5n4a04.htm##
00560000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704032900073002001200402#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#70#66#article#124#<p><font face="Verdana
" size="2">Em outro estudo publicado por MacEwen<SUP>5</SUP>    foram verificado
s em 246 indiv&iacute;duos diversos tipos de les&otilde;es.    Destas, 110 (44,7
%) foram em jogadores de futebol, 24 (9,8%) no r&uacute;gbi,    16 (6,5%) no <I>
badminton</I> e 68 (27,6%) em outros esportes. </font></p>     ^cY#v5n4a04.htm##
00636000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704040500073002001200478#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#71#67#article#124#<p><font face="Verdana
" size="2">Barrell <I>et al</I>.<SUP>6</SUP>, ao atenderem    118 indiv&iacute;d
uos, constataram que a freq&uuml;&ecirc;ncia de les&otilde;es    foi proveniente
 do <I>squash</I>, <I>badminton</I>, t&ecirc;nis de campo, t&ecirc;nis    de mes
a, cr&iacute;quete e futebol. Nesse estudo, a incid&ecirc;ncia maior de    les&o
tilde;es foi provocada pelo <I>squash</I>. </font></p>     ^cY#v5n4a04.htm##
00675000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704044400073002001200517#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#72#68#article#124#<p><font face="Verdana
" size="2">Ao contr&aacute;rio, Filipe <I>et al</I>.<SUP>7</SUP>,    ao avaliare
m 84 pacientes com les&otilde;es esportivas por um per&iacute;odo    de tr&ecirc
;s anos, verificaram que as modalidades esportivas respons&aacute;veis    pela m
aior freq&uuml;&ecirc;ncia de traumas oculares foram, respectivamente,    o fute
bol <I>outdoor</I> (campo) e o <I>indoor</I> (sal&atilde;o) (72,6% dos    casos)
. </font></p>     ^cY#v5n4a04.htm##
00919000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704068800073002001200761#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#73#69#article#124#<p><font face="Verdana
" size="2">O tipo mais freq&uuml;ente de les&atilde;o foi    o hifema (dep&oacut
e;sito de sangue entre a parte posterior da c&oacute;rnea    e a parte anterior 
da &iacute;ris). Dos 45 indiv&iacute;duos que apresentaram    esse quadro, 24 (5
3,3%) tinham les&otilde;es v&iacute;treas e/ou na retina.    Quando se comparou 
com indiv&iacute;duos sem hifema, a percentagem caiu para    33,3%. Em 19 indiv&
iacute;duos dos 58 avaliados (32,8%) com acuidade visual    normal (<u>&gt;</u> 
20/40 p&eacute;s), a causa mais comum foi a les&atilde;o    v&iacute;trea ou ret
iniana. No futebol, o trauma mais freq&uuml;ente encontrado    por eles foi o hi
fema. </font></p>     ^cY#v5n4a04.htm##
00504000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704027300073002001200346#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#74#70#article#124#<p><font face="Verdana
" size="2">Apesar da importante contribui&ccedil;&atilde;o    desses estudos, n&
atilde;o encontramos nenhum relato na literatura mostrando    o perfil de acuida
de visual e/ou press&atilde;o intra-ocular em jogadores de    futebol. </font></
p>     ^cY#v5n4a04.htm##
00636000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704040500073002001200478#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#75#71#article#124#<p><font face="Verdana
" size="2">No presente estudo, pudemos verificar altera&ccedil;&otilde;es    ocu
lares importantes em atletas futebolistas (<a href="/img/revistas/rbme/v5n4/a04t
ab07.gif">tabela    7</a>). Em alguns casos, a press&atilde;o intra-ocular se mo
strou elevada, sendo    necess&aacute;ria a investiga&ccedil;&atilde;o de poss&i
acute;vel quadro glaucomatoso    familiar. </font></p>     ^cY#v5n4a04.htm##
00845000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704061400073002001200687#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#76#72#article#124#<p><font face="Verdana
" size="2">Em outro caso, um futebolista da categoria infantil,    com 14 anos d
e idade, apresentou no olho direito (OD) acuidade visual de 20/200    p&eacute;s
. Quando submetido ao exame de auto-refra&ccedil;&atilde;o computadorizada,    a
presentou ambliopia ex-anopsia refracional (olho pregui&ccedil;oso) em OD de    
+1,00&#186; DE (hipermetropia) com &#150;5,50&#176; DC (astigmatismo). J&aacute;
    o olho esquerdo (OE) apresentou-se plano (emetrope). A press&atilde;o intra-
ocular    em ambos os olhos foi de 13,0 e 15,0mmHg, respectivamente, considerada
 normal.    </font></p>     ^cY#v5n4a04.htm##
00640000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704040900073002001200482#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#77#73#article#124#<p><font face="Verdana
" size="2">Em mais um caso verificado na categoria infantil,    um atleta aprese
ntou vis&atilde;o de 20/200 AO. Entretanto, a press&atilde;o    intra-ocular foi
 considerada normal, ou seja, 15,8 e 13,8mmHg em ambos os olhos,    respectivame
nte. Contudo, o teste de auto-refra&ccedil;&atilde;o mostrou em    ambos os olho
s &#150;1,50&#186; DE com &#150;0,25&#186; DC. </font></p>     ^cY#v5n4a04.htm##
00536000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704030500073002001200378#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#78#74#article#124#<p><font face="Verdana
" size="2">Dois jogadores juniores apresentaram astigmatismo    em OD de &#150;1
,25&#186; e &#150;2,50&#186; dioptrias cil&iacute;ndricas (DC),    respectivamen
te. Nesses atletas n&atilde;o foi verificada ambliopia e a tonometria    era nor
mal em ambos os olhos. </font></p>     ^cY#v5n4a04.htm##
00675000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704044400073002001200517#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#79#75#article#124#<p><font face="Verdana
" size="2">Em uma goleira, de 16 anos e cor negra, foi encontrado    em OD +0,75
&#186; dioptria esf&eacute;rica e astigmatismo de &#150;2,50&#186;    e em OE +0
,50&#186; DE e astigmatismo de &#150;1,75&#186; DC. Entretanto, os    n&iacute;v
eis de press&atilde;o intra-ocular foram considerados suspeitos devido    &agrav
e; idade e &agrave; ra&ccedil;a (18,4 e 17,8mmHg em OD e OE, respectivamente).  
  </font></p>     ^cY#v5n4a04.htm##
00380000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704014900073002001200222#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#80#76#article#124#<p><font face="Verdana
" size="2">Em uma atacante, de origem japonesa, foi constatada    catarata <I>pu
ntata</I> cong&ecirc;nita. </font></p>     ^cY#v5n4a04.htm##
00547000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704031600073002001200389#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#81#77#article#124#<p><font face="Verdana
" size="2">Portanto, ficou comprovado neste estudo que a    maioria das altera&c
cedil;&otilde;es na acuidade visual dos atletas avaliados    se deveu a v&iacute
;cios de refra&ccedil;&atilde;o (em ambos os olhos ou unilateral,    levando &ag
rave;s vezes &agrave; ambliopia). </font></p>     ^cY#v5n4a04.htm##
00553000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704032200073002001200395#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#82#78#article#124#<p><font face="Verdana
" size="2">Contudo, vale a pena ressaltar que devem ser    investigados aqueles 
casos em atletas, que, apesar de se apresentarem sem v&iacute;cios    de refra&c
cedil;&atilde;o, demonstraram acuidade visual abaixo do esperado e/ou    press&a
tilde;o intra-ocular <I>borderline</I>. </font></p>     ^cY#v5n4a04.htm##
00656000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704042500073002001200498#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#83#79#article#124#<p><font face="Verdana
" size="2">O presente estudo comprovou o importante papel    social da oftalmolo
gia dentro de uma institui&ccedil;&atilde;o desportiva, como    medida preventiv
a na poss&iacute;vel identifica&ccedil;&atilde;o de altera&ccedil;&otilde;es    
oftalmol&oacute;gicas que possam comprometer o desempenho t&eacute;cnico e,    s
obretudo, para preservar a integridade ocular em seus atletas. </font></p>     ^
cY#v5n4a04.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#84#80#article#124#<p>&nbsp; </p>     ^cY
#v5n4a04.htm##
00306000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007500073002001200148#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#85#81#article#124#<p><font face="Verdana
" size="3"><B>AGRADECIMENTOS</B> </font></p>     ^cY#v5n4a04.htm##
00457000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704022600073002001200299#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#86#82#article#124#<p><font face="Verdana
" size="2">Gostar&iacute;amos de agradecer ao professor    de l&iacute;ngua ingl
esa Humberto Blancato por sua colabora&ccedil;&atilde;o    na reda&ccedil;&atild
e;o do <I>Abstract</I>. </font></p>     ^cY#v5n4a04.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#87#83#article#124#<p>&nbsp; </p>     ^cY
#v5n4a04.htm##
00309000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007800073002001200151#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#88#84#article#124#<p><font face="Verdana
" size="3"><B>REFER&Ecirc;NCIAS</B> </font></p>     ^cY#v5n4a04.htm##
00443000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069888000200073704019800075002001200273#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#89#85#article#124#1#<p><font
 face="Verdana" size="2">1. Carvalho DM, Gon&ccedil;alves P. Vis&atilde;o    per
if&eacute;rica e futebol (testes e treinamento). 1&#170; ed. Goi&acirc;nia:    E
ditora Grafopel, 1997.    ^cY#v5n4a04.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002100073002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#90#86#article#124# </font></p>     ^cY#v
5n4a04.htm##
00387000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069888000200073704014200075002001200217#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#91#87#article#124#2#<p><font
 face="Verdana" size="2">2. Stock JG, Cornell FM. Prevention of sports    relate
d eye injury. Am Fam Physician 1991;44:515-20.    ^cY#v5n4a04.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002100073002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#92#88#article#124# </font></p>     ^cY#v
5n4a04.htm##
00356000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069888000200073704011100075002001200186#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#93#89#article#124#3#<p><font
 face="Verdana" size="2">3. Fong LP. Sports-related eye injuries. Med    J Aust 
1994;160:743-7.    ^cY#v5n4a04.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002100073002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#94#90#article#124# </font></p>     ^cY#v
5n4a04.htm##
00406000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069888000200073704016100075002001200236#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#95#91#article#124#4#<p><font
 face="Verdana" size="2">4. Marees H. Performance diagnosis of the locomotor    
system and sensory organs? Sportverletz Sportschaden 1989;3:53-7.    ^cY#v5n4a04
.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002100073002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#96#92#article#124# </font></p>     ^cY#v
5n4a04.htm##
00394000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069888000200073704014900075002001200224#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#97#93#article#124#5#<p><font
 face="Verdana" size="2">5. MacEwen CJ. Sports associated eye injury:    a casua
lty department survey. Br J Ophthalmol 1987;71:701-5.    ^cY#v5n4a04.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002100073002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#98#94#article#124# </font></p>     ^cY#v
5n4a04.htm##
00473000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069888000200073704022800075002001200303#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#99#95#article#124#6#<p><font
 face="Verdana" size="2">6. Barrell GV, Cooper PJ, Elkington AR, MacFadyen    JM
, Powell RG, Tormey P. Squash ball to eye ball: the likelihood of squash players
    in occurring an eye injury. Br Med J 1981;893-5.    ^cY#v5n4a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704002100074002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#100#96#article#124# </font></p>     ^cY#
v5n4a04.htm##
00423000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070888000200074704017700076002001200253#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#101#97#article#124#7#<p><fon
t face="Verdana" size="2">7. Filipe JA, Barros H, Castro-Correia J. Sports    re
lated ocular injuries. A three year follow-up study. Ophthalmology 1997;104:313-
8.    ^cY#v5n4a04.htm##
00256000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704002400074002001200098#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#102#98#article#124#    </font></p>     ^
cY#v5n4a04.htm##
00502000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070888000200074704025600076002001200332#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#103#99#article#124#8#<p><fon
t face="Verdana" size="2">8. Mizusawa K, Sweeting RL, Knouse SB. Comparative    
studies of color fields, visual acuity fields and movement perception limits    
among varsity athletes and non-varsity groups. Percept Mot Skills 1983;56:887-92
.    ^cY#v5n4a04.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#104#100#article#124#    </font></p>     
^cY#v5n4a04.htm##
00387000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704014000077002001200217#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#105#101#article#124#9#<p><fo
nt face="Verdana" size="2">9. Erie JC. Eye injuries: prevention, evaluation,    
and treatment. Phys Sports Med 1991;19:108-22.    ^cY#v5n4a04.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#106#102#article#124# </font></p>     ^cY
#v5n4a04.htm##
00406000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015800078002001200236#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#107#103#article#124#10#<p><f
ont face="Verdana" size="2">10. Larrison WI, Hersh PS, Kunzweiler T, Shingleton 
   BJ. Sport-related ocular trauma. Ophthalmology 1990;97:1265-9.    ^cY#v5n4a04
.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#108#104#article#124# </font></p>     ^cY
#v5n4a04.htm##
00405000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015700078002001200235#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#109#105#article#124#11#<p><f
ont face="Verdana" size="2">11. Strahlman E, Sommer A. The epidemiology of    sp
orts-related ocular trauma. Int Ophthalmol Clin 1988;28:199-202.    ^cY#v5n4a04.
htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#110#106#article#124# </font></p>     ^cY
#v5n4a04.htm##
00406000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015800078002001200236#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#111#107#article#124#12#<p><f
ont face="Verdana" size="2">12. Vinger PF. The eye and sports medicine. In:    T
asman W, editor. Duane's clinical ophthalmology. Chap 45:5, 1994.    ^cY#v5n4a04
.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#112#108#article#124# </font></p>     ^cY
#v5n4a04.htm##
00389000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704014100078002001200219#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#113#109#article#124#13#<p><f
ont face="Verdana" size="2">13. Leydhecker W. Os glaucomas na pr&aacute;tica    
m&eacute;dica. 3&#170; ed. Editora Manole, 1980.    ^cY#v5n4a04.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#114#110#article#124# </font></p>     ^cY
#v5n4a04.htm##
00362000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704011400078002001200192#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#115#111#article#124#14#<p><f
ont face="Verdana" size="2">14. Vaughan D, Asbury T. Oftalmologia geral.    2&#1
70; ed. Ateneu, 1983.    ^cY#v5n4a04.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#116#112#article#124# </font></p>     ^cY
#v5n4a04.htm##
00453000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704020500078002001200283#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#117#113#article#124#15#<p><f
ont face="Verdana" size="2">15. Verdaguer J, Rojas B, Ibanez S, Leghuga M,    Sc
hmidt A. Desprendimiento retinal por pelotazo en el juego del f&uacute;tbol.    
Arch Chil Oftalmol 1981;38:31-6.    ^cY#v5n4a04.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#118#114#article#124# </font></p>     ^cY
#v5n4a04.htm##
00491000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704024300078002001200321#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#p#119#115#article#124#16#<p><f
ont face="Verdana" size="2">16. A Joint Statement of the American Academy    of 
Pediatrics and the American Academy of Ophthalmology, February 1995 and 1996.   
 Protective eyewear for young athletes. Ophthalmology 1996;103:1325-8.    ^cY#v5
n4a04.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#120#116#article#124# </font></p>     ^cY
#v5n4a04.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#121#117#article#124#<p>&nbsp;</p>     ^c
Y#v5n4a04.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#122#118#article#124#<p>&nbsp;</p>     ^c
Y#v5n4a04.htm##
00421000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704018800075002001200263#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#123#119#article#124#<p><font face="Verda
na" size="2"><a name="send"></a><B><a href="#topo"><img src="/img/revistas/rbme/
v5n4/seta.gif" border="0"></a>    Endere&ccedil;o para correspond&ecirc;ncia</B>
    ^cY#v5n4a04.htm##
00307000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704007400075002001200149#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#124#120#article#124#<BR>   Cl&iacute;nic
a Oftalmos &amp; Cirurgia Oftalmol&oacute;gica    ^cY#v5n4a04.htm##
00277000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704004400075002001200119#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#125#121#article#124#<BR>   Em&iacute;dio
 Valenti Tavares    ^cY#v5n4a04.htm##
00290000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704005700075002001200132#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#126#122#article#124#<br>   Rua Dr. Coron
el Portilho, 75 &#150; Centro    ^cY#v5n4a04.htm##
00278000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704004500075002001200120#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#127#123#article#124#<br>   07012-050 &#1
50; Guarulhos, SP    ^cY#v5n4a04.htm##
00288000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704005500075002001200130#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a04.htm#S#p#128#124#article#124#<BR>   Tel./fax (0XX
11) 6440-1835 </font> </p>     ^cY#v5n4a04.htm##
00483000000000253000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160019000740160020000930180
05400113063000200167066000800169062001700177065000900194064000500203865000900208
002001200217#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#c#129#1#articl
e#16#1#^rND^sCarvalho^nDM#^rND^sGonçalves^nP.#Visão periférica e futebol (testes
 e treinamento)^lpt#1#Goiânia#Editora Grafopel#19970000#1997#19990800#v5n4a04.ht
m##
00520000000000277000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100016000740100019000900120
04400109030001700153065000900170064000500179031000300184014000700187865000900194
002001200203035001000215801001700225#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a04.htm#S#c#130#2#article#16#2#^rND^sStock^nJG#^rND^sCornell^nFM.#Prevention of 
sports related eye injury^len#Am Fam Physician#19910000#1991#44#515-20#19990800#
v5n4a04.htm#0002-838X#Am Fam Physician##
00465000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100016000740120032000900300
01100122065000900133064000500142031000400147014000600151865000900157002001200166
035001000178801001100188#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#c#
131#3#article#16#3#^rND^sFong^nLP.#Sports-related eye injuries^len#Med J Aust#19
940000#1994#160#743-7#19990800#v5n4a04.htm#0025-729X#Med J Aust##
00531000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100017000740120070000910300
02600161065000900187064000500196031000200201014000500203865000900208002001200217
035001000229801002600239#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#c#
132#4#article#16#4#^rND^sMarees^nH.#Performance diagnosis of the locomotor syste
m and sensory organs?^len#Sportverletz Sportschaden#19890000#1989#3#53-7#1999080
0#v5n4a04.htm#0932-0555#Sportverletz Sportschaden##
00508000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100019000740120063000930300
01600156065000900172064000500181031000300186014000600189865000900195002001200204
035001000216801001600226#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#c#
133#5#article#16#5#^rND^sMacEwen^nCJ.#Sports associated eye injury: a casualty d
epartment survey^len#Br J Ophthalmol#19870000#1987#71#701-5#19990800#v5n4a04.htm
#0007-1161#Br J Ophthalmol##
00655000000000313000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100018000740100017000920100
02000109010002000129010001700149010001700166012008900183030000900272065000900281
064000500290014000600295865000900301002001200310035001000322801000900332#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#c#134#6#article#16#6#^rND^sBarrell
^nGV#^rND^sCooper^nPJ#^rND^sElkington^nAR#^rND^sMacFadyen^nJM#^rND^sPowell^nRG#^
rND^sTormey^nP.#Squash ball to eye ball: the likelihood of squash players in occ
urring an eye injury^len#Br Med J#19810000#1981#893-5#19990800#v5n4a04.htm#0007-
1447#Br Med J##
00570000000000289000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100017000740100016000910100
02500107012006500132030001400197065000900211064000500220031000400225014000600229
865000900235002001200244035001000256801001400266#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a04.htm#S#c#135#7#article#16#7#^rND^sFilipe^nJA#^rND^sBarros^nH#^rND
^sCastro-Correia^nJ.#Sports related ocular injuries. A three year follow-up stud
y^len#Ophthalmology#19970000#1997#104#313-8#19990800#v5n4a04.htm#0161-6420#Ophth
almology##
00651000000000289000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100018000740100019000920100
01800111012013900129030001900268065000900287064000500296031000300301014000700304
865000900311002001200320035001000332801001900342#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a04.htm#S#c#136#8#article#16#8#^rND^sMizusawa^nK#^rND^sSweeting^nRL#
^rND^sKnouse^nSB.#Comparative studies of color fields, visual acuity fields and 
movement perception limits among varsity athletes and non-varsity groups^len#Per
cept Mot Skills#19830000#1983#56#887-92#19990800#v5n4a04.htm#0031-5125#Percept M
ot Skills##
00462000000000253000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100015000740120056000890300
01600145710000200161065000900163064000500172031000300177014000700180865000900187
002001200196#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#c#137#9#articl
e#16#9#^rND^sErie^nJC#Eye injuries: prevention, evaluation, and treatment^len#Ph
ys Sports Med#2#19910000#1991#19#108-22#19990800#v5n4a04.htm##
00570000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100016000950100
02000111010002200131012003200153030001400185065000900199064000500208031000300213
014000700216865000900223002001200232035001000244801001400254#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a04.htm#S#c#138#10#article#16#10#^rND^sLarrison^nWI#^rND
^sHersh^nPS#^rND^sKunzweiler^nT#^rND^sShingleton^nBJ.#Sport-related ocular traum
a^len#Ophthalmology#19900000#1990#97#1265-9#19990800#v5n4a04.htm#0161-6420#Ophth
almology##
00539000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100017000950120
05300112030002000165065000900185064000500194031000300199014000800202865000900210
002001200219035001000231801002000241#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a04.htm#S#c#139#11#article#16#11#^rND^sStrahlman^nE#^rND^sSommer^nA.#The epidemi
ology of sports-related ocular trauma^len#Int Ophthalmol Clin#19880000#1988#28#1
99-202#19990800#v5n4a04.htm#0020-8167#Int Ophthalmol Clin##
00488000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760120032000940160
01600126018003500142062000500177031000300182020000200185065000900187064000500196
865000900201002001200210#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#c#
140#12#article#16#12#^rND^sVinger^nPF.#The eye and sports medicine^len#^rED^sTas
man^nW#Duane's clinical ophthalmology^len#Chap#45#5#19940000#1994#19990800#v5n4a
04.htm##
00414000000000229000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160021000760180035000970200
00200132062001500134065000900149064000500158865000900163002001200172#v5n4#V:\Sci
ELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#c#141#13#article#16#13#^rED^sLeydhecke
r^nW.#Os glaucomas na prática médica^lpt#3#Editora Manole#19800000#1980#19990800
#v5n4a04.htm##
00419000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160017000760160017000930180
02300110063000200133062000700135065000900142064000500151865000900156002001200165
#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#c#142#14#article#16#14#^rN
D^sVaughan^nD#^rND^sAsbury^nT.#Oftalmologia geral^lpt#2#Ateneu#19830000#1983#199
90800#v5n4a04.htm##
00591000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100015000950100
01600110010001700126010001800143012006400161030001900225710000200244065000900246
064000500255031000300260014000500263865000900268002001200277#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a04.htm#S#c#143#15#article#16#15#^rND^sVerdaguer^nJ#^rND
^sRojas^nB#^rND^sIbanez^nS#^rND^sLeghuga^nM#^rND^sSchmidt^nA.#Desprendimiento re
tinal por pelotazo en el juego del fútbol^les#Arch Chil Oftalmol#2#19810000#1981
#38#31-6#19990800#v5n4a04.htm##
00579000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730120165000760300014002410650
00900255064000500264031000400269014000700273865000900280002001200289035001000301
801001400311#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a04.htm#S#c#144#16#artic
le#16#16#A Joint Statement of the American Academy of Pediatrics and the America
n Academy of Ophthalmology, February 1995 and 1996. Protective eyewear for young
 athletes^len#Ophthalmology#19960000#1996#103#1325-8#19990800#v5n4a04.htm#0161-6
420#Ophthalmology##
00271000000000169000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670910009000690920007000780020012000857030
00400097#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#o#1#1#article#1#20
110405#115556#v5n4a05.htm#101##
02616000000000529000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000400087121000300091049000800094158000300102030002100105
03100020012603200020012806500090013001400110013903500100015001200680016001200690
02280100033002970100022003300100024003520830752003760850008011280850029011360850
03301165085002501198083072701223085000801950085003001958085003401988085002702022
058001602049117000602065072000302071002001202074#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a05.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#TAB#05#RBME120#nd#Rev Br
as Med Esporte#5#4#19990800#^f144^l146#1517-8692#Reabilitação e condicionamento 
físico após transplante cardíaco^lpt#Rehabilitation and physical training after 
heart transplantation^len#^rND^nGuilherme Veiga^sGuimarães#^rND^nFernando^sBacal
#^rND^nEdimar A.^sBocchi#^lpt^aNas últimas décadas a prática regular de atividad
e física tem sido estimulada entre pessoas saudáveis e pacientes cardiopatas. Os
 programas de reabilitação cardíaca têm objetivos profiláticos e terapêuticos. E
ntretanto, existem poucos relatos de programas de reabilitação e condicionamento
 físico pós-transplante cardíaco no Brasil. O presente trabalho relata a experiê
ncia dos autores com pacientes pós-transplante cardíaco submetidos a programa de
 reabilitação física, na fase hospitalar e pós-alta hospitalar em programas de c
ondicionamento físico supervisionados e não supervisionados. Finalmente, é apres
entado o guia de reabilitação e condicionamento físico pós-transplante cardíaco,
 com indicações e contra-indicações para o procedimento.#^dnd^i1#^tm^lpt^kExercí
cio físico^i1#^tm^lpt^kTransplante cardíaco^i1#^tm^lpt^kReabilitação^i1#^len^aIn
 the last decades, the regular practice of physical activity has been stimulated
 among healthy people and cardiac patients. Cardiac rehabilitation programs have
 prophylactic and therapeutic objectives. However, there are few reports of reha
bilitation programs and physical training after heart transplantation in Brazil.
 The present paper reports the authors' experience with patients after heart tra
nsplantation, undergoing a physical rehabilitation program, in-hospital and ambu
latorial phases, in physical training programs, both supervised and non-supervis
ed. Finally, a guide of rehabilitation and physical training post heart transpla
ntation is presented, with indications and contraindications to the procedure.#^
dnd^i2#^tm^len^kPhysical training^i2#^tm^len^kHeart transplantation^i2#^tm^len^k
Rehabilitation^i2#Délcio Teixeira#other#08#v5n4a05.htm##
02630000000000529000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000400087121000300091049000800094158000300102030002100105
03100020012603200020012806500090013001400110013903500100015001200750016001200760
02350100033003110100022003440100024003660830752003900850008011420850029011500850
03301179085002501212083072701237085000801964085003001972085003402002085002702036
058001602063117000602079072000302085002001202088#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a05.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#TAB#05#RBME120#nd#Rev Br
as Med Esporte#5#4#19990800#^f144^l146#1517-8692#<b>Reabilitação e condicionamen
to físico após transplante cardíaco</b>^lpt#<b>Rehabilitation and physical train
ing after heart transplantation</b>^len#^rND^nGuilherme Veiga^sGuimarães#^rND^nF
ernando^sBacal#^rND^nEdimar A.^sBocchi#^lpt^aNas últimas décadas a prática regul
ar de atividade física tem sido estimulada entre pessoas saudáveis e pacientes c
ardiopatas. Os programas de reabilitação cardíaca têm objetivos profiláticos e t
erapêuticos. Entretanto, existem poucos relatos de programas de reabilitação e c
ondicionamento físico pós-transplante cardíaco no Brasil. O presente trabalho re
lata a experiência dos autores com pacientes pós-transplante cardíaco submetidos
 a programa de reabilitação física, na fase hospitalar e pós-alta hospitalar em 
programas de condicionamento físico supervisionados e não supervisionados. Final
mente, é apresentado o guia de reabilitação e condicionamento físico pós-transpl
ante cardíaco, com indicações e contra-indicações para o procedimento.#^dnd^i1#^
tm^lpt^kExercício físico^i1#^tm^lpt^kTransplante cardíaco^i1#^tm^lpt^kReabilitaç
ão^i1#^len^aIn the last decades, the regular practice of physical activity has b
een stimulated among healthy people and cardiac patients. Cardiac rehabilitation
 programs have prophylactic and therapeutic objectives. However, there are few r
eports of rehabilitation programs and physical training after heart transplantat
ion in Brazil. The present paper reports the authors' experience with patients a
fter heart transplantation, undergoing a physical rehabilitation program, in-hos
pital and ambulatorial phases, in physical training programs, both supervised an
d non-supervised. Finally, a guide of rehabilitation and physical training post 
heart transplantation is presented, with indications and contraindications to th
e procedure.#^dnd^i2#^tm^len^kPhysical training^i2#^tm^len^kHeart transplantatio
n^i2#^tm^len^kRehabilitation^i2#Délcio Teixeira#other#08#v5n4a05.htm##
02744000000000553000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670640013000690710003000820400003000850010
00600088042000200094120000400096038000400100121000300104049000800107158000300115
03000240011803100020014203200020014406500090014601400110015503500100016601200680
01760120069002440100033003130100022003460100023003680830752003910850008011430850
02901151085003301180085002501213083072701238085000801965085003001973085003402003
085002702037058001602064117000602080072000302086002001202089008008902101#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#l#4#1#article#1#^mago.^a1999#oa#pt
#br1.1#1#4.0#tab#05#RBME120#nd#Rev. bras. med. esporte#5#4#19990800#^f144^l146#1
517-8692#Reabilitação e condicionamento físico após transplante cardíaco^lpt#Reh
abilitation and physical training after heart transplantation^len#^rND^nGuilherm
e Veiga^sGuimarães#^rND^nFernando^sBacal#^rND^nEdimar A^sBocchi#^lpt^aNas última
s décadas a prática regular de atividade física tem sido estimulada entre pessoa
s saudáveis e pacientes cardiopatas. Os programas de reabilitação cardíaca têm o
bjetivos profiláticos e terapêuticos. Entretanto, existem poucos relatos de prog
ramas de reabilitação e condicionamento físico pós-transplante cardíaco no Brasi
l. O presente trabalho relata a experiência dos autores com pacientes pós-transp
lante cardíaco submetidos a programa de reabilitação física, na fase hospitalar 
e pós-alta hospitalar em programas de condicionamento físico supervisionados e n
ão supervisionados. Finalmente, é apresentado o guia de reabilitação e condicion
amento físico pós-transplante cardíaco, com indicações e contra-indicações para 
o procedimento.#^dnd^i1#^tm^lpt^kExercício físico^i1#^tm^lpt^kTransplante cardía
co^i1#^tm^lpt^kReabilitação^i1#^len^aIn the last decades, the regular practice o
f physical activity has been stimulated among healthy people and cardiac patient
s. Cardiac rehabilitation programs have prophylactic and therapeutic objectives.
 However, there are few reports of rehabilitation programs and physical training
 after heart transplantation in Brazil. The present paper reports the authors' e
xperience with patients after heart transplantation, undergoing a physical rehab
ilitation program, in-hospital and ambulatorial phases, in physical training pro
grams, both supervised and non-supervised. Finally, a guide of rehabilitation an
d physical training post heart transplantation is presented, with indications an
d contraindications to the procedure.#^dnd^i2#^tm^len^kPhysical training^i2#^tm^
len^kHeart transplantation^i2#^tm^len^kRehabilitation^i2#Délcio Teixeira#other#0
8#v5n4a05.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S
1517-86921999000400005##
00326000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000300067704009800070002001200168#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#5#1#article#89#<p align="right"><font fa
ce="Verdana" size="2"><b>ARTIGO DE REVIS&Atilde;O</b></font></p>     ^cY#v5n4a05
.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000300067704002200070002001200092#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#6#2#article#89#<p>&nbsp;</p>     ^cY#v5n
4a05.htm##
00409000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000300067704018100070002001200251#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#7#3#article#89#<p><font face="Verdana" s
ize="4"><b><a name="topo"></a>Reabilita&ccedil;&atilde;o    e condicionamento f&
iacute;sico ap&oacute;s transplante card&iacute;aco </b></font></p>     ^cY#v5n4
a05.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000300067704002300070002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#8#4#article#89#<p>&nbsp; </p>     ^cY#v5
n4a05.htm##
00355000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000300067704012700070002001200197#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#9#5#article#89#<p><font face="Verdana" s
ize="3"><b>Rehabilitation and physical training after    heart transplantation</
b></font></p>     ^cY#v5n4a05.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000300068704002300071002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#10#6#article#89#<p>&nbsp; </p>     ^cY#v
5n4a05.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000300068704002300071002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#11#7#article#89#<p>&nbsp; </p>     ^cY#v
5n4a05.htm##
00396000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000300068704016700071002001200238#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#12#8#article#89#<p><font face="Verdana" 
size="2"><b>Guilherme Veiga Guimar&atilde;es<sup>I</sup>;    Fernando Bacal<SUP>
II</SUP>; Edimar A. Bocchi<sup>II</sup></b></font></p>     ^cY#v5n4a05.htm##
00394000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000300068704016500071002001200236#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#13#9#article#89#<p><font face="Verdana" 
size="2">Unidade de Insufici&ecirc;ncia Card&iacute;aca,    Instituto do Cora&cc
edil;&atilde;o, HC/FMUSP &#150; S&atilde;o Paulo, SP     ^cY#v5n4a05.htm##
00289000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704005900072002001200131#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#14#10#article#89#<br>   <sup>I</sup>Fisi
ologista do exerc&iacute;cio    ^cY#v5n4a05.htm##
00284000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704005400072002001200126#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#15#11#article#89#<br>   <sup>II</sup>Car
diologista </font></p>     ^cY#v5n4a05.htm##
00345000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704011500072002001200187#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#16#12#article#89#<p><font face="Verdana"
 size="2"><a href="#send">Endere&ccedil;o para correspond&ecirc;ncia</a></font><
/p>     ^cY#v5n4a05.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002200072002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#17#13#article#89#<p>&nbsp;</p>     ^cY#v
5n4a05.htm##
00274000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704004400072002001200116#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#18#14#article#89#<p>&nbsp;</p> <hr size=
"1" noshade>     ^cY#v5n4a05.htm##
00296000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704006600072002001200138#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#19#15#article#89#<p><font face="Verdana"
 size="2"><B>RESUMO</B></font></p>     ^cY#v5n4a05.htm##
01307000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704107700072002001201149#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#20#16#article#89#<p><font face="Verdana"
 size="2">Nas &uacute;ltimas d&eacute;cadas a pr&aacute;tica    regular de ativi
dade f&iacute;sica tem sido estimulada entre pessoas saud&aacute;veis    e pacie
ntes cardiopatas. Os programas de reabilita&ccedil;&atilde;o card&iacute;aca    
t&ecirc;m objetivos profil&aacute;ticos e terap&ecirc;uticos. Entretanto, existe
m    poucos relatos de programas de reabilita&ccedil;&atilde;o e condicionamento
    f&iacute;sico p&oacute;s-transplante card&iacute;aco no Brasil. O presente t
rabalho    relata a experi&ecirc;ncia dos autores com pacientes p&oacute;s-trans
plante    card&iacute;aco submetidos a programa de reabilita&ccedil;&atilde;o f&
iacute;sica,    na fase hospitalar e p&oacute;s-alta hospitalar em programas de 
condicionamento    f&iacute;sico supervisionados e n&atilde;o supervisionados. F
inalmente, &eacute;    apresentado o guia de reabilita&ccedil;&atilde;o e condic
ionamento f&iacute;sico    p&oacute;s-transplante card&iacute;aco, com indica&cc
edil;&otilde;es e contra-indica&ccedil;&otilde;es    para o procedimento. </font
></p>     ^cY#v5n4a05.htm##
00420000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704019000072002001200262#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#21#17#article#89#<p><font face="Verdana"
 size="2"><B>Palavras-chave:</B> Exerc&iacute;cio f&iacute;sico.    Transplante 
card&iacute;aco. Reabilita&ccedil;&atilde;o. </font></p> <hr size="1" noshade>  
   ^cY#v5n4a05.htm##
00299000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704006900072002001200141#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#22#18#article#89#<p><font face="Verdana"
 size="2"><B>ABSTRACT</B> </font></p>     ^cY#v5n4a05.htm##
01031000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704080100072002001200873#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#23#19#article#89#<p><font face="Verdana"
 size="2">In the last decades, the regular practice of    physical activity has 
been stimulated among healthy people and cardiac patients.    Cardiac rehabilita
tion programs have prophylactic and therapeutic objectives.    However, there ar
e few reports of rehabilitation programs and physical training    after heart tr
ansplantation in Brazil. The present paper reports the authors'    experience wi
th patients after heart transplantation, undergoing a physical    rehabilitation
 program, in-hospital and ambulatorial phases, in physical training    programs,
 both supervised and non-supervised. Finally, a guide of rehabilitation    and p
hysical training post heart transplantation is presented, with indications    an
d contraindications to the procedure. </font></p>     ^cY#v5n4a05.htm##
00384000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704015400072002001200226#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#24#20#article#89#<p><font face="Verdana"
 size="2"><B>Key words:</B> Physical training. Heart transplantation.    Rehabil
itation. </font></p> <hr size="1" noshade>     ^cY#v5n4a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002300072002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#25#21#article#89#<p>&nbsp; </p>     ^cY#
v5n4a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002300072002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#26#22#article#89#<p>&nbsp; </p>     ^cY#
v5n4a05.htm##
00981000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704075100072002001200823#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#27#23#article#89#<p><font face="Verdana"
 size="2">Um n&uacute;mero crescente de evid&ecirc;ncias    demonstra, com algum
as controv&eacute;rsias, que a inatividade f&iacute;sica    e os maus h&aacute;b
itos de vida, como a alimenta&ccedil;&atilde;o inadequada,    tabagismo, estress
e emocional e consumo excessivo de &aacute;lcool, provocam    uma s&eacute;ria a
mea&ccedil;a a nosso organismo, podendo causar altera&ccedil;&otilde;es    na ca
pacidade funcional. Assim, problemas comuns e s&eacute;rios, como a doen&ccedil;
a    arterial coronariana, hipertens&atilde;o arterial, obesidade, ansiedade, de
press&atilde;o,    sedentarismo e problemas de coluna, t&ecirc;m sido relacionad
os, direta ou indiretamente,    com o estilo de vida<SUP>1,2</SUP>. </font></p> 
    ^cY#v5n4a05.htm##
00559000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704032900072002001200401#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#28#24#article#89#<p><font face="Verdana"
 size="2">A atividade f&iacute;sica regular tem tido um    papel importante na m
elhora da qualidade de vida, tanto para indiv&iacute;duos    saud&aacute;veis co
mo em pacientes cardiopatas, quer seja na fase prim&aacute;ria    como na secund
&aacute;ria da doen&ccedil;a card&iacute;aca. </font></p>     ^cY#v5n4a05.htm##
01378000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704114800072002001201220#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#29#25#article#89#<p><font face="Verdana"
 size="2">Os pacientes cardiopatas submetidos ao transplante    card&iacute;aco 
(op&ccedil;&atilde;o de tratamento para o est&aacute;gio final    da insufici&ec
irc;ncia card&iacute;aca congestiva refrat&aacute;ria &agrave;    terap&ecirc;ut
ica medicamentosa) apresentam melhora da qualidade de vida p&oacute;s-transplant
e.    Por&eacute;m, freq&uuml;entemente apresentam similares problemas cl&iacute
;nicos    no p&oacute;s-operat&oacute;rio, como o descondicionamento f&iacute;si
co, atrofia    e fraqueza dos m&uacute;sculos e menor capacidade aer&oacute;bia 
m&aacute;xima,    decorrentes em parte da inatividade pr&eacute;-operat&oacute;r
ia e de fatores    como diferen&ccedil;a de superf&iacute;cie corporal doador/re
ceptor e denerva&ccedil;&atilde;o    do cora&ccedil;&atilde;o<SUP>3,4</SUP>. A t
erapia imunossupressora, que ajuda    o receptor a tolerar o cora&ccedil;&atilde
;o do doador, limita ainda mais a    capacidade f&iacute;sica, assim como os epi
s&oacute;dios de rejei&ccedil;&atilde;o    ou sintomas que sugiram redu&ccedil;&
atilde;o do desempenho cardiocirculat&oacute;rio<SUP>3</SUP>.    </font></p>    
 ^cY#v5n4a05.htm##
00740000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704051000072002001200582#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#30#26#article#89#<p><font face="Verdana"
 size="2">A atividade f&iacute;sica regular tem um papel    importante na terap&
ecirc;utica n&atilde;o medicamentosa dos transplantados,    devendo ser iniciada
 o mais precocemente poss&iacute;vel na fase hospitalar,    dando prosseguimento
 p&oacute;s-alta hospitalar, para que possam retornar a    um estilo de vida sem
elhante ao que tinham antes da doen&ccedil;a, permitindo    conv&iacute;vio soci
al satisfat&oacute;rio, com vida ativa e produtiva<SUP>5</SUP>.    </font></p>  
   ^cY#v5n4a05.htm##
01866000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704163600072002001201708#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#31#27#article#89#<p><font face="Verdana"
 size="2">Na fase hospitalar, d&aacute;-se in&iacute;cio    ao programa de condi
cionamento f&iacute;sico, assim que ocorra o restabelecimento    hemodin&acirc;m
ico e o desmame das drogas endovenosas dos pacientes, exceto    aqueles que tran
sitoriamente apresentem uma contra-indica&ccedil;&atilde;o<SUP>4,5</SUP>.    Ess
a fase pode ser considerada como o processo de restaura&ccedil;&atilde;o    f&ia
cute;sica, psicol&oacute;gica e social dos transplantados. O programa de    reab
ilita&ccedil;&atilde;o f&iacute;sica utilizado nesta fase &eacute; o proposto   
 pela Universidade de Stanford, que consiste em exerc&iacute;cios aer&oacute;bio
s    em cicloerg&ocirc;metro, come&ccedil;ando com cinco minutos de dura&ccedil;
&atilde;o,    com progress&atilde;o di&aacute;ria at&eacute; 25 minutos, velocid
ade de 40    a 60rpm em carga livre; a partir da&iacute;, ser&aacute; introduzid
a carga com    aumento gradual e progressivo e/ou caminhada em esteira/corredor,
 iniciando    com dez minutos de dura&ccedil;&atilde;o, com aumento di&aacute;ri
o at&eacute;    30 minutos, com velocidade de 1,5 a 3mph ou 40 a 80 passos/min.,
 ambos com monitora&ccedil;&atilde;o    da freq&uuml;&ecirc;ncia card&iacute;aca
, do cansa&ccedil;o subjetivo (escala    de Borg) e da press&atilde;o arterial e
m repouso, na metade, no final da atividade    e na recupera&ccedil;&atilde;o. E
m nossa experi&ecirc;ncia nessa fase, al&eacute;m    do programa aer&oacute;bio 
proposto, tamb&eacute;m iniciamos um trabalho leve    de mobilidade articular, d
e flexibilidade e de resist&ecirc;ncia dos grandes    grupos musculares. </font>
</p>     ^cY#v5n4a05.htm##
01313000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704108300072002001201155#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#32#28#article#89#<p><font face="Verdana"
 size="2">A denerva&ccedil;&atilde;o do cora&ccedil;&atilde;o    transplantado r
esulta em perda do controle direto do sistema nervoso aut&ocirc;nomo    com alte
ra&ccedil;&otilde;es hemodin&acirc;micas, respirat&oacute;rias e metab&oacute;li
cas    em repouso e durante o exerc&iacute;cio (<a href="#tab1">tabela 1</a>).</
font><font face="Verdana" size="2">    Portanto, &eacute; importante ressaltar q
ue, em fun&ccedil;&atilde;o da denerva&ccedil;&atilde;o,    no in&iacute;cio do 
exerc&iacute;cio e no exerc&iacute;cio subm&aacute;ximo,    a resposta da eleva&
ccedil;&atilde;o do d&eacute;bito card&iacute;aco &eacute;    mediada pelo aumen
to na pr&eacute;-carga, via mecanismo de Frank-Starling, e    o aumento da freq&
uuml;&ecirc;ncia card&iacute;aca e da press&atilde;o arterial    durante o exerc
&iacute;cio passa a depender do n&iacute;vel de catecolaminas    circulantes, e 
isso est&aacute; relacionado com a massa muscular envolvida,    bem como com a i
ntensidade e dura&ccedil;&atilde;o da atividade f&iacute;sica<SUP>6,7</SUP>.    
</font></p>     ^cY#v5n4a05.htm##
00265000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704003500072002001200107#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#33#29#article#89#<p><a name="tab1"></a><
/p>     ^cY#v5n4a05.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002200072002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#34#30#article#89#<p>&nbsp;</p>     ^cY#v
5n4a05.htm##
00309000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704007900072002001200151#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#35#31#article#89#<p align="center"><img 
src="/img/revistas/rbme/v5n4/a05tab01.gif"></p>     ^cY#v5n4a05.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002200072002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#36#32#article#89#<p>&nbsp;</p>     ^cY#v
5n4a05.htm##
01131000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704090100072002001200973#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#37#33#article#89#<p><font face="Verdana"
 size="2">Na fase p&oacute;s-alta hospitalar, quando a    capacidade f&iacute;si
ca geralmente &eacute; desconhecida, recomenda-se a utiliza&ccedil;&atilde;o    
de exerc&iacute;cios de baixa intensidade, tr&ecirc;s vezes por semana, com    s
ess&otilde;es de 60 minutos, mantendo-se o padr&atilde;o da fase hospitalar,    
com o intuito de melhor adapta&ccedil;&atilde;o hemodin&acirc;mica e muscular.  
  Ap&oacute;s um m&ecirc;s da alta hospitalar e maior adapta&ccedil;&atilde;o   
 funcional do transplantado, recomenda-se a realiza&ccedil;&atilde;o de um teste
    de esfor&ccedil;o, de prefer&ecirc;ncia com ergoespirometria, para avaliar a
    capacidade cardiopulmonar e para prescri&ccedil;&atilde;o individualizada de
    intensidade em um programa de condicionamento f&iacute;sico adaptado &agrave
;s    condi&ccedil;&otilde;es f&iacute;sicas do paciente. </font></p>     ^cY#v5
n4a05.htm##
01107000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704087700072002001200949#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#38#34#article#89#<p><font face="Verdana"
 size="2">Entretanto, a intensidade adequada para o treinamento    f&iacute;sico
 de transplantados ainda n&atilde;o est&aacute; bem estabelecida.    Certos m&ea
cute;todos t&ecirc;m sido sugeridos por alguns autores para a prescri&ccedil;&at
ilde;o    de atividade f&iacute;sica, como percentual da freq&uuml;&ecirc;ncia c
ard&iacute;aca    m&aacute;xima alcan&ccedil;ada, percentual da freq&uuml;&ecirc
;ncia card&iacute;aca    mais escala de Borg, percentual do consumo m&aacute;xim
o de oxig&ecirc;nio e    limiar ventilat&oacute;rio<SUP>5-8</SUP>. Independente 
do m&eacute;todo de prescri&ccedil;&atilde;o    utilizado no programa de condici
onamento f&iacute;sico regular p&oacute;s-transplante    card&iacute;aco, os pac
ientes t&ecirc;m obtido resultados ben&eacute;ficos,    que s&atilde;o descritos
 na <a href="#tab2">tabela 2</a>. </font></p>     ^cY#v5n4a05.htm##
00265000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704003500072002001200107#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#39#35#article#89#<p><a name="tab2"></a><
/p>     ^cY#v5n4a05.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002200072002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#40#36#article#89#<p>&nbsp;</p>     ^cY#v
5n4a05.htm##
00309000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704007900072002001200151#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#41#37#article#89#<p align="center"><img 
src="/img/revistas/rbme/v5n4/a05tab02.gif"></p>     ^cY#v5n4a05.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002200072002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#42#38#article#89#<p>&nbsp;</p>     ^cY#v
5n4a05.htm##
02553000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704232300072002001202395#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#43#39#article#89#<p><font face="Verdana"
 size="2">Na experi&ecirc;ncia do Instituto do Cora&ccedil;&atilde;o    (InCor),
 o programa supervisionado de condicionamento f&iacute;sico p&oacute;s-transplan
te    card&iacute;aco em adultos e crian&ccedil;as, p&oacute;s-per&iacute;odo de
 adapta&ccedil;&atilde;o,    englobava exerc&iacute;cios de alongamento, mobilid
ade articular, de resist&ecirc;ncia,    exerc&iacute;cios aer&oacute;bios e de r
elaxamento. A dura&ccedil;&atilde;o    do programa foi de 64 semanas, com sess&o
tilde;es de 60 minutos tr&ecirc;s vezes    por semana. A intensidade da atividad
e aer&oacute;bia foi prescrita entre o    limiar anaer&oacute;bio e o ponto de c
ompensa&ccedil;&atilde;o respirat&oacute;rio    obtidos no teste ergoespirom&eac
ute;trico. O aumento de intensidade durante    o programa foi feito de forma pro
gressiva, levando-se em conta a freq&uuml;&ecirc;ncia    card&iacute;aca, press&
atilde;o arterial, escala de Borg e os epis&oacute;dios    de rejei&ccedil;&atil
de;o. A sess&atilde;o foi dividida em cinco minutos de    aquecimento, com exerc
&iacute;cios gerais e de alongamento, 30 minutos de exerc&iacute;cio    aer&oacu
te;bio, bicicleta estacion&aacute;ria ou caminhada/corrida em sess&otilde;es    
alternadas, cinco minutos de recupera&ccedil;&atilde;o ativa, 15 minutos de    e
xerc&iacute;cios localizados mais alongamento e cinco minutos de relaxamento.   
 O programa de atividade f&iacute;sica n&atilde;o supervisionado foi aplicado   
 com base no teste ergoespirom&eacute;trico, tamb&eacute;m adotado pela Institui
&ccedil;&atilde;o    em fun&ccedil;&atilde;o de alguns pacientes que, impossibil
itados de freq&uuml;entar    o servi&ccedil;o de condicionamento f&iacute;sico, 
eram orientados a caminhar    todos os dias, por um per&iacute;odo m&iacute;nimo
 de 30 minutos, em lugares    planos, evitando os hor&aacute;rios mais quentes. 
A reavalia&ccedil;&atilde;o    e a reprograma&ccedil;&atilde;o ocorreram em per&
iacute;odos em m&eacute;dia    de tr&ecirc;s meses, com a realiza&ccedil;&atilde
;o de um novo teste ergoespirom&eacute;trico.    Ao final do programa, houve aum
ento da capacidade f&iacute;sica, por&eacute;m    os maiores benef&iacute;cios d
escritos na <a href="#tab2">tabela 2</a> foram    observados nos pacientes que p
articiparam do programa supervisionado. </font></p>     ^cY#v5n4a05.htm##
00604000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704037400072002001200446#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#44#40#article#89#<p><font face="Verdana"
 size="2">Em resumo, a atividade f&iacute;sica regular    p&oacute;s-transplante
 card&iacute;aco contribui para o restabelecimento mais    r&aacute;pido da capa
cidade f&iacute;sica, possibilitando aos pacientes voltarem    a realizar a maio
ria de suas atividades di&aacute;rias e tamb&eacute;m as recreativas    mais pre
cocemente. </font></p>     ^cY#v5n4a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002300072002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#45#41#article#89#<p>&nbsp; </p>     ^cY#
v5n4a05.htm##
00405000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704017500072002001200247#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#46#42#article#89#<p> <font face="Verdana
" size="3"><B>GUIA DE REABILITA&Ccedil;&Atilde;O E CONDICIONAMENTO    F&Iacute;S
ICO P&Oacute;S-TRANSPLANTE CARD&Iacute;ACO </b></font></p> <B>      ^cY#v5n4a05.
htm##
00298000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704006800072002001200140#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#47#43#article#89#<p><font face="Verdana"
 size="2">Classe I:</font></p> </B>      ^cY#v5n4a05.htm##
00414000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704018400072002001200256#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#48#44#article#89#<p><font face="Verdana"
 size="2">Condi&ccedil;&otilde;es em que h&aacute; evid&ecirc;ncia    e/ou conse
nso de que dado procedimento &eacute; eficaz ou &uacute;til; </font></p>     ^cY
#v5n4a05.htm##
00337000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704010700072002001200179#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#49#45#article#89#<p><font face="Verdana"
 size="2">1)reabilita&ccedil;&atilde;o f&iacute;sica precoce    </font></p>     
^cY#v5n4a05.htm##
00346000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704011600072002001200188#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#50#46#article#89#<p><font face="Verdana"
 size="2">2)programa de condicionamento f&iacute;sico supervisionado;    </font>
</p>     ^cY#v5n4a05.htm##
00426000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704019600072002001200268#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#51#47#article#89#<p><font face="Verdana"
 size="2">3)teste de esfor&ccedil;o de prefer&ecirc;ncia    com ergoespirometria
, para posterior prescri&ccedil;&atilde;o de atividade f&iacute;sica.    </font>
</p>     ^cY#v5n4a05.htm##
00301000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704007100072002001200143#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#52#48#article#89#<p><font face="Verdana"
 size="2"><B>Classe II:</B> </font></p>     ^cY#v5n4a05.htm##
00473000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704024300072002001200315#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#53#49#article#89#<p><font face="Verdana"
 size="2">Condi&ccedil;&atilde;o em que h&aacute; evid&ecirc;ncias    conflitant
es e/ou diverg&ecirc;ncia de opini&atilde;o a respeito da utilidade    e efic&aa
cute;cia de procedimento ou tratamento; </font></p>     ^cY#v5n4a05.htm##
00370000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704014000072002001200212#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#54#50#article#89#<p><font face="Verdana"
 size="2">II a &#150; Evid&ecirc;ncia ou opini&atilde;o    que favorece utilidad
e do tratamento: </font></p>     ^cY#v5n4a05.htm##
00357000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704012700072002001200199#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#55#51#article#89#<p><font face="Verdana"
 size="2">1)programa de condicionamento f&iacute;sico n&atilde;o    supervisiona
do; </font></p>     ^cY#v5n4a05.htm##
00344000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704011400072002001200186#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#56#52#article#89#<p><font face="Verdana"
 size="2">2)trabalho de resist&ecirc;ncia muscular com    baixa carga; </font></
p>     ^cY#v5n4a05.htm##
00361000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704013100072002001200203#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#57#53#article#89#<p><font face="Verdana"
 size="2">II b &#150; Evid&ecirc;ncia ou opini&atilde;o    &eacute; menos estabe
lecida: </font></p>     ^cY#v5n4a05.htm##
00360000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704013000072002001200202#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#58#54#article#89#<p><font face="Verdana"
 size="2">1)participa&ccedil;&atilde;o em jogos competitivos    sem supervis&ati
lde;o; </font></p>     ^cY#v5n4a05.htm##
00353000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704012300072002001200195#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#59#55#article#89#<p><font face="Verdana"
 size="2">2)atividade f&iacute;sica espor&aacute;dica de    grande intensidade. 
</font></p>     ^cY#v5n4a05.htm##
00302000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704007200072002001200144#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#60#56#article#89#<p><font face="Verdana"
 size="2"><B>Classe III:</B> </font></p>     ^cY#v5n4a05.htm##
00459000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704022900072002001200301#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#61#57#article#89#<p><font face="Verdana"
 size="2">Condi&ccedil;&atilde;o em que h&aacute; evid&ecirc;ncia    e/ou consen
so de que o procedimento/tratamento n&atilde;o &eacute; &uacute;til    e em algu
ns casos pode ser nocivo. </font></p>     ^cY#v5n4a05.htm##
00319000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704008900072002001200161#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#62#58#article#89#<p><font face="Verdana"
 size="2">1)instabilidade hemodin&acirc;mica; </font></p>     ^cY#v5n4a05.htm##
00351000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704012100072002001200193#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#63#59#article#89#<p><font face="Verdana"
 size="2">2)epis&oacute;dio de rejei&ccedil;&atilde;o de    moderado a grave; </
font></p>     ^cY#v5n4a05.htm##
00321000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704009100072002001200163#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#64#60#article#89#<p><font face="Verdana"
 size="2">3)processo de infec&ccedil;&atilde;o; </font></p>     ^cY#v5n4a05.htm#
#
00412000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704018200072002001200254#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#65#61#article#89#<p><font face="Verdana"
 size="2">4)limita&ccedil;&atilde;o cl&iacute;nica, ortop&eacute;dica    e neuro
l&oacute;gica que impossibilite a atividade f&iacute;sica. </font></p>     ^cY#v
5n4a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002300072002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#66#62#article#89#<p>&nbsp; </p>     ^cY#
v5n4a05.htm##
00305000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704007500072002001200147#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#67#63#article#89#<p><font face="Verdana"
 size="3"><B>AGRADECIMENTOS</B> </font></p>     ^cY#v5n4a05.htm##
00398000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704016800072002001200240#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#68#64#article#89#<p><font face="Verdana"
 size="2">Agradecemos a D&eacute;lcio Teixeira pela colabora&ccedil;&atilde;o   
 na revis&atilde;o da reda&ccedil;&atilde;o. </font></p>     ^cY#v5n4a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002300072002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#69#65#article#89#<p>&nbsp; </p>     ^cY#
v5n4a05.htm##
00308000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704007800072002001200150#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#70#66#article#89#<p><font face="Verdana"
 size="3"><B>REFER&Ecirc;NCIAS</B> </font></p>     ^cY#v5n4a05.htm##
00377000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069888000200072704013300074002001200207#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#p#71#67#article#89#1#<p><font 
face="Verdana" size="2">1. Gohlke H, Gohlke-B&auml;rwolf C. Cardiac rehabilitati
on.    Eur Heart J 1998; 19:1004-10.    ^cY#v5n4a05.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002100072002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#72#68#article#89# </font></p>     ^cY#v5
n4a05.htm##
00447000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069888000200072704020300074002001200277#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#p#73#69#article#89#2#<p><font 
face="Verdana" size="2">2. Thompson DR, Bowman GS, Kitson AL, Bono DP,    Hopkin
s A. Cardiac rehabilitation in the United Kingdom: guidelines and adult    stand
ards. Heart 1996;75:89-93.    ^cY#v5n4a05.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002100072002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#74#70#article#89# </font></p>     ^cY#v5
n4a05.htm##
00388000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069888000200072704014400074002001200218#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#p#75#71#article#89#3#<p><font 
face="Verdana" size="2">3. Squires RW. Exercise training after cardiac    transp
lantation. Med Sci Sports Exerc 1991;23:686-94.    ^cY#v5n4a05.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002100072002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#76#72#article#89# </font></p>     ^cY#v5
n4a05.htm##
00451000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069888000200072704020700074002001200281#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#p#77#73#article#89#4#<p><font 
face="Verdana" size="2">4. Ferraz AS, Arakaki H. Atividade f&iacute;sica    e qu
alidade de vida ap&oacute;s transplante card&iacute;aco. Rev Soc Cardiol    Est 
S&atilde;o Paulo 1995;5:670-8.    ^cY#v5n4a05.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002100072002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#78#74#article#89# </font></p>     ^cY#v5
n4a05.htm##
00544000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069888000200072704030000074002001200374#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#p#79#75#article#89#5#<p><font 
face="Verdana" size="2">5. Yazbek Jr P, Battistella LR. Condicionamento    f&iac
ute;sico do atleta ao transplante: aspectos multidisciplinares na preven&ccedil;
&atilde;o    e reabilita&ccedil;&atilde;o card&iacute;aca. 1&#170; ed. S&atilde;
o Paulo:    Sarvier &#150; APM, 1994:201-9.    ^cY#v5n4a05.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002100072002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#80#76#article#89# </font></p>     ^cY#v5
n4a05.htm##
00435000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069888000200072704019100074002001200265#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#p#81#77#article#89#6#<p><font 
face="Verdana" size="2">6. Kobashigawa JA, Leaf DA, Lee N, et al. A controlled  
  trial of exercise rehabilitation after heart transplantation. N Engl J Med 199
9;340:4,272-7.    ^cY#v5n4a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002400072002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#82#78#article#89#    </font></p>     ^cY
#v5n4a05.htm##
00455000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069888000200072704021100074002001200285#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#p#83#79#article#89#7#<p><font 
face="Verdana" size="2">7. Lampert E, Mettauer B, Hoppeler H, et al.    Skeletal
 muscle response to short endurance training in heart transplant recipients.    
J Am Coll Cardiol 1998;32:2,420-6.    ^cY#v5n4a05.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002100072002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#84#80#article#89# </font></p>     ^cY#v5
n4a05.htm##
00388000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069888000200072704014400074002001200218#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#p#85#81#article#89#8#<p><font 
face="Verdana" size="2">8. McCartney N. Role of resistance training in    heart 
disease. Med Sci Sports Exerc 1998;30:S396-402.    ^cY#v5n4a05.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002100072002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#86#82#article#89# </font></p>     ^cY#v5
n4a05.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002200072002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#87#83#article#89#<p>&nbsp;</p>     ^cY#v
5n4a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704002300072002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#88#84#article#89#<p>&nbsp; </p>     ^cY#
v5n4a05.htm##
00418000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704018800072002001200260#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#89#85#article#89#<p><font face="Verdana"
 size="2"><b><a name="send"></a><a href="#topo"><img src="/img/revistas/rbme/v5n
4/seta.gif" border="0"></a>    Endere&ccedil;o para correspond&ecirc;ncia</b>   
 ^cY#v5n4a05.htm##
00277000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704004700072002001200119#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#90#86#article#89#<br>   Guilherme Veiga 
Guimar&atilde;es    ^cY#v5n4a05.htm##
00268000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704003800072002001200110#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#91#87#article#89#<br>   Rua Dr. Baeta Ne
ves, 98    ^cY#v5n4a05.htm##
00282000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704005200072002001200124#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#92#88#article#89#<br>   05444-050 &#150;
 S&atilde;o Paulo, SP    ^cY#v5n4a05.htm##
00315000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000300069704008500072002001200157#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a05.htm#S#p#93#89#article#89#<br>   E-mail: <a href=
"mailto:gvguma@usp.br">gvguma@usp.br</a> </font> </p>     ^cY#v5n4a05.htm##
00498000000000277000450000400050000070200460000570500020005170600020005370000030
00557010002000587090008000607080002000681180002000700100016000720100025000880120
02700113030001200140065000900152064000500161031000300166014000800169865000900177
002001200186035001000198801001200208#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a05.htm#S#c#94#1#article#8#1#^rND^sGohlke^nH#^rND^sGohlke-Bärwolf^nC.#Cardiac re
habilitation^len#Eur Heart J#19980000#1998#19#1004-10#19990800#v5n4a05.htm#0195-
668X#Eur Heart J##
00619000000000313000450000400050000070200460000570500020005170600020005370000030
00557010002000587090008000607080002000681180002000700100019000720100017000910100
01700108010001500125010001800140012008100158030000600239065000900245064000500254
031000300259014000600262865000900268002001200277035001000289801000600299#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#c#95#2#article#8#2#^rND^sThompson^
nDR#^rND^sBowman^nGS#^rND^sKitson^nAL#^rND^sBono^nDP#^rND^sHopkins^nA.#Cardiac r
ehabilitation in the United Kingdom: guidelines and adult standards^len#Heart#19
960000#1996#75#89-93#19990800#v5n4a05.htm#1355-6037#Heart##
00505000000000265000450000400050000070200460000570500020005170600020005370000030
00557010002000587090008000607080002000681180002000700100018000720120052000900300
02100142065000900163064000500172031000300177014000700180865000900187002001200196
035001000208801002100218#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#c#
96#3#article#8#3#^rND^sSquires^nRW#Exercise training after cardiac transplantati
on^len#Med Sci Sports Exerc#19910000#1991#23#686-94#19990800#v5n4a05.htm#0195-91
31#Med Sci Sports Exerc##
00515000000000265000450000400050000070200460000570500020005170600020005370000030
00557010002000587090008000607080002000681180002000700100017000720100018000890120
06700107030003000174710000200204065000900206064000500215031000200220014000600222
865000900228002001200237#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#c#
97#4#article#8#4#^rND^sFerraz^nAS#^rND^sArakaki^nH.#Atividade física e qualidade
 de vida após transplante cardíaco^lpt#Rev Soc Cardiol Est São Paulo#2#19950000#
1995#5#670-8#19990800#v5n4a05.htm##
00565000000000265000450000400050000070200460000570500020005170600020005370000030
00557010002000587090008000607080002000681180002000700160019000720160023000910180
11800114063000200232066001000234062001400244065000900258064000500267014000600272
865000900278002001200287#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#c#
98#5#article#8#5#^rND^sYazbek Jr^nP#^rND^sBattistella^nLR.#Condicionamento físic
o do atleta ao transplante: aspectos multidisciplinares na prevenção e reabilita
ção cardíaca^lpt#1#São Paulo#Sarvier - APM#19940000#1994#201-9#19990800#v5n4a05.
htm##
00604000000000313000450000400050000070200460000570500020005170600020005370000030
00557010002000587090008000607080002000681180002000700100022000720100015000940100
01300109810000700122012007800129030001300207065000900220064000500229031000400234
032000200238014000600240865000900246002001200255035001000267801001300277#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#c#99#6#article#8#6#^rND^sKobashiga
wa^nJA#^rND^sLeaf^nDA#^rND^sLee^nN#et al.#A controlled trial of exercise rehabil
itation after heart transplantation^len#N Engl J Med#19990000#1999#340#4#272-7#1
9990800#v5n4a05.htm#0028-4793#N Engl J Med##
00627000000000313000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080002000691180002000710100017000730100018000900100
01800108810000700126012008800133030001800221065000900239064000500248031000300253
032000200256014000600258865000900264002001200273035001000285801001800295#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#c#100#7#article#8#7#^rND^sLampert^
nE#^rND^sMettauer^nB#^rND^sHoppeler^nH#et al.#Skeletal muscle response to short 
endurance training in heart transplant recipients^len#J Am Coll Cardiol#19980000
#1998#32#2#420-6#19990800#v5n4a05.htm#0735-1097#J Am Coll Cardiol##
00507000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080002000691180002000710100020000730120049000930300
02100142065000900163064000500172031000300177014000900180865000900189002001200198
035001000210801002100220#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a05.htm#S#c#
101#8#article#8#8#^rND^sMcCartney^nN.#Role of resistance training in heart disea
se^len#Med Sci Sports Exerc#19980000#1998#30#S396-402#19990800#v5n4a05.htm#0195-
9131#Med Sci Sports Exerc##
00267000000000169000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640910009000660920007000750020012000827030
00300094#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#o#1#1#text#1#20110
405#115559#v5n4a06.htm#94##
00677000000000385000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640710003000660400003000690010006000720420
00200078120000400080038000300084121000300087049000800090158000300098030002100101
03100020012203200020012406500090012601400110013503500100014612300020015601200370
0158010002600195070004900221117000600270072000300276002001200279#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#h#2#1#text#1#oa#pt#br1.1#1#4.0#ND#06#RBME1
20#nd#Rev Bras Med Esporte#5#4#19990800#^f147^l149#1517-8692#1#Atividade física 
e sáude pública^lpt#^rND^1A01^nRicardo^sStein#UFRGS^iA01^1Hospital de Clínicas d
e Porto Alegre#other#14#v5n4a06.htm##
00684000000000385000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640710003000660400003000690010006000720420
00200078120000400080038000300084121000300087049000800090158000300098030002100101
03100020012203200020012406500090012601400110013503500100014612300020015601200440
0158010002600202070004900228117000600277072000300283002001200286#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#f#3#1#text#1#oa#pt#br1.1#1#4.0#ND#06#RBME1
20#nd#Rev Bras Med Esporte#5#4#19990800#^f147^l149#1517-8692#1#<b>Atividade físi
ca e sáude pública</b>^lpt#^rND^1A01^nRicardo^sStein#UFRGS^iA01^1Hospital de Clí
nicas de Porto Alegre#other#14#v5n4a06.htm##
00793000000000397000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640640013000660710003000790400003000820010
00600085042000200091120000400093121000300097049000800100158000300108030002400111
03100020013503200020013706500090013901400110014803500100015912300020016901200370
0171010002600208070005100234117000600285072000300291002001200294008008900306#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#l#4#1#text#1#^mago.^a1999#oa#p
t#br1.1#1#4.0#06#RBME120#nd#Rev. bras. med. esporte#5#4#19990800#^f147^l149#1517
-8692#1#Atividade física e sáude pública^lpt#^rND^1A01^nRicardo^sStein#^iA01^1UF
RGS^2Hospital de Clínicas de Porto Alegre#other#14#v5n4a06.htm#Internet^ihttp://
www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-86921999000400006##
00327000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704010200067002001200169#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#5#1#text#76#<p align="right"><font face=
"Verdana" size="2"><b>ARTIGO DE REVIS&Atilde;O</b>    </font></p>     ^cY#v5n4a0
6.htm##
00247000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704002200067002001200089#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#6#2#text#76#<p>&nbsp;</p>     ^cY#v5n4a0
6.htm##
00361000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704013600067002001200203#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#7#3#text#76#<p><font face="Verdana" size
="4"><b><a name="topo"></a>Atividade f&iacute;sica    e s&aacute;ude p&uacute;bl
ica</b> </font></p>     ^cY#v5n4a06.htm##
00247000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704002200067002001200089#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#8#4#text#76#<p>&nbsp;</p>     ^cY#v5n4a0
6.htm##
00247000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704002200067002001200089#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#9#5#text#76#<p>&nbsp;</p>     ^cY#v5n4a0
6.htm##
00299000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704007300068002001200141#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#10#6#text#76#<p><font face="Verdana" siz
e="2"><b>Ricardo Stein</b></font></p>     ^cY#v5n4a06.htm##
00510000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704028400068002001200352#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#11#7#text#76#<p><font face="Verdana" siz
e="2">Servi&ccedil;o de Cardiologia, Hospital de Cl&iacute;nicas    de Porto Ale
gre &#150; UFRGS, Porto Alegre, RS, Brasil. M&eacute;dico do Esporte;    Mestre 
em Cardiologia pela UFRGS; Professor de Educa&ccedil;&atilde;o F&iacute;sica.</f
ont></p>     ^cY#v5n4a06.htm##
00345000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704011900068002001200187#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#12#8#text#76#<p><font face="Verdana" siz
e="2"><a href="#send">Endere&ccedil;o para correspond&ecirc;ncia</a>    </font><
/p>     ^cY#v5n4a06.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704002300068002001200091#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#13#9#text#76#<p>&nbsp; </p>     ^cY#v5n4
a06.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#14#10#text#76#<p>&nbsp; </p>     ^cY#v5n
4a06.htm##
00637000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704041000069002001200479#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#15#11#text#76#<p><font face="Verdana" si
ze="2">Com a introdu&ccedil;&atilde;o de novas tecnologias    o homem moderno tr
ansformou-se. Se em um passado n&atilde;o t&atilde;o distante    ele era um indi
v&iacute;duo do campo, sendo fisicamente ativo, com as ondas    migrat&oacute;ri
as para as grandes cidades passou a adotar um estilo de vida    urbano, com um c
omportamento tipicamente sedent&aacute;rio. </font></p>     ^cY#v5n4a06.htm##
01013000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704078600069002001200855#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#16#12#text#76#<p><font face="Verdana" si
ze="2">Estudos epidemiol&oacute;gicos<SUP>1,2</SUP>    realizados em pa&iacute;s
es do Hemisf&eacute;rio Norte explicitam uma realidade    que parece n&atilde;o 
ser diferente em nosso meio. Os dados encontrados demonstraram    existir maior 
preval&ecirc;ncia na pr&aacute;tica de atividades f&iacute;sicas    entre as cam
adas mais privilegiadas da popula&ccedil;&atilde;o. Estudos subseq&uuml;entes<SU
P>3,4</SUP>    sugerem que a freq&uuml;&ecirc;ncia na pr&aacute;tica de exerc&ia
cute;cios tenha    aumentado nos &uacute;ltimos 20 anos, embora tal aumento n&at
ilde;o tenha sido    verificado de modo uniforme em todos os estratos sociais da
 popula&ccedil;&atilde;o,    permanecendo a assertiva de que os menos abastados 
exercitam-se menos. </font></p>     ^cY#v5n4a06.htm##
01047000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704082000069002001200889#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#17#13#text#76#<p><font face="Verdana" si
ze="2">No final da d&eacute;cada de 70, Duncan <I>et    al.</I><SUP>5</SUP> real
izaram um estudo observacional representativo da popula&ccedil;&atilde;o    adul
ta de Porto Alegre. Os autores constataram que, na faixa et&aacute;ria entre    
20 e 39 anos, apenas 40% dos homens e 10% das mulheres se exercitavam regularmen
te.    Cabe salientar que, com o aumento na idade, os percentuais de indiv&iacut
e;duos    fisicamente ativos reduziam-se significativamente. Tal achado reflete 
uma realidade    perigosa do ponto de vista de sa&uacute;de p&uacute;blica, uma 
vez que estudos    cl&iacute;nicos e epidemiol&oacute;gicos demonstram existir e
vid&ecirc;ncias    relacionando o sedentarismo com diferentes doen&ccedil;as que
 afetam o homem    contempor&acirc;neo<SUP>1-4</SUP>. </font></p>     ^cY#v5n4a0
6.htm##
00734000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704050700069002001200576#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#18#14#text#76#<p><font face="Verdana" si
ze="2">Por outro lado, a grande maioria dos estudos    realizados com o objetivo
 de determinar o papel da atividade f&iacute;sica em    rela&ccedil;&atilde;o &a
grave; sa&uacute;de demonstrou que a pr&aacute;tica    de exerc&iacute;cios regu
lares em bases cr&ocirc;nicas aponta para um benef&iacute;cio    real. Genericam
ente, um efeito protetor contra doen&ccedil;as cr&ocirc;nico-degenerativas,    e
specialmente as de origem cardiovascular, pode ser esperado. </font></p>     ^cY
#v5n4a06.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002200069002001200091#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#19#15#text#76#<p>&nbsp;</p>     ^cY#v5n4
a06.htm##
00311000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704008400069002001200153#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#20#16#text#76#<p><font face="Verdana" si
ze="3"><B>PREVEN&Ccedil;&Atilde;O</B> </font></p>     ^cY#v5n4a06.htm##
01116000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704088900069002001200958#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#21#17#text#76#<p><font face="Verdana" si
ze="2">Existem evid&ecirc;ncias de que ao exercitar-se    o indiv&iacute;duo ass
ume uma postura positiva em rela&ccedil;&atilde;o a outros    fatores de risco, 
procurando assumir um h&aacute;bito de vida mais saud&aacute;vel.    Logo, ao en
gajar-se em um programa de atividade f&iacute;sica, exercitando-se    de forma r
egular, o praticante passa a dispor de um aliado. Isso pode ser mencionado,    u
ma vez que existe uma rela&ccedil;&atilde;o inversa entre a pr&aacute;tica    de
 exerc&iacute;cios f&iacute;sicos e diferentes h&aacute;bitos n&atilde;o recomen
d&aacute;veis    em se tratando de sa&uacute;de. O exerc&iacute;cio pode ter um 
impacto sobre    o tabagismo, sobre a ingesta cal&oacute;rica inadequada, sobre 
o estresse exagerado,    al&eacute;m de poder atuar sobre a depend&ecirc;ncia de
 &aacute;lcool e de drogas    psicoativas. </font></p>     ^cY#v5n4a06.htm##
02752000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704252500069002001202594#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#22#18#text#76#<p><font face="Verdana" si
ze="2">Estudos prospectivos<SUP>3,6</SUP> sugerem que    exista uma rela&ccedil;
&atilde;o inversa entre o n&iacute;vel de atividade f&iacute;sica    e os &iacut
e;ndices de morbimortalidade cardiovascular em pessoas assintom&aacute;ticas.   
 Em estudo cl&aacute;ssico realizado no final da d&eacute;cada de 70, Paffenbarg
er    <I>et al.</I><SUP>6</SUP> observaram um grupo de ex-alunos da Universidade
 de    Harvard, tendo acompanhado esses sujeitos por um per&iacute;odo de tempo 
que    variou de seis a dez anos. Os autores constataram que aqueles indiv&iacut
e;duos    que apresentavam menor &iacute;ndice de atividade f&iacute;sica labora
l ou nas    horas de lazer tinham maior risco para uma primeira manifesta&ccedil
;&atilde;o    isqu&ecirc;mica. Mais recentemente, 10.224 homens e 3.120 mulheres
 foram seguidos    por Blair <I>et al.</I><SUP>3</SUP>. Nesse estudo longitudina
l que durou cerca    de oito anos, os autores puderam observar que os indiv&iacu
te;duos com menor    capacidade funcional na entrada apresentaram mortalidade su
bseq&uuml;ente maior.    Portanto, todos esses trabalhos t&ecirc;m o m&eacute;ri
to de refor&ccedil;ar    a associa&ccedil;&atilde;o entre a atividade f&iacute;s
ica regular e a preven&ccedil;&atilde;o    de doen&ccedil;as isqu&ecirc;micas do
 cora&ccedil;&atilde;o em popula&ccedil;&otilde;es    aparentemente sadias. No q
ue diz respeito &agrave; preven&ccedil;&atilde;o secund&aacute;ria    da doen&cc
edil;a isqu&ecirc;mica do mioc&aacute;rdio, metan&aacute;lises realizadas    no 
final da d&eacute;cada de 80<SUP>7,8</SUP> sugerem que os programas de reabilita
&ccedil;&atilde;o    card&iacute;aca podem exercer um papel ben&eacute;fico na r
edu&ccedil;&atilde;o    de eventos, pois parece haver diminui&ccedil;&atilde;o n
a mortalidade cardiovascular    global, al&eacute;m de ocorrer diminui&ccedil;&a
tilde;o importante no risco    de morte s&uacute;bita nessa popula&ccedil;&atild
e;o de cardiopatas. Entretanto,    embora exista uma tend&ecirc;ncia favor&aacut
e;vel, a medicina embasada em evid&ecirc;ncias    aguarda novos estudos, em que 
um grande n&uacute;mero de pacientes possa ser    arrolado e seguido por um long
o per&iacute;odo. Somente atrav&eacute;s de estudos    bem delineados, como s&at
ilde;o os ensaios cl&iacute;nicos randomizados, multic&ecirc;ntricos    controla
dos, os achados oriundos das metan&aacute;lises supracitadas poder&atilde;o    s
er definitivamente incorporados como verdades cient&iacute;ficas concretas.    <
/font></p>     ^cY#v5n4a06.htm##
01185000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704095800069002001201027#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#23#19#text#76#<p><font face="Verdana" si
ze="2">Muitos pesquisadores sugerem que o exerc&iacute;cio    f&iacute;sico regu
lar seja capaz de ter impacto significativo sobre a preven&ccedil;&atilde;o    e
/ou controle da hipertens&atilde;o arterial sist&ecirc;mica, <I>diabetes mellitu
s</I>    n&atilde;o insulino-dependente, dislipidemia, obesidade, osteoporose, a
sma br&ocirc;nquica    e outras doen&ccedil;as pulmonares, al&eacute;m de poder 
diminuir sintomas depressivos    e de ansiedade. No entanto, &eacute; importante
 frisar que a pr&aacute;tica    de exerc&iacute;cios tamb&eacute;m possui seus r
iscos. Traumas mec&acirc;nicos,    altera&ccedil;&otilde;es metab&oacute;licas, 
al&eacute;m de problemas psicol&oacute;gicos,    podem advir da atividade f&iacu
te;sica realizada de forma inadequada. O supertreinamento,    assim como esfor&c
cedil;os vigorosos realizados por pessoas n&atilde;o aptas,    pode resultar em 
verdadeiras cat&aacute;strofes. </font></p>     ^cY#v5n4a06.htm##
01038000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704081100069002001200880#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#24#20#text#76#<p><font face="Verdana" si
ze="2">A ocorr&ecirc;ncia de morte s&uacute;bita relacionada    com os esfor&cce
dil;os tamb&eacute;m tem sido observada, principalmente em praticantes    de exe
rc&iacute;cios aer&oacute;bios de longa dura&ccedil;&atilde;o. Portanto,    embo
ra o exerc&iacute;cio seja considerado um fator de prote&ccedil;&atilde;o    par
a a doen&ccedil;a arterial coron&aacute;ria, ele n&atilde;o "imuniza" o indiv&ia
cute;duo    contra tal enfermidade. Logo, cabe salientar que, se a atividade f&i
acute;sica    intensa tem o potencial de aumentar transitoriamente o risco de mo
rte s&uacute;bita,    a atividade f&iacute;sica realizada de forma regular compe
nsa esta possibilidade,    o que se traduz em redu&ccedil;&atilde;o do risco glo
bal para morte s&uacute;bita<SUP>9</SUP>.    </font></p>     ^cY#v5n4a06.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#25#21#text#76#<p>&nbsp; </p>     ^cY#v5n
4a06.htm##
00369000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704014200069002001200211#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#26#22#text#76#<p><font face="Verdana" si
ze="3"><B>RECOMENDA&Ccedil;&Otilde;ES GLOBAIS PARA A    PR&Aacute;TICA DE EXERC&
Iacute;CIOS</B> </font></p>     ^cY#v5n4a06.htm##
01841000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704161400069002001201683#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#27#23#text#76#<p><font face="Verdana" si
ze="2">Na pr&aacute;tica, recomenda-se que todo e qualquer    programa de exerc&
iacute;cio inicie com um per&iacute;odo maior ou menor de    adapta&ccedil;&atil
de;o, j&aacute; que toda experi&ecirc;ncia nova requer aclimata&ccedil;&atilde;o
    gradual. Um per&iacute;odo vari&aacute;vel entre uma e quatro semanas costum
a    ser suficiente. &Eacute; por demais importante que a escolha do tipo de ati
vidade    f&iacute;sica a ser desenvolvida seja feito de acordo com o gosto do p
articipante.    Dessa forma, ao serem respeitados os princ&iacute;pios da adapta
&ccedil;&atilde;o    e da individualidade biol&oacute;gica, a ader&ecirc;ncia &a
grave; pr&aacute;tica    regular e cr&ocirc;nica da atividade f&iacute;sica pass
a a ser facilitada. A    intensidade recomendada deve variar, no mais das vezes,
 entre 60 e 85% da freq&uuml;&ecirc;ncia    card&iacute;aca m&aacute;xima previs
ta para idade (calcula-se FC m&aacute;xima    em batimentos por minuto como send
o 220 menos a idade). Na pr&aacute;tica, pode-se    utilizar a escala de percep&
ccedil;&atilde;o do esfor&ccedil;o de Borg<SUP>10</SUP>    ou simplesmente procu
rar exercitar-se de forma que o indiv&iacute;duo se sinta    algo fatigado, mas 
n&atilde;o exausto. Para determinados tipos de atividades,    como a caminhada o
u a corrida, o uso do "teste da conversa" pode servir como    bom par&acirc;metr
o. Exercitar-se em intensidade que permita conversa&ccedil;&atilde;o,    mesmo q
ue uma leve dispn&eacute;ia esteja presente, d&aacute; uma id&eacute;ia    subje
tiva do grau leve a moderado do esfor&ccedil;o. </font></p>     ^cY#v5n4a06.htm#
#
01338000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704111100069002001201180#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#28#24#text#76#<p><font face="Verdana" si
ze="2">At&eacute; poucos anos atr&aacute;s preconizava-se    que, para fins de p
romo&ccedil;&atilde;o de sa&uacute;de, a atividade f&iacute;sica    deveria ser 
obrigatoriamente de car&aacute;ter cont&iacute;nuo<SUP>11</SUP>.    Sess&otilde;
es tr&ecirc;s a cinco vezes por semana, com dura&ccedil;&atilde;o    vari&aacute
;vel entre 20 e 60 minutos, faziam parte da maioria das prescri&ccedil;&otilde;e
s    de exerc&iacute;cio. Hoje em dia recomenda-se que toda crian&ccedil;a e tod
o    adulto ocupem 30 minutos ou mais do seu dia em atividades f&iacute;sicas de
    intensidade moderada. Atividades intermitentes, sejam elas de car&aacute;ter
    ocupacional, tarefas do dia-a-dia ou ainda realizadas no lazer, fornecem ben
ef&iacute;cio    cardiovascular significativo<SUP>12</SUP>. Por exemplo, 15 minu
tos de atividades    aer&oacute;bias em um determinado per&iacute;odo do dia acr
escidos de outros    15 minutos em outro hor&aacute;rio ao longo das mesmas 24 h
oras parecem ser    adequados em se tratando de preven&ccedil;&atilde;o prim&aac
ute;ria<SUP>12</SUP>.    </font></p>     ^cY#v5n4a06.htm##
00737000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704051000069002001200579#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#29#25#text#76#<p><font face="Verdana" si
ze="2">Diferentes estudos<SUP>11,12</SUP> sugerem que    as atividades r&iacute;
tmicas aer&oacute;bias e/ou antigravitacionais, em que    a contra&ccedil;&atild
e;o de grandes grupos musculares est&aacute; presente,    s&atilde;o aquelas que
 trazem os maiores benef&iacute;cios. Exerc&iacute;cios    como caminhada, corri
da, ciclismo, nata&ccedil;&atilde;o, hidrogin&aacute;stica,    futebol, t&ecirc;
nis, voleibol e basquete s&atilde;o exemplos dignos de nota.    </font></p>     
^cY#v5n4a06.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#30#26#text#76#<p>&nbsp; </p>     ^cY#v5n
4a06.htm##
00378000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704015100069002001200220#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#31#27#text#76#<p><font face="Verdana" si
ze="3"><B>ORIENTA&Ccedil;&Otilde;ES M&Eacute;DICAS PARA    PR&Aacute;TICA DA ATI
VIDADE F&Iacute;SICA</B> </font></p>     ^cY#v5n4a06.htm##
01530000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704130300069002001201372#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#32#28#text#76#<p><font face="Verdana" si
ze="2">Para que os benef&iacute;cios da pr&aacute;tica    de exerc&iacute;cios s
ejam otimizados e os riscos diminu&iacute;dos, recomenda-se    avalia&ccedil;&at
ilde;o m&eacute;dica pr&eacute;via ao in&iacute;cio do programa.    Para os indi
v&iacute;duos assintom&aacute;ticos, anamnese cuidadosa e exame    f&iacute;sico
 abrangente costumam ser inicialmente suficientes. J&aacute; naquelas    pessoas
 com sinais e/ou sintomas que sugerem poss&iacute;vel doen&ccedil;a card&iacute;
aca,    o encaminhamento ao cardiologista, para avalia&ccedil;&atilde;o mais det
alhada,    &eacute; recomend&aacute;vel. O eletrocardiograma de esfor&ccedil;o, 
a ergoespirometria,    o ecocardiograma, entre outros exames, podem fornecer inf
orma&ccedil;&otilde;es    importantes na decis&atilde;o cl&iacute;nica sobre que
 tipo de programa de exerc&iacute;cio    deva ser seguido ou se contra-indica&cc
edil;&otilde;es para a pr&aacute;tica    de exerc&iacute;cios se imp&otilde;em. 
Se, porventura, ocorrerem sinais ou sintomas    que sugiram doen&ccedil;a cardio
vascular ou de outro sistema org&acirc;nico    ao longo do programa de exerc&iac
ute;cios, aconselha-se a interrup&ccedil;&atilde;o    na atividade f&iacute;sica
 e imediata investiga&ccedil;&atilde;o m&eacute;dica.    </font></p>     ^cY#v5n
4a06.htm##
01129000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704090200069002001200971#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#33#29#text#76#<p><font face="Verdana" si
ze="2">As contra-indica&ccedil;&otilde;es absolutas    para pr&aacute;tica de at
ividades f&iacute;sicas do ponto de vista cardiovascular    s&atilde;o: estenose
 a&oacute;rtica ou pulmonar moderada a grave, a cardiomiopatia    hipertr&oacute
;fica com gradiente importante na via de sa&iacute;da do ventr&iacute;culo    es
querdo, incluindo-se a&iacute; suas variantes, as arritmias card&iacute;acas    
avan&ccedil;adas e de mau progn&oacute;stico, os bloqueios card&iacute;acos    d
e alto grau n&atilde;o "protegidos" por marcapasso, a insufici&ecirc;ncia card&i
acute;aca    descompensada, a miocardite e a insufici&ecirc;ncia coron&aacute;ri
a inst&aacute;vel.    S&atilde;o contra-indica&ccedil;&otilde;es tempor&aacute;r
ias as infec&ccedil;&otilde;es    agudas, a DPOC, o <I>diabetes mellitus</I> e a
 hipertens&atilde;o arterial,    quando descompensados. </font></p>     ^cY#v5n4
a06.htm##
00922000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704069500069002001200764#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#34#30#text#76#<p><font face="Verdana" si
ze="2">No que diz respeito ao paciente hipertenso, este    pode ter benef&iacute
;cio com a pr&aacute;tica de exerc&iacute;cios aer&oacute;bios    (isot&ocirc;ni
cos). No entanto, at&eacute; a presente data, n&atilde;o existe    um consenso a
 respeito do impacto da execu&ccedil;&atilde;o de exerc&iacute;cios    isom&eacu
te;tricos nesses pacientes. Logo, a recomenda&ccedil;&atilde;o atual    &eacute;
 de que exerc&iacute;cios com tais caracter&iacute;sticas n&atilde;o    devam se
r prescritos para esse subgrupo de pacientes at&eacute; que surjam evid&ecirc;nc
ias    mais claras de que seus benef&iacute;cios suplantem os riscos<SUP>13,14</
SUP>.    </font></p>     ^cY#v5n4a06.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#35#31#text#76#<p>&nbsp; </p>     ^cY#v5n
4a06.htm##
00417000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704019000069002001200259#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#36#32#text#76#<p><font face="Verdana" si
ze="3"><B>A RESPONSABILIDADE DO M&Eacute;DICO NAS INFORMA&Ccedil;&Otilde;ES    S
OBRE ATIVIDADE F&Iacute;SICA PARA A POPULA&Ccedil;&Atilde;O</B> </font></p>     
^cY#v5n4a06.htm##
00799000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704057200069002001200641#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#37#33#text#76#<p><font face="Verdana" si
ze="2">Para que uma pol&iacute;tica de sa&uacute;de    seja efetiva &eacute; fun
damental que se criem medidas abrangentes com o intuito    de diminuir o impacto
 negativo dos diferentes fatores de risco sobre a sociedade.    Em se tratando d
e combate ao sedentarismo, a id&eacute;ia vigente &eacute; de    que um aumento 
moderado nos n&iacute;veis de atividade f&iacute;sica dos indiv&iacute;duos    s
edent&aacute;rios parece ter repercuss&atilde;o significativa sobre a qualidade 
   da sa&uacute;de da sociedade como um todo. </font></p>     ^cY#v5n4a06.htm##
00892000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704066500069002001200734#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#38#34#text#76#<p><font face="Verdana" si
ze="2">Dessa forma, &eacute; muito importante que o    agente de sa&uacute;de re
comende, encoraje, oriente e sirva como facilitador    para que um estilo de vid
a mais ativo seja adotado. O esclarecimento de crian&ccedil;as    e jovens deve 
ser priorizado, uma vez que a interven&ccedil;&atilde;o nesses    per&iacute;odo
s da vida sedimentam h&aacute;bitos que ser&atilde;o levados para    o futuro. A
l&eacute;m disso, &eacute; poss&iacute;vel que, quando adultos, esses    jovens 
venham a servir como multiplicadores de h&aacute;bitos adquiridos previamente,  
  atuando direta e/ou indiretamente contra o sedentarismo. </font></p>     ^cY#v
5n4a06.htm##
01136000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704090900069002001200978#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#39#35#text#76#<p><font face="Verdana" si
ze="2">A mensagem de que a pr&aacute;tica de exerc&iacute;cios    regulares &eac
ute; saud&aacute;vel e ben&eacute;fica para o corpo e para mente    deve ser sis
tematicamente dirigida para todas as pessoas. Ao organizarem campanhas    p&uacu
te;blicas, as associa&ccedil;&otilde;es e entidades da &aacute;rea da    sa&uacu
te;de almejam que os &iacute;ndices de atividade f&iacute;sica da popula&ccedil;
&atilde;o    atinjam um patamar m&iacute;nimo e que o exerc&iacute;cio f&iacute;
sico regular    e continuado se estabele&ccedil;a como uma norma social. Nesse a
specto, os meios    de comunica&ccedil;&atilde;o exercem um papel muito importan
te na divulga&ccedil;&atilde;o    de tais campanhas, alastrando a informa&ccedil
;&atilde;o de que a promo&ccedil;&atilde;o    de sa&uacute;de atrav&eacute;s da 
preven&ccedil;&atilde;o pode ser "o melhor    rem&eacute;dio". </font></p>     ^
cY#v5n4a06.htm##
00726000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704049900069002001200568#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#40#36#text#76#<p><font face="Verdana" si
ze="2">Logo, para que a pr&aacute;tica de atividades    f&iacute;sicas em bases 
regulares possa ser assumida como uma regra, n&atilde;o    servindo apenas para 
privilegiar grupos sociais mais esclarecidos e diferenciados    economicamente, 
devemos criar condi&ccedil;&otilde;es fact&iacute;veis e pr&aacute;ticas    para
 que a globaliza&ccedil;&atilde;o do exerc&iacute;cio se torne uma realidade    
preventiva em termos de sa&uacute;de p&uacute;blica. </font></p>     ^cY#v5n4a06
.htm##
00709000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704048200069002001200551#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#41#37#text#76#<p><font face="Verdana" si
ze="2">A educa&ccedil;&atilde;o f&iacute;sica em todas    as escolas deve servir
 como uma fonte fomentadora do h&aacute;bito, sendo ministrada    de forma criat
iva e motivadora. Cabe salientar que os custos para tal a&ccedil;&atilde;o    n&
atilde;o necessitam ser elevados, sendo este aspecto fundamental, uma vez    que
 vivemos em um pa&iacute;s onde os recursos s&atilde;o escassos ou n&atilde;o   
 dispon&iacute;veis com facilidade. </font></p>     ^cY#v5n4a06.htm##
00774000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704054700069002001200616#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#42#38#text#76#<p><font face="Verdana" si
ze="2">Nas atividades comunit&aacute;rias, &ecirc;nfase    para pr&aacute;ticas 
orientadas para adultos podem ser dadas. Podemos citar    como exemplo o interva
lo para o caf&eacute; ou para o cigarro que costuma ocorrer    entre um turno e 
outro de trabalho em diversas empresas de nosso pa&iacute;s.    Em vez de tomar 
caf&eacute; ou fumar, o trabalhador poder&aacute; ser muito    beneficiado ao se
r exposto, de forma orientada, a um programa de atividade f&iacute;sica    em se
u local de trabalho. </font></p>     ^cY#v5n4a06.htm##
00764000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704053700069002001200606#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#43#39#text#76#<p><font face="Verdana" si
ze="2">Por fim, o processo organizado de exposi&ccedil;&atilde;o    ao exerc&iac
ute;cio, al&eacute;m de possibilitar a aquisi&ccedil;&atilde;o do    gosto pelas
 atividades que movimentem o corpo, &eacute; um potencial redutor    de fatores 
de riscos, sendo um elemento que tamb&eacute;m pode ter um impacto    positivo s
obre a mente, sendo, portanto, indicado para todas as pessoas, salvo    naquelas
 situa&ccedil;&otilde;es cl&iacute;nicas especiais em que se prove em    contr&a
acute;rio. </font></p>     ^cY#v5n4a06.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#44#40#text#76#<p>&nbsp; </p>     ^cY#v5n
4a06.htm##
00305000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704007800069002001200147#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#45#41#text#76#<p><font face="Verdana" si
ze="3"><B>REFER&Ecirc;NCIAS</B> </font></p>     ^cY#v5n4a06.htm##
00424000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704018300071002001200254#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#p#46#42#text#76#1#<p><font fac
e="Verdana" size="2">1. La Porte RE, Adams LL, Cook T, et al. Cardiovascular    
disease and health: an epidemiologic perspective. Am J Epidemiolol 1984;120:507-
17.    ^cY#v5n4a06.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002400069002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#47#43#text#76#    </font></p>     ^cY#v5
n4a06.htm##
00397000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704015600071002001200227#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#p#48#44#text#76#2#<p><font fac
e="Verdana" size="2">2. Diversos autores. Public health aspects of    physical a
ctivity and exercise. Public Health Rep 1985;100:18-224.    ^cY#v5n4a06.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#49#45#text#76# </font></p>     ^cY#v5n4a
06.htm##
00452000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704021100071002001200282#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#p#50#46#text#76#3#<p><font fac
e="Verdana" size="2">3. Blair SN, Kohl HW, Barlow CE, et al. Changes    in physi
cal fitness and all-cause mortality. A prospective study of healthy    and unhea
lthy men. JAMA 1995;273:1093-8.    ^cY#v5n4a06.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#51#47#text#76# </font></p>     ^cY#v5n4a
06.htm##
00512000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704027100071002001200342#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#p#52#48#text#76#4#<p><font fac
e="Verdana" size="2">4. Ekelund LG, Haskell WL, Sheps DS, et al. Physical    fit
ness as a predictor of cardiovascular mortality in asymptomatic North American  
  men. The Lipid Research Clinics Mortality Follow-up Study. N Engl J Med 1988;3
19:1379-84.    ^cY#v5n4a06.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002400069002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#53#49#text#76#    </font></p>     ^cY#v5
n4a06.htm##
00538000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704029700071002001200368#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#p#54#50#text#76#5#<p><font fac
e="Verdana" size="2">5. Ara&uacute;jo CGSD, Ara&uacute;jo DSMSD. Exerc&iacute;ci
o    e sa&uacute;de (vol I-VII Guia de Estudo). 2&#170; ed. Bras&iacute;lia: Sec
retaria    de Educa&ccedil;&atilde;o F&iacute;sica e Desportos, Minist&eacute;ri
o da Educa&ccedil;&atilde;o,    1986.    ^cY#v5n4a06.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#55#51#text#76# </font></p>     ^cY#v5n4a
06.htm##
00426000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704018500071002001200256#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#p#56#52#text#76#6#<p><font fac
e="Verdana" size="2">6. Paffenbarger RS, Wing AL, Hyde RT. Physical    activity 
as an index of heart attack risk in college alumni. Am J Epidemiolol    1978;108
:161.    ^cY#v5n4a06.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#57#53#text#76# </font></p>     ^cY#v5n4a
06.htm##
00455000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704021400071002001200285#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#p#58#54#text#76#7#<p><font fac
e="Verdana" size="2">7. Oldridge NB, Guyatt GH, Rimm AA, et al. Cardiac    rehab
ilitation after myocardial infarction. Combined experience of randomized    clin
ical trials. JAMA 1988;260:945-50.    ^cY#v5n4a06.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#59#55#text#76# </font></p>     ^cY#v5n4a
06.htm##
00452000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704021100071002001200282#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#p#60#56#text#76#8#<p><font fac
e="Verdana" size="2">8. O'Connor GT, Buring JE, Yusuf S, et al. An    overview o
f randomized trials of rehabilitation with exercise after myocardial    infarcti
on. Circulation 1989;80:234-44.    ^cY#v5n4a06.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#61#57#text#76# </font></p>     ^cY#v5n4a
06.htm##
00439000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704019800071002001200269#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#p#62#58#text#76#9#<p><font fac
e="Verdana" size="2">9. Franklin BA, Blair SN, Van Camp SP, et al.    Exercise a
nd cardiac complication. Do the benefits outweigh the risks? Physician    Sports
 Med 1994;22:56-8.    ^cY#v5n4a06.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#63#59#text#76# </font></p>     ^cY#v5n4a
06.htm##
00384000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000300069704014200072002001200214#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#p#64#60#text#76#10#<p><font fa
ce="Verdana" size="2">10. Borg G. Perceived exertion as an indicator    of somat
ic stress. Scand J Rehabil Med 1970;2:92-8.    ^cY#v5n4a06.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#65#61#text#76# </font></p>     ^cY#v5n4a
06.htm##
00593000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000300069704035100072002001200423#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#p#66#62#text#76#11#<p><font fa
ce="Verdana" size="2">11. Ward A, Malloy P, Rippe J. Orienta&ccedil;&atilde;o   
 para prescri&ccedil;&atilde;o de exerc&iacute;cios para as popula&ccedil;&otild
e;es    normal e card&iacute;aca. In: Hanson P. Cl&iacute;nicas cardiol&oacute;g
icas:    Exerc&iacute;cios e o cora&ccedil;&atilde;o. Philadelphia: WB Saunders,
 1987;5:199.    ^cY#v5n4a06.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002400069002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#67#63#text#76#    </font></p>     ^cY#v5
n4a06.htm##
00399000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000300069704015700072002001200229#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#p#68#64#text#76#12#<p><font fa
ce="Verdana" size="2">12. Diversos autores. Physical Activity and Cardiovascular
    Health. NIH Consensus Conference. JAMA 1996;276:241-6.    ^cY#v5n4a06.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#69#65#text#76# </font></p>     ^cY#v5n4a
06.htm##
00434000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000300069704019200072002001200264#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#p#70#66#text#76#13#<p><font fa
ce="Verdana" size="2">13. American College of Sports Medicine. Position    Stand
. Physical activity, physical fitness and hypertension. Med Sci Sports    Exerc 
1993;25: i-x.    ^cY#v5n4a06.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#71#67#text#76# </font></p>     ^cY#v5n4a
06.htm##
00440000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000300069704019800072002001200270#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#p#72#68#text#76#14#<p><font fa
ce="Verdana" size="2">14. Waib PH, Burini RC. Efeitos do condicionamento    f&ia
cute;sico aer&oacute;bio no controle da press&atilde;o arterial. Arq Bras    Car
diol 1995;64:243-6.    ^cY#v5n4a06.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002100069002001200090#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#73#69#text#76# </font></p>     ^cY#v5n4a
06.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#74#70#text#76#<p>&nbsp; </p>     ^cY#v5n
4a06.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#75#71#text#76#<p>&nbsp; </p>     ^cY#v5n
4a06.htm##
00415000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704018800069002001200257#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#76#72#text#76#<p><font face="Verdana" si
ze="2"><b><a name="send"></a><a href="#topo"><img src="/img/revistas/rbme/v5n4/s
eta.gif" border="0"></a>    Endere&ccedil;o para correspond&ecirc;ncia</b>    ^c
Y#v5n4a06.htm##
00274000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704004700069002001200116#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#77#73#text#76#<br>   Rua Dr. Jo&atilde;o
 Dutra, 11/03    ^cY#v5n4a06.htm##
00275000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704004800069002001200117#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#78#74#text#76#<br>   90630-100 &#150; Po
rto Alegre, RS    ^cY#v5n4a06.htm##
00273000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704004600069002001200115#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#79#75#text#76#<br>   Tels. (051) 333-414
3 e 960-9381    ^cY#v5n4a06.htm##
00317000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704009000069002001200159#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a06.htm#S#p#80#76#text#76#<br>   E-mail: <a href="ma
ilto:kuqui@hotnet.net">Kuqui@hotnet.net</a> </font></p>     ^cY#v5n4a06.htm##
00549000000000289000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100019000700100016000890100
01400105810000700119012006800126030001700194710000200211065000900213064000500222
031000400227014000700231865000900238002001200247#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a06.htm#S#c#81#1#text#14#1#^rND^sLa Porte^nRE#^rND^sAdams^nLL#^rND^s
Cook^nT#et al.#Cardiovascular disease and health: an epidemiologic perspective^l
en#Am J Epidemiolol#2#19840000#1984#120#507-17#19990800#v5n4a06.htm##
00522000000000277000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100005000700100017000750120
06000092030001800152065000900170064000500179031000400184014000700188865000900195
002001200204035001000216801001800226#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a06.htm#S#c#82#2#text#14#2#^rND#Diversos autores#Public health aspects of physic
al activity and exercise^len#Public Health Rep#19850000#1985#100#18-224#19990800
#v5n4a06.htm#0033-3549#Public health rep##
00599000000000301000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100016000700100015000860100
01700101810000700118012010600125030000500231065000900236064000500245031000400250
014000700254865000900261002001200270035001000282801000500292#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a06.htm#S#c#83#3#text#14#3#^rND^sBlair^nSN#^rND^sKohl^nH
W#^rND^sBarlow^nCE#et al.#Changes in physical fitness and all-cause mortality. A
 prospective study of healthy and unhealthy men^len#JAMA#19950000#1995#273#1093-
8#19990800#v5n4a06.htm#0098-7484#JAMA##
00667000000000301000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100018000700100018000880100
01600106810000700122012015300129030001300282065000900295064000500304031000400309
014000800313865000900321002001200330035001000342801001300352#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a06.htm#S#c#84#4#text#14#4#^rND^sEkelund^nLG#^rND^sHaske
ll^nWL#^rND^sSheps^nDS#et al.#Physical fitness as a predictor of cardiovascular 
mortality in asymptomatic North American men. The Lipid Research Clinics Mortali
ty Follow-up Study^len#N Engl J Med#19880000#1988#319#1379-84#19990800#v5n4a06.h
tm#0028-4793#N Engl J Med##
00525000000000253000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680160019000700160020000890180
04900109063000300158066000900161062006600170065000900236064000500245865000900250
002001200259#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#c#85#5#text#14
#5#^rND^sAraújo^nCGSD#^rND^sAraújo^nDSMSD#Exercício e saúde (vol I-VII Guia de E
studo)^lpt#2ª#Brasília#Secretaria de Educação Física e Desportos, Ministério da 
Educação#19860000#1986#19990800#v5n4a06.htm##
00537000000000277000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100023000700100015000930100
01600108012007300124030001700197710000200214065000900216064000500225031000400230
020000400234865000900238002001200247#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a06.htm#S#c#86#6#text#14#6#^rND^sPaffenbarger^nRS#^rND^sWing^nAL#^rND^sHyde^nRT.
#Physical activity as an index of heart attack risk in college alumni^len#Am J E
pidemiolol#2#19780000#1978#108#161#19990800#v5n4a06.htm##
00602000000000301000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100019000700100017000890100
01500106810000700121012010600128030000500234065000900239064000500248031000400253
014000700257865000900264002001200273035001000285801000500295#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a06.htm#S#c#87#7#text#14#7#^rND^sOldridge^nNB#^rND^sGuya
tt^nGH#^rND^sRimm^nAA#et al.#Cardiac rehabilitation after myocardial infarction.
 Combined experience of randomized clinical trials^len#JAMA#19880000#1988#260#94
5-50#19990800#v5n4a06.htm#0098-7484#JAMA##
00606000000000301000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100019000700100017000890100
01500106810000700121012009700128030001200225065000900237064000500246031000300251
014000700254865000900261002001200270035001000282801001200292#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a06.htm#S#c#88#8#text#14#8#^rND^sO'Connor^nGT#^rND^sBuri
ng^nJE#^rND^sYusuf^nS#et al.#An overview of randomized trials of rehabilitation 
with exercise after myocardial infarction^len#Circulation#19890000#1989#80#234-4
4#19990800#v5n4a06.htm#0009-7322#Circulation##
00562000000000289000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080003000651180002000680100019000700100016000890100
01900105810000700124012007500131030002100206710000200227065000900229064000500238
031000300243014000500246865000900251002001200260#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a06.htm#S#c#89#9#text#14#9#^rND^sFranklin^nBA#^rND^sBlair^nSN#^rND^s
Van Camp^nSP#et al.#Exercise and cardiac complication. Do the benefits outweigh 
the risks?^len#Physician Sports Med#2#19940000#1994#22#56-8#19990800#v5n4a06.htm
##
00502000000000265000450000400050000070200460000570500020005170600020005370000030
00557010003000587090005000617080003000661180003000690100015000720120057000870300
02000144065000900164064000500173031000200178014000500180865000900185002001200194
035001000206801002000216#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#c#
90#10#text#14#10#^rND^sBorg^nG.#Perceived exertion as an indicator of somatic st
ress^len#Scand J Rehabil Med#19700000#1970#2#92-8#19990800#v5n4a06.htm#0036-5505
#Scand J Rehabil Med##
00636000000000301000450000400050000070200460000570500020005170600020005370000030
00557010003000587090005000617080003000661180003000690100014000720100016000860100
01600102012008200118016001700200018005100217066001300268062001200281065000900293
064000500302031000200307020000400309865000900313002001200322#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a06.htm#S#c#91#11#text#14#11#^rND^sWard^nA#^rND^sMalloy^
nP#^rND^sRippe^nJ.#Orientação para prescrição de exercícios para as populações n
ormal e cardíaca^lpt#^rND^sHanson^nP.#Clínicas cardiológicas: Exercícios e o cor
ação^lpt#Philadelphia#WB Saunders#19870000#1987#5#199#19990800#v5n4a06.htm##
00511000000000277000450000400050000070200460000570500020005170600020005370000030
00557010003000587090005000617080003000661180003000690100005000720100017000770120
07400094030000500168065000900173064000500182031000400187014000600191865000900197
002001200206035001000218801000500228#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a06.htm#S#c#92#12#text#14#12#^rND#Diversos autores#Physical Activity and Cardiov
ascular Health. NIH Consensus Conference^len#JAMA#19960000#1996#276#241-6#199908
00#v5n4a06.htm#0098-7484#JAMA##
00541000000000265000450000400050000070200460000570500020005170600020005370000030
00557010003000587090005000617080003000661180003000690110036000720120073001080300
02100181065000900202064000500211031000300216014000400219865000900223002001200232
035001000244801002100254#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a06.htm#S#c#
93#13#text#14#13#American College of Sports Medicine#Position Stand. Physical ac
tivity, physical fitness and hypertension^len#Med Sci Sports Exerc#19930000#1993
#25#i-x#19990800#v5n4a06.htm#0195-9131#Med Sci Sports Exerc##
00549000000000277000450000400050000070200460000570500020005170600020005370000030
00557010003000587090005000617080003000661180003000690100015000720100018000870120
07800105030001700183065000900200064000500209031000300214014000600217865000900223
002001200232035001000244801001700254#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a06.htm#S#c#94#14#text#14#14#^rND^sWaib^nPH#^rND^sBurini^nRC.#Efeitos do condici
onamento físico aeróbio no controle da pressão arterial^lpt#Arq Bras Cardiol#199
50000#1995#64#243-6#19990800#v5n4a06.htm#0066-782X#Arq Bras Cardiol##
00271000000000169000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670910009000690920007000780020012000857030
00400097#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#o#1#1#article#1#20
110405#115615#v5n4a07.htm#520##
01710000000000445000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000300087121000300090049000800093158000300101030002100104
03100020012503200020012706500090012901400110013803500100014901200470015901000260
02060100031002320100025002630100024002880100025003120700046003370830596003830580
26300979117000601242072000401248002001201252#v5n4#V:\SciELO\serial\rbme\v5n4\mar
kup\v5n4a07.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#ND#07#RBME260#nd#Rev Bras Me
d Esporte#5#4#19990800#^f150^l158#1517-8692#A tríade da atleta: posicionamento o
ficial^lpt#^rND^1A01^nCarol L.^sOtis#^rND^1A01^nBarbara^sDrinkwater#^rND^1A01^nM
imi^sJohnson#^rND^1A01^nAnne^sLoucks#^rND^1A01^nJack^sWilmore#Colégio Americano 
de Medicina do Esporte^iA01#^lpt^aA tríade da atleta é uma síndrome que ocorre e
m adolescentes e mulheres fisicamente ativas. Os seus componentes inter-relacion
ados são distúrbios alimentares, amenorréia e osteoporose. A pressão à qual adol
escentes e mulheres jovens são submetidas para atingir ou manter um peso corpora
l irrealmente baixo está por trás dessa síndrome. Possuem maior risco as adolesc
entes e mulheres que praticam esportes nos quais um baixo peso corporal é import
ante para o desempenho ou por razões estéticas. As jovens e mulheres com um dos 
componentes dessa tríade devem ser investigadas para os outros.#Este documento f
oi revisado para o Colégio Americano de Medicina do Esporte pelo Comitê de Pronu
nciamentos e por: Dra. Rosemary Agostini, Prof. Joan Duda, Prof. Roger Goldingay
, Profa. Randa Ryan, Profa. Christine Snow, Dr. Steven Van Camp e Dra. Michelle 
Warren#other#141#v5n4a07.htm##
01724000000000445000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000300087121000300090049000800093158000300101030002100104
03100020012503200020012706500090012901400110013803500100014901200610015901000260
02200100031002460100025002770100024003020100025003260700046003510830596003970580
26300993117000601256072000401262002001201266#v5n4#V:\SciELO\serial\rbme\v5n4\mar
kup\v5n4a07.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#ND#07#RBME260#nd#Rev Bras Me
d Esporte#5#4#19990800#^f150^l158#1517-8692#<b>A tríade da atleta</b>: <b>posici
onamento oficial</b>^lpt#^rND^1A01^nCarol L.^sOtis#^rND^1A01^nBarbara^sDrinkwate
r#^rND^1A01^nMimi^sJohnson#^rND^1A01^nAnne^sLoucks#^rND^1A01^nJack^sWilmore#Colé
gio Americano de Medicina do Esporte^iA01#^lpt^aA tríade da atleta é uma síndrom
e que ocorre em adolescentes e mulheres fisicamente ativas. Os seus componentes 
inter-relacionados são distúrbios alimentares, amenorréia e osteoporose. A press
ão à qual adolescentes e mulheres jovens são submetidas para atingir ou manter u
m peso corporal irrealmente baixo está por trás dessa síndrome. Possuem maior ri
sco as adolescentes e mulheres que praticam esportes nos quais um baixo peso cor
poral é importante para o desempenho ou por razões estéticas. As jovens e mulher
es com um dos componentes dessa tríade devem ser investigadas para os outros.#Es
te documento foi revisado para o Colégio Americano de Medicina do Esporte pelo C
omitê de Pronunciamentos e por: Dra. Rosemary Agostini, Prof. Joan Duda, Prof. R
oger Goldingay, Profa. Randa Ryan, Profa. Christine Snow, Dr. Steven Van Camp e 
Dra. Michelle Warren#other#141#v5n4a07.htm##
01825000000000457000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670640013000690710003000820400003000850010
00600088042000200094120000400096121000300100049000800103158000300111030002400114
03100020013803200020014006500090014201400110015103500100016201200470017201000250
02190100031002440100025002750100024003000100025003240700048003490830596003970580
26300993117000601256072000401262002001201266008008901278#v5n4#V:\SciELO\serial\r
bme\v5n4\markup\v5n4a07.htm#S#l#4#1#article#1#^mago.^a1999#oa#pt#br1.1#1#4.0#07#
RBME260#nd#Rev. bras. med. esporte#5#4#19990800#^f150^l158#1517-8692#A tríade da
 atleta: posicionamento oficial^lpt#^rND^1A01^nCarol L^sOtis#^rND^1A01^nBarbara^
sDrinkwater#^rND^1A01^nMimi^sJohnson#^rND^1A01^nAnne^sLoucks#^rND^1A01^nJack^sWi
lmore#^iA01^1Colégio Americano de Medicina do Esporte#^lpt^aA tríade da atleta é
 uma síndrome que ocorre em adolescentes e mulheres fisicamente ativas. Os seus 
componentes inter-relacionados são distúrbios alimentares, amenorréia e osteopor
ose. A pressão à qual adolescentes e mulheres jovens são submetidas para atingir
 ou manter um peso corporal irrealmente baixo está por trás dessa síndrome. Poss
uem maior risco as adolescentes e mulheres que praticam esportes nos quais um ba
ixo peso corporal é importante para o desempenho ou por razões estéticas. As jov
ens e mulheres com um dos componentes dessa tríade devem ser investigadas para o
s outros.#Este documento foi revisado para o Colégio Americano de Medicina do Es
porte pelo Comitê de Pronunciamentos e por: Dra. Rosemary Agostini, Prof. Joan D
uda, Prof. Roger Goldingay, Profa. Randa Ryan, Profa. Christine Snow, Dr. Steven
 Van Camp e Dra. Michelle Warren#other#141#v5n4a07.htm#Internet^ihttp://www.scie
lo.br/scielo.php?script=sci_arttext&pid=S1517-86921999000400007##
00338000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704010900071002001200180#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#5#1#article#375#<p align="right"><font f
ace="Verdana" size="2"><b>AMERICAN COLLEGE OF SPORTS MEDICINE</b></font></p>    
 ^cY#v5n4a07.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704002200071002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#6#2#article#375#<p>&nbsp;</p>     ^cY#v5
n4a07.htm##
00314000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704008500071002001200156#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#7#3#article#375#<p><font face="Verdana" 
size="4"><b>A tr&iacute;ade da atleta</b></font></p>     ^cY#v5n4a07.htm##
00311000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704008200071002001200153#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#8#4#article#375#<p><font face="Verdana" 
size="3"><b>Posicionamento oficial</b></font></p>     ^cY#v5n4a07.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704002200071002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#9#5#article#375#<p>&nbsp;</p>     ^cY#v5
n4a07.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704002300072002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#10#6#article#375#<p>&nbsp; </p>     ^cY#
v5n4a07.htm##
00367000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704013700072002001200209#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#11#7#article#375#<p><font face="Verdana"
 size="2"><b>Carol L. Otis; Barbara Drinkwater; Mimi Johnson;    Anne Loucks; Ja
ck Wilmore</b></font></p>     ^cY#v5n4a07.htm##
00330000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704010000072002001200172#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#12#8#article#375#<p><font face="Verdana"
 size="2">Col&eacute;gio Americano de Medicina do Esporte</font></p>     ^cY#v5n
4a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704002200072002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#13#9#article#375#<p>&nbsp;</p>     ^cY#v
5n4a07.htm##
00275000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704004400073002001200117#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#14#10#article#375#<p>&nbsp;</p> <hr size
="1" noshade>     ^cY#v5n4a07.htm##
00297000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704006600073002001200139#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#15#11#article#375#<p><font face="Verdana
" size="2"><B>RESUMO</B></font></p>     ^cY#v5n4a07.htm##
01035000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704080400073002001200877#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#16#12#article#375#<p><font face="Verdana
" size="2">A tr&iacute;ade da atleta &eacute; uma s&iacute;ndrome    que ocorre 
em adolescentes e mulheres fisicamente ativas. Os seus componentes    inter-rela
cionados s&atilde;o dist&uacute;rbios alimentares, amenorr&eacute;ia    e osteop
orose. A press&atilde;o &agrave; qual adolescentes e mulheres jovens    s&atilde
;o submetidas para atingir ou manter um peso corporal irrealmente baixo    est&a
acute; por tr&aacute;s dessa s&iacute;ndrome. Possuem maior risco as adolescente
s    e mulheres que praticam esportes nos quais um baixo peso corporal &eacute; 
importante    para o desempenho ou por raz&otilde;es est&eacute;ticas. As jovens
 e mulheres    com um dos componentes dessa tr&iacute;ade devem ser investigadas
 para os outros.    </font></p> <hr size="1" noshade>     ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#17#13#article#375#<p>&nbsp; </p>     ^cY
#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#18#14#article#375#<p>&nbsp; </p>     ^cY
#v5n4a07.htm##
00315000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704008400073002001200157#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#19#15#article#375#<p><font face="Verdana
" size="3"><B>INTRODU&Ccedil;&Atilde;O</B></font></p>     ^cY#v5n4a07.htm##
00819000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704058800073002001200661#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#20#16#article#375#<p><font face="Verdana
" size="2">A maioria das adolescentes e mulheres podem obter    benef&iacute;cio
s importantes em termos de sa&uacute;de advindos de uma pr&aacute;tica    regula
r de exerc&iacute;cios sem estar submetidas a riscos para a sa&uacute;de<SUP>1-3
</SUP>.    Elas devem ser estimuladas a serem fisicamente ativas em todas as fas
es de suas    vidas. Se ocorrerem les&otilde;es ou problemas cl&iacute;nicos, es
tes devem    ser rapidamente identificados e tratados por profissionais especial
istas e com    experi&ecirc;ncia com mulheres fisicamente ativas. </font></p>   
  ^cY#v5n4a07.htm##
00547000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704031600073002001200389#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#21#17#article#375#<p><font face="Verdana
" size="2">Em 1992 a Tr&iacute;ade da Atleta foi o tema    central de uma confer
&ecirc;ncia de consenso da For&ccedil;a-Tarefa de Assuntos    Femininos do Col&e
acute;gio Americano de Medicina do Esporte<SUP>4</SUP>. Os    tr&ecirc;s compone
ntes da tr&iacute;ade s&atilde;o: </font></p>     ^cY#v5n4a07.htm##
01024000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704079300073002001200866#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#22#18#article#375#<p><font face="Verdana
" size="2"><B>1. Dist&uacute;rbios alimentares.</B> Os dist&uacute;rbios    alim
entares englobam um amplo espectro de comportamentos alimentares delet&eacute;ri
os    e freq&uuml;entemente pouco eficientes utilizados na tentativa de reduzir 
o    peso ou atingir uma apar&ecirc;ncia esbelta. Esses comportamentos anormais 
variam    nos extremos de gravidade desde uma restri&ccedil;&atilde;o da ingest&
atilde;o    alimentar, passando pelo ciclo empanturrar-purgar at&eacute; a anore
xia nervosa    e bulimia nervosa, na categoria DSM-IV<SUP>5-10</SUP>. Os dist&ua
cute;rbios    alimentares podem aumentar a morbidade a curto e longo prazos, red
uzir o desempenho,    provocar amenorr&eacute;ia e at&eacute; mesmo aumentar a m
ortalidade<SUP>11-14</SUP>.    </font></p>     ^cY#v5n4a07.htm##
00677000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704044600073002001200519#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#23#19#article#375#<p><font face="Verdana
" size="2"><B>2. Amenorr&eacute;ia.</B> A amenorr&eacute;ia    prim&aacute;ria (
retardo da menarca) &eacute; a aus&ecirc;ncia de menstrua&ccedil;&atilde;o    em
 uma menina de 16 anos com caracteres sexuais secund&aacute;rios<SUP>15</SUP>.  
  A amenorr&eacute;ia secund&aacute;ria &eacute; a aus&ecirc;ncia de tr&ecirc;s 
   ou mais ciclos menstruais consecutivos ap&oacute;s a menarca<SUP>15-19</SUP>.
    </font></p>     ^cY#v5n4a07.htm##
00768000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704053700073002001200610#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#24#20#article#375#<p><font face="Verdana
" size="2">A amenorr&eacute;ia associada com o exerc&iacute;cio    ou com anorex
ia nervosa &eacute; de origem hipotal&acirc;mica<SUP>20-22</SUP>.    A amenorr&e
acute;ia hipotal&acirc;mica resulta em uma produ&ccedil;&atilde;o    reduzida de
 horm&ocirc;nios ovarianos e hipoestrogenemia semelhantes &agrave;    menopausa.
 Tanto a amenorr&eacute;ia hipotal&acirc;mica quanto a menopausa est&atilde;o   
 associadas com uma redu&ccedil;&atilde;o densidade mineral &oacute;ssea<SUP>3,2
3-30</SUP>.    </font></p>     ^cY#v5n4a07.htm##
00755000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704052400073002001200597#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#25#21#article#375#<p><font face="Verdana
" size="2"><B>3. Osteoporose.</B> A osteoporose &eacute;    uma doen&ccedil;a ca
racterizada por uma massa &oacute;ssea reduzida e uma deteriora&ccedil;&atilde;o
    da microarquitetura do tecido &oacute;sseo, o que leva a uma maior fragilida
de    esquel&eacute;tica e um maior risco de fraturas<SUP>24</SUP>. Um painel de
 especialistas    promovido pela Organiza&ccedil;&atilde;o Mundial da Sa&uacute;
de estabeleceu    os seguintes crit&eacute;rios diagn&oacute;sticos<SUP>31</SUP>
: </font></p>     ^cY#v5n4a07.htm##
00443000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704021200073002001200285#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#26#22#article#375#<p><font face="Verdana
" size="2">a. Normal: densidade mineral &oacute;ssea (DMO)    que n&atilde;o est
eja mais do que um Desvio Padr&atilde;o (DP) abaixo da m&eacute;dia    de adulto
s jovens. </font></p>     ^cY#v5n4a07.htm##
00365000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704013400073002001200207#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#27#23#article#375#<p><font face="Verdana
" size="2">b. Osteopenia: DMO entre 1 e 2,5 DP abaixo da    m&eacute;dia de adul
tos jovens. </font></p>     ^cY#v5n4a07.htm##
00364000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704013300073002001200206#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#28#24#article#375#<p><font face="Verdana
" size="2">c. Osteoporose: DMO mais de 2,5 DP abaixo da    m&eacute;dia de adult
os jovens. </font></p>     ^cY#v5n4a07.htm##
00396000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704016500073002001200238#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#29#25#article#375#<p><font face="Verdana
" size="2">d. Osteoporose grave: DMO mais de 2,5 DP abaixo    da m&eacute;dia de
 adultos jovens mais uma ou mais fraturas. </font></p>     ^cY#v5n4a07.htm##
00572000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704034100073002001200414#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#30#26#article#375#<p><font face="Verdana
" size="2">A principal causa de osteoporose pr&eacute;-menopausa    em mulheres 
ativas &eacute; uma redu&ccedil;&atilde;o da produ&ccedil;&atilde;o    de horm&o
circ;nios ovarianos e hipoestrogenemia em conseq&uuml;&ecirc;ncia de    uma amen
orr&eacute;ia hipotal&acirc;mica<SUP>23,26-30,32,33</SUP>. </font></p>     ^cY#v
5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#31#27#article#375#<p>&nbsp; </p>     ^cY
#v5n4a07.htm##
00313000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704008200073002001200155#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#32#28#article#375#<p><font face="Verdana
" size="3"><B>POSICIONAMENTO OFICIAL</B></font></p>     ^cY#v5n4a07.htm##
00530000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704029900073002001200372#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#33#29#article#375#<p><font face="Verdana
" size="2">Com base em uma abrangente revis&atilde;o da    literatura, em estudo
s de pesquisa, relatos de casos e no consenso de especialistas<SUP>4</SUP>,    &
eacute; posi&ccedil;&atilde;o oficial do Col&eacute;gio Americano de Medicina   
 do Esporte que: </font></p>     ^cY#v5n4a07.htm##
01117000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704088600073002001200959#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#34#30#article#375#<p><font face="Verdana
" size="2">1. A Tr&iacute;ade da Atleta &eacute; uma s&iacute;ndrome    importan
te que consiste de dist&uacute;rbios alimentares, amenorr&eacute;ia    e osteopo
rose. Os componentes da Tr&iacute;ade est&atilde;o inter-relacionados    na etio
logia, na patog&ecirc;nese e nas conseq&uuml;&ecirc;ncias. Devido &agrave;    de
fini&ccedil;&atilde;o recente da Tr&iacute;ade<SUP>4</SUP>, estudos de preval&ec
irc;ncia    ainda n&atilde;o foram conclu&iacute;dos. Contudo, n&atilde;o ocorre
 somente    em atletas de elite mas tamb&eacute;m em jovens fisicamente ativas e
 mulheres    que participam em uma ampla s&eacute;rie de tipos de atividade f&ia
cute;sica.    A Tr&iacute;ade pode resultar em um decl&iacute;nio do desempenho 
f&iacute;sico,    um aumento da morbidade cl&iacute;nica e psicol&oacute;gica e 
tamb&eacute;m    um aumento da mortalidade. </font></p>     ^cY#v5n4a07.htm##
00522000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704029100073002001200364#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#35#31#article#375#<p><font face="Verdana
" size="2">2. As press&otilde;es internas e externas &agrave;s    quais s&atilde
;o submetidas jovens e mulheres para atingir ou manter um peso    corporal irrea
lmente baixo est&aacute; por tr&aacute;s do desenvolvimento desses    dist&uacut
e;rbios. </font></p>     ^cY#v5n4a07.htm##
00720000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704048900073002001200562#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#36#32#article#375#<p><font face="Verdana
" size="2">3. Esta Tr&iacute;ade &eacute; freq&uuml;entemente    negada, n&atild
e;o diagnosticada e subnotificada. Os profissionais da &aacute;rea    de Medicin
a do Esporte devem estar atentos &agrave; patogenia inter-relacionada    e &agra
ve; apresenta&ccedil;&atilde;o variada dos componentes da Tr&iacute;ade.    Deve
m ser capazes de reconhecer, diagnosticar e tratar ou encaminhar mulheres    com
 qualquer um dos componentes da Tr&iacute;ade. </font></p>     ^cY#v5n4a07.htm##
00918000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704068700073002001200760#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#37#33#article#375#<p><font face="Verdana
" size="2">4. As mulheres que tiverem um dos componentes    da Tr&iacute;ade dev
em ser investigadas para os outros componentes<SUP>34,35</SUP>.    A investiga&c
cedil;&atilde;o da Tr&iacute;ade pode ser realizada no momento    da avalia&cced
il;&atilde;o pr&eacute;-participa&ccedil;&atilde;o e durante a    avalia&ccedil;
&atilde;o cl&iacute;nica das seguintes condi&ccedil;&otilde;es:    altera&ccedil
;&otilde;es menstruais, padr&otilde;es alterados de alimenta&ccedil;&atilde;o,  
  altera&ccedil;&otilde;es do peso corporal, arritmias card&iacute;acas, incluin
do    bradicardia, depress&atilde;o ou fraturas de estresse<SUP>8,11,34-39</SUP>
.    </font></p>     ^cY#v5n4a07.htm##
01012000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704078100073002001200854#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#38#34#article#375#<p><font face="Verdana
" size="2">5. Todos os profissionais da &aacute;rea de Medicina    do Esporte e 
incluindo tamb&eacute;m t&eacute;cnicos e treinadores, devem aprender    sobre a
 preven&ccedil;&atilde;o e o reconhecimento dos sintomas e riscos da    Tr&iacut
e;ade. Todos os profissionais que trabalham com jovens e mulheres fisicamente   
 ativas devem prescrever um treinamento que seja medicamente e psicologicamente 
   adequado. Deve-se evitar pressionar as jovens e as mulheres a reduzir o peso.
    Os profissionais devem conhecer conceitos b&aacute;sicos sobre nutri&ccedil;
&atilde;o    e devem ter como encaminhar as atletas para aconselhamento nutricio
nal e avalia&ccedil;&atilde;o    m&eacute;dica e de sa&uacute;de mental, quando 
necess&aacute;rio. </font></p>     ^cY#v5n4a07.htm##
00554000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704032300073002001200396#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#39#35#article#375#<p><font face="Verdana
" size="2">6. Os pais devem evitar pressionar as suas filhas    a fazerem dieta 
e reduzirem o seu peso. Os pais devem ser esclarecidos sobre    os sinais de ale
rta da Tr&iacute;ade e procurar um tratamento cl&iacute;nico    para as suas fil
has se esses sinais estiverem presentes. </font></p>     ^cY#v5n4a07.htm##
00978000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704074700073002001200820#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#40#36#article#375#<p><font face="Verdana
" size="2">7. Os profissionais da &aacute;rea de Medicina    do Esporte, os admi
nistradores desportivos e as autoridades governamentais ligadas    &agrave; &aac
ute;rea de esportes t&ecirc;m responsabilidade conjunta na preven&ccedil;&atilde
;o,    diagn&oacute;stico e tratamento da Tr&iacute;ade. As institui&ccedil;&oti
lde;es    governamentais devem trabalhar no sentido de oferecer oportunidades de
 programas    educacionais para os t&eacute;cnicos para esclarec&ecirc;-los e ha
bilit&aacute;-los    profissionalmente. Deve-se trabalhar no sentido de desenvol
ver programas para    monitorizar os t&eacute;cnicos e outros profissionais envo
lvidos para assegurar    pr&aacute;ticas de treinamento seguras. </font></p>    
 ^cY#v5n4a07.htm##
00631000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704040000073002001200473#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#41#37#article#375#<p><font face="Verdana
" size="2">8. Jovens e mulheres fisicamente ativas devem    ser esclarecidas sob
re uma nutri&ccedil;&atilde;o adequada, pr&aacute;ticas    seguras de treinament
o e os sinais e sintomas de alerta da Tr&iacute;ade. Estas    devem ser encaminh
adas para avalia&ccedil;&atilde;o m&eacute;dica ao primeiro    sinal de qualquer
 um dos componentes da Tr&iacute;ade. </font></p>     ^cY#v5n4a07.htm##
00485000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704025400073002001200327#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#42#38#article#375#<p><font face="Verdana
" size="2">9. Estudos adicionais s&atilde;o necess&aacute;rios    para melhor es
clarecer a preval&ecirc;ncia, as causas, as formas de preven&ccedil;&atilde;o,  
  o tratamento e as seq&uuml;elas da Tr&iacute;ade. </font></p>     ^cY#v5n4a07.
htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#43#39#article#375#<p>&nbsp;</p>     ^cY#
v5n4a07.htm##
00355000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704012400073002001200197#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#44#40#article#375#<p><font face="Verdana
" size="3"><B>FUNDAMENTOS TE&Oacute;RICOS PARA ESTE POSICIONAMENTO    OFICIAL </
B></font></p>     ^cY#v5n4a07.htm##
00324000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704009300073002001200166#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#45#41#article#375#<p><font face="Verdana
" size="2"><B>Composi&ccedil;&atilde;o Corporal</B></font></p>     ^cY#v5n4a07.h
tm##
01279000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704104800073002001201121#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#46#42#article#375#<p><font face="Verdana
" size="2">H&aacute; uma neglig&ecirc;ncia cada vez maior    sobre a influ&ecirc
;ncia da composi&ccedil;&atilde;o corporal sobre o desempenho    desportivo. Em 
algumas modalidades, um aumento do peso corporal pode reduzir    o desempenho<SU
P>40</SUP>. Entretanto, a press&atilde;o para reduzir o peso    corporal ou o pe
rcentual de gordura corporal a n&iacute;veis irreais pode contribuir    para o d
esenvolvimento de pr&aacute;ticas alimentares inadequadas<SUP>41,42</SUP>.    Um
a redu&ccedil;&atilde;o excessiva de peso pode levar &agrave; redu&ccedil;&atild
e;o    da massa corporal magra, desidrata&ccedil;&atilde;o e redu&ccedil;&atilde
;o    do desempenho<SUP>43,44</SUP>. Um atleta em treinamento, que inadvertidame
nte    ou voluntariamente restrinja a sua ingest&atilde;o cal&oacute;rica a um n
&iacute;vel    inferior ao do seu gasto energ&eacute;tico pode desenvolver dist&
uacute;rbios    semelhantes, dependendo da dura&ccedil;&atilde;o e da magnitude 
do desequil&iacute;brio    energ&eacute;tico. </font></p>     ^cY#v5n4a07.htm##
01536000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704130500073002001201378#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#47#43#article#375#<p><font face="Verdana
" size="2">&Eacute; fundamental reconhecer as limita&ccedil;&otilde;es    das t&
eacute;cnicas atuais para avaliar a composi&ccedil;&atilde;o corporal    e os pr
oblemas associados com o estabelecimento de padr&otilde;es para o percentual    
de gordura corporal. A densitometria, utilizando a t&eacute;cnica de pesagem    
hidrost&aacute;tica, &eacute; considerada o padr&atilde;o-ouro para avaliar    c
omposi&ccedil;&atilde;o corporal<SUP>45,46</SUP>. Entretanto, h&aacute; uma    f
aixa de erro de pelo menos 3 a 4% em uma popula&ccedil;&atilde;o normal e saud&a
acute;vel    com essa t&eacute;cnica<SUP>47,48</SUP>. Novas t&eacute;cnicas est&
atilde;o    dispon&iacute;veis, tais como a an&aacute;lise com bioimped&acirc;nc
ia e a medi&ccedil;&atilde;o    de absor&ccedil;&atilde;o de raios X de dupla en
ergia<SUP>49</SUP>, mas a sua    acur&aacute;cia, particularmente para popula&cc
edil;&otilde;es de atletas magros,    ainda n&atilde;o est&aacute; adequadamente
 estabelecida<SUP>46,48,50</SUP>.    &Eacute; particularmente importante estar a
tento &agrave; deflagra&ccedil;&atilde;o    de padr&otilde;es alimentares inadeq
uados em mulheres e jovens altamente sens&iacute;veis    ao seu peso corporal qu
ando se superenfatiza ou se superestima a gordura corporal.    </font></p>     ^
cY#v5n4a07.htm##
01594000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704136300073002001201436#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#48#44#article#375#<p><font face="Verdana
" size="2">Os padr&otilde;es da literatura de valores m&eacute;dios    para o pe
rcentual de gordura corporal para pequenos n&uacute;meros de atletas<SUP>40</SUP
>    s&atilde;o arbitr&aacute;rios. N&atilde;o se leva em conta os erros de mens
ura&ccedil;&atilde;o,    nem a ampla varia&ccedil;&atilde;o de percentual de gor
dura corporal compat&iacute;vel    com um desempenho excelente e nem a varia&cce
dil;&atilde;o gen&eacute;tica dentro    de um determinado somatotipo<SUP>40</SUP
>. Se padr&otilde;es precisam ser estabelecidos,    deve-se determinar ent&atild
e;o uma faixa de valores que contemple a variabilidade    interindividual e os e
rros metodol&oacute;gicos<SUP>40</SUP>. O limite superior    da faixa deve ser j
ustificado para um indiv&iacute;duo e atingido com o m&iacute;nimo    risco de d
eflagrar um comportamento alimentar inadequado. O limite inferior    da faixa de
ve representar o menor valor atingido por atletas de elite que estejam    saud&a
acute;veis e n&atilde;o apresentem sinais nem sintomas de dist&uacute;rbios    d
o comportamento alimentar. Estudos adicionais s&atilde;o necess&aacute;rios    p
ara documentar as influ&ecirc;ncias de uma redu&ccedil;&atilde;o excessiva    de
 peso e uma restri&ccedil;&atilde;o cal&oacute;rica exagerada sobre a sa&uacute;
de    e o desempenho<SUP>43,51-53</SUP>. </font></p>     ^cY#v5n4a07.htm##
00333000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704010200073002001200175#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#49#45#article#375#<p><font face="Verdana
" size="2"><B>Comportamentos Alimentares Inadequados</B>    </font></p>     ^cY#
v5n4a07.htm##
01128000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704089700073002001200970#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#50#46#article#375#<p><font face="Verdana
" size="2">Durante a puberdade, os garotos ganham massa    muscular e s&atilde;o
 estimulados a aumentar de peso para melhorar o desempenho    f&iacute;sico. Ao 
contr&aacute;rio, as garotas ganham gordura corporal durante    a puberdade e s&
atilde;o estimuladas a perder peso para melhorar o desempenho    e/ou a apar&eci
rc;ncia. A maior parte das meninas e mulheres tentam ser irrealmente    esbeltas
 devido a padr&otilde;es e press&atilde;o sociais. Elas podem tentar    reduzir 
o peso ou a gordura corporal atrav&eacute;s de uma restri&ccedil;&atilde;o    ca
l&oacute;rica ou uma ampla variedade de pr&aacute;ticas alimentares inadequadas<
SUP>9,10,41,54-57</SUP>.    Estas pr&aacute;ticas ocorrem dentro de um amplo esp
ectro e incluem o jejum,    p&iacute;lulas para emagrecer, laxantes, diur&eacute
;ticos e provoca&ccedil;&atilde;o    de v&ocirc;mitos. </font></p>     ^cY#v5n4a
07.htm##
01222000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704099100073002001201064#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#51#47#article#375#<p><font face="Verdana
" size="2">Os comportamentos de restri&ccedil;&atilde;o    alimentar incluem a f
alha inadvertida em equilibrar o gasto energ&eacute;tico    com a ingest&atilde;
o cal&oacute;rica, jejum epis&oacute;dico e a auto-imposi&ccedil;&atilde;o    vo
lunt&aacute;ria cr&ocirc;nica de passar fome. Uma restri&ccedil;&atilde;o    cal
&oacute;rica importante reduz a taxa metab&oacute;lica e provoca altera&ccedil;&
otilde;es    nos sistemas m&uacute;sculo-esquel&eacute;tico<SUP>23,30,58,59</SUP
> , cardiovascular<SUP>14,37,53,60,61</SUP>,    end&oacute;crino<SUP>35,62-64</S
UP>, termorregulat&oacute;rio<SUP>14</SUP> e    outros<SUP>11-13,35,65,66</SUP>.
 A anorexia nervosa &eacute; o extremo do comportamento    restritivo alimentar,
 no qual o indiv&iacute;duo se v&ecirc; como acima do peso,    mesmo que esteja 
15% abaixo do peso corporal ideal. A amenorr&eacute;ia &eacute;    um dos crit&e
acute;rios diagn&oacute;sticos para anorexia nervosa<SUP>6</SUP>.    </font></p>
     ^cY#v5n4a07.htm##
01439000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704120800073002001201281#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#52#48#article#375#<p><font face="Verdana
" size="2">O comportamento bul&iacute;mico &eacute; um ciclo    de restri&ccedil
;&atilde;o alimentar ou jejum levando a uma alimenta&ccedil;&atilde;o    em exce
sso (devido a fome fisiol&oacute;gica), seguida por purgamento. O comportamento 
   purgativo inclui a indu&ccedil;&atilde;o de v&ocirc;mitos, o uso de laxantes,
    diur&eacute;ticos ou enemas e exerc&iacute;cio excessivo<SUP>6</SUP>. As per
das    de l&iacute;quidos e eletr&oacute;litos durante esse comportamento purgat
ivo    s&atilde;o as causas principais de morbidade a curto prazo, incluindo a d
esidrata&ccedil;&atilde;o,    desequil&iacute;brios &aacute;cido-b&aacute;sico e
 eletrol&iacute;tico e arritmias    card&iacute;acas<SUP>12,13,37</SUP>. Esse ti
po de comportamento pode provocar    dist&uacute;rbios f&iacute;sicos cr&ocirc;n
icos, incluindo dist&uacute;rbios    gastrointestinais, aumento da gl&acirc;ndul
a par&oacute;tida<SUP>67</SUP> e    eros&atilde;o do esmalte do dente<SUP>13,35,
68</SUP>. Problemas psicol&oacute;gicos    agudos e cr&ocirc;nicos associados co
m o ciclo empanturrar-purgar incluem baixa    auto-estima, ansiedade, depress&at
ilde;o e suic&iacute;dio<SUP>5-7,66</SUP>.    </font></p>     ^cY#v5n4a07.htm##
01058000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704082700073002001200900#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#53#49#article#375#<p><font face="Verdana
" size="2">Nas extremidades do espectro dos dist&uacute;rbios    alimentares est
&atilde;o a anorexia nervosa e a bulimia nervosa<SUP>6</SUP>.    Entre 0,5 e 1% 
das mulheres jovens t&ecirc;m anorexia nervosa<SUP>5,6</SUP>    e um a quatro po
r cento t&ecirc;m bulimia nervosa, conforme os crit&eacute;rios    para diagn&oa
cute;stico psiqui&aacute;trico DSM-IV<SUP>5,6</SUP>. Muitas mulheres    que t&ec
irc;m dist&uacute;rbios alimentares cr&ocirc;nicos n&atilde;o se enquadram    ne
sses crit&eacute;rios r&iacute;gidos. Entretanto, essas mulheres que apresentam 
   quest&otilde;es importantes quanto ao seu peso, alimenta&ccedil;&atilde;o e  
  imagem corporal, possuem um maior risco de morbidade e mortalidade, necessitan
do    de avalia&ccedil;&atilde;o e tratamento<SUP>7,51,69</SUP>. </font></p>    
 ^cY#v5n4a07.htm##
00951000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704072000073002001200793#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#54#50#article#375#<p><font face="Verdana
" size="2">Meninas e mulheres atletas e fisicamente ativas    possuem um maior r
isco de dist&uacute;rbios alimentares do que a popula&ccedil;&atilde;o    geral?
 &Eacute; muito dif&iacute;cil a condu&ccedil;&atilde;o de estudos acurados    d
e preval&ecirc;ncia entre popula&ccedil;&otilde;es de atletas. Os comportamentos
    de dist&uacute;rbios alimentares s&atilde;o freq&uuml;entemente negados por 
   atletas em question&aacute;rios padronizados<SUP>70</SUP>. A preval&ecirc;nci
a    relatada de dist&uacute;rbios alimentares entre algumas atletas colegiais e
    de elite &eacute; semelhante ou maior do que a da popula&ccedil;&atilde;o ge
ral<SUP>9,10,54,56,57,70,71</SUP>.    </font></p>     ^cY#v5n4a07.htm##
01098000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704086700073002001200940#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#55#51#article#375#<p><font face="Verdana
" size="2">Muitos fatores contribuem para o desenvolvimento    de dist&uacute;rb
ios alimentares. Entre eles podemos incluir press&otilde;es    da sociedade para
 que as meninas sejam magras<SUP>55,69,72</SUP>, dietas cr&ocirc;nicas<SUP>51,70
</SUP>,    baixa auto-estima e depress&atilde;o<SUP>66</SUP>, problemas familiar
es<SUP>73,74</SUP>,    abuso f&iacute;sico ou sexual<SUP>75</SUP> e fatores biol
&oacute;gicos<SUP>76</SUP>.    Outros fatores para atletas incluem uma &ecirc;nf
ase no peso corporal relacionada    &agrave; modalidade praticada, perfeccionism
o, falta de conhecimentos de nutri&ccedil;&atilde;o,    a vontade de treinar e v
encer a qualquer custo, o impacto de les&otilde;es e    a press&atilde;o para re
duzir o peso imposta pelos pais, t&eacute;cnicos, ju&iacute;zes    e outros<SUP>
41,42,44,55,77,78</SUP>. </font></p>     ^cY#v5n4a07.htm##
01077000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704084600073002001200919#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#56#52#article#375#<p><font face="Verdana
" size="2">Quando questionados, muitos atletas acham que    os dist&uacute;rbios
 alimentares n&atilde;o s&atilde;o prejudiciais &agrave;    sa&uacute;de<SUP>9,7
8</SUP>. Os atletas acreditam ou s&atilde;o levados a acreditar    que a redu&cc
edil;&atilde;o de peso por qualquer m&eacute;todo &eacute; capaz    de melhorar 
o desempenho<SUP>9</SUP>. Na realidade, uma ingest&atilde;o cal&oacute;rica    i
nadequada e pr&aacute;ticas inadequadas de alimenta&ccedil;&atilde;o prejudicam 
   o desempenho e a sa&uacute;de<SUP>43,52,53</SUP>. Os problemas incluem a depl
e&ccedil;&atilde;o    das reservas de glicog&ecirc;nio muscular, desidrata&ccedi
l;&atilde;o, perda    de massa muscular, hipoglicemia, dist&uacute;rbios eletrol
&iacute;ticos, anemia,    amenorr&eacute;ia e osteoporose<SUP>11-13,35,43,79</SU
P>. </font></p>     ^cY#v5n4a07.htm##
01199000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704096800073002001201041#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#57#53#article#375#<p><font face="Verdana
" size="2">Os dist&uacute;rbios de alimenta&ccedil;&atilde;o    s&atilde;o doen&
ccedil;as cr&ocirc;nicas com seq&uuml;elas importantes dos pontos    de vista cl
&iacute;nico e psicol&oacute;gico. Entre elas temos a depress&atilde;o,    abuso
 de subst&acirc;ncias e morte por suic&iacute;dio ou arritmias card&iacute;acas<
SUP>5,7,12,13,14,37,42,61,80</SUP>    . O tratamento requer uma abordagem indivi
dualizada, a longo prazo e multidisciplinar.    Habitualmente envolve um m&eacut
e;dico cl&iacute;nico, um especialista em sa&uacute;de    mental e um nutricioni
sta, todos apoiados pela fam&iacute;lia e outras pessoas    importantes para o p
aciente<SUP>34,39,66,74,81</SUP>. O progn&oacute;stico para    a recupera&ccedil
;&atilde;o depende de uma interven&ccedil;&atilde;o precoce,    da dura&ccedil;&
atilde;o e da gravidade do dist&uacute;rbio e da vontade do    indiv&iacute;duo 
em procurar ajuda e permanecer no tratamento. </font></p>     ^cY#v5n4a07.htm##
00309000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007800073002001200151#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#58#54#article#375#<p><font face="Verdana
" size="2"><B>Amenorr&eacute;ia</B> </font></p>     ^cY#v5n4a07.htm##
01250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704101900073002001201092#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#59#55#article#375#<p><font face="Verdana
" size="2">O ciclo menstrual mensal &eacute; uma complexa    intera&ccedil;&atil
de;o dos sistemas end&oacute;crino e reprodutor. Est&iacute;mulos    externos af
etam esse sistema atrav&eacute;s de sinais hormonais para o hipot&aacute;lamo.  
  H&aacute; muito j&aacute; se reconheceu a interrup&ccedil;&atilde;o da menstru
a&ccedil;&atilde;o    com o treinamento f&iacute;sico<SUP>16,17,20,82-90</SUP>. 
Entretanto, a etiologia,    a preval&ecirc;ncia, as seq&uuml;elas e o tratamento
 da amenorr&eacute;ia associada    com o exerc&iacute;cio ainda n&atilde;o est&a
tilde;o completamente estabelecidos.    Entre dois e cinco por cento das mulhere
s em idade reprodutora que n&atilde;o    estejam gr&aacute;vidas ou em fase de l
acta&ccedil;&atilde;o experimentam alguma    forma de amenorr&eacute;ia secund&a
acute;ria<SUP>91-93</SUP>. Estudos relatam    que entre um e 44% das mulheres at
letas t&ecirc;m amenorr&eacute;ia em alguma    &eacute;poca de suas vidas<SUP>16
,83-85,88</SUP>. </font></p>     ^cY#v5n4a07.htm##
00920000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704068900073002001200762#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#60#56#article#375#<p><font face="Verdana
" size="2">Uma redu&ccedil;&atilde;o da freq&uuml;&ecirc;ncia    das eleva&ccedi
l;&otilde;es do horm&ocirc;nio luteinizante (LH) da hip&oacute;fise    &eacute; 
a causa direta da amenorr&eacute;ia e subseq&uuml;ente supress&atilde;o    ovari
ana nas mulheres fisicamente ativas<SUP>17,21,22,86,87</SUP>. A redu&ccedil;&ati
lde;o    da freq&uuml;&ecirc;ncia dos pulsos de LH &eacute; supostamente causada
 por    uma redu&ccedil;&atilde;o da freq&uuml;&ecirc;ncia dos pulsos da gonadot
rofina.    A regula&ccedil;&atilde;o das c&eacute;lulas que secretam esse horm&o
circ;nio    &eacute; o foco das pesquisas atuais nessa &aacute;rea<SUP>21,86,87<
/SUP>. </font></p>     ^cY#v5n4a07.htm##
01707000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704147600073002001201549#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#61#57#article#375#<p><font face="Verdana
" size="2">Na d&eacute;cada de 70, um baixo peso corporal<SUP>94</SUP>    e um b
aixo percentual de gordura corporal<SUP>95</SUP> foram colocados como    causas 
de amenorr&eacute;ia. Pesquisas subseq&uuml;entes descartaram essas hip&oacute;t
eses    e indicaram outros fatores envolvidos<SUP>16,96-98</SUP>. Um estudo indu
ziu    experimentalmente altera&ccedil;&otilde;es do sistema reprodutor atrav&ea
cute;s    da imposi&ccedil;&atilde;o abrupta de um grande volume de exerc&iacute
;cios    intensos com controle da ingest&atilde;o di&aacute;ria de nutrientes<SU
P>82</SUP>.    Portanto, o exerc&iacute;cio em excesso e a disponibilidade de en
ergia est&atilde;o    sendo investigadas como as causas potenciais da interrup&c
cedil;&atilde;o do    gerador do pulso de gonadotrofina. A hip&oacute;tese segun
do a qual o estresse    gerado pelo exerc&iacute;cio altera essa fisiologia se b
aseia em estudos que    demonstraram que eletrochoques ativam o eixo hipot&aacut
e;lamo-hipofis&aacute;rio-adrenal    e interrompem a fun&ccedil;&atilde;o reprod
utora em animais<SUP>99</SUP> e se    baseia tamb&eacute;m em observa&ccedil;&ot
ilde;es de altos n&iacute;veis de    cortisol em repouso<SUP>21,100</SUP> e resp
ostas atenuadas de cortisol ao exerc&iacute;cio    em atletas com amenorr&eacute
;ia<SUP>101,102</SUP>. Os que defendem a hip&oacute;tese    do estresse pelo exe
rc&iacute;cio v&ecirc;em o cortisol como o horm&ocirc;nio    do estresse. </font
></p>     ^cY#v5n4a07.htm##
01475000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704124400073002001201317#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#62#58#article#375#<p><font face="Verdana
" size="2">A disponibilidade de energia pode ser definida    como a ingest&atild
e;o de energia pela dieta menos o gasto energ&eacute;tico    pelo exerc&iacute;c
io. Contudo, tanto a ingest&atilde;o quanto o gasto energ&eacute;tico    s&atild
e;o dif&iacute;ceis de medir de forma confi&aacute;vel. A hip&oacute;tese    seg
undo a qual uma baixa disponibilidade de energia seria capaz de romper o    gera
dor de pulso de gonadotrofina se baseia em relatos que mulheres atletas    conso
mem menos energia na dieta do que elas precisariam para os seus n&iacute;veis   
 de atividade<SUP>103</SUP> e se baseia tamb&eacute;m em observa&ccedil;&otilde;
es    de baixos n&iacute;veis de T3<SUP>104,105</SUP> e balan&ccedil;o energ&eac
ute;tico    negativo em atletas com amenorr&eacute;ia<SUP>105-107</SUP>. Altera&
ccedil;&otilde;es    da menstrua&ccedil;&atilde;o podem ser causadas por uma fal
ha na compensa&ccedil;&atilde;o    da ingest&atilde;o de energia pela dieta para
 o gasto energ&eacute;tico do exerc&iacute;cio,    mais do que pelo exerc&iacute
;cio propriamente. Os defensores dessa hip&oacute;tese    v&ecirc;em o cortisol 
como um regulador das concentra&ccedil;&otilde;es de glicose    sangu&iacute;nea
. </font></p>     ^cY#v5n4a07.htm##
01268000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704103700073002001201110#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#63#59#article#375#<p><font face="Verdana
" size="2">Um experimento recente em mulheres ativas eumenorr&eacute;icas    rel
atou que a pulsatilidade do LH foi suprimida ap&oacute;s tr&ecirc;s dias    de t
reinamento f&iacute;sico enquanto a ingest&atilde;o pela dieta foi reduzida,    
mas n&atilde;o com suplementa&ccedil;&atilde;o diet&eacute;tica<SUP>108</SUP>.  
  Em um outro experimento, a freq&uuml;&ecirc;ncia dos pulsos de LH foi reduzida
    tanto em mulheres que n&atilde;o se exercitavam quando a sua ingest&atilde;o
    energ&eacute;tica foi restringida quanto em mulheres que se exercitavam e cu
jas    ingest&otilde;es pela dieta n&atilde;o foram suplementadas para satisfaze
r o    gasto energ&eacute;tico do exerc&iacute;cio<SUP>109</SUP>. O estudo tamb&
eacute;m    relatou que o estresse do exerc&iacute;cio n&atilde;o reduziu a freq
&uuml;&ecirc;ncia    dos pulsos de LH quando mulheres com disponibilidades energ
&eacute;ticas semelhantes    que se exercitavam e que n&atilde;o se exercitavam 
foram comparadas<SUP>109</SUP>.    </font></p>     ^cY#v5n4a07.htm##
01254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704102300073002001201096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#64#60#article#375#<p><font face="Verdana
" size="2">Atletas de <I>endurance</I>, por causa do seu    grande gasto cal&oac
ute;rico di&aacute;rio, podem estar em d&eacute;ficit energ&eacute;tico    se co
nsumirem as mesmas dietas adequadas para mulheres sedent&aacute;rias. As    atle
tas podem n&atilde;o apresentar nenhuma evid&ecirc;ncia de dist&uacute;rbio    d
e alimenta&ccedil;&atilde;o e podem n&atilde;o estar restringindo conscientement
e    a sua dieta. Entretanto, estas podem inadvertidamente estar consumindo meno
s    calorias do que o necess&aacute;rio para manter o seu alto gasto energ&eacu
te;tico    e podem desenvolver amenorr&eacute;ia como resultado do desequil&iacu
te;brio    energ&eacute;tico<SUP>105,107</SUP>. Para evitar altera&ccedil;&otild
e;es nos    seus horm&ocirc;nios reprodutores e fun&ccedil;&atilde;o menstrual, 
mulheres    fisicamente ativas podem ter que modificar os seus padr&otilde;es al
imentares    para atingir uma ingest&atilde;o que satisfa&ccedil;a o seu gasto e
nerg&eacute;tico.    </font></p>     ^cY#v5n4a07.htm##
01571000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704134000073002001201413#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#65#61#article#375#<p><font face="Verdana
" size="2">A amenorr&eacute;ia, antes considerada uma condi&ccedil;&atilde;o    
benigna e revers&iacute;vel<SUP>84,90</SUP>, foi ligada a uma redu&ccedil;&atild
e;o    prematura da densidade mineral &oacute;ssea desde 1984<SUP>25,26,28</SUP>
. A    amenorr&eacute;ia n&atilde;o &eacute; nem desej&aacute;vel nem um resulta
do    "normal" do treinamento f&iacute;sico<SUP>15,18,19</SUP>. &Eacute; um sint
oma    de um problema subjacente que exige avalia&ccedil;&atilde;o m&eacute;dica
 nos    primeiros tr&ecirc;s meses de sua ocorr&ecirc;ncia<SUP>15,18,19,36,110</
SUP>.    Entretanto, muitas mulheres fisicamente ativas e seus treinadores n&ati
lde;o    consideram ou relatam a amenorr&eacute;ia como anormal. As mulheres pod
em receber    bem a conveni&ecirc;ncia de n&atilde;o menstruar. Alguns cr&ecirc;
em erroneamente    que a amenorr&eacute;ia &eacute; um indicador de uma intensid
ade adequada de    treinamento e n&atilde;o um sintoma que requeira aten&ccedil;
&atilde;o m&eacute;dica.    A amenorr&eacute;ia &eacute; o sintoma mais facilmen
te reconhec&iacute;vel da    Tr&iacute;ade da Atleta e as mulheres e seus t&eacu
te;cnicos devem ser informados    que a amenorr&eacute;ia exige uma pronta avali
a&ccedil;&atilde;o m&eacute;dica    para esclarecer a sua causa e suas implica&c
cedil;&otilde;es. </font></p>     ^cY#v5n4a07.htm##
01204000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704097300073002001201046#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#66#62#article#375#<p><font face="Verdana
" size="2">A ovula&ccedil;&atilde;o e a revers&atilde;o    da amenorr&eacute;ia 
s&atilde;o imprevis&iacute;veis em mulheres amenorr&eacute;icas.    J&aacute; qu
e a ovula&ccedil;&atilde;o precede a menstrua&ccedil;&atilde;o,    todas as mulh
eres amenorr&eacute;icas sexualmente ativas devem ser testadas    para gravidez 
como parte da sua avalia&ccedil;&atilde;o m&eacute;dica e devem    receber acons
elhamento sobre anticoncep&ccedil;&atilde;o<SUP>36,111</SUP>. A    amenorr&eacut
e;ia associada ao exerc&iacute;cio &eacute; um diagn&oacute;stico    de exclus&a
tilde;o e todas as outras causas de amenorr&eacute;ia devem ser exclu&iacute;das
    atrav&eacute;s de uma avalia&ccedil;&atilde;o m&eacute;dica completa<SUP>15,
18,19,110</SUP>.    Mulheres amenorr&eacute;icas devem ser estimuladas a ingerir
 pelo menos 1.500mg    de c&aacute;lcio elementar por dia para assegurar um equi
l&iacute;brio do c&aacute;lcio<SUP>18,36</SUP>.    </font></p>     ^cY#v5n4a07.h
tm##
01011000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704078000073002001200853#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#67#63#article#375#<p><font face="Verdana
" size="2">A revers&atilde;o da amenorr&eacute;ia j&aacute;    foi relatada ap&o
acute;s uma les&atilde;o, durante uma redu&ccedil;&atilde;o    do treinamento e 
com um aumento da ingest&atilde;o cal&oacute;rica<SUP>84,112-116</SUP>.    Entre
tanto, n&atilde;o h&aacute; dados epidemiol&oacute;gicos dispon&iacute;veis    s
obre a taxa de sucesso de qualquer altera&ccedil;&atilde;o do estilo de vida    
ou tratamento para reverter a amenorr&eacute;ia, aumentar a massa &oacute;ssea  
  ou a fertilidade<SUP>97</SUP>. Estudos prospectivos s&atilde;o necess&aacute;r
ios    para estabelecer a patog&ecirc;nese da amenorr&eacute;ia induzida pelo ex
erc&iacute;cio    e definir as interven&ccedil;&otilde;es poss&iacute;veis e o s
eu tratamento.    </font></p>     ^cY#v5n4a07.htm##
00303000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007200073002001200145#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#68#64#article#375#<p><font face="Verdana
" size="2"><B>Osteoporose</B> </font></p>     ^cY#v5n4a07.htm##
02033000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704180200073002001201875#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#69#65#article#375#<p><font face="Verdana
" size="2">Baixas concentra&ccedil;&otilde;es de horm&ocirc;nios    ovarianos em
 mulheres atletas amenorr&eacute;icas ou oligomenorr&eacute;icas    est&atilde;o
 associadas com uma redu&ccedil;&atilde;o da massa &oacute;ssea    e maiores tax
as de perda &oacute;ssea. Essa perda &eacute; semelhante &agrave;    que ocorre 
em mulheres p&oacute;s-menopausa ou em mulheres com uma hipoestrogenemia    pato
l&oacute;gica como uma insufici&ecirc;ncia ovariana precoce, um tumor de    hip&
oacute;fise ou anorexia nervosa<SUP>30,58,117,118</SUP>. Em estudos anteriores<S
UP>25,26,28</SUP>,    uma redu&ccedil;&atilde;o da densidade mineral &oacute;sse
a (DMO) foi relatada    apenas na coluna lombar. T&eacute;cnicas novas e mais pr
ecisas para medir a    DMO em outros locais indicam que o d&eacute;ficit parece 
ser generalizado em    todo o esqueleto<SUP>38,119-121</SUP>. O fato da redu&cce
dil;&atilde;o da massa    &oacute;ssea ser ou n&atilde;o observada em todas as p
artes do esqueleto depende    em parte da magnitude da carga mec&acirc;nica impo
sta nas diferentes partes    do aparelho locomotor nas diversas modalidades desp
ortivas<SUP>122</SUP>. A    observa&ccedil;&atilde;o de pr&aacute;ticas alimenta
res inadequadas com baixa    ingest&atilde;o de c&aacute;lcio combinada com disf
un&ccedil;&atilde;o menstrual    pode exacerbar a perda &oacute;ssea. Nem todas 
as atletas com amenorr&eacute;ia    t&ecirc;m DMO baixa. O seu estado esquel&eac
ute;tico depende da dura&ccedil;&atilde;o    e da gravidade da sua irregularidad
e menstrual, bem como de fatores que influenciem    a sua DMO antes do in&iacute
;cio da amenorr&eacute;ia: o tipo de carga esquel&eacute;tica    durante a ativi
dade, o seu estado nutricional e o componente gen&eacute;tico<SUP>123</SUP>.    
</font></p>     ^cY#v5n4a07.htm##
01756000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704152500073002001201598#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#70#66#article#375#<p><font face="Verdana
" size="2">Uma quest&atilde;o importante para atletas com    baixa DMO devido a 
hipoestrogenemia &eacute; relativa ao risco de fraturas durante    os seus anos 
de competi&ccedil;&otilde;es e o risco futuro de fraturas prematuras    por oste
oporose<SUP>124</SUP>. As fraturas de colo de f&ecirc;mur e fraturas    m&uacute
;ltiplas de compress&atilde;o nas v&eacute;rtebras, comuns entre mulheres    ido
sas, foram documentadas em mulheres jovens com anorexia nervosa<SUP>30,125</SUP>
.    Enquanto que atletas de baixo peso podem n&atilde;o satisfazer todos os cri
t&eacute;rios    para anorexia nervosa ou bulimia nervosa, uma ingest&atilde;o c
al&oacute;rica    inadequada ou uma m&aacute; nutri&ccedil;&atilde;o com o objet
ivo de atingir    um peso irrealmente baixo pode colocar essas mulheres em risco
 para fraturas    importantes<SUP>111,126</SUP>. Estudos relatam uma maior incid
&ecirc;ncia de    les&otilde;es e fraturas de estresse entre mulheres amenorr&ea
cute;icas e oligomenorr&eacute;icas    do que em mulheres eumenorr&eacute;icas<S
UP>79,124,126,127</SUP>. Um estudo<SUP>38</SUP>    relata uma DMO mais baixa em 
atletas mulheres que tiveram fraturas de estresse    do que entre indiv&iacute;d
uos controle sem les&otilde;es. Este achado n&atilde;o    foi confirmado em um o
utro estudo<SUP>128</SUP>. Enquanto que o estado hipoestrog&ecirc;nico    n&atil
de;o &eacute; um pr&eacute;-requisito para uma fratura de estresse, uma    baixa
 DMO pode colocar o atleta em maior risco. </font></p>     ^cY#v5n4a07.htm##
01226000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704099500073002001201068#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#71#67#article#375#<p><font face="Verdana
" size="2">Pesquisadores<SUP>27,29,32,33,129</SUP> relatam    que uma hist&oacut
e;ria menstrual pr&eacute;via &eacute; o melhor preditor da    DMO atual. Mulher
es com hist&oacute;ria de amenorr&eacute;ia t&ecirc;m uma DMO    mais baixa do q
ue aquelas cujos ciclos sempre foram regulares. Como a taxa de    perda &oacute;
ssea em mulheres hipoestrog&ecirc;nicas &eacute; maior nos cinco    a seis anos 
que se seguem &agrave; redu&ccedil;&atilde;o dos n&iacute;veis de    estrog&ecir
c;nio end&oacute;geno, pode haver somente uma breve janela de oportunidade    pa
ra iniciar o tratamento para prevenir uma perda &oacute;ssea irrevers&iacute;vel
.    Na atleta adolescente, uma m&aacute; nutri&ccedil;&atilde;o e uma condi&cce
dil;&atilde;o    hipoestrog&ecirc;nica pode resultar em uma redu&ccedil;&atilde;
o da forma&ccedil;&atilde;o    do banco &oacute;sseo durante os anos cr&iacute;t
icos da consolida&ccedil;&atilde;o    do esqueleto<SUP>23,130-134</SUP>. </font>
</p>     ^cY#v5n4a07.htm##
01416000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704118500073002001201258#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#72#68#article#375#<p><font face="Verdana
" size="2">Uma quest&atilde;o importante &eacute; se a baixa    DMO hipoestrog&e
circ;nica pode ser tratada ou revertida at&eacute; atingir uma    DMO normal. No
vas t&eacute;cnicas de mensura&ccedil;&atilde;o da DMO, especificamente    a abs
orciometria por raios X de dupla energia<SUP>49</SUP> pode identificar    indiv&
iacute;duos com baixa DMO e, se realizadas seriadamente, podem avaliar    aquele
s que est&atilde;o perdendo massa &oacute;ssea rapidamente e monitorizar    a su
a resposta ao tratamento. Tr&ecirc;s estudos<SUP>112,115,116</SUP> relatam    um
 aumento da DMO em atletas amenorr&eacute;icas que voltam a menstruar normalment
e    mas parece que esses ganhos s&atilde;o limitados. Atletas amenorr&eacute;ic
as    que utilizam terapia de reposi&ccedil;&atilde;o hormonal em doses utilizad
as    para mulheres p&oacute;s-menopausa demonstraram manuten&ccedil;&atilde;o d
a    DMO mas nenhum ganho<SUP>135</SUP>. Mulheres com amenorr&eacute;ia e perdas
    &oacute;sseas mais leves podem preferir ajustar o treinamento e os padr&otil
de;es    nutricionais para retornar ao seu ciclo reprodutivo normal<SUP>15,18,27
,113,114,136</SUP>.    </font></p>     ^cY#v5n4a07.htm##
00319000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704008800073002001200161#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#73#69#article#375#<p><font face="Verdana
" size="2"><B>Quem est&aacute; sob risco?</B> </font></p>     ^cY#v5n4a07.htm##
00859000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704062800073002001200701#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#74#70#article#375#<p><font face="Verdana
" size="2">Potencialmente todas as garotas e mulheres fisicamente    ativas pode
m estar sob risco de desenvolver um ou mais dos componentes da Tr&iacute;ade.   
 As altera&ccedil;&otilde;es biol&oacute;gicas, a press&atilde;o dos pares, a   
 exig&ecirc;ncia da sociedade para serem esbeltas e a preocupa&ccedil;&atilde;o 
   com a imagem corporal que ocorre na puberdade tornam a adolesc&ecirc;ncia a  
  idade mais vulner&aacute;vel. A participa&ccedil;&atilde;o em esportes que enf
atizem    um baixo peso corporal pode tamb&eacute;m ser um fator de risco. Entre
 esses    esportes temos: </font></p>     ^cY#v5n4a07.htm##
00484000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704025300073002001200326#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#75#71#article#375#<p><font face="Verdana
" size="2">1. Esportes nos quais o desempenho &eacute; julgado    subjetivamente
 (dan&ccedil;a, patina&ccedil;&atilde;o art&iacute;stica, saltos    ornamentais,
 gin&aacute;stica e dan&ccedil;a aer&oacute;bica). </font></p>     ^cY#v5n4a07.h
tm##
00431000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704020000073002001200273#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#76#72#article#375#<p><font face="Verdana
" size="2">2. Esportes de <I>endurance</I> que enfatizem    um baixo peso corpor
al (corrida de longa dist&acirc;ncia, ciclismo, esqui de    plan&iacute;cie). </
font></p>     ^cY#v5n4a07.htm##
00586000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704035500073002001200428#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#77#73#article#375#<p><font face="Verdana
" size="2">3. Esportes que utilizem roupas colantes ou aderentes    ao corpo na 
competi&ccedil;&atilde;o (v&ocirc;lei, nata&ccedil;&atilde;o, saltos    ornament
ais, corrida <I>cross-country</I>, esqui de plan&iacute;cie, corrida    de <I>cr
oss-country</I>, participa&ccedil;&atilde;o em torcidas organizadas).    </font>
</p>     ^cY#v5n4a07.htm##
00430000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704019900073002001200272#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#78#74#article#375#<p><font face="Verdana
" size="2">4. Esportes que utilizem categorias por peso    para participa&ccedil
;&atilde;o (hipismo, algumas artes marciais, levantamento    de peso, remo). </f
ont></p>     ^cY#v5n4a07.htm##
00483000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704025200073002001200325#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#79#75#article#375#<p><font face="Verdana
" size="2">5. Esportes que enfatizem uma apar&ecirc;ncia    corporal pr&eacute;-
p&uacute;bere para um desempenho de sucesso (patina&ccedil;&atilde;o    art&iacu
te;stica, gin&aacute;stica e saltos ornamentais). </font></p>     ^cY#v5n4a07.ht
m##
00889000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704065800073002001200731#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#80#76#article#375#<p><font face="Verdana
" size="2">Os atletas do sexo masculino, particularmente    os que participam de
 esportes categorizados por peso ou esportes de <I>endurance</I>,    tamb&eacute
;m possuem risco para desenvolver dist&uacute;rbios alimentares<SUP>137,138</SUP
>    e anorexia nervosa. Exerc&iacute;cio exagerado e anorexia nervosa em homens
    est&atilde;o associados com hipogonadismo e osteoporose<SUP>30,137,139,140</
SUP>.    A Tr&iacute;ade da Atleta tamb&eacute;m ocorre em n&atilde;o atletas e 
em garotas    e mulheres fisicamente ativas que n&atilde;o est&atilde;o treinand
o ou competindo    em nenhum esporte espec&iacute;fico. </font></p>     ^cY#v5n4
a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#81#77#article#375#<p>&nbsp; </p>     ^cY
#v5n4a07.htm##
00308000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007700073002001200150#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#82#78#article#375#<p><font face="Verdana
" size="3"><B>CONCLUS&Atilde;O</B> </font></p>     ^cY#v5n4a07.htm##
01342000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704111100073002001201184#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#83#79#article#375#<p><font face="Verdana
" size="2">Com base nas evid&ecirc;ncias dispon&iacute;veis    sobre a magnitude
 e a seriedade dos problemas associados com a Tr&iacute;ade    da Atleta, o Col&
eacute;gio Americano de Medicina do Esporte fortemente adverte    que estrat&eac
ute;gias espec&iacute;ficas sejam desenvolvidas para prevenir,    reconhecer e t
ratar essa s&iacute;ndrome. Estrat&eacute;gias espec&iacute;ficas    para preven
&ccedil;&atilde;o, avalia&ccedil;&atilde;o, acompanhamento, pesquisa,    medir a
s conseq&uuml;&ecirc;ncias para a sa&uacute;de, proporcionar cuidados    m&eacut
e;dicos e fornecer educa&ccedil;&atilde;o para o p&uacute;blico em geral    e os
 profissionais m&eacute;dicos devem ser desenvolvidas, implementadas e monitoriz
adas.    Grupos-alvo para as a&ccedil;&otilde;es educacionais s&atilde;o os trei
nadores,    t&eacute;cnicos, pais, atletas, pares, administradores desportivos, 
autoridades    das institui&ccedil;&otilde;es governamentais que lidam com espor
tes e profissionais    da &aacute;rea de sa&uacute;de que lidem com indiv&iacute
;duos fisicamente ativos.    </font></p>     ^cY#v5n4a07.htm##
01456000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704122500073002001201298#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#84#80#article#375#<p><font face="Verdana
" size="2">S&atilde;o necess&aacute;rios estudos adicionais    em v&aacute;rias 
&aacute;reas relacionadas com a Tr&iacute;ade: composi&ccedil;&atilde;o    corpo
ral, dist&uacute;rbios alimentares, amenorr&eacute;ia, osteoporose, fatores    p
sicol&oacute;gicos, preval&ecirc;ncia, sinais de alerta, tratamento e evolu&cced
il;&atilde;o.    Estudos prospectivos longitudinais devem incluir atletas e mulh
eres e homens    ativos de diversas atividades, idades, esportes e proced&ecirc;
ncias. Devem    ser desenvolvidos modelos saud&aacute;veis e positivos que sejam
 desportivamente    e etnicamente relevantes para garotas e mulheres fisicamente
 ativas. Deve-se    desenvolver e disseminar para audi&ecirc;ncias selecionadas 
orienta&ccedil;&otilde;es    adicionais para o reconhecimento, avalia&ccedil;&at
ilde;o, tratamento e libera&ccedil;&atilde;o    para participa&ccedil;&atilde;o 
desportiva. Administradores desportivos e autoridades    de institui&ccedil;&oti
lde;es governamentais devem desenvolver padr&otilde;es    e estimular o esclarec
imento para os t&eacute;cnicos e treinadores sobre como    monitorizar as mulher
es jovens para prevenir e tratar a Tr&iacute;ade da Atleta.    </font></p>     ^
cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#85#81#article#375#<p>&nbsp; </p>     ^cY
#v5n4a07.htm##
00306000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007500073002001200148#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#86#82#article#375#<p><font face="Verdana
" size="3"><B>AGRADECIMENTOS</B> </font></p>     ^cY#v5n4a07.htm##
00570000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704033900073002001200412#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#87#83#article#375#<p><font face="Verdana
" size="2">Este documento foi revisado para o Col&eacute;gio    Americano de Med
icina do Esporte pelo Comit&ecirc; de Pronunciamentos e por:    Dra. Rosemary Ag
ostini, Prof. Joan Duda, Prof. Roger Goldingay, Profa. Randa    Ryan, Profa. Chr
istine Snow, Dr. Steven Van Camp e Dra. Michelle Warren. </font></p>     ^cY#v5n
4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#88#84#article#375#<p>&nbsp; </p>     ^cY
#v5n4a07.htm##
00309000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007800073002001200151#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#89#85#article#375#<p><font face="Verdana
" size="3"><B>REFER&Ecirc;NCIAS</B> </font></p>     ^cY#v5n4a07.htm##
00463000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069888000200073704021800075002001200293#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#90#86#article#375#1#<p><font
 face="Verdana" size="2">1. Harris S, Casperson CJ, Defriese GH. Physical    act
ivity counseling for healthy adults as a primary preventive intervention    in t
he clinical setting. JAMA 1989;261:3590-8.    ^cY#v5n4a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002100073002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#91#87#article#375# </font></p>     ^cY#v
5n4a07.htm##
00455000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069888000200073704021000075002001200285#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#92#88#article#375#2#<p><font
 face="Verdana" size="2">2. O'Toole ML, Douglas PS. Fitness: definition    and d
evelopments. In: Shangol M, Mirkin G, editors. Women and exercise. Philadelphia:
    F.A. Davis Company, 1988:4-16.    ^cY#v5n4a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002100073002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#93#89#article#375# </font></p>     ^cY#v
5n4a07.htm##
00391000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069888000200073704014600075002001200221#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#94#90#article#375#3#<p><font
 face="Verdana" size="2">3. Riggs BL, Melton III IJ. The prevention and    treat
ment of osteoporosis. N Engl J Med 1992;327:620-7.    ^cY#v5n4a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002100073002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#95#91#article#375# </font></p>     ^cY#v
5n4a07.htm##
00400000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069888000200073704015500075002001200230#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#96#92#article#375#4#<p><font
 face="Verdana" size="2">4. Yeager KK, Agostini R, Nattiv A, Drinkwater    B. Th
e female athlete triad. Med Sci Sports Exerc 1993;25:775-7.    ^cY#v5n4a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002100073002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#97#93#article#375# </font></p>     ^cY#v
5n4a07.htm##
00463000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069888000200073704021800075002001200293#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#98#94#article#375#5#<p><font
 face="Verdana" size="2">5. American Psychiatric Association. Diagnostic    stat
istical manual of mental disorders. 3<SUP>rd</SUP> ed. Revised. Washington,    D
C: American Psychiatric Association, 1987.    ^cY#v5n4a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002100073002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#99#95#article#375# </font></p>     ^cY#v
5n4a07.htm##
00460000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070888000200074704021400076002001200290#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#100#96#article#375#6#<p><fon
t face="Verdana" size="2">6. American Psychiatric Association. Diagnostic,    an
d statistical manual of mental disorders. 4<SUP>th</SUP> ed. Washington, DC:    
American Psychiatric Association, 1994.    ^cY#v5n4a07.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704002100074002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#101#97#article#375# </font></p>     ^cY#
v5n4a07.htm##
00378000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070888000200074704013200076002001200208#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#102#98#article#375#7#<p><fon
t face="Verdana" size="2">7. Garner DM, Garfinkel P. Anorexia nervosa and    bul
imia. New York: Guilford Press, 1985.    ^cY#v5n4a07.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704002100074002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#103#99#article#375# </font></p>     ^cY#
v5n4a07.htm##
00385000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704013800077002001200215#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#104#100#article#375#8#<p><fo
nt face="Verdana" size="2">8. Johnson MD. Disordered eating in active and    ath
letic women. Clin Sports Med 1994;13:355-69.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#105#101#article#375# </font></p>     ^cY
#v5n4a07.htm##
00413000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704016600077002001200243#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#106#102#article#375#9#<p><fo
nt face="Verdana" size="2">9. Rosen LW, McKeag DB, Hough DO. Pathogenic    weigh
t-control behavior in female athletes. Physician Sportsmed 1986:1479-86.    ^cY#
v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#107#103#article#375#    </font></p>     
^cY#v5n4a07.htm##
00414000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016600078002001200244#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#108#104#article#375#10#<p><f
ont face="Verdana" size="2">10. Rosen LW, Hough DO. Pathogenic weight-control   
 behaviors of female college gymnasts. Physician Sportsmed 1988;16:141-6.    ^cY
#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#109#105#article#375# </font></p>     ^cY
#v5n4a07.htm##
00553000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704030500078002001200383#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#110#106#article#375#11#<p><f
ont face="Verdana" size="2">11. Eichner ER. General health issues of low    body
 weight and undereating in athletes. In: Brownell KD, Rodin J, Wilmore JH,    ed
itors. Eating, body weight and performance in athletes: disorders of modern    s
ociety. Philadelphia: Lea and Febiger, 1992:191-201.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#111#107#article#375# </font></p>     ^cY
#v5n4a07.htm##
00346000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704009800078002001200176#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#112#108#article#375#12#<p><f
ont face="Verdana" size="2">12. Harris RT. Bulimarexia. Ann Intern Med 1983;99:8
00-7.    ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#113#109#article#375#    </font></p>     
^cY#v5n4a07.htm##
00369000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704012100078002001200199#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#114#110#article#375#13#<p><f
ont face="Verdana" size="2">13. Herzog DB, Copeland PM. Eating disorders.    N E
ngl J Med 1985;313: 295-303.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#115#111#article#375# </font></p>     ^cY
#v5n4a07.htm##
00398000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015000078002001200228#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#116#112#article#375#14#<p><f
ont face="Verdana" size="2">14. Palla B, Litt IF. Medical complications of    ea
ting disorders in adolescents. Pediatrics 1988;81:613-23.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#117#113#article#375# </font></p>     ^cY
#v5n4a07.htm##
00424000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017600078002001200254#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#118#114#article#375#15#<p><f
ont face="Verdana" size="2">15. Shangold MM, Rebar RW, Wentz AC, Ichiff I.    Ev
aluation and management of menstrual dysfunction in athletes. JAMA 1990;263:1665
-9.    ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#119#115#article#375#    </font></p>     
^cY#v5n4a07.htm##
00385000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704013700078002001200215#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#120#116#article#375#16#<p><f
ont face="Verdana" size="2">16. Loucks AB, Horvath SM. Athletic amenorrhea:    a
 review. Med Sci Sports Exerc 1985;17:56-72.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#121#117#article#375# </font></p>     ^cY
#v5n4a07.htm##
00539000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029100078002001200369#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#122#118#article#375#17#<p><f
ont face="Verdana" size="2">17. Loucks AB. The reproductive system. In: Bar-Or  
  O, Lamb DR, Clarkson PM, editors. Perspectives in exercise science and sports 
   medicine: Vol 9. Exercise and the female. A life span approach. Carmel, IN:  
  Cooper Publishing Group, 1996:41-71.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#123#119#article#375# </font></p>     ^cY
#v5n4a07.htm##
00369000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704012100078002001200199#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#124#120#article#375#18#<p><f
ont face="Verdana" size="2">18. Otis CL. Exercise associated amenorrhea.    Clin
 Sports Med 1992;11: 351-62.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#125#121#article#375# </font></p>     ^cY
#v5n4a07.htm##
00416000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016800078002001200246#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#126#122#article#375#19#<p><f
ont face="Verdana" size="2">19. Shangold MM. Menstruation. In: Shangold M,    Mi
rkin G, editors. Women and exercise. Philadelphia: F.A. Davis, 1988:129-45.    ^
cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#127#123#article#375#    </font></p>     
^cY#v5n4a07.htm##
00405000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015700078002001200235#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#128#124#article#375#20#<p><f
ont face="Verdana" size="2">20. Baker ER. Menstrual dysfunction and hormonal    
status in athletic women: a review. Fertil Steril 1981;36:691-6.    ^cY#v5n4a07.
htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#129#125#article#375# </font></p>     ^cY
#v5n4a07.htm##
00493000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704024500078002001200323#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#130#126#article#375#21#<p><f
ont face="Verdana" size="2">21. Loucks AB, Mortola JF, Girton L, Yen SSC.    Alt
erations in the hypothalamic-pituitary-ovarian and the hypothalamic-pituitary-ad
renal    axes in athletic women. J Clin Endocrinol Metab 1989;68:402-11.    ^cY#
v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#131#127#article#375# </font></p>     ^cY
#v5n4a07.htm##
00490000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704024200078002001200320#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#132#128#article#375#22#<p><f
ont face="Verdana" size="2">22. Veldhuis JD, Evans WS, Demers LM, Thorner    MO,
 Wakat D, Rogol AD. Altered neuroendocrine regulation of gonadotropin secretion 
   in women distance runners. J Clin Endocrinol Metab 1985;61:557-63.    ^cY#v5n
4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#133#129#article#375# </font></p>     ^cY
#v5n4a07.htm##
00433000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704018500078002001200263#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#134#130#article#375#23#<p><f
ont face="Verdana" size="2">23. Bachrach LK, Guido D, Katzman D, Marcus R.    De
creased bone density in adolescent girls with anorexia nervosa. Pediatrics    19
90;86:440-7.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#135#131#article#375# </font></p>     ^cY
#v5n4a07.htm##
00449000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704020100078002001200279#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#136#132#article#375#24#<p><f
ont face="Verdana" size="2">24. Bouillon P, Burckhardt P, Christiansen C,    et 
al. Consensus development conference: prophylaxis and treatment of osteoporosis.
    Am J Med 1991;90:107-10.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#137#133#article#375# </font></p>     ^cY
#v5n4a07.htm##
00412000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016400078002001200242#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#138#134#article#375#25#<p><f
ont face="Verdana" size="2">25. Cann CE, Martin MC, Genant HK, Jaffe RB.    Decr
eased spinal mineral content in amenorrheic women. JAMA 1984;251:626-9.    ^cY#v
5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#139#135#article#375#    </font></p>     
^cY#v5n4a07.htm##
00473000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704022500078002001200303#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#140#136#article#375#26#<p><f
ont face="Verdana" size="2">26. Drinkwater BL, Nilson K, Chesnut III CH,    Brem
ner WJ, Shainholtz S, Southworth MB. Bone mineral content of amenorrheic    and 
eumenorrheic athletes. N Engl J Med 1984;311:277-81.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#141#137#article#375# </font></p>     ^cY
#v5n4a07.htm##
00441000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019300078002001200271#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#142#138#article#375#27#<p><f
ont face="Verdana" size="2">27. Drinkwater BL, Bruemner B, Chesnut III CH.    Me
nstrual history as a determinant of current bone density in young athletes.    J
AMA 1990; 263:545-8.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#143#139#article#375# </font></p>     ^cY
#v5n4a07.htm##
00428000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704018000078002001200258#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#144#140#article#375#28#<p><f
ont face="Verdana" size="2">28. Marcus R, Cann C, Madvig P, et al. Menstrual    
function and bone mass in elite women distance runners. Ann Intern Med 1985;102:
158-63.    ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#145#141#article#375#    </font></p>     
^cY#v5n4a07.htm##
00467000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704021900078002001200297#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#146#142#article#375#29#<p><f
ont face="Verdana" size="2">29. Micklesfield LK, Lambert EV, Fataar AB, Noakes  
  TD, Myburgh KB. Bone mineral density in mature, premenopausal ultramarathon   
 runners. Med Sci Sports Exerc 1995;27:688-96.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#147#143#article#375# </font></p>     ^cY
#v5n4a07.htm##
00415000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016700078002001200245#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#148#144#article#375#30#<p><f
ont face="Verdana" size="2">30. Rigotti NA, Nussbaum SR, Herzog DB, Neer    RM. 
Osteoporosis in women with anorexia nervosa. N Engl J Med 1984;311:1601-6.    ^c
Y#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#149#145#article#375#    </font></p>     
^cY#v5n4a07.htm##
00424000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017600078002001200254#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#150#146#article#375#31#<p><f
ont face="Verdana" size="2">31. Kanis JA, Melton III J, Christiansen C, Johnston
    CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-
41.    ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#151#147#article#375#    </font></p>     
^cY#v5n4a07.htm##
00491000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704024300078002001200321#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#152#148#article#375#32#<p><f
ont face="Verdana" size="2">32. Cann CE, Cavanaugh DJ, Schnurpfiel K, Martin    
MC. Menstrual history is the primary determinant of trabecular bone density    i
n women runners (Abstract). Med Sci Sports Exerc 1988;20(Suppl 5):354.    ^cY#v5
n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#153#149#article#375# </font></p>     ^cY
#v5n4a07.htm##
00467000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704021900078002001200297#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#154#150#article#375#33#<p><f
ont face="Verdana" size="2">33. Lloyd T, Myers C, Buchanan JR, Demers LM.    Col
legiate women athletes with irregular menses during adolescence have decreased  
  bone density. Obstet Gynecol 1988;72:639-42.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#155#151#article#375# </font></p>     ^cY
#v5n4a07.htm##
00399000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015100078002001200229#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#156#152#article#375#34#<p><f
ont face="Verdana" size="2">34. Johnson MD. Tailoring, the preparticipation    e
xam to female athletes. Physician Sportsmed 1992;20:61-72.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#157#153#article#375# </font></p>     ^cY
#v5n4a07.htm##
00534000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704028600078002001200364#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#158#154#article#375#35#<p><f
ont face="Verdana" size="2">35. Pomeroy C, Mitchell JE. Medical issues in    the
 eating disorders. In: Brownell KD, Rodin J, Wilmore JH, editors. Eating,    bod
y weight and performance in athletes: disorders of modern society. Philadelphia:
    Lea and Febiger, 1992:202-21.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#159#155#article#375# </font></p>     ^cY
#v5n4a07.htm##
00386000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704013800078002001200216#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#160#156#article#375#36#<p><f
ont face="Verdana" size="2">36. Committee on Sports Medicine. Amenorrhea    in a
dolescent athletes. Pediatrics 1989;84:394-5.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#161#157#article#375# </font></p>     ^cY
#v5n4a07.htm##
00399000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015100078002001200229#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#162#158#article#375#37#<p><f
ont face="Verdana" size="2">37. Kreipe RE, Harris JP. Myocardial impairment    r
esulting from eating disorders. Pediatr Ann 1992;21:760-8.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#163#159#article#375# </font></p>     ^cY
#v5n4a07.htm##
00459000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704021100078002001200289#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#164#160#article#375#38#<p><f
ont face="Verdana" size="2">38. Myburgh KH, Hutchins J, Fataar AB, Hough    SF, 
Noakes TD. Low bone density is an etiologic factor for stress fractures    in at
hletes. Ann Intern Med 1990;113:754-9.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#165#161#article#375# </font></p>     ^cY
#v5n4a07.htm##
00530000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704028200078002001200360#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#166#162#article#375#39#<p><f
ont face="Verdana" size="2">39. Ryan R. Management of eating problems in    athl
etic settings. In: Brownell KD, Rodin J, Wilmore JH, editors. Eating, body    we
ight and performance in athletes: disorders of modern society. Philadelphia:    
Lea and Febiger, 1992:344-60.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#167#163#article#375# </font></p>     ^cY
#v5n4a07.htm##
00530000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704028200078002001200360#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#168#164#article#375#40#<p><f
ont face="Verdana" size="2">40. Wilmore JH. Body weight standards and athletic  
  performance. In: Brownell KD, Rodin J, Wilmore JH, editors. Eating, body weigh
t    and performance in athletes: disorders of modern society. Philadelphia: Lea
    and Febiger, 1992:315-29.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#169#165#article#375# </font></p>     ^cY
#v5n4a07.htm##
00443000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019500078002001200273#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#170#166#article#375#41#<p><f
ont face="Verdana" size="2">41. Sundot-Borgen J. Risk and trigger factors    for
 the development of eating disorders in female elite athletes. Med Sci Sports   
 Exerc 1994;26: 414-9.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#171#167#article#375# </font></p>     ^cY
#v5n4a07.htm##
00568000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704032000078002001200398#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#172#168#article#375#42#<p><f
ont face="Verdana" size="2">42. Wilson GT, Eldredge KL. Pathology and developmen
t    of eating disorders: implications for athletes. In: Brownell KD, Rodin J, W
ilmore    JH, editors. Eating, body weight and performance in athletes: disorder
s of modern    society. Philadelphia: Lea and Febiger, 1992:115-27.    ^cY#v5n4a
07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#173#169#article#375# </font></p>     ^cY
#v5n4a07.htm##
00565000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704031700078002001200395#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#174#170#article#375#43#<p><f
ont face="Verdana" size="2">43. Brownell KD, Steen SN. Weight cycling in    athl
etes: effects on behavior, physiology and health. In: Brownell KD, Rodin    J, W
ilmore JH, editors. Eating, body weight and performance in athletes: disorders  
  of modern society. Philadelphia: Lea and Febiger, 1992:159-71.    ^cY#v5n4a07.
htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#175#171#article#375# </font></p>     ^cY
#v5n4a07.htm##
00391000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704014300078002001200221#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#176#172#article#375#44#<p><f
ont face="Verdana" size="2">44. Wilmore JH. Eating and weight disorders in    th
e female athlete. Int J Sports Nutr 1991;1:104-17.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#177#173#article#375# </font></p>     ^cY
#v5n4a07.htm##
00424000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017600078002001200254#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#178#174#article#375#45#<p><f
ont face="Verdana" size="2">45. Jackson AS, Pollock ML, Ward A. Generalized    e
quations for predicting body density of women. Med Sci Sports Exerc 1980;12:175-
82.    ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#179#175#article#375#    </font></p>     
^cY#v5n4a07.htm##
00384000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704013600078002001200214#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#180#176#article#375#46#<p><f
ont face="Verdana" size="2">46. Kohrt WM. Body composition by DXA: tried    and 
true? Med Sci Sports Exerc 1995;27:1349-53.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#181#177#article#375# </font></p>     ^cY
#v5n4a07.htm##
00426000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017800078002001200256#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#182#178#article#375#47#<p><f
ont face="Verdana" size="2">47. Lohman TG. Applicability of body composition    
techniques and constants for children and youths. Exerc Sport Sci Rev 1986;14:32
5-57.    ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#183#179#article#375#    </font></p>     
^cY#v5n4a07.htm##
00413000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016500078002001200243#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#184#180#article#375#48#<p><f
ont face="Verdana" size="2">48. Lukaski HC. Methods for the assessment of    hum
an body composition: traditional and new. Am J Clin Nutr 1987;46:537-56.    ^cY#
v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#185#181#article#375#    </font></p>     
^cY#v5n4a07.htm##
00400000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015200078002001200230#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#186#182#article#375#49#<p><f
ont face="Verdana" size="2">49. Johnson Jr CC, Slemenda CW, Melton III LJ.    Cl
inical use of bone densitometry. N Engl J Med 1991;324:104.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#187#183#article#375# </font></p>     ^cY
#v5n4a07.htm##
00512000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704026400078002001200342#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#188#184#article#375#50#<p><f
ont face="Verdana" size="2">50. Wilmore JH. Body weight and body composition.   
 In: Brownell KD, Rodin J, Wilmore JH, editors. Eating, body weight and performa
nce    in athletes: disorders of modern society. Philadelphia: Lea and Febiger, 
1992:77-93.    ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#189#185#article#375#    </font></p>     
^cY#v5n4a07.htm##
00453000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704020500078002001200283#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#190#186#article#375#51#<p><f
ont face="Verdana" size="2">51. Brownell KD, Steen SN, Wilmore JH. Weight    reg
ulation practices in athletes: analysis of metabolic and health effects.    Med 
Sci Sports Exerc 1987;19:546-56.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#191#187#article#375# </font></p>     ^cY
#v5n4a07.htm##
00445000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019700078002001200275#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#192#188#article#375#52#<p><f
ont face="Verdana" size="2">52. Gleeson M, Greenhoff PL, Maughan RJ. Influence  
  of a 24 hour fast on high intensity exercise performance in man. Eur J Appl   
 Physiol 1988; 57:653-9.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#193#189#article#375# </font></p>     ^cY
#v5n4a07.htm##
00449000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704020100078002001200279#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#194#190#article#375#53#<p><f
ont face="Verdana" size="2">53. Ingjer F, Sundgot-Borgen J. Influence of    body
 weight reduction on maximal oxygen uptake in female elite athletes. Scand    J 
Med Sci Sports 1991;1:141-6.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#195#191#article#375# </font></p>     ^cY
#v5n4a07.htm##
00440000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019200078002001200270#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#196#192#article#375#54#<p><f
ont face="Verdana" size="2">54. Dummer GM, Rosen LW, Heusner WW, et al. Pathogen
ic    weight-control behaviors of young competitive swimmers. Physician Sportsme
d    1987;15:75-86.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#197#193#article#375# </font></p>     ^cY
#v5n4a07.htm##
00530000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704028200078002001200360#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#198#194#article#375#55#<p><f
ont face="Verdana" size="2">55. Rodin J, Larson L. Social factors and the    ide
al body shape. In: Brownell KD, Rodin J, Wilmore JH, editors. Eating, body    we
ight and performance in athletes: disorders of modern society. Philadelphia:    
Lea and Febiger, 1992:146-58.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#199#195#article#375# </font></p>     ^cY
#v5n4a07.htm##
00400000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015200078002001200230#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#200#196#article#375#56#<p><f
ont face="Verdana" size="2">56. Sundot-Borgen J. Prevalence of eating disorders 
   in elite female athletes. Int J Sport Nutr 1993;3:29-40.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#201#197#article#375# </font></p>     ^cY
#v5n4a07.htm##
00469000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704022100078002001200299#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#202#198#article#375#57#<p><f
ont face="Verdana" size="2">57. Sundot-Borgen J, Larsen S. Pathologic weight-con
trol    methods and self-reported eating disorders in female elite athletes and 
control.    Scand J Med Sci Sports 1993;3:150-5.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#203#199#article#375# </font></p>     ^cY
#v5n4a07.htm##
00407000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015900078002001200237#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#204#200#article#375#58#<p><f
ont face="Verdana" size="2">58. Salisbury JJ, Mitchell JE. Bone mineral density 
   and anorexia nervosa in women. Am J Psychiatry 1991;148:768-74.    ^cY#v5n4a0
7.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#205#201#article#375# </font></p>     ^cY
#v5n4a07.htm##
00510000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704026200078002001200340#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#206#202#article#375#59#<p><f
ont face="Verdana" size="2">59. Warren MP, Brooks-Gunn J, Fox RP, Lancelot    C,
 Newman D, Hamilton WG. Lack of bone accretion and amenorrhea: evidence for    a
 relative osteopenia in weight-bearing bones. J Clin Endocrinol Metab 1991;    7
2:847-53.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#207#203#article#375# </font></p>     ^cY
#v5n4a07.htm##
00402000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015400078002001200232#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#208#204#article#375#60#<p><f
ont face="Verdana" size="2">60. Amrein PC, Friedman R, Kosinski K, Ellman    L. 
Hematologic changes in anorexia nervosa. JAMA 1979;24:2190-1.    ^cY#v5n4a07.htm
##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#209#205#article#375# </font></p>     ^cY
#v5n4a07.htm##
00407000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015900078002001200237#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#210#206#article#375#61#<p><f
ont face="Verdana" size="2">61. Isner JM, Roberts WC, Heymsfield SB, Yager    J.
 Anorexia nervosa and sudden death. Ann Intern Med 1985;102:49-52.    ^cY#v5n4a0
7.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#211#207#article#375# </font></p>     ^cY
#v5n4a07.htm##
00412000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016400078002001200242#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#212#208#article#375#62#<p><f
ont face="Verdana" size="2">62. Hurd HP, Palumbo PJ, Gharid H. Hypothalamic-endo
crine    dysfunction in anorexia nervosa. Mayo Clin Proc 1977;52:711-6.    ^cY#v
5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#213#209#article#375# </font></p>     ^cY
#v5n4a07.htm##
00464000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704021600078002001200294#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#214#210#article#375#63#<p><f
ont face="Verdana" size="2">63. Vigorsky RA, Anderson AE, Thompson RH, Loriaux  
  DL. Hypothalamic dysfunction in secondary amenorrhea associated with simple   
 weight loss. N Engl J Med 1977;297:1141-5.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#215#211#article#375# </font></p>     ^cY
#v5n4a07.htm##
00411000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016300078002001200241#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#216#212#article#375#64#<p><f
ont face="Verdana" size="2">64. Warren MP, Vandewiele RL. Clinical and metabolic
    features of anorexia nervosa. Am J Obstet Gynecol 1973;117:435-49.    ^cY#v5
n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#217#213#article#375# </font></p>     ^cY
#v5n4a07.htm##
00418000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017000078002001200248#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#218#214#article#375#65#<p><f
ont face="Verdana" size="2">65. Bowers TK, Eckert E. Leukopenia in anorexia    n
ervosa: lack of increased risk of infection. Arch Intern Med 1978;138:1520-3.   
 ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#219#215#article#375#    </font></p>     
^cY#v5n4a07.htm##
00401000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015300078002001200231#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#220#216#article#375#66#<p><f
ont face="Verdana" size="2">66. Garfinkel PE, Garner DM. Anorexia nervosa:    a 
multidimensional perspective. New York: Brunner/Mazel, 1982.    ^cY#v5n4a07.htm#
#
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#221#217#article#375# </font></p>     ^cY
#v5n4a07.htm##
00416000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016800078002001200246#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#222#218#article#375#67#<p><f
ont face="Verdana" size="2">67. Levin PA, Falko JM, Dixon K, Gallup EM, Saunders
    W. Benign parotid enlargement in bulimia. Ann Intern Med 1980;93:827-9.    ^
cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#223#219#article#375# </font></p>     ^cY
#v5n4a07.htm##
00420000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017200078002001200250#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#224#220#article#375#68#<p><f
ont face="Verdana" size="2">68. Roberts MW, Li SH. Oral findings in anorexia    
nervosa and bulimia nervosa: a study of 47 cases. J Am Dent Assoc 1987;115:407. 
   ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#225#221#article#375#    </font></p>     
^cY#v5n4a07.htm##
00466000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704021800078002001200296#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#226#222#article#375#69#<p><f
ont face="Verdana" size="2">69. Silverstein B, Perdup L. The relationship    bet
ween role concern, preferences for slimness, and symptoms of eating problems    
among college women. Sex Roles 1988;18:101-6.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#227#223#article#375# </font></p>     ^cY
#v5n4a07.htm##
00536000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704028800078002001200366#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#228#224#article#375#70#<p><f
ont face="Verdana" size="2">70. Brownell KD, Rodin J. Prevalence of eating    di
sorders in athletes. In: Brownell KD, Rodin J, Wilmore JH, editors. Eating,    b
ody weight and performance in athletes: disorders of modern society. Philadelphi
a:    Lea and Febiger, 1992:128-45.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#229#225#article#375# </font></p>     ^cY
#v5n4a07.htm##
00420000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017200078002001200250#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#230#226#article#375#71#<p><f
ont face="Verdana" size="2">71. O'Conner PJ, Lewis RD, Kirchner EM. Eating    di
sorder symptoms in female college gymnasts. Med Sci Sports Exerc 1995;27:550-5. 
   ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#231#227#article#375#    </font></p>     
^cY#v5n4a07.htm##
00419000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017100078002001200249#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#232#228#article#375#72#<p><f
ont face="Verdana" size="2">72. Striegel-Moore RH, Silberstein LR, Rodin    J. T
oward an understanding of risk factors for bulimia. Am Psychol 1986;41:246-63.  
  ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#233#229#article#375#    </font></p>     
^cY#v5n4a07.htm##
00426000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017800078002001200256#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#234#230#article#375#73#<p><f
ont face="Verdana" size="2">73. Minuchin S, Rosman BL, Baker L. Psychosomatic   
 families: anorexia nervosa in context. Cambridge: Harvard University Press,    
1978.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#235#231#article#375# </font></p>     ^cY
#v5n4a07.htm##
00401000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015300078002001200231#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#236#232#article#375#74#<p><f
ont face="Verdana" size="2">74. Root MPP, Fallon P, Friedrich WN. Bulimia:    a 
systems approach to treatment. New York: Norton Books, 1986.    ^cY#v5n4a07.htm#
#
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#237#233#article#375# </font></p>     ^cY
#v5n4a07.htm##
00439000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019100078002001200269#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#238#234#article#375#75#<p><f
ont face="Verdana" size="2">75. Root MPP. Persistent disordered eating as    a g
ender-specific, post-traumatic stress response to sexual assault. Psychotherapy 
   1991;28:96-102.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#239#235#article#375# </font></p>     ^cY
#v5n4a07.htm##
00380000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704013200078002001200210#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#240#236#article#375#76#<p><f
ont face="Verdana" size="2">76. Kaye WH, Weltzin TE. Neurochemistry of bulimia  
  nervosa. J Clin Psychol 1991;52:21-8.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#241#237#article#375# </font></p>     ^cY
#v5n4a07.htm##
00534000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704028600078002001200364#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#242#238#article#375#77#<p><f
ont face="Verdana" size="2">77. Lopiano DA, Zotos C. Modern athletics, the    pr
essure to perform. In: Brownell KD, Rodin J, Wilmore JH, editors. Eating,    bod
y weight and performance in athletes: disorders of modern society. Philadelphia:
    Lea and Febiger, 1992:275-92.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#243#239#article#375# </font></p>     ^cY
#v5n4a07.htm##
00395000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704014700078002001200225#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#244#240#article#375#78#<p><f
ont face="Verdana" size="2">78. Zucker P. Eating disorders in young athletes:   
 a round table. Physician Sportsmed 1985;13:11:89-106.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#245#241#article#375# </font></p>     ^cY
#v5n4a07.htm##
00432000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704018400078002001200262#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#246#242#article#375#79#<p><f
ont face="Verdana" size="2">79. Barrow GW, Saha S. Menstrual irregularity    and
 stress fractures in collegiate female distance runners. Am J Sports Med    1988
;16:209-16.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#247#243#article#375# </font></p>     ^cY
#v5n4a07.htm##
00425000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017700078002001200255#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#248#244#article#375#80#<p><f
ont face="Verdana" size="2">80. Ratnasuriya RH, Eisler I, Szmuckler GI. Anorexia
    nervosa: outcome and prognostic factors after 20 years. Br J Psych 1991;158:
495.    ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#249#245#article#375#    </font></p>     
^cY#v5n4a07.htm##
00542000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029400078002001200372#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#250#246#article#375#81#<p><f
ont face="Verdana" size="2">81. Tobin DL, Johnson CL, Franke K. Clinical    trea
tment of eating disorders. In: Brownell KD, Rodin J, Wilmore JH, editors.    Eat
ing, body weight and performance in athletes: disorders of modern society.    Ph
iladelphia: Lea and Febiger, 1992:330-43.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#251#247#article#375# </font></p>     ^cY
#v5n4a07.htm##
00478000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704023000078002001200308#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#252#248#article#375#82#<p><f
ont face="Verdana" size="2">82. Bullen BA, Skrinar GS, Bettins IZ, von Mering   
 G, Turnbull BA, McArthur JW. Induction of menstrual disorders by strenous exerc
ise    in untrained women. N Engl J Med 1985;312:1349-53.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#253#249#article#375# </font></p>     ^cY
#v5n4a07.htm##
00400000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015200078002001200230#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#254#250#article#375#83#<p><f
ont face="Verdana" size="2">83. Dale E, Gerlach DH, Wilhite AL. Menstrual    dys
function in distance runners. Obstet Gynecol 1979;54:47-53.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#255#251#article#375# </font></p>     ^cY
#v5n4a07.htm##
00375000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704012700078002001200205#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#256#252#article#375#84#<p><f
ont face="Verdana" size="2">84. Erdelyi GJ. Gynecological survey of female    at
hletes. J Sports Med 1962;2:174-9.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#257#253#article#375# </font></p>     ^cY
#v5n4a07.htm##
00410000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016200078002001200240#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#258#254#article#375#85#<p><f
ont face="Verdana" size="2">85. Feicht CB, Johnson TS, Martin BJ, Sparks    KE, 
Wagner Jr WW. Secondary amenorrhea in athletes. Lancet 1978;2:1145-6.    ^cY#v5n
4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#259#255#article#375# </font></p>     ^cY
#v5n4a07.htm##
00422000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017400078002001200252#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#260#256#article#375#86#<p><f
ont face="Verdana" size="2">86. Loucks AB. Effects of exercise training on    th
e menstrual cycle: existence and mechanisms. Med Sci Sports Exerc 1990;22:275-80
.    ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#261#257#article#375#    </font></p>     
^cY#v5n4a07.htm##
00425000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017700078002001200255#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#262#258#article#375#87#<p><f
ont face="Verdana" size="2">87. Loucks AB, Vaitukaitis J, Cameron JL. The    rep
roductive system and exercise in women. Med Sci Sports Exerc 1992;24(Suppl):S288
-93.    ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#263#259#article#375#    </font></p>     
^cY#v5n4a07.htm##
00414000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016600078002001200244#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#264#260#article#375#88#<p><f
ont face="Verdana" size="2">88. Puhl JL, Brown CH, editors. The menstrual    cyc
le and physical activity. Champaign, IL: Human Kinetics Publishers, 1986.    ^cY
#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#265#261#article#375#    </font></p>     
^cY#v5n4a07.htm##
00444000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019600078002001200274#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#266#262#article#375#89#<p><f
ont face="Verdana" size="2">89. Schwartz B, Cumming DC, Riordan E, Selye    M, Y
en SS, Rebar RW. Exercise-associated amenorrhea: a distinct entity? Obstet    Gy
necol 1981; 141:662-70.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#267#263#article#375# </font></p>     ^cY
#v5n4a07.htm##
00396000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704014800078002001200226#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#268#264#article#375#90#<p><f
ont face="Verdana" size="2">90. Zaharieva E. Olympic participation by women:    
effects on pregnancy and childbirth. JAMA 1972;221:992.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#269#265#article#375# </font></p>     ^cY
#v5n4a07.htm##
00423000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017500078002001200253#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#270#266#article#375#91#<p><f
ont face="Verdana" size="2">91. Bachman GA, Kemann E. Prevalence of oligomenorrh
ea    and amenorrhea in a college population. Am J Obstet Gynecol 1982;144:98-10
2.    ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#271#267#article#375#    </font></p>     
^cY#v5n4a07.htm##
00438000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019000078002001200268#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#272#268#article#375#92#<p><f
ont face="Verdana" size="2">92. Petterson F, Fires H, Nillius SJ. Epidemiology  
  of secondary amenorrhea: incidence and prevalence rates. Am J Obstet Gynecol  
  1973;117: 80-6.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#273#269#article#375# </font></p>     ^cY
#v5n4a07.htm##
00384000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704013600078002001200214#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#274#270#article#375#93#<p><f
ont face="Verdana" size="2">93. Singh KB. Menstrual disorders in college    stud
ents. Am J Obstet Gynecol 1981;140:299-302.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#275#271#article#375# </font></p>     ^cY
#v5n4a07.htm##
00409000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016100078002001200239#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#276#272#article#375#94#<p><f
ont face="Verdana" size="2">94. Frisch RE, Revelle R. Height and weight at    me
narche and a hypothesis of menarche. Arch Dis Child 1971;46:695-701.    ^cY#v5n4
a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#277#273#article#375# </font></p>     ^cY
#v5n4a07.htm##
00461000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704021300078002001200291#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#278#274#article#375#95#<p><f
ont face="Verdana" size="2">95. Frisch RE, McArthur JW. Menstrual cycles:    fat
ness as a determinant of minimum weight for height necessary for their maintenan
ce    or onset. Science 1974;185:949-51.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#279#275#article#375# </font></p>     ^cY
#v5n4a07.htm##
00417000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016900078002001200247#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#280#276#article#375#96#<p><f
ont face="Verdana" size="2">96. Bronson FH, Manning JM. The energetic regulation
    of ovulation: a realistic role for body fat. Biol Reprod 1991;44:945-50.    
^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#281#277#article#375# </font></p>     ^cY
#v5n4a07.htm##
00456000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704020800078002001200286#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#282#278#article#375#97#<p><f
ont face="Verdana" size="2">97. Sanborn CF, Albrecht BH, Wagner Jr WW. Medically
    induced reversal of infertility in athletic amenorrhea (Abstract). Med Sci S
ports    Exerc 1987;19(Suppl 5):27.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#283#279#article#375# </font></p>     ^cY
#v5n4a07.htm##
00396000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704014800078002001200226#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#284#280#article#375#98#<p><f
ont face="Verdana" size="2">98. Sinning WE, Little KD. Body composition and    m
enstrual function in athletes. Sports Med 1987;4:34-45.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#285#281#article#375# </font></p>     ^cY
#v5n4a07.htm##
00456000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704020800078002001200286#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#286#282#article#375#99#<p><f
ont face="Verdana" size="2">99. Rivier C, Rivest S. Effect of stress on the    a
ctivity of the hypothalamic-pituary-gonadal axis: peripheral and central mechani
sms.    Biol Reprod 1991;45:523-32.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#287#283#article#375# </font></p>     ^cY
#v5n4a07.htm##
00454000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704020500079002001200284#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#288#284#article#375#100#<p><
font face="Verdana" size="2">100. Ding J-H, Sheckter CB, Drinkwater BL, Soules  
  MR, Bremmer WJ. High serum cortisol levels in exercise-associated amenorrhea. 
   Ann Intern Med 1988;108:530-4.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#289#285#article#375# </font></p>     ^cY
#v5n4a07.htm##
00501000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704025200079002001200331#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#290#286#article#375#101#<p><
font face="Verdana" size="2">101. De Souza MJ, Maguire MS, Maresh CM, Kraemer   
 WJ, Rubin KR, Loucks AB. Adrenal activation and the prolactin response to exerc
ise    in eumenorrheic and amenorrheic runners. J Appl Physiol 1991;70: 2378-87.
    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#291#287#article#375# </font></p>     ^cY
#v5n4a07.htm##
00439000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704019000079002001200269#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#292#288#article#375#102#<p><
font face="Verdana" size="2">102. Loucks AB, Horvath SM. Exercise-induced    str
ess responses to amenorrheic and eumenorrheic runner. J Clin Endocrinol Metab   
 1984; 59:1109-20.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#293#289#article#375# </font></p>     ^cY
#v5n4a07.htm##
00462000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704021300079002001200292#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#294#290#article#375#103#<p><
font face="Verdana" size="2">103. Wilmore JH, Wambsqans KC, Brenner M, et    al.
 Is there energy conservation in amenorrheic compared with eumenorrheic distance
    runner? J Appl Physiol 1992;72:15-22.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#295#291#article#375# </font></p>     ^cY
#v5n4a07.htm##
00489000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704024000079002001200319#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#296#292#article#375#104#<p><
font face="Verdana" size="2">104. Loucks AB, Laughlin GA, Mortola JF, Girton    
L, Nelson JC, Yen SSC. Hypothalamic-pituitary-thyroidal function in eumenorrheic
    and amenorrheic athletes. J Clin Endocrinol Metab 1992;75:514-8.    ^cY#v5n4
a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#297#293#article#375# </font></p>     ^cY
#v5n4a07.htm##
00457000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704020800079002001200287#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#298#294#article#375#105#<p><
font face="Verdana" size="2">105. Myerson M, Gutin B, Warren MP, et al. Resting 
   metabolic rate and energy balance in amenorrheic and eumenorrheic runners. Me
d    Sci Sports Exerc 1991;25:15-22.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#299#295#article#375# </font></p>     ^cY
#v5n4a07.htm##
00550000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704030100079002001200380#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#300#296#article#375#106#<p><
font face="Verdana" size="2">106. Cameron JL, Nosbisch C, Helmreich LD, Parfitt 
   DB. Reversal of exercise-induced amenorrhea in female cynomolgus monkeys (Mac
aca    fascicularis) by increasing food intake (Abstract). Proceedings of the En
docrine    Society 72nd Annual Meeting, 1990:285.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#301#297#article#375# </font></p>     ^cY
#v5n4a07.htm##
00448000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704019900079002001200278#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#302#298#article#375#107#<p><
font face="Verdana" size="2">107. Edwards JE, Lindeman AK, Mikesky AE, Stager   
 JM. Energy balance in highly trained female endurance runners. Med Sci Sports  
  Exerc 1993; 25:1398-1404.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#303#299#article#375# </font></p>     ^cY
#v5n4a07.htm##
00492000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704024300079002001200322#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#304#300#article#375#108#<p><
font face="Verdana" size="2">108. Williams NI, Young JC, McArthur JW, Bullen    
B, Skrinar GS, Turnbull B. Strenuous exercise with caloric restriction: effect  
  on luteinizing hormone secretion. Med Sci Sport Exerc 1995;27:1390-8.    ^cY#v
5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#305#301#article#375# </font></p>     ^cY
#v5n4a07.htm##
00525000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704027600079002001200355#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#306#302#article#375#109#<p><
font face="Verdana" size="2">109. Loucks AB, Heath EM, King K, Morrall D,    Ver
dun M, Watts JR. Low energy availability alters luteinizing hormone pulsatility 
   in regularly menstruating, young exercising women (Abstract 822). Endocrine  
  Society Meeting, 1994.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#307#303#article#375# </font></p>     ^cY
#v5n4a07.htm##
00407000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704015800079002001200237#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#308#304#article#375#110#<p><
font face="Verdana" size="2">110. Highet R. Athletic amenorrhea: an update    on
 aetiology, implications and management. Sports Med 1989;7:82-108.    ^cY#v5n4a0
7.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#309#305#article#375# </font></p>     ^cY
#v5n4a07.htm##
00444000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704019500079002001200274#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#310#306#article#375#111#<p><
font face="Verdana" size="2">111. Nelson ME, Fisher EC, Catsos PD, Meredith    C
N, Turksoy RN, Evans WJ. Diet and bone status in amenorrheic runners. Am J    Cl
in Nutr 1986; 43:910-6.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#311#307#article#375# </font></p>     ^cY
#v5n4a07.htm##
00443000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704019400079002001200273#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#312#308#article#375#112#<p><
font face="Verdana" size="2">112. Drinkwater BL, Nilson K, Ott S, Chesnut    III
 CH. Bone mineral density after resumption of menses in amenorrheic athletes.   
 JAMA 1986; 256:380-2.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#313#309#article#375# </font></p>     ^cY
#v5n4a07.htm##
00453000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704020400079002001200283#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#314#310#article#375#113#<p><
font face="Verdana" size="2">113. Dueck CA, Matt KS, Manore MM, Skinner JS.    T
reatment of athletic amenorrhea with a diet and training intervention program.  
  Int J Sport Nutr 1996;6:24-40.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#315#311#article#375# </font></p>     ^cY
#v5n4a07.htm##
00417000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704016800079002001200247#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#316#312#article#375#114#<p><
font face="Verdana" size="2">114. Dueck CA, Manore MM, Matt KS. Role of energy  
  balance in athletic menstrual dysfunction. Int J Sport Nutr 1996;6:165-90.    
^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#317#313#article#375# </font></p>     ^cY
#v5n4a07.htm##
00468000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704021900079002001200298#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#318#314#article#375#115#<p><
font face="Verdana" size="2">115. Jonnavithula S, Warren MP, Fox RP, Lazaro    M
I. Bone density is compromised in amenorrheic women despite returning menses:   
 a 2-year study. Obstet Gynecol 1993;81:669-74.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#319#315#article#375# </font></p>     ^cY
#v5n4a07.htm##
00468000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704021900079002001200298#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#320#316#article#375#116#<p><
font face="Verdana" size="2">116. Lindberg JS, Powell MR, Hunt MM, Ducey DE,    
Wade CE. Increased vertebral bone mineral in response to reduced exercise in    
amenorrheic runners. West J Med 1987;146:39-42.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#321#317#article#375# </font></p>     ^cY
#v5n4a07.htm##
00527000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704027800079002001200357#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#322#318#article#375#117#<p><
font face="Verdana" size="2">117. Emans SJ, Grace E, Hoffer FA, Gundberg C,    R
avnikar V, Woods ER. Estrogen deficiency in adolescents and young adults: impact
    on bone mineral content and effects of estrogen replacement therapy. Obstet 
   Gynecol 1990;76:585-92.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#323#319#article#375# </font></p>     ^cY
#v5n4a07.htm##
00444000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704021100075002001200286#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#324#320#article#375#<p><font face="Verda
na" size="2">118. Schlechte JA, Sherman B, Martin R. Bone    density in amenorrh
eic women with and without hyperprolactinemia. J Clin Endocrinol    Metab 1983; 
56:1120-3. </font></p>     ^cY#v5n4a07.htm##
00470000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704022100079002001200300#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#325#321#article#375#119#<p><
font face="Verdana" size="2">119. Myburgh KH, Bachrach LK, Lewis B, Kent K,    M
arcus R. Bone mineral density at axial and appendicular sites in amenorrheic    
athletes. Med Sci Sports Exerc 1993;25:1197-1202.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#326#322#article#375# </font></p>     ^cY
#v5n4a07.htm##
00454000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704020500079002001200284#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#327#323#article#375#120#<p><
font face="Verdana" size="2">120. Rencken M, Drinkwater BL, Chestnut III CH.    
Decreased bone density in the lower extremity of amenorrheic athletes. J Bone   
 Miner Res 1993; 8(Suppl 1):S254.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#328#324#article#375# </font></p>     ^cY
#v5n4a07.htm##
00422000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704017300079002001200252#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#329#325#article#375#121#<p><
font face="Verdana" size="2">121. Rencken M, Chesnut CH, Drinkwater BL. Bone    
density at multiple skeletal sites in amenorrheic athletes. JAMA 1996;276:238-40
.    ^cY#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#330#326#article#375#    </font></p>     
^cY#v5n4a07.htm##
00453000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704020400079002001200283#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#331#327#article#375#122#<p><
font face="Verdana" size="2">122. Slemenda CW, Johnson CC. High density activiti
es    in young women: site specific bone mass effects among female figure skater
s.    Bone Miner 1993;20:125-32.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#332#328#article#375# </font></p>     ^cY
#v5n4a07.htm##
00459000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704021000079002001200289#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#333#329#article#375#123#<p><
font face="Verdana" size="2">123. Dequeker J, Nus J, Verstraeten A, Guesens    P
, Gevers G. Genetic determination of bone mineral content at the spine and    ra
dius: a twin study. Bone 1987;8:207-9.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#334#330#article#375# </font></p>     ^cY
#v5n4a07.htm##
00444000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704019500079002001200274#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#335#331#article#375#124#<p><
font face="Verdana" size="2">124. Warren MP, Brooks-Gunn J, Hamilton LH, Warren 
   LF, Hamilton WG. Scoliosis and fractures in young ballet dancers. N Engl J Me
d    1986; 314:1348-53.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#336#332#article#375# </font></p>     ^cY
#v5n4a07.htm##
00411000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704016200079002001200241#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#337#333#article#375#125#<p><
font face="Verdana" size="2">125. Brotman AW, Stern TA. Osteoporosis, and    pat
hologic fractures in anorexia nervosa. Am J Psychiatry 1985;142:495-6.    ^cY#v5
n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#338#334#article#375# </font></p>     ^cY
#v5n4a07.htm##
00435000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704018600079002001200265#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#339#335#article#375#126#<p><
font face="Verdana" size="2">126. Dugowson CE, Drinkwater BL, Clark JM. Nontraum
atic    femur fracture in an oligomenorrheic athlete. Med Sci Sports Exerc 1991;
23:    1323-5.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#340#336#article#375# </font></p>     ^cY
#v5n4a07.htm##
00464000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704021500079002001200294#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#341#337#article#375#127#<p><
font face="Verdana" size="2">127. Lloyd T, Triantafyllou SJ, Baker ER, et    al.
 Women athletes with menstrual irregularity have increased musculoskeletal    in
juries. Med Sci Sports Exerc 1986;18:374-9.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#342#338#article#375# </font></p>     ^cY
#v5n4a07.htm##
00450000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704020100079002001200280#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#343#339#article#375#128#<p><
font face="Verdana" size="2">128. Grimston SK, Engsberg JR, Kloiber R, Hanley   
 DA. Bone mass, external loads and stress fractures in female runners. Int J    
Sport Biomech 1991;7:293-302.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#344#340#article#375# </font></p>     ^cY
#v5n4a07.htm##
00449000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704020000079002001200279#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#345#341#article#375#129#<p><
font face="Verdana" size="2">129. Georgiou E, Ntalles K, Papageorgiou A, Korkots
idis    A, Proukakis C. Bone mineral loss related to menstrual history. Acta Ort
hop    Scand 1989; 60:192-4.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#346#342#article#375# </font></p>     ^cY
#v5n4a07.htm##
00447000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704019800079002001200277#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#347#343#article#375#130#<p><
font face="Verdana" size="2">130. Dhuper S, Warren MP, Brooks-Gunn J, Fox    R. 
Effects of hormonal status on bone density in adolescent girls. J Clin Endocrino
l    Metab 1990;71:1083-8.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#348#344#article#375# </font></p>     ^cY
#v5n4a07.htm##
00410000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704016100079002001200240#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#349#345#article#375#131#<p><
font face="Verdana" size="2">131. Gilsanz V, Gibbens DT, Roe TF. Vertebral    bo
ne density in children: effect of puberty. Radiology 1988;166:847-50.    ^cY#v5n
4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#350#346#article#375# </font></p>     ^cY
#v5n4a07.htm##
00444000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704019500079002001200274#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#351#347#article#375#132#<p><
font face="Verdana" size="2">132. Johnston Jr CC, Miller JZ, Slemenda CW.    Cal
cium supplementation and increases in bone mineral density in children. N    Eng
l J Med 1992; 327:82-7.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#352#348#article#375# </font></p>     ^cY
#v5n4a07.htm##
00383000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704013400079002001200213#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#353#349#article#375#133#<p><
font face="Verdana" size="2">133. Recker RR, Davies KM, Hinders SM. Bone gain   
 in young adult women. JAMA 1992;268:2403.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#354#350#article#375# </font></p>     ^cY
#v5n4a07.htm##
00449000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704020000079002001200279#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#355#351#article#375#134#<p><
font face="Verdana" size="2">134. White CM, Hengenroeder AC, Klish WJ. Bone    m
ineral density in 15- to 21-year-old eumenorrheic and amenorrheic subjects.    A
m J Dis Child 1992;146:31-5.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#356#352#article#375# </font></p>     ^cY
#v5n4a07.htm##
00453000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704020400079002001200283#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#357#353#article#375#135#<p><
font face="Verdana" size="2">135. Hergenroeder AC. Bone mineralization, hypothal
amic    amenorrhea, and sex steroid therapy in female adolescents and young adul
ts.    J Pediatr 1995;126:683-9.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#358#354#article#375# </font></p>     ^cY
#v5n4a07.htm##
00460000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704021100079002001200290#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#359#355#article#375#136#<p><
font face="Verdana" size="2">136. Bachrach LK, Katzman DK, Litt IF, Guido    D, 
Marcus R. Recovery from osteopenia in adolescent girls with anorexia nervosa.   
 J Clin Endocrinol Metab 1991;72:602-6.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#360#356#article#375# </font></p>     ^cY
#v5n4a07.htm##
00528000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704027900079002001200358#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#361#357#article#375#137#<p><
font face="Verdana" size="2">137. Andersen AE. Eating disorders in males:    a s
pecial case? In: Brownell KD, Rodin J, Wilmore JH, editors. Eating, body    weig
ht and performance in athletes: disorders of modern society. Philadelphia:    Le
a and Febiger, 1992:172-90.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#362#358#article#375# </font></p>     ^cY
#v5n4a07.htm##
00465000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704021600079002001200295#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#363#359#article#375#138#<p><
font face="Verdana" size="2">138. Depalma MT, Koszewski WM. Case JG, Barile    R
J, Depalma BF, Oliaro SM. Weight control practices of lightweight football    pl
ayers. Med Sci Sports Exerc 1993;25:694-701.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#364#360#article#375# </font></p>     ^cY
#v5n4a07.htm##
00480000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704023100079002001200310#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#365#361#article#375#139#<p><
font face="Verdana" size="2">139. Finkelstein JS, Klibanski A, Neer RM, Greenspa
n    SL, Rosenthal DI, Crowley Jr WF. Osteoporosis in men with idiopathic hypogo
nadotropic    hypogonadism. Ann Intern Med 1987;106:354-61.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#366#362#article#375# </font></p>     ^cY
#v5n4a07.htm##
00446000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704019700079002001200276#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#367#363#article#375#140#<p><
font face="Verdana" size="2">140. Hetland ML, Haarbo J, Christiansen C. Low    b
one mass and high bone turnover in male long distance runners. J Clin Endocrinol
    Metab 1993; 77:700-5.    ^cY#v5n4a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#368#364#article#375# </font></p>     ^cY
#v5n4a07.htm##
00414000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000400075704016500079002001200244#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#p#369#365#article#375#141#<p><
font face="Verdana" size="2">141. Jackson JA, Kleerekoper M. Osteoporosis    in 
men: diagnosis, pathophysiology, and prevention. Medicine 1990;69:137-52.    ^cY
#v5n4a07.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#370#366#article#375#    </font></p>     
^cY#v5n4a07.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#371#367#article#375#<p>&nbsp;</p>     ^c
Y#v5n4a07.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#372#368#article#375#<p>&nbsp;</p>     ^c
Y#v5n4a07.htm##
00456000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704022300075002001200298#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#373#369#article#375#<p><font face="Verda
na" size="2">Traduzido, com permiss&atilde;o por escrito,    do original: Americ
an College of Sports Medicine. Position Stand on the Female    Athlete Triad. Me
d Sci Sports Exerc 1997;29(5):i-ix.    ^cY#v5n4a07.htm##
00299000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704006600075002001200141#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#374#370#article#375#<br>   </font><font 
face="Verdana" size="2">Traduzido por:    ^cY#v5n4a07.htm##
00312000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704007900075002001200154#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#375#371#article#375#<br>   </font><font 
face="Verdana" size="2">Jos&eacute; Kawazoe Lazzoli    ^cY#v5n4a07.htm##
00305000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704007200075002001200147#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#376#372#article#375#<BR>   Editor-Chefe 
da Revista Brasileira de Medicina do Esporte    ^cY#v5n4a07.htm##
00328000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704009500075002001200170#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#377#373#article#375#<br>   Primeiro-Secr
et&aacute;rio da Sociedade de Medicina Desportiva do Rio de Janeiro    ^cY#v5n4a
07.htm##
00401000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704016800075002001200243#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#378#374#article#375#<br>   Professor do 
Depto. de Morfologia e da Disciplina de Medicina do Exerc&iacute;cio    e do Esp
orte, da Universidade Federal Fluminense, Niter&oacute;i, RJ    ^cY#v5n4a07.htm#
#
00354000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704012100075002001200196#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a07.htm#S#p#379#375#article#375#<br>   Diretor do er
gocenter &#150; Instituto Petropolitano de Ergometria, Petr&oacute;polis,    RJ 
</font> </p>     ^cY#v5n4a07.htm##
00600000000000289000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080004000691180002000730100016000750100020000910100
02000111012011300131030000500244065000900249064000500258031000400263014000700267
865000900274002001200283035001000295801000500305#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#380#1#article#141#1#^rND^sHarris^nS#^rND^sCasperson^nCJ#
^rND^sDefriese^nGH.#Physical activity counseling for healthy adults as a primary
 preventive intervention in the clinical setting^len#JAMA#19890000#1989#261#3590
-8#19990800#v5n4a07.htm#0098-7484#JAMA##
00571000000000289000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080004000691180002000730100018000750100019000930120
04100112016001700153016001600170018002300186066001300209062001900222065000900241
064000500250014000500255865000900260002001200269#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#381#2#article#141#2#^rND^sO'Toole^nML#^rND^sDouglas^nPS.
#Fitness: definition and developments^len#^rED^sShangol^nM#^rED^sMirkin^nG#Women
 and exercise^len#Philadelphia#F.A. Davis Company#19880000#1988#4-16#19990800#v5
n4a07.htm##
00520000000000277000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080004000691180002000730100016000750100021000910120
04900112030001300161065000900174064000500183031000400188014000600192865000900198
002001200207035001000219801001300229#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#382#3#article#141#3#^rND^sRiggs^nBL#^rND^sMelton^nIII IJ#The prevent
ion and treatment of osteoporosis^len#N Engl J Med#19920000#1992#327#620-7#19990
800#v5n4a07.htm#0028-4793#N Engl J Med##
00574000000000301000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080004000691180002000730100017000750100018000920100
01600110010002100126012002900147030002100176065000900197064000500206031000300211
014000600214865000900220002001200229035001000241801002100251#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#383#4#article#141#4#^rND^sYeager^nKK#^rND^sA
gostini^nR#^rND^sNattiv^nA#^rND^sDrinkwater^nB.#The female athlete triad^len#Med
 Sci Sports Exerc#19930000#1993#25#775-7#19990800#v5n4a07.htm#0195-9131#Med Sci 
Sports Exerc##
00509000000000253000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080004000691180002000730170033000750180054001080630
00200162061000800164066001500172062003300187065000900220064000500229865000900234
002001200243#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#384#5#articl
e#141#5#American Psychiatric Association#Diagnostic statistical manual of mental
 disorders^len#3#Revised#Washington^eDC#American Psychiatric Association#1987000
0#1987#19990800#v5n4a07.htm##
00494000000000241000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080004000691180002000730170033000750180059001080630
00200167066001500169062003300184065000900217064000500226865000900231002001200240
#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#385#6#article#141#6#Amer
ican Psychiatric Association#Diagnostic, and statistical manual of mental disord
ers^len#4#Washington^eDC#American Psychiatric Association#19940000#1994#19990800
#v5n4a07.htm##
00446000000000241000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080004000691180002000730160017000750160020000920180
03300112066000900145062001500154065000900169064000500178865000900183002001200192
#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#386#7#article#141#7#^rND
^sGarner^nDM#^rND^sGarfinkel^nP.#Anorexia nervosa and bulimia^len#New York#Guilf
ord Press#19850000#1985#19990800#v5n4a07.htm##
00498000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080004000691180002000730100019000750120051000940300
01600145065000900161064000500170031000300175014000700178865000900185002001200194
035001000206801001600216#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
387#8#article#141#8#^rND^sJohnson^nMD.#Disordered eating in active and athletic 
women^len#Clin Sports Med#19940000#1994#13#355-69#19990800#v5n4a07.htm#0278-5919
#Clin Sports Med##
00514000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080004000691180002000730100016000750100017000910100
01700108012005800125030002000183710000200203065000900205064000500214014000800219
865000900227002001200236#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
388#9#article#141#9#^rND^sRosen^nLW#^rND^sMcKeag^nDB#^rND^sHough^nDO.#Pathogenic
 weight-control behavior in female athletes^len#Physician Sportsmed#2#19860000#1
986#1479-86#19990800#v5n4a07.htm##
00509000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100016000770100017000930120
06700110030002000177710000200197065000900199064000500208031000300213014000600216
865000900222002001200231#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
389#10#article#141#10#^rND^sRosen^nLW#^rND^sHough^nDO.#Pathogenic weight-control
 behaviors of female college gymnasts^len#Physician Sportsmed#2#19880000#1988#16
#141-6#19990800#v5n4a07.htm##
00664000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770120073000960160
01900169016001500188016001800203018008100221066001300302062001600315065000900331
064000500340014000800345865000900353002001200362#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#390#11#article#141#11#^rND^sEichner^nER.#General health 
issues of low body weight and undereating in athletes^len#^rED^sBrownell^nKD#^rE
D^sRodin^nJ#^rED^sWilmore^nJH#Eating, body weight and performance in athletes: d
isorders of modern society^len#Philadelphia#Lea and Febiger#19920000#1992#191-20
1#19990800#v5n4a07.htm##
00461000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100018000770120016000950300
01500111065000900126064000500135031000300140014000600143865000900149002001200158
035001000170801001500180#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
391#12#article#141#12#^rND^sHarris^nRT.#Bulimarexia^len#Ann Intern Med#19830000#
1983#99#800-7#19990800#v5n4a07.htm#0003-4819#Ann Intern Med##
00496000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100020000940120
02100114030001300135065000900148064000500157031000400162014000800166865000900174
002001200183035001000195801001300205#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#392#13#article#141#13#^rND^sHerzog^nDB#^rND^sCopeland^nPM.#Eating di
sorders^len#N Engl J Med#19850000#1985#313#295-303#19990800#v5n4a07.htm#0028-479
3#N Engl J Med##
00523000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100015000770100015000920120
06100107030001100168065000900179064000500188031000300193014000700196865000900203
002001200212035001000224801001100234#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#393#14#article#141#14#^rND^sPalla^nB#^rND^sLitt^nIF#Medical complica
tions of eating disorders in adolescents^len#Pediatrics#19880000#1988#81#613-23#
19990800#v5n4a07.htm#0031-4005#Pediatrics##
00580000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770100016000960100
01600112010001700128012006700145030000500212065000900217064000500226031000400231
014000700235865000900242002001200251035001000263801000500273#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#394#15#article#141#15#^rND^sShangold^nMM#^rN
D^sRebar^nRW#^rND^sWentz^nAC#^rND^sIchiff^nI.#Evaluation and management of menst
rual dysfunction in athletes^len#JAMA#19900000#1990#263#1665-9#19990800#v5n4a07.
htm#0098-7484#JAMA##
00521000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100019000940120
03400113030002100147065000900168064000500177031000300182014000600185865000900191
002001200200035001000212801002100222#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#395#16#article#141#16#^rND^sLoucks^nAB#^rND^sHorvath^nSM.#Athletic a
menorrhea: a review^len#Med Sci Sports Exerc#19850000#1985#17#56-72#19990800#v5n
4a07.htm#0195-9131#Med Sci Sports Exerc##
00650000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100018000770120028000950160
01600123016001500139016001900154018011100173066001100284062002400295065000900319
064000500328014000600333865000900339002001200348#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#396#17#article#141#17#^rND^sLoucks^nAB.#The reproductive
 system^len#^rED^sBar-Or^nO#^rED^sLamb^nDR#^rED^sClarkson^nPM#Perspectives in ex
ercise science and sports medicine: Vol 9. Exercise and the female. A life span 
approach^len#Carmel^eIN#Cooper Publishing Group#19960000#1996#41-71#19990800#v5n
4a07.htm##
00481000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100016000770120035000930300
01600128065000900144064000500153031000300158014000700161865000900168002001200177
035001000189801001600199#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
397#18#article#141#18#^rND^sOtis^nCL.#Exercise associated amenorrhea^len#Clin Sp
orts Med#19920000#1992#11#351-62#19990800#v5n4a07.htm#0278-5919#Clin Sports Med#
#
00515000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100020000770120017000970160
01800114016001600132018002300148066001300171062001100184065000900195064000500204
014000700209865000900216002001200225#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#398#19#article#141#19#^rND^sShangold^nMM.#Menstruation^len#^rED^sSha
ngold^nM#^rED^sMirkin^nG#Women and exercise^len#Philadelphia#F.A. Davis#19880000
#1988#129-45#19990800#v5n4a07.htm##
00516000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770120074000940300
01400168065000900182064000500191031000300196014000600199865000900205002001200214
035001000226801001400236#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
399#20#article#141#20#^rND^sBaker^nER.#Menstrual dysfunction and hormonal status
 in athletic women: a review^len#Fertil Steril#19810000#1981#36#691-6#19990800#v
5n4a07.htm#0015-0282#Fertil Steril##
00665000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100018000940100
01600112010001600128012011600144030002400260065000900284064000500293031000300298
014000700301865000900308002001200317035001000329801002400339#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#400#21#article#141#21#^rND^sLoucks^nAB#^rND^
sMortola^nJF#^rND^sGirton^nL#^rND^sYen^nSSC.#Alterations in the hypothalamic-pit
uitary-ovarian and the hypothalamic-pituitary-adrenal axes in athletic women^len
#J Clin Endocrinol Metab#19890000#1989#68#402-11#19990800#v5n4a07.htm#0021-972X#
J Clin Endocrinol Metab##
00698000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770100016000960100
01700112010001800129010001500147010001700162012009000179030002400269065000900293
06400050030203100030030701400070031086500090031700200120032603500100033880100240
0348#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#401#22#article#141#2
2#^rND^sVeldhuis^nJD#^rND^sEvans^nWS#^rND^sDemers^nLM#^rND^sThorner^nMO#^rND^sWa
kat^nD#^rND^sRogol^nAD.#Altered neuroendocrine regulation of gonadotropin secret
ion in women distance runners^len#J Clin Endocrinol Metab#19850000#1985#61#557-6
3#19990800#v5n4a07.htm#0021-972X#J Clin Endocrinol Metab##
00592000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770100015000960100
01700111010001700128012006900145030001100214065000900225064000500234031000300239
014000600242865000900248002001200257035001000269801001100279#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#402#23#article#141#23#^rND^sBachrach^nLK#^rN
D^sGuido^nD#^rND^sKatzman^nD#^rND^sMarcus^nR.#Decreased bone density in adolesce
nt girls with anorexia nervosa^len#Pediatrics#19900000#1990#86#440-7#19990800#v5
n4a07.htm#0031-4005#Pediatrics##
00598000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100018000770100020000950100
02200115810000600137012008000143030000900223065000900232064000500241031000300246
014000700249865000900256002001200265035001000277801000900287#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#403#24#article#141#24#^rND^sBouillon^nP#^rND
^sBurckhardt^nP#^rND^sChristiansen^nC#et al#Consensus development conference: pr
ophylaxis and treatment of osteoporosis^len#Am J Med#19910000#1991#90#107-10#199
90800#v5n4a07.htm#0002-9343#Am J Med##
00568000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100015000770100017000920100
01700109010001700126012005800143030000500201065000900206064000500215031000400220
014000600224865000900230002001200239035001000251801000500261#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#404#25#article#141#25#^rND^sCann^nCE#^rND^sM
artin^nMC#^rND^sGenant^nHK#^rND^sJaffe^nRB.#Decreased spinal mineral content in 
amenorrheic women^len#JAMA#19840000#1984#251#626-9#19990800#v5n4a07.htm#0098-748
4#JAMA##
00670000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100021000770100016000980100
02200114010001800136010002000154010002200174012006600196030001300262065000900275
06400050028403100040028901400070029386500090030000200120030903500100032180100130
0331#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#405#26#article#141#2
6#^rND^sDrinkwater^nBL#^rND^sNilson^nK#^rND^sChesnut^nIII CH#^rND^sBremner^nWJ#^
rND^sShainholtz^nS#^rND^sSouthworth^nMB.#Bone mineral content of amenorrheic and
 eumenorrheic athletes^len#N Engl J Med#19840000#1984#311#277-81#19990800#v5n4a0
7.htm#0028-4793#N Engl J Med##
00575000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100021000770100018000980100
02300116012008100139030000500220065000900225064000500234031000400239014000600243
865000900249002001200258035001000270801000500280#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#406#27#article#141#27#^rND^sDrinkwater^nBL#^rND^sBruemne
r^nB#^rND^sChesnut^nIII CH.#Menstrual history as a determinant of current bone d
ensity in young athletes^len#JAMA#19900000#1990#263#545-8#19990800#v5n4a07.htm#0
098-7484#JAMA##
00587000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100016000770100014000930100
01600107810000700123012006900130030001500199065000900214064000500223031000400228
014000700232865000900239002001200248035001000260801001500270#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#407#28#article#141#28#^rND^sMarcus^nR#^rND^s
Cann^nC#^rND^sMadvig^nP#et al.#Menstrual function and bone mass in elite women d
istance runners^len#Ann Intern Med#19850000#1985#102#158-63#19990800#v5n4a07.htm
#0003-4819#Ann Intern Med##
00654000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100023000770100018001000100
01700118010001700135010001900152012007200171030002100243065000900264064000500273
031000300278014000700281865000900288002001200297035001000309801002100319#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#408#29#article#141#29#^rND^sMick
lesfield^nLK#^rND^sLambert^nEV#^rND^sFataar^nAB#^rND^sNoakes^nTD#^rND^sMyburgh^n
KB.#Bone mineral density in mature, premenopausal ultramarathon runners^len#Med 
Sci Sports Exerc#19950000#1995#27#688-96#19990800#v5n4a07.htm#0195-9131#Med Sci 
Sports Exerc##
00579000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100018000770100019000950100
01700114010001600131012004800147030001300195065000900208064000500217031000400222
014000700226865000900233002001200242035001000254801001300264#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#409#30#article#141#30#^rND^sRigotti^nNA#^rND
^sNussbaum^nSR#^rND^sHerzog^nDB#^rND^sNeer^nRM.#Osteoporosis in women with anore
xia nervosa^len#N Engl J Med#19840000#1984#311#1601-6#19990800#v5n4a07.htm#0028-
4793#N Engl J Med##
00610000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100016000770100020000930100
02200113010001900135010001900154012003400173030001700207065000900224064000500233
031000200238014000800240865000900248002001200257035001000269801001700279#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#410#31#article#141#31#^rND^sKani
s^nJA#^rND^sMelton^nIII J#^rND^sChristiansen^nC#^rND^sJohnston^nCC#^rND^sKhaltae
v^nN.#The diagnosis of osteoporosis^len#J Bone Miner Res#19940000#1994#9#1137-41
#19990800#v5n4a07.htm#0884-0431#J Bone Miner Res##
00673000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100015000770100020000920100
02100112010001800133012010400151030002100255065000900276064000500285031000300290
032001000293020000400303865000900307002001200316035001000328801002100338#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#411#32#article#141#32#^rND^sCann
^nCE#^rND^sCavanaugh^nDJ#^rND^sSchnurpfiel^nK#^rND^sMartin^nMC.#Menstrual histor
y is the primary determinant of trabecular bone density in women runners (Abstra
ct)^len#Med Sci Sports Exerc#19880000#1988#20#^sSuppl 5#354#19990800#v5n4a07.htm
#0195-9131#Med Sci Sports Exerc##
00630000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100015000770100015000920100
01900107010001800126012009900144030001500243065000900258064000500267031000300272
014000700275865000900282002001200291035001000303801001500313#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#412#33#article#141#33#^rND^sLloyd^nT#^rND^sM
yers^nC#^rND^sBuchanan^nJR#^rND^sDemers^nLM.#Collegiate women athletes with irre
gular menses during adolescence have decreased bone density^len#Obstet Gynecol#1
9880000#1988#72#639-42#19990800#v5n4a07.htm#0029-7844#Obstet Gynecol##
00476000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770120060000960300
02000156710000200176065000900178064000500187031000300192014000600195865000900201
002001200210#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#413#34#artic
le#141#34#^rND^sJohnson^nMD.#Tailoring, the preparticipation exam to female athl
etes^len#Physician Sportsmed#2#19920000#1992#20#61-72#19990800#v5n4a07.htm##
00663000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100020000940120
04300114016001900157016001500176016001800191018008100209066001300290062001600303
065000900319064000500328014000700333865000900340002001200349#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#414#35#article#141#35#^rND^sPomeroy^nC#^rND^
sMitchell^nJE.#Medical issues in the eating disorders^len#^rED^sBrownell^nKD#^rE
D^sRodin^nJ#^rED^sWilmore^nJH#Eating, body weight and performance in athletes: d
isorders of modern society^len#Philadelphia#Lea and Febiger#19920000#1992#202-21
#19990800#v5n4a07.htm##
00486000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740110029000770120038001060300
01100144065000900155064000500164031000300169014000600172865000900178002001200187
035001000199801001100209#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
415#36#article#141#36#Committee on Sports Medicine#Amenorrhea in adolescent athl
etes^len#Pediatrics#19890000#1989#84#394-5#19990800#v5n4a07.htm#0031-4005#Pediat
rics##
00526000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100018000940120
05800112030001200170065000900182064000500191031000300196014000600199865000900205
002001200214035001000226801001200236#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#416#37#article#141#37#^rND^sKreipe^nRE#^rND^sHarris^nJP.#Myocardial 
impairment resulting from eating disorders^len#Pediatr Ann#19920000#1992#21#760-
8#19990800#v5n4a07.htm#0090-4481#Pediatr Ann##
00640000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100018000770100018000950100
01700113010001600130010001800146012007700164030001500241065000900256064000500265
031000400270014000600274865000900280002001200289035001000301801001500311#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#417#38#article#141#38#^rND^sMybu
rgh^nKH#^rND^sHutchins^nJ#^rND^sFataar^nAB#^rND^sHough^nSF#^rND^sNoakes^nTD.#Low
 bone density is an etiologic factor for stress fractures in athletes^len#Ann In
tern Med#19900000#1990#113#754-9#19990800#v5n4a07.htm#0003-4819#Ann Intern Med##
00641000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100015000770120055000920160
01900147016001500166016001800181018008100199066001300280062001600293065000900309
064000500318014000700323865000900330002001200339#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#418#39#article#141#39#^rND^sRyan^nR.#Management of eatin
g problems in athletic settings^len#^rED^sBrownell^nKD#^rED^sRodin^nJ#^rED^sWilm
ore^nJH#Eating, body weight and performance in athletes: disorders of modern soc
iety^len#Philadelphia#Lea and Febiger#19920000#1992#344-60#19990800#v5n4a07.htm#
#
00641000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770120051000960160
01900147016001500166016001800181018008100199066001300280062001600293065000900309
064000500318014000700323865000900330002001200339#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#419#40#article#141#40#^rND^sWilmore^nJH.#Body weight sta
ndards and athletic performance^len#^rED^sBrownell^nKD#^rED^sRodin^nJ#^rED^sWilm
ore^nJH#Eating, body weight and performance in athletes: disorders of modern soc
iety^len#Philadelphia#Lea and Febiger#19920000#1992#315-29#19990800#v5n4a07.htm#
#
00557000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100024000770120094001010300
02100195065000900216064000500225031000300230014000600233865000900239002001200248
035001000260801002100270#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
420#41#article#141#41#^rND^sSundot-Borgen^nJ.#Risk and trigger factors for the d
evelopment of eating disorders in female elite athletes^len#Med Sci Sports Exerc
#19940000#1994#26#414-9#19990800#v5n4a07.htm#0195-9131#Med Sci Sports Exerc##
00697000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100020000940120
07700114016001900191016001500210016001800225018008100243066001300324062001600337
065000900353064000500362014000700367865000900374002001200383#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#421#42#article#141#42#^rND^sWilson^nGT#^rND^
sEldredge^nKL.#Pathology and development of eating disorders: implications for a
thletes^len#^rED^sBrownell^nKD#^rED^sRodin^nJ#^rED^sWilmore^nJH#Eating, body wei
ght and performance in athletes: disorders of modern society^len#Philadelphia#Le
a and Febiger#19920000#1992#115-27#19990800#v5n4a07.htm##
00693000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770100016000960120
07500112016001900187016001500206016001800221018008100239066001300320062001600333
065000900349064000500358014000700363865000900370002001200379#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#422#43#article#141#43#^rND^sBrownell^nKD#^rN
D^sSteen^nSN#Weight cycling in athletes: effects on behavior, physiology and hea
lth^len#^rED^sBrownell^nKD#^rED^sRodin^nJ#^rED^sWilmore^nJH#Eating, body weight 
and performance in athletes: disorders of modern society^len#Philadelphia#Lea an
d Febiger#19920000#1992#159-71#19990800#v5n4a07.htm##
00468000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770120054000960300
01800150710000200168065000900170064000500179031000200184014000700186865000900193
002001200202#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#423#44#artic
le#141#44#^rND^sWilmore^nJH.#Eating and weight disorders in the female athlete^l
en#Int J Sports Nutr#2#19910000#1991#1#104-17#19990800#v5n4a07.htm##
00578000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100018000770100018000950100
01500113012006300128030002100191065000900212064000500221031000300226014000700229
865000900236002001200245035001000257801002100267#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#424#45#article#141#45#^rND^sJackson^nAS#^rND^sPollock^nM
L#^rND^sWard^nA.#Generalized equations for predicting body density of women^len#
Med Sci Sports Exerc#19800000#1980#12#175-82#19990800#v5n4a07.htm#0195-9131#Med 
Sci Sports Exerc##
00503000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770120045000940300
02100139065000900160064000500169031000300174014000800177865000900185002001200194
035001000206801002100216#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
425#46#article#141#46#^rND^sKohrt^nWM.#Body composition by DXA: tried and true?^
len#Med Sci Sports Exerc#19950000#1995#27#1349-53#19990800#v5n4a07.htm#0195-9131
#Med Sci Sports Exerc##
00543000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100018000770120087000950300
02000182065000900202064000500211031000300216014000700219865000900226002001200235
035001000247801002000257#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
426#47#article#141#47#^rND^sLohman^nTG.#Applicability of body composition techni
ques and constants for children and youths^len#Exerc Sport Sci Rev#19860000#1986
#14#325-57#19990800#v5n4a07.htm#0091-6331#Exerc Sport Sci Rev##
00525000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770120078000960300
01500174065000900189064000500198031000300203014000700206865000900213002001200222
035001000234801001500244#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
427#48#article#141#48#^rND^sLukaski^nHC.#Methods for the assessment of human bod
y composition: traditional and new^len#Am J Clin Nutr#19870000#1987#46#537-56#19
990800#v5n4a07.htm#0002-9165#Am J Clin Nutr##
00546000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100021000770100019000980100
02200117012003800139030001300177065000900190064000500199031000400204020000400208
865000900212002001200221035001000233801001300243#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#428#49#article#141#49#^rND^sJohnson Jr^nCC#^rND^sSlemend
a^nCW#^rND^sMelton^nIII LJ.#Clinical use of bone densitometry^len#N Engl J Med#1
9910000#1991#324#104#19990800#v5n4a07.htm#0028-4793#N Engl J Med##
00626000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770120037000960160
01900133016001500152016001800167018008100185066001300266062001600279065000900295
064000500304014000600309865000900315002001200324#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#429#50#article#141#50#^rND^sWilmore^nJH.#Body weight and
 body composition^len#^rED^sBrownell^nKD#^rED^sRodin^nJ#^rED^sWilmore^nJH#Eating
, body weight and performance in athletes: disorders of modern society^len#Phila
delphia#Lea and Febiger#19920000#1992#77-93#19990800#v5n4a07.htm##
00604000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770100016000960100
01900112012008600131030002100217065000900238064000500247031000300252014000700255
865000900262002001200271035001000283801002100293#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#430#51#article#141#51#^rND^sBrownell^nKD#^rND^sSteen^nSN
#^rND^sWilmore^nJH.#Weight regulation practices in athletes: analysis of metabol
ic and health effects^len#Med Sci Sports Exerc#19870000#1987#19#546-56#19990800#
v5n4a07.htm#0195-9131#Med Sci Sports Exerc##
00593000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100020000940100
01900114012007800133030001900211065000900230064000500239031000300244014000600247
865000900253002001200262035001000274801001900284#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#431#52#article#141#52#^rND^sGleeson^nM#^rND^sGreenhoff^n
PL#^rND^sMaughan^nRJ.#Influence of a 24 hour fast on high intensity exercise per
formance in man^len#Eur J Appl Physiol#19880000#1988#57#653-9#19990800#v5n4a07.h
tm#0301-5548#Eur J Appl Physiol##
00584000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100016000770100025000930120
08900118030002300207065000900230064000500239031000200244014000600246865000900252
002001200261035001000273801002300283#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#432#53#article#141#53#^rND^sIngjer^nF#^rND^sSundgot-Borgen^nJ.#Influ
ence of body weight reduction on maximal oxygen uptake in female elite athletes^
len#Scand J Med Sci Sports#19910000#1991#1#141-6#19990800#v5n4a07.htm#0905-7188#
Scand J Med Sci Sports##
00560000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100016000940100
01800110810000600128012007000134030002000204710000200224065000900226064000500235
031000300240014000600243865000900249002001200258#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#433#54#article#141#54#^rND^sDummer^nGM#^rND^sRosen^nLW#^
rND^sHeusner^nWW#et al#Pathogenic weight-control behaviors of young competitive 
swimmers^len#Physician Sportsmed#2#19870000#1987#15#75-86#19990800#v5n4a07.htm##
00659000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100015000770100017000920120
04400109016001900153016001500172016001800187018008100205066001300286062001600299
065000900315064000500324014000700329865000900336002001200345#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#434#55#article#141#55#^rND^sRodin^nJ#^rND^sL
arson^nL.#Social factors and the ideal body shape^len#^rED^sBrownell^nKD#^rED^sR
odin^nJ#^rED^sWilmore^nJH#Eating, body weight and performance in athletes: disor
ders of modern society^len#Philadelphia#Lea and Febiger#19920000#1992#146-58#199
90800#v5n4a07.htm##
00514000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100024000770120060001010300
01700161065000900178064000500187031000200192014000600194865000900200002001200209
035001000221801001700231#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
435#56#article#141#56#^rND^sSundot-Borgen^nJ.#Prevalence of eating disorders in 
elite female athletes^len#Int J Sport Nutr#19930000#1993#3#29-40#19990800#v5n4a0
7.htm#1050-1606#Int J Sport Nutr##
00604000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100023000770100017001000120
11000117030002300227065000900250064000500259031000200264014000600266865000900272
002001200281035001000293801002300303#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#436#57#article#141#57#^rND^sSundot-Borgen^nJ#^rND^sLarsen^nS.#Pathol
ogic weight-control methods and self-reported eating disorders in female elite a
thletes and control^len#Scand J Med Sci Sports#19930000#1993#3#150-5#19990800#v5
n4a07.htm#0905-7188#Scand J Med Sci Sports##
00538000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100020000770100020000970120
05500117030001600172065000900188064000500197031000400202014000700206865000900213
002001200222035001000234801001600244#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#437#58#article#141#58#^rND^sSalisbury^nJJ#^rND^sMitchell^nJE.#Bone m
ineral density and anorexia nervosa in women^len#Am J Psychiatry#19910000#1991#1
48#768-74#19990800#v5n4a07.htm#0002-953X#Am J Psychiatry##
00714000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100021000940100
01400115010001800129010001600147010002000163012010200183030002400285065000900309
06400050031803100030032301400070032686500090033300200120034203500100035480100240
0364#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#438#59#article#141#5
9#^rND^sWarren^nMP#^rND^sBrooks-Gunn^nJ#^rND^sFox^nRP#^rND^sLancelot^nC#^rND^sNe
wman^nD#^rND^sHamilton^nWG.#Lack of bone accretion and amenorrhea: evidence for 
a relative osteopenia in weight-bearing bones^len#J Clin Endocrinol Metab#199100
00#1991#72#847-53#19990800#v5n4a07.htm#0021-972X#J Clin Endocrinol Metab##
00558000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100018000940100
01800112010001700130012004400147030000500191065000900196064000500205031000300210
014000700213865000900220002001200229035001000241801000500251#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#439#60#article#141#60#^rND^sAmrein^nPC#^rND^
sFriedman^nR#^rND^sKosinski^nK#^rND^sEllman^nL.#Hematologic changes in anorexia 
nervosa^len#JAMA#19790000#1979#24#2190-1#19990800#v5n4a07.htm#0098-7484#JAMA##
00573000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100016000770100018000930100
02100111010001600132012003800148030001500186065000900201064000500210031000400215
014000600219865000900225002001200234035001000246801001500256#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#440#61#article#141#61#^rND^sIsner^nJM#^rND^s
Roberts^nWC#^rND^sHeymsfield^nSB#^rND^sYager^nJ.#Anorexia nervosa and sudden dea
th^len#Ann Intern Med#19850000#1985#102#49-52#19990800#v5n4a07.htm#0003-4819#Ann
 Intern Med##
00560000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100015000770100018000920100
01700110012005900127030001500186065000900201064000500210031000300215014000600218
865000900224002001200233035001000245801001500255#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#441#62#article#141#62#^rND^sHurd^nHP#^rND^sPalumbo^nPJ#^
rND^sGharid^nH.#Hypothalamic-endocrine dysfunction in anorexia nervosa^len#Mayo 
Clin Proc#19770000#1977#52#711-6#19990800#v5n4a07.htm#0025-6196#Mayo Clin Proc##
00625000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770100019000960100
01900115010001900134012008800153030001300241065000900254064000500263031000400268
014000700272865000900279002001200288035001000300801001300310#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#442#63#article#141#63#^rND^sVigorsky^nRA#^rN
D^sAnderson^nAE#^rND^sThompson^nRH#^rND^sLoriaux^nDL.#Hypothalamic dysfunction i
n secondary amenorrhea associated with simple weight loss^len#N Engl J Med#19770
000#1977#297#1141-5#19990800#v5n4a07.htm#0028-4793#N Engl J Med##
00546000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100022000940120
05600116030002000172065000900192064000500201031000400206014000700210865000900217
002001200226035001000238801002000248#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#443#64#article#141#64#^rND^sWarren^nMP#^rND^sVandewiele^nRL.#Clinica
l and metabolic features of anorexia nervosa^len#Am J Obstet Gynecol#19730000#19
73#117#435-49#19990800#v5n4a07.htm#0002-9378#Am J Obstet Gynecol##
00549000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100017000940120
07200111030001600183065000900199064000500208031000400213014000700217865000900224
002001200233035001000245801001600255#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#444#65#article#141#65#^rND^sBowers^nTK#^rND^sEckert^nE.#Leukopenia i
n anorexia nervosa: lack of increased risk of infection^len#Arch Intern Med#1978
0000#1978#138#1520-3#19990800#v5n4a07.htm#0003-9926#Arch Intern Med##
00468000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740160020000770160018000970180
05300115066000900168062001400177065000900191064000500200865000900205002001200214
#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#445#66#article#141#66#^r
ND^sGarfinkel^nPE#^rND^sGarner^nDM.#Anorexia nervosa: a multidimensional perspec
tive^len#New York#Brunner/Mazel#19820000#1982#19990800#v5n4a07.htm##
00600000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100016000770100016000930100
01500109010001700124010001900141012004200160030001500202065000900217064000500226
031000300231014000600234865000900240002001200249035001000261801001500271#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#446#67#article#141#67#^rND^sLevi
n^nPA#^rND^sFalko^nJM#^rND^sDixon^nK#^rND^sGallup^nEM#^rND^sSaunders^nW.#Benign 
parotid enlargement in bulimia^len#Ann Intern Med#19800000#1980#93#827-9#1999080
0#v5n4a07.htm#0003-4819#Ann Intern Med##
00551000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100018000770100014000950120
07900109030001600188065000900204064000500213031000400218020000400222865000900226
002001200235035001000247801001600257#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#447#68#article#141#68#^rND^sRoberts^nMW#^rND^sLi^nSH.#Oral findings 
in anorexia nervosa and bulimia nervosa: a study of 47 cases^len#J Am Dent Assoc
#19870000#1987#115#407#19990800#v5n4a07.htm#0002-8177#J Am Dent Assoc##
00588000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100021000770100017000980120
12100115030001000236065000900246064000500255031000300260014000600263865000900269
002001200278035001000290801001000300#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#448#69#article#141#69#^rND^sSilverstein^nB#^rND^sPerdup^nL.#The rela
tionship between role concern, preferences for slimness, and symptoms of eating 
problems among college women^len#Sex Roles#19880000#1988#18#101-6#19990800#v5n4a
07.htm#0360-0025#SEX ROLES##
00665000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770100016000960120
04700112016001900159016001500178016001800193018008100211066001300292062001600305
065000900321064000500330014000700335865000900342002001200351#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#449#70#article#141#70#^rND^sBrownell^nKD#^rN
D^sRodin^nJ.#Prevalence of eating disorders in athletes^len#^rED^sBrownell^nKD#^
rED^sRodin^nJ#^rED^sWilmore^nJH#Eating, body weight and performance in athletes:
 disorders of modern society^len#Philadelphia#Lea and Febiger#19920000#1992#128-
45#19990800#v5n4a07.htm##
00574000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770100016000960100
02000112012005600132030002100188065000900209064000500218031000300223014000600226
865000900232002001200241035001000253801002100263#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#450#71#article#141#71#^rND^sO'Conner^nPJ#^rND^sLewis^nRD
#^rND^sKirchner^nEM.#Eating disorder symptoms in female college gymnasts^len#Med
 Sci Sports Exerc#19950000#1995#27#550-5#19990800#v5n4a07.htm#0195-9131#Med Sci 
Sports Exerc##
00563000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100025000770100022001020100
01600124012005600140030001100196065000900207064000500216031000300221014000700224
865000900231002001200240035001000252801001100262#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#451#72#article#141#72#^rND^sStriegel-Moore^nRH#^rND^sSil
berstein^nLR#^rND^sRodin^nJ.#Toward an understanding of risk factors for bulimia
^len#Am Psychol#19860000#1986#41#246-63#19990800#v5n4a07.htm#0003-066X#Am Psycho
l##
00508000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740160018000770160017000950160
01600112018005600128066001000184062002500194065000900219064000500228865000900233
002001200242#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#452#73#artic
le#141#73#^rND^sMinuchin^nS#^rND^sRosman^nBL#^rND^sBaker^nL.#Psychosomatic famil
ies: anorexia nervosa in context^len#Cambridge#Harvard University Press#19780000
#1978#19990800#v5n4a07.htm##
00486000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740160016000770160016000930160
02100109018004500130066000900175062001300184065000900197064000500206865000900211
002001200220#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#453#74#artic
le#141#74#^rND^sRoot^nMPP#^rND^sFallon^nP#^rND^sFriedrich^nWN.#Bulimia: a system
s approach to treatment^len#New York#Norton Books#19860000#1986#19990800#v5n4a07
.htm##
00547000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770120104000940300
01400198065000900212064000500221031000300226014000700229865000900236002001200245
035001000257801001400267#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
454#75#article#141#75#^rND^sRoot^nMPP.#Persistent disordered eating as a gender-
specific, post-traumatic stress response to sexual assault^len#Psychotherapy#199
10000#1991#28#96-102#19990800#v5n4a07.htm#0033-3204#PSYCHOTHERAPY##
00510000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100015000770100019000920120
03800111030001500149065000900164064000500173031000300178014000500181865000900186
002001200195035001000207801001500217#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#455#76#article#141#76#^rND^sKaye^nWH#^rND^sWeltzin^nTE.#Neurochemist
ry of bulimia nervosa^len#J Clin Psychol#19910000#1991#52#21-8#19990800#v5n4a07.
htm#0021-9762#J Clin Psychol##
00663000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100018000770100016000950120
04600111016001900157016001500176016001800191018008100209066001300290062001600303
065000900319064000500328014000700333865000900340002001200349#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#456#77#article#141#77#^rND^sLopiano^nDA#^rND
^sZotos^nC.#Modern athletics, the pressure to perform^len#^rED^sBrownell^nKD#^rE
D^sRodin^nJ#^rED^sWilmore^nJH#Eating, body weight and performance in athletes: d
isorders of modern society^len#Philadelphia#Lea and Febiger#19920000#1992#275-92
#19990800#v5n4a07.htm##
00484000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770120054000940300
02000148710000200168065000900170064000500179031000300184032000300187014000700190
865000900197002001200206#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
457#78#article#141#78#^rND^sZucker^nP.#Eating disorders in young athletes: a rou
nd table^len#Physician Sportsmed#2#19850000#1985#13#11#89-106#19990800#v5n4a07.h
tm##
00560000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100015000940120
08600109030001600195065000900211064000500220031000300225014000700228865000900235
002001200244035001000256801001600266#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#458#79#article#141#79#^rND^sBarrow^nGW#^rND^sSaha^nS.#Menstrual irre
gularity and stress fractures in collegiate female distance runners^len#Am J Spo
rts Med#19880000#1988#16#209-16#19990800#v5n4a07.htm#0363-5465#Am J Sports Med##
00538000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100022000770100016000990100
02100115012006800136030001100204710000200215065000900217064000500226031000400231
020000400235865000900239002001200248#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#459#80#article#141#80#^rND^sRatnasuriya^nRH#^rND^sEisler^nI#^rND^sSz
muckler^nGI.#Anorexia nervosa: outcome and prognostic factors after 20 years^len
#Br J Psych#2#19910000#1991#158#495#19990800#v5n4a07.htm##
00689000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100016000770100018000930100
01700111012004300128016001900171016001500190016001800205018008100223066001300304
062001600317065000900333064000500342014000700347865000900354002001200363#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#460#81#article#141#81#^rND^sTobi
n^nDL#^rND^sJohnson^nCL#^rND^sFranke^nK.#Clinical treatment of eating disorders^
len#^rED^sBrownell^nKD#^rED^sRodin^nJ#^rED^sWilmore^nJH#Eating, body weight and 
performance in athletes: disorders of modern society^len#Philadelphia#Lea and Fe
biger#19920000#1992#330-43#19990800#v5n4a07.htm##
00675000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100018000940100
01800112010002000130010001900150010002000169012007700189030001300266065000900279
06400050028803100040029301400080029786500090030500200120031403500100032680100130
0336#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#461#82#article#141#8
2#^rND^sBullen^nBA#^rND^sSkrinar^nGS#^rND^sBettins^nIZ#^rND^svon Mering^nG#^rND^
sTurnbull^nBA#^rND^sMcArthur^nJW.#Induction of menstrual disorders by strenous e
xercise in untrained women^len#N Engl J Med#19850000#1985#312#1349-53#19990800#v
5n4a07.htm#0028-4793#N Engl J Med##
00548000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100014000770100018000910100
01900109012004600128030001500174065000900189064000500198031000300203014000600206
865000900212002001200221035001000233801001500243#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#462#83#article#141#83#^rND^sDale^nE#^rND^sGerlach^nDH#^r
ND^sWilhite^nAL.#Menstrual dysfunction in distance runners^len#Obstet Gynecol#19
790000#1979#54#47-53#19990800#v5n4a07.htm#0029-7844#Obstet Gynecol##
00485000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770120044000960300
01300140065000900153064000500162031000200167014000600169865000900175002001200184
035001000196801001300206#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
463#84#article#141#84#^rND^sErdelyi^nGJ.#Gynecological survey of female athletes
^len#J Sports Med#19620000#1962#2#174-9#19990800#v5n4a07.htm#0090-4201#J Sports 
Med##
00586000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100018000940100
01700112010001700129010002100146012003700167030000700204065000900211064000500220
031000200225014000700227865000900234002001200243035001000255801000700265#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#464#85#article#141#85#^rND^sFeic
ht^nCB#^rND^sJohnson^nTS#^rND^sMartin^nBJ#^rND^sSparks^nKE#^rND^sWagner Jr^nWW.#
Secondary amenorrhea in athletes^len#Lancet#19780000#1978#2#1145-6#19990800#v5n4
a07.htm#0099-5355#Lancet##
00540000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100018000770120082000950300
02100177065000900198064000500207031000300212014000700215865000900222002001200231
035001000243801002100253#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
465#86#article#141#86#^rND^sLoucks^nAB.#Effects of exercise training on the mens
trual cycle: existence and mechanisms^len#Med Sci Sports Exerc#19900000#1990#22#
275-80#19990800#v5n4a07.htm#0195-9131#Med Sci Sports Exerc##
00592000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100021000940100
01900115012005000134030002100184065000900205064000500214031000300219032000800222
014000800230865000900238002001200247035001000259801002100269#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#466#87#article#141#87#^rND^sLoucks^nAB#^rND^
sVaitukaitis^nJ#^rND^sCameron^nJL.#The reproductive system and exercise in women
^len#Med Sci Sports Exerc#19920000#1992#24#^sSuppl#S288-93#19990800#v5n4a07.htm#
0195-9131#Med Sci Sports Exerc##
00471000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740160015000770160016000920180
04600108066001400154062002600168065000900194064000500203865000900208002001200217
#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#467#88#article#141#88#^r
ED^sPuhl^nJL#^rED^sBrown^nCH#The menstrual cycle and physical activity^len#Champ
aign^eIL#Human Kinetics Publishers#19860000#1986#19990800#v5n4a07.htm##
00643000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100018000770100018000950100
01700113010001500130010001400145010001700159012005500176030001500231065000900246
06400050025503100040026001400070026486500090027100200120028003500100029280100150
0302#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#468#89#article#141#8
9#^rND^sSchwartz^nB#^rND^sCumming^nDC#^rND^sRiordan^nE#^rND^sSelye^nM#^rND^sYen^
nSS#^rND^sRebar^nRW.#Exercise-associated amenorrhea: a distinct entity?^len#Obst
et Gynecol#19810000#1981#141#662-70#19990800#v5n4a07.htm#0029-7844#Obstet Gyneco
l##
00498000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100020000770120072000970300
00500169065000900174064000500183031000400188020000400192865000900196002001200205
035001000217801000500227#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
469#90#article#141#90#^rND^sZaharieva^nE.#Olympic participation by women: effect
s on pregnancy and childbirth^len#JAMA#19720000#1972#221#992#19990800#v5n4a07.ht
m#0098-7484#JAMA##
00558000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100018000770100017000950120
07200112030002000184065000900204064000500213031000400218014000700222865000900229
002001200238035001000250801002000260#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#470#91#article#141#91#^rND^sBachman^nGA#^rND^sKemann^nE.#Prevalence 
of oligomenorrhea and amenorrhea in a college population^len#Am J Obstet Gynecol
#19820000#1982#144#98-102#19990800#v5n4a07.htm#0002-9378#Am J Obstet Gynecol##
00587000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100019000770100015000960100
01900111012007300130030002000203065000900223064000500232031000400237014000500241
865000900246002001200255035001000267801002000277#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#471#92#article#141#92#^rND^sPetterson^nF#^rND^sFires^nH#
^rND^sNillius^nSJ.#Epidemiology of secondary amenorrhea: incidence and prevalenc
e rates^len#Am J Obstet Gynecol#19730000#1973#117#80-6#19990800#v5n4a07.htm#0002
-9378#Am J Obstet Gynecol##
00501000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770120044000940300
02000138065000900158064000500167031000400172014000800176865000900184002001200193
035001000205801002000215#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
472#93#article#141#93#^rND^sSingh^nKB.#Menstrual disorders in college students^l
en#Am J Obstet Gynecol#19810000#1981#140#299-302#19990800#v5n4a07.htm#0002-9378#
Am J Obstet Gynecol##
00539000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100018000940120
06300112030001500175065000900190064000500199031000300204014000800207865000900215
002001200224035001000236801001500246#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#473#94#article#141#94#^rND^sFrisch^nRE#^rND^sRevelle^nR.#Height and 
weight at menarche and a hypothesis of menarche^len#Arch Dis Child#19710000#1971
#46#695-701#19990800#v5n4a07.htm#0003-9888#Arch Dis Child##
00581000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100017000770100020000940120
11700114030000800231065000900239064000500248031000400253014000700257865000900264
002001200273035001000285801000800295#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#474#95#article#141#95#^rND^sFrisch^nRE#^rND^sMcArthur^nJW.#Menstrual
 cycles: fatness as a determinant of minimum weight for height necessary for the
ir maintenance or onset^len#Science#19740000#1974#185#949-51#19990800#v5n4a07.ht
m#0036-8075#Science##
00544000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100018000770100019000950120
07300114030001200187065000900199064000500208031000300213014000700216865000900223
002001200232035001000244801001200254#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#475#96#article#141#96#^rND^sBronson^nFH#^rND^sManning^nJM.#The energ
etic regulation of ovulation: a realistic role for body fat^len#Biol Reprod#1991
0000#1991#44#945-50#19990800#v5n4a07.htm#0006-3363#Biol Reprod##
00620000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100018000770100019000950100
02100114012008000135030002100215065000900236064000500245031000300250032001000253
020000300263865000900266002001200275035001000287801002100297#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#476#97#article#141#97#^rND^sSanborn^nCF#^rND
^sAlbrecht^nBH#^rND^sWagner Jr^nWW.#Medically induced reversal of infertility in
 athletic amenorrhea (Abstract)^len#Med Sci Sports Exerc#19870000#1987#19#^sSupp
l 5#27#19990800#v5n4a07.htm#0195-9131#Med Sci Sports Exerc##
00522000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100018000770100018000950120
05600113030001100169065000900180064000500189031000200194014000600196865000900202
002001200211035001000223801001100233#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#477#98#article#141#98#^rND^sSinning^nWE#^rND^sLittle^nKD.#Body compo
sition and menstrual function in athletes^len#Sports Med#19870000#1987#4#34-45#1
9990800#v5n4a07.htm#0112-1642#Sports Med##
00580000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080004000701180003000740100016000770100017000930120
11300110030001200223065000900235064000500244031000300249014000700252865000900259
002001200268035001000280801001200290#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#478#99#article#141#99#^rND^sRivier^nC#^rND^sRivest^nS.#Effect of str
ess on the activity of the hypothalamic-pituary-gonadal axis: peripheral and cen
tral mechanisms^len#Biol Reprod#19910000#1991#45#523-32#19990800#v5n4a07.htm#000
6-3363#Biol Reprod##
00635000000000313000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100016000790100019000950100
02100114010001700135010001900152012006500171030001500236065000900251064000500260
031000400265014000600269865000900275002001200284035001000296801001500306#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#479#100#article#141#100#^rND^sDi
ng^nJ-H#^rND^sSheckter^nCB#^rND^sDrinkwater^nBL#^rND^sSoules^nMR#^rND^sBremmer^n
WJ.#High serum cortisol levels in exercise-associated amenorrhea^len#Ann Intern 
Med#19880000#1988#108#530-4#19990800#v5n4a07.htm#0003-4819#Ann Intern Med##
00699000000000325000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100019000790100018000980100
01700116010001800133010001600151010001800167012010200185030001500287065000900302
06400050031103100030031601400080031986500090032700200120033603500100034880100150
0358#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#480#101#article#141#
101#^rND^sDe Souza^nMJ#^rND^sMaguire^nMS#^rND^sMaresh^nCM#^rND^sKraemer^nWJ#^rND
^sRubin^nKR#^rND^sLoucks^nAB.#Adrenal activation and the prolactin response to e
xercise in eumenorrheic and amenorrheic runners^len#J Appl Physiol#19910000#1991
#70#2378-87#19990800#v5n4a07.htm#0021-8987#J Appl Physiol##
00574000000000277000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100017000790100019000960120
07700115030002400192065000900216064000500225031000300230014000800233865000900241
002001200250035001000262801002400272#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#481#102#article#141#102#^rND^sLoucks^nAB#^rND^sHorvath^nSM.#Exercise
-induced stress responses to amenorrheic and eumenorrheic runner^len#J Clin Endo
crinol Metab#19840000#1984#59#1109-20#19990800#v5n4a07.htm#0021-972X#J Clin Endo
crinol Metab##
00619000000000301000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100018000790100020000970100
01700117810000700134012009200141030001500233065000900248064000500257031000300262
014000600265865000900271002001200280035001000292801001500302#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#482#103#article#141#103#^rND^sWilmore^nJH#^r
ND^sWambsqans^nKC#^rND^sBrenner^nM#et al.#Is there energy conservation in amenor
rheic compared with eumenorrheic distance runner?^len#J Appl Physiol#19920000#19
92#72#15-22#19990800#v5n4a07.htm#0021-8987#J Appl Physiol##
00697000000000325000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100017000790100019000960100
01800115010001600133010001700149010001600166012008700182030002400269065000900293
06400050030203100030030701400060031086500090031600200120032503500100033780100240
0347#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#483#104#article#141#
104#^rND^sLoucks^nAB#^rND^sLaughlin^nGA#^rND^sMortola^nJF#^rND^sGirton^nL#^rND^s
Nelson^nJC#^rND^sYen^nSSC.#Hypothalamic-pituitary-thyroidal function in eumenorr
heic and amenorrheic athletes^len#J Clin Endocrinol Metab#19920000#1992#75#514-8
#19990800#v5n4a07.htm#0021-972X#J Clin Endocrinol Metab##
00619000000000301000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100017000790100015000960100
01700111810000700128012008600135030002100221065000900242064000500251031000300256
014000600259865000900265002001200274035001000286801002100296#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#484#105#article#141#105#^rND^sMyerson^nM#^rN
D^sGutin^nB#^rND^sWarren^nMP#et al.#Resting metabolic rate and energy balance in
 amenorrheic and eumenorrheic runners^len#Med Sci Sports Exerc#19910000#1991#25#
15-22#19990800#v5n4a07.htm#0195-9131#Med Sci Sports Exerc##
00657000000000265000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750160018000790160018000970160
02000115016001900135018013200154053006000286055001200346054000800358020000400366
865000900370002001200379#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
485#106#article#141#106#^rND^sCameron^nJL#^rND^sNosbisch^nC#^rND^sHelmreich^nLD#
^rND^sParfitt^nDB.#Reversal of exercise-induced amenorrhea in female cynomolgus 
monkeys (Macaca fascicularis) by increasing food intake (Abstract)^len#Proceedin
gs of the Endocrine Society 72nd Annual Meeting^i1#19900000^i1#1990^i1#285#19990
800#v5n4a07.htm##
00616000000000301000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100018000790100019000970100
01800116010001800134012006200152030002100214065000900235064000500244031000300249
014001000252865000900262002001200271035001000283801002100293#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#486#107#article#141#107#^rND^sEdwards^nJE#^r
ND^sLindeman^nAK#^rND^sMikesky^nAE#^rND^sStager^nJM.#Energy balance in highly tr
ained female endurance runners^len#Med Sci Sports Exerc#19930000#1993#25#1398-14
04#19990800#v5n4a07.htm#0195-9131#Med Sci Sports Exerc##
00656000000000313000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100019000790100016000980100
01900114010001600133010001800149010001900167012008900186030002000275710000200295
065000900297064000500306031000300311014000700314865000900321002001200330#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#487#108#article#141#108#^rND^sWi
lliams^nNI#^rND^sYoung^nJC#^rND^sMcArthur^nJW#^rND^sBullen^nB#^rND^sSkrinar^nGS#
^rND^sTurnbull^nB.#Strenuous exercise with caloric restriction: effect on lutein
izing hormone secretion^len#Med Sci Sport Exerc#2#19950000#1995#27#1390-8#199908
00#v5n4a07.htm##
00656000000000277000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750160017000790160016000960160
01400112016001700126016001600143016001700159018013200176053002900308055001200337
054000800349865000900357002001200366#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#488#109#article#141#109#^rND^sLoucks^nAB#^rND^sHeath^nEM#^rND^sKing^
nK#^rND^sMorrall^nD#^rND^sVerdun^nM#^rND^sWatts^nJR.#Low energy availability alt
ers luteinizing hormone pulsatility in regularly menstruating, young exercising 
women (Abstract 822)^len#Endocrine Society Meeting^i1#19940000^i1#1994^i1#199908
00#v5n4a07.htm##
00515000000000265000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100017000790120077000960300
01100173065000900184064000500193031000200198014000700200865000900207002001200216
035001000228801001100238#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
489#110#article#141#110#^rND^sHighet^nR.#Athletic amenorrhea: an update on aetio
logy, implications and management^len#Sports Med#19890000#1989#7#82-108#19990800
#v5n4a07.htm#0112-1642#Sports Med##
00642000000000325000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100017000790100017000960100
01700113010001900130010001800149010001700167012004800184030001500232065000900247
06400050025603100030026101400060026486500090027000200120027903500100029180100150
0301#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#490#111#article#141#
111#^rND^sNelson^nME#^rND^sFisher^nEC#^rND^sCatsos^nPD#^rND^sMeredith^nCN#^rND^s
Turksoy^nRN#^rND^sEvans^nWJ.#Diet and bone status in amenorrheic runners^len#Am 
J Clin Nutr#19860000#1986#43#910-6#19990800#v5n4a07.htm#0002-9165#Am J Clin Nutr
##
00595000000000301000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100021000790100016001000100
01300116010002300129012007600152030000500228065000900233064000500242031000400247
014000600251865000900257002001200266035001000278801000500288#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#491#112#article#141#112#^rND^sDrinkwater^nBL
#^rND^sNilson^nK#^rND^sOtt^nS#^rND^sChesnut^nIII CH.#Bone mineral density after 
resumption of menses in amenorrheic athletes^len#JAMA#19860000#1986#256#380-2#19
990800#v5n4a07.htm#0098-7484#JAMA##
00618000000000301000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100016000790100015000950100
01700110010001900127012008300146030001700229065000900246064000500255031000200260
014000600262865000900268002001200277035001000289801001700299#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#492#113#article#141#113#^rND^sDueck^nCA#^rND
^sMatt^nKS#^rND^sManore^nMM#^rND^sSkinner^nJS.#Treatment of athletic amenorrhea 
with a diet and training intervention program^len#Int J Sport Nutr#19960000#1996
#6#24-40#19990800#v5n4a07.htm#1050-1606#Int J Sport Nutr##
00567000000000289000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100016000790100017000950100
01600112012006100128030001700189065000900206064000500215031000200220014000700222
865000900229002001200238035001000250801001700260#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#493#114#article#141#114#^rND^sDueck^nCA#^rND^sManore^nMM
#^rND^sMatt^nKS.#Role of energy balance in athletic menstrual dysfunction^len#In
t J Sport Nutr#19960000#1996#6#165-90#19990800#v5n4a07.htm#1050-1606#Int J Sport
 Nutr##
00630000000000301000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100022000790100017001010100
01400118010001700132012009400149030001500243065000900258064000500267031000300272
014000700275865000900282002001200291035001000303801001500313#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#494#115#article#141#115#^rND^sJonnavithula^n
S#^rND^sWarren^nMP#^rND^sFox^nRP#^rND^sLazaro^nMI#Bone density is compromised in
 amenorrheic women despite returning menses: a 2-year study^len#Obstet Gynecol#1
9930000#1993#81#669-74#19990800#v5n4a07.htm#0029-7844#Obstet Gynecol##
00645000000000313000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100019000790100017000980100
01500115010001600130010001600146012009200162030001100254065000900265064000500274
031000400279014000600283865000900289002001200298035001000310801001100320#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#495#116#article#141#116#^rND^sLi
ndberg^nJS#^rND^sPowell^nMR#^rND^sHunt^nMM#^rND^sDucey^nDE#^rND^sWade^nCE.#Incre
ased vertebral bone mineral in response to reduced exercise in amenorrheic runne
rs^len#West J Med#19870000#1987#146#39-42#19990800#v5n4a07.htm#0093-0415#West J 
Med##
00723000000000325000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100016000790100015000950100
01700110010001800127010001800145010001700163012013200180030001500312065000900327
06400050033603100030034101400070034486500090035100200120036003500100037280100150
0382#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#496#117#article#141#
117#^rND^sEmans^nSJ#^rND^sGrace^nE#^rND^sHoffer^nFA#^rND^sGundberg^nC#^rND^sRavn
ikar^nV#^rND^sWoods^nER.#Estrogen deficiency in adolescents and young adults: im
pact on bone mineral content and effects of estrogen replacement therapy^len#Obs
tet Gynecol#19900000#1990#76#585-92#19990800#v5n4a07.htm#0029-7844#Obstet Gyneco
l##
00600000000000289000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100020000790100017000990100
01700116012007400133030002400207065000900231064000500240031000300245014000700248
865000900255002001200264035001000276801002400286#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#497#118#article#141#118#^rND^sSchlechte^nJA#^rND^sSherma
n^nB#^rND^sMartin^nR.#Bone density in amenorrheic women with and without hyperpr
olactinemia^len#J Clin Endocrinol Metab#19830000#1983#56#1120-3#19990800#v5n4a07
.htm#0021-972X#J Clin Endocrinol Metab##
00657000000000313000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100018000790100019000970100
01500116010001400131010001700145012008100162030002100243065000900264064000500273
031000300278014001000281865000900291002001200300035001000312801002100322#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#498#119#article#141#119#^rND^sMy
burgh^nKH#^rND^sBachrach^nLK#^rND^sLewis^nB#^rND^sKent^nK#^rND^sMarcus^nR.#Bone 
mineral density at axial and appendicular sites in amenorrheic athletes^len#Med 
Sci Sports Exerc#19930000#1993#25#1197-1202#19990800#v5n4a07.htm#0195-9131#Med S
ci Sports Exerc##
00612000000000301000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100017000790100021000960100
02300117012007400140030001700214065000900231064000500240031000200245032001000247
020000500257865000900262002001200271035001000283801001700293#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#499#120#article#141#120#^rND^sRencken^nM#^rN
D^sDrinkwater^nBL#^rND^sChestnut^nIII CH#Decreased bone density in the lower ext
remity of amenorrheic athletes^len#J Bone Miner Res#19930000#1993#8#^sSuppl 1#S2
54#19990800#v5n4a07.htm#0884-0431#J Bone Miner Res##
00559000000000289000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100017000790100018000960100
02100114012006800135030000500203065000900208064000500217031000400222014000700226
865000900233002001200242035001000254801000500264#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#500#121#article#141#121#^rND^sRencken^nM#^rND^sChesnut^n
CH#^rND^sDrinkwater^nBL#Bone density at multiple skeletal sites in amenorrheic a
thletes^len#JAMA#19960000#1996#276#238-40#19990800#v5n4a07.htm#0098-7484#JAMA##
00575000000000277000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100019000790100018000980120
10400116030001100220065000900231064000500240031000300245014000700248865000900255
002001200264035001000276801001100286#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#501#122#article#141#122#^rND^sSlemenda^nCW#^rND^sJohnson^nCC#High de
nsity activities in young women: site specific bone mass effects among female fi
gure skaters^len#Bone Miner#19930000#1993#20#125-32#19990800#v5n4a07.htm#0169-60
09#Bone Miner##
00630000000000313000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100018000790100013000970100
02100110010001700131010001700148012008800165030000500253065000900258064000500267
031000200272014000600274865000900280002001200289035001000301801000500311#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#502#123#article#141#123#^rND^sDe
queker^nJ#^rND^sNus^nJ#^rND^sVerstraeten^nA#^rND^sGuesens^nP#^rND^sGevers^nG.#Ge
netic determination of bone mineral content at the spine and radius: a twin stud
y^len#Bone#19870000#1987#8#207-9#19990800#v5n4a07.htm#8756-3282#Bone##
00622000000000313000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100017000790100021000960100
01900117010001700136010002000153012005200173030001300225065000900238064000500247
031000400252014000800256865000900264002001200273035001000285801001300295#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#503#124#article#141#124#^rND^sWa
rren^nMP#^rND^sBrooks-Gunn^nJ#^rND^sHamilton^nLH#^rND^sWarren^nLF#^rND^sHamilton
^nWG.#Scoliosis and fractures in young ballet dancers^len#N Engl J Med#19860000#
1986#314#1348-53#19990800#v5n4a07.htm#0028-4793#N Engl J Med##
00542000000000277000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100018000790100017000970120
06300114030001600177065000900193064000500202031000400207014000600211865000900217
002001200226035001000238801001600248#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#504#125#article#141#125#^rND^sBrotman^nAW#^rND^sStern^nTA.#Osteoporo
sis, and pathologic fractures in anorexia nervosa^len#Am J Psychiatry#19850000#1
985#142#495-6#19990800#v5n4a07.htm#0002-953X#Am J Psychiatry##
00585000000000289000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100019000790100021000980100
01700119012006200136030002100198065000900219064000500228031000300233014000700236
865000900243002001200252035001000264801002100274#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#505#126#article#141#126#^rND^sDugowson^nCE#^rND^sDrinkwa
ter^nBL#^rND^sClark^nJM.#Nontraumatic femur fracture in an oligomenorrheic athle
te^len#Med Sci Sports Exerc#19910000#1991#23#1323-5#19990800#v5n4a07.htm#0195-91
31#Med Sci Sports Exerc##
00626000000000301000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100015000790100024000940100
01600118810000700134012008700141030002100228065000900249064000500258031000300263
014000600266865000900272002001200281035001000293801002100303#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#506#127#article#141#127#^rND^sLloyd^nT#^rND^
sTriantafyllou^nSJ#^rND^sBaker^nER#et al.#Women athletes with menstrual irregula
rity have increased musculoskeletal injuries^len#Med Sci Sports Exerc#19860000#1
986#18#374-9#19990800#v5n4a07.htm#0195-9131#Med Sci Sports Exerc##
00577000000000289000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100019000790100019000980100
01700117010001700134012006900151030002000220710000200240065000900242064000500251
031000200256014000800258865000900266002001200275#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#507#128#article#141#128#^rND^sGrimston^nSK#^rND^sEngsber
g^nJR#^rND^sKloiber^nR#^rND^sHanley^nDA#Bone mass, external loads and stress fra
ctures in female runners^len#Int J Sport Biomech#2#19910000#1991#7#293-302#19990
800#v5n4a07.htm##
00632000000000313000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100018000790100017000970100
02200114010002100136010002000157012005100177030001800228065000900246064000500255
031000300260014000600263865000900269002001200278035001000290801001800300#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#508#129#article#141#129#^rND^sGe
orgiou^nE#^rND^sNtalles^nK#^rND^sPapageorgiou^nA#^rND^sKorkotsidis^nA#^rND^sProu
kakis^nC.#Bone mineral loss related to menstrual history^len#Acta Orthop Scand#1
9890000#1989#60#192-4#19990800#v5n4a07.htm#0001-6470#Acta Orthop Scand##
00619000000000301000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100016000790100017000950100
02100112010001400133012006700147030002400214065000900238064000500247031000300252
014000700255865000900262002001200271035001000283801002400293#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a07.htm#S#c#509#130#article#141#130#^rND^sDhuper^nS#^rND
^sWarren^nMP#^rND^sBrooks-Gunn^nJ#^rND^sFox^nR.#Effects of hormonal status on bo
ne density in adolescent girls^len#J Clin Endocrinol Metab#19900000#1990#71#1083
-8#19990800#v5n4a07.htm#0021-972X#J Clin Endocrinol Metab##
00553000000000289000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100017000790100018000960100
01500114012005800129030001000187065000900197064000500206031000400211014000700215
865000900222002001200231035001000243801001000253#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#510#131#article#141#131#^rND^sGilsanz^nV#^rND^sGibbens^n
DT#^rND^sRoe^nTF.#Vertebral bone density in children: effect of puberty^len#Radi
ology#19880000#1988#166#847-50#19990800#v5n4a07.htm#0033-8419#Radiology##
00585000000000289000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100022000790100017001010100
01900118012007800137030001300215065000900228064000500237031000400242014000500246
865000900251002001200260035001000272801001300282#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#511#132#article#141#132#^rND^sJohnston Jr^nCC#^rND^sMill
er^nJZ#^rND^sSlemenda^nCW#Calcium supplementation and increases in bone mineral 
density in children^len#N Engl J Med#19920000#1992#327#82-7#19990800#v5n4a07.htm
#0028-4793#N Engl J Med##
00521000000000289000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100017000790100017000960100
01900113012003500132030000500167065000900172064000500181031000400186020000500190
865000900195002001200204035001000216801000500226#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#512#133#article#141#133#^rND^sRecker^nRR#^rND^sDavies^nK
M#^rND^sHinders^nSM.#Bone gain in young adult women^len#JAMA#19920000#1992#268#2
403#19990800#v5n4a07.htm#0098-7484#JAMA##
00594000000000289000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100016000790100023000950100
01700118012008500135030001500220065000900235064000500244031000400249014000500253
865000900258002001200267035001000279801001500289#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#513#134#article#141#134#^rND^sWhite^nCM#^rND^sHengenroed
er^nAC#^rND^sKlish^nWJ.#Bone mineral density in 15- to 21-year-old eumenorrheic 
and amenorrheic subjects^len#Am J Dis Child#19920000#1992#146#31-5#19990800#v5n4
a07.htm#0002-922X#Am J Dis Child##
00557000000000265000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100024000790120113001030300
01000216065000900226064000500235031000400240014000600244865000900250002001200259
035001000271801001000281#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#
514#135#article#141#135#^rND^sHergenroeder^nAC.#Bone mineralization, hypothalami
c amenorrhea, and sex steroid therapy in female adolescents and young adults^len
#J Pediatr#19950000#1995#126#683-9#19990800#v5n4a07.htm#0022-3476#J Pediatr##
00650000000000313000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100019000790100018000980100
01500116010001500131010001700146012007100163030002400234065000900258064000500267
031000300272014000600275865000900281002001200290035001000302801002400312#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#515#136#article#141#136#^rND^sBa
chrach^nLK#^rND^sKatzman^nDK#^rND^sLitt^nIF#^rND^sGuido^nD#^rND^sMarcus^nR.#Reco
very from osteopenia in adolescent girls with anorexia nervosa^len#J Clin Endocr
inol Metab#19910000#1991#72#602-6#19990800#v5n4a07.htm#0021-972X#J Clin Endocrin
ol Metab##
00639000000000289000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100019000790120047000980160
01900145016001500164016001800179018008100197066001300278062001600291065000900307
064000500316014000700321865000900328002001200337#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#516#137#article#141#137#^rND^sAndersen^nAE#Eating disord
ers in males: a special case?^len#^rED^sBrownell^nKD#^rED^sRodin^nJ#^rED^sWilmor
e^nJH#Eating, body weight and performance in athletes: disorders of modern socie
ty^len#Philadelphia#Lea and Febiger#19920000#1992#172-90#19990800#v5n4a07.htm##
00669000000000325000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100018000790100020000970100
01500117010001700132010001800149010001700167012006100184030002100245065000900266
06400050027503100030028001400080028386500090029100200120030003500100031280100210
0322#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#517#138#article#141#
138#^rND^sDepalma^nMT#^rND^sKoszewski^nWM#^rND^sCase^nJG#^rND^sBarile^nRJ#^rND^s
Depalma^nBF#^rND^sOliaro^nSM#Weight control practices of lightweight football pl
ayers^len#Med Sci Sports Exerc#19930000#1993#25#694-701#19990800#v5n4a07.htm#019
5-9131#Med Sci Sports Exerc##
00679000000000325000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100022000790100019001010100
01500120010002000135010002000155010002200175012007000197030001500267065000900282
06400050029103100040029601400070030086500090030700200120031603500100032880100150
0338#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a07.htm#S#c#518#139#article#141#
139#^rND^sFinkelstein^nJS#^rND^sKlibanski^nA#^rND^sNeer^nRM#^rND^sGreenspan^nSL#
^rND^sRosenthal^nDI#^rND^sCrowley Jr^nWF.#Osteoporosis in men with idiopathic hy
pogonadotropic hypogonadism^len#Ann Intern Med#19870000#1987#106#354-61#19990800
#v5n4a07.htm#0003-4819#Ann Intern Med##
00599000000000289000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100018000790100016000970100
02300113012007100136030002400207065000900231064000500240031000300245014000600248
865000900254002001200263035001000275801002400285#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a07.htm#S#c#519#140#article#141#140#^rND^sHetland^nML#^rND^sHaarbo^n
J#^rND^sChristiansen^nC.#Low bone mass and high bone turnover in male long dista
nce runners^len#J Clin Endocrinol Metab#19930000#1993#77#700-5#19990800#v5n4a07.
htm#0021-972X#J Clin Endocrinol Metab##
00538000000000277000450000400050000070200460000570500020005170600020005370000040
00557010004000597090008000637080004000711180004000750100018000790100022000970120
06800119030000900187065000900196064000500205031000300210014000700213865000900220
002001200229035001000241801000900251#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a07.htm#S#c#520#141#article#141#141#^rND^sJackson^nJA#^rND^sKleerekoper^nM.#Oste
oporosis in men: diagnosis, pathophysiology, and prevention^len#Medicine#1990000
0#1990#69#137-52#19990800#v5n4a07.htm#0025-7974#Medicine##
00271000000000169000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670910009000690920007000780020012000857030
00400097#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#o#1#1#article#1#20
110405#115622#v5n4a08.htm#298##
03050000000000517000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000500087038000400092121000300096049000800099158000300107
03000210011003100020013103200020013306500090013501400110014403500100015501200950
01650100037002600100032002970700129003290700108004580831774005660850008023400850
02102348085002202369085001902391085002202410085002902432085002302461085002702484
117000602511072000302517002001202520#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a08.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#ILUS#TAB#08#RBME240#nd#Rev Bras Med 
Esporte#5#4#19990800#^f159^l166#1517-8692#O sistema imunológico (II): importânci
a dos imunomoduladores na recuperação do desportista^lpt#^rND^1A01^nAlfredo Córd
ova^sMartínez#^rND^1A01^nMelchor^sAlvarez-Mon#E.U. Fisioterapia de Soria^iA01^1Á
rea de Fisiologia^2Departamento de Bioquímica, Biologia Molecular e Fisiologia^c
Soria^pEspanha#Universidade de Alcalá^iA02^1Hospital Universitário Príncipe de A
sturias^2Departamento de Medicina^pEspanha#^lpt^aDe uma forma geral, a atividade
 física produz processos de adaptação no organismo que são determinados pelo tip
o, pela intensidade e pela duração das cargas. Quando os processos de adaptação 
orgânica e muscular são insuficientes, ocorre a síndrome da fadiga. Esta não dev
e ser considerada somente como um fator negativo, já que a fadiga deve ser compr
eendida também como um sistema de alerta e um potente fator de mobilização dos r
ecursos funcionais, o que a torna um poderoso elemento de adaptação. O surgiment
o da fadiga produz uma série de sinais e sintomas caracterizados por uma redução
 da força com hiperexcitabilidade muscular, alterações metabólicas e eletrolític
as e alterações neuroendócrinas, todos esses fatores levando a uma redução do de
sempenho físico. Nessas condições é originado um grau importante de "estresse" f
ísico e psíquico, com um grande comprometimento muscular (inflamação e lesão), q
ue são mais evidentes à medida em que o estado de fadiga se prolonga. Ou seja, o
corre um processo de comprometimento do sistema imunológico, já que acaba se tor
nando incompetente para lidar com os fenômenos inflamatórios acima mencionados. 
Essa situação de "estresse" origina uma supressão de diversos índices da função 
imunológica. Por trás do período de recuperação, o surgimento tardio de hidroxip
rolina excretada e a liberação tardia das enzimas CPK e LDH musculares sugerem u
ma lesão no tecido muscular. Por outro lado, o processo inflamatório inclui a pa
rticipação de diversos fatores fisiopatológicos: sanguíneos, imunológicos, tissu
lares, metabólicos e vasculares. A instauração de tratamentos com imunomodulador
es pode prevenir e auxiliar na recuperação da inflamação e do dano tissular caus
ado pelo estresse devido ao exercício intenso e mantido.#^dnd^i1#^tm^lpt^kEstres
se^i1#^tm^lpt^kExercício^i1#^tm^lpt^kFadiga^i1#^tm^lpt^kImunidade^i1#^tm^lpt^kIm
unomoduladores^i1#^tm^lpt^kInflamação^i1#^tm^lpt^kLesão muscular^i1#other#62#v5n
4a08.htm##
03064000000000517000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000500087038000400092121000300096049000800099158000300107
03000210011003100020013103200020013306500090013501400110014403500100015501201090
01650100037002740100032003110700129003430700108004720831774005800850008023540850
02102362085002202383085001902405085002202424085002902446085002302475085002702498
117000602525072000302531002001202534#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a08.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#ILUS#TAB#08#RBME240#nd#Rev Bras Med 
Esporte#5#4#19990800#^f159^l166#1517-8692#<b>O sistema imunológico (II)</b>: <b>
importância dos imunomoduladores na recuperação do desportista</b>^lpt#^rND^1A01
^nAlfredo Córdova^sMartínez#^rND^1A01^nMelchor^sAlvarez-Mon#E.U. Fisioterapia de
 Soria^iA01^1Área de Fisiologia^2Departamento de Bioquímica, Biologia Molecular 
e Fisiologia^cSoria^pEspanha#Universidade de Alcalá^iA02^1Hospital Universitário
 Príncipe de Asturias^2Departamento de Medicina^pEspanha#^lpt^aDe uma forma gera
l, a atividade física produz processos de adaptação no organismo que são determi
nados pelo tipo, pela intensidade e pela duração das cargas. Quando os processos
 de adaptação orgânica e muscular são insuficientes, ocorre a síndrome da fadiga
. Esta não deve ser considerada somente como um fator negativo, já que a fadiga 
deve ser compreendida também como um sistema de alerta e um potente fator de mob
ilização dos recursos funcionais, o que a torna um poderoso elemento de adaptaçã
o. O surgimento da fadiga produz uma série de sinais e sintomas caracterizados p
or uma redução da força com hiperexcitabilidade muscular, alterações metabólicas
 e eletrolíticas e alterações neuroendócrinas, todos esses fatores levando a uma
 redução do desempenho físico. Nessas condições é originado um grau importante d
e "estresse" físico e psíquico, com um grande comprometimento muscular (inflamaç
ão e lesão), que são mais evidentes à medida em que o estado de fadiga se prolon
ga. Ou seja, ocorre um processo de comprometimento do sistema imunológico, já qu
e acaba se tornando incompetente para lidar com os fenômenos inflamatórios acima
 mencionados. Essa situação de "estresse" origina uma supressão de diversos índi
ces da função imunológica. Por trás do período de recuperação, o surgimento tard
io de hidroxiprolina excretada e a liberação tardia das enzimas CPK e LDH muscul
ares sugerem uma lesão no tecido muscular. Por outro lado, o processo inflamatór
io inclui a participação de diversos fatores fisiopatológicos: sanguíneos, imuno
lógicos, tissulares, metabólicos e vasculares. A instauração de tratamentos com 
imunomoduladores pode prevenir e auxiliar na recuperação da inflamação e do dano
 tissular causado pelo estresse devido ao exercício intenso e mantido.#^dnd^i1#^
tm^lpt^kEstresse^i1#^tm^lpt^kExercício^i1#^tm^lpt^kFadiga^i1#^tm^lpt^kImunidade^
i1#^tm^lpt^kImunomoduladores^i1#^tm^lpt^kInflamação^i1#^tm^lpt^kLesão muscular^i
1#other#62#v5n4a08.htm##
03183000000000541000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670640013000690710003000820400003000850010
00600088042000200094120000400096038000500100038000400105121000300109049000800112
15800030012003000240012303100020014703200020014906500090015101400110016003500100
01710120095001810100037002760100032003130700131003450700110004760831774005860850
00802360085002102368085002202389085001902411085002202430085002902452085002302481
085002702504117000602531072000302537002001202540008008902552#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a08.htm#S#l#4#1#article#1#^mago.^a1999#oa#pt#br1.1#1#4.0
#ilus#tab#08#RBME240#nd#Rev. bras. med. esporte#5#4#19990800#^f159^l166#1517-869
2#O sistema imunológico (II): importância dos imunomoduladores na recuperação do
 desportista^lpt#^rND^1A01^nAlfredo Córdova^sMartínez#^rND^1A01^nMelchor^sAlvare
z-Mon#^iA01^1E.U. Fisioterapia de Soria^2Área de Fisiologia^3Departamento de Bio
química, Biologia Molecular e Fisiologia^cSoria^pEspanha#^iA02^1Universidade de 
Alcalá^2Hospital Universitário Príncipe de Asturias^3Departamento de Medicina^pE
spanha#^lpt^aDe uma forma geral, a atividade física produz processos de adaptaçã
o no organismo que são determinados pelo tipo, pela intensidade e pela duração d
as cargas. Quando os processos de adaptação orgânica e muscular são insuficiente
s, ocorre a síndrome da fadiga. Esta não deve ser considerada somente como um fa
tor negativo, já que a fadiga deve ser compreendida também como um sistema de al
erta e um potente fator de mobilização dos recursos funcionais, o que a torna um
 poderoso elemento de adaptação. O surgimento da fadiga produz uma série de sina
is e sintomas caracterizados por uma redução da força com hiperexcitabilidade mu
scular, alterações metabólicas e eletrolíticas e alterações neuroendócrinas, tod
os esses fatores levando a uma redução do desempenho físico. Nessas condições é 
originado um grau importante de "estresse" físico e psíquico, com um grande comp
rometimento muscular (inflamação e lesão), que são mais evidentes à medida em qu
e o estado de fadiga se prolonga. Ou seja, ocorre um processo de comprometimento
 do sistema imunológico, já que acaba se tornando incompetente para lidar com os
 fenômenos inflamatórios acima mencionados. Essa situação de "estresse" origina 
uma supressão de diversos índices da função imunológica. Por trás do período de 
recuperação, o surgimento tardio de hidroxiprolina excretada e a liberação tardi
a das enzimas CPK e LDH musculares sugerem uma lesão no tecido muscular. Por out
ro lado, o processo inflamatório inclui a participação de diversos fatores fisio
patológicos: sanguíneos, imunológicos, tissulares, metabólicos e vasculares. A i
nstauração de tratamentos com imunomoduladores pode prevenir e auxiliar na recup
eração da inflamação e do dano tissular causado pelo estresse devido ao exercíci
o intenso e mantido.#^dnd^i1#^tm^lpt^kEstresse^i1#^tm^lpt^kExercício^i1#^tm^lpt^
kFadiga^i1#^tm^lpt^kImunidade^i1#^tm^lpt^kImunomoduladores^i1#^tm^lpt^kInflamaçã
o^i1#^tm^lpt^kLesão muscular^i1#other#62#v5n4a08.htm#Internet^ihttp://www.scielo
.br/scielo.php?script=sci_arttext&pid=S1517-86921999000400008##
00318000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704008900071002001200160#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#5#1#article#232#<p align="right"><font f
ace="Verdana" size="2"><b>ARTIGO DE REVIS&Atilde;O</b><b>    ^cY#v5n4a08.htm##
00292000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704006300071002001200134#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#6#2#article#232#<br>   ARCHIVOS DE MEDIC
INA DEL DEPORTE</b></font></p>     ^cY#v5n4a08.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704002200071002001200093#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#7#3#article#232#<p>&nbsp;</p>     ^cY#v5
n4a08.htm##
00431000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704020200071002001200273#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#8#4#article#232#<p><font face="Verdana" 
size="4"><a name="topo"></a><b>O sistema imunol&oacute;gico    (II): import&acir
c;ncia dos imunomoduladores na recupera&ccedil;&atilde;o do    desportista</b></
font></p>     ^cY#v5n4a08.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704002300071002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#9#5#article#232#<p>&nbsp; </p>     ^cY#v
5n4a08.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704002300072002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#10#6#article#232#<p>&nbsp; </p>     ^cY#
v5n4a08.htm##
00377000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704014700072002001200219#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#11#7#article#232#<p><font face="Verdana"
 size="2"><b>Alfredo C&oacute;rdova Mart&iacute;nez<SUP>I</SUP>;    Melchor Alva
rez-Mon<SUP>II</SUP></b></font></p>     ^cY#v5n4a08.htm##
00465000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704023500072002001200307#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#12#8#article#232#<p><font face="Verdana"
 size="2"><sup>I</sup>Departamento de Bioqu&iacute;mica,    Biologia Molecular e
 Fisiologia. &Aacute;rea de Fisiologia. E.U. Fisioterapia    de Soria. Campus Un
iversit&aacute;rio de Soria. Soria, Espanha.    ^cY#v5n4a08.htm##
00497000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704026700072002001200339#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#13#9#article#232#<br>   <sup>II</sup>Ser
vi&ccedil;o de Medicina Interna. Doen&ccedil;as do Sistema Imunol&oacute;gico   
 e Oncologia. Departamento de Medicina. Hospital Universit&aacute;rio "Pr&iacute
;ncipe    de Asturias". Universidade de Alcal&aacute;. Espanha. </font></p>     
^cY#v5n4a08.htm##
00350000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704011900073002001200192#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#14#10#article#232#<p><font face="Verdana
" size="2"><a href="#send">Endere&ccedil;o para correspond&ecirc;ncia</a>    </f
ont></p>     ^cY#v5n4a08.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#15#11#article#232#<p>&nbsp;</p>     ^cY#
v5n4a08.htm##
00276000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704004500073002001200118#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#16#12#article#232#<p>&nbsp; </p> <hr siz
e="1" noshade>     ^cY#v5n4a08.htm##
00298000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704006700073002001200140#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#17#13#article#232#<p><font face="Verdana
" size="2"><B>RESUMO</B> </font></p>     ^cY#v5n4a08.htm##
02652000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704242100073002001202494#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#18#14#article#232#<p><font face="Verdana
" size="2">De uma forma geral, a atividade f&iacute;sica    produz processos de 
adapta&ccedil;&atilde;o no organismo que s&atilde;o determinados    pelo tipo, p
ela intensidade e pela dura&ccedil;&atilde;o das cargas. Quando    os processos 
de adapta&ccedil;&atilde;o org&acirc;nica e muscular s&atilde;o    insuficientes
, ocorre a s&iacute;ndrome da fadiga. Esta n&atilde;o deve ser    considerada so
mente como um fator negativo, j&aacute; que a fadiga deve ser    compreendida ta
mb&eacute;m como um sistema de alerta e um potente fator de mobiliza&ccedil;&ati
lde;o    dos recursos funcionais, o que a torna um poderoso elemento de adapta&c
cedil;&atilde;o.    O surgimento da fadiga produz uma s&eacute;rie de sinais e s
intomas caracterizados    por uma redu&ccedil;&atilde;o da for&ccedil;a com hipe
rexcitabilidade muscular,    altera&ccedil;&otilde;es metab&oacute;licas e eletr
ol&iacute;ticas e altera&ccedil;&otilde;es    neuroend&oacute;crinas, todos esse
s fatores levando a uma redu&ccedil;&atilde;o    do desempenho f&iacute;sico. Ne
ssas condi&ccedil;&otilde;es &eacute; originado    um grau importante de "estres
se" f&iacute;sico e ps&iacute;quico, com um grande    comprometimento muscular (
inflama&ccedil;&atilde;o e les&atilde;o), que s&atilde;o    mais evidentes &agra
ve; medida em que o estado de fadiga se prolonga. Ou seja,    ocorre um processo
 de comprometimento do sistema imunol&oacute;gico, j&aacute;    que acaba se tor
nando incompetente para lidar com os fen&ocirc;menos inflamat&oacute;rios    aci
ma mencionados. Essa situa&ccedil;&atilde;o de "estresse" origina uma supress&at
ilde;o    de diversos &iacute;ndices da fun&ccedil;&atilde;o imunol&oacute;gica.
 Por tr&aacute;s    do per&iacute;odo de recupera&ccedil;&atilde;o, o surgimento
 tardio de hidroxiprolina    excretada e a libera&ccedil;&atilde;o tardia das en
zimas CPK e LDH musculares    sugerem uma les&atilde;o no tecido muscular. Por o
utro lado, o processo inflamat&oacute;rio    inclui a participa&ccedil;&atilde;o
 de diversos fatores fisiopatol&oacute;gicos:    sangu&iacute;neos, imunol&oacut
e;gicos, tissulares, metab&oacute;licos e vasculares.    A instaura&ccedil;&atil
de;o de tratamentos com imunomoduladores pode prevenir    e auxiliar na recupera
&ccedil;&atilde;o da inflama&ccedil;&atilde;o e do dano    tissular causado pelo
 estresse devido ao exerc&iacute;cio intenso e mantido.    </font></p>     ^cY#v
5n4a08.htm##
00449000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704021800073002001200291#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#19#15#article#232#<p><font face="Verdana
" size="2"><B>Palavras-chave:</B> Estresse. Exerc&iacute;cio.    Fadiga. Imunida
de. Imunomoduladores. Inflama&ccedil;&atilde;o. Les&atilde;o    muscular. </font
></p> <hr size="1" noshade>     ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#20#16#article#232#<p>&nbsp; </p>     ^cY
#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#21#17#article#232#<p>&nbsp; </p>     ^cY
#v5n4a08.htm##
00318000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704008700073002001200160#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#22#18#article#232#<p><font face="Verdana
" size="3"><B>I. INTRODU&Ccedil;&Atilde;O</B></font></p>     ^cY#v5n4a08.htm##
01120000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704088900073002001200962#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#23#19#article#232#<p><font face="Verdana
" size="2">O exerc&iacute;cio f&iacute;sico consiste em    contra&ccedil;&otilde
;es musculares conc&ecirc;ntricas, isom&eacute;ricas e    exc&ecirc;ntricas, iso
ladas ou combinadas. De uma forma geral, a atividade f&iacute;sica    produz pro
cessos adaptativos no organismo, determinados pelo tipo, pela intensidade    e p
ela dura&ccedil;&atilde;o das cargas. Al&eacute;m disso, quando se analisa    um
 determinado tipo de atividade f&iacute;sica, &eacute; necess&aacute;rio disting
uir    o per&iacute;odo de treinamento do per&iacute;odo de competi&ccedil;&atil
de;o,    pois as exig&ecirc;ncias das respostas fisiol&oacute;gicas dos diferent
es &oacute;rg&atilde;os    e sistemas s&atilde;o diferentes, atingindo-se numa c
ompeti&ccedil;&atilde;o    o n&iacute;vel m&aacute;ximo de solicita&ccedil;&atil
de;o das atividades funcionais<SUP>1</SUP>.    </font></p>     ^cY#v5n4a08.htm##
01189000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704095800073002001201031#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#24#20#article#232#<p><font face="Verdana
" size="2">Com exerc&iacute;cios de dura&ccedil;&atilde;o    prolongada e baixa 
intensidade, s&atilde;o produzidos nos m&uacute;sculos um    aumento do n&uacute
;mero de mitoc&ocirc;ndrias e um aumento da vasculariza&ccedil;&atilde;o,    o q
ue favorece a <I>endurance</I> muscular e reduz o n&iacute;vel de fadiga.    Os 
exerc&iacute;cios de alta intensidade e curta dura&ccedil;&atilde;o produzem    
principalmente o aumento do tamanho das fibras e da atividade das enzimas muscul
ares<SUP>2</SUP>.    Nesse aspecto, Evans e col.<SUP>3</SUP> observaram que os e
xerc&iacute;cios    exc&ecirc;ntricos de alta intensidade em indiv&iacute;duos n
&atilde;o treinados    est&atilde;o associados a dano muscular, que &eacute; evi
denciado pelo aumento    na circula&ccedil;&atilde;o das enzimas musculares, por
 les&atilde;o da ultra-estrutura    das fibras e desenvolvimento de uma importan
te resposta inflamat&oacute;ria.    </font></p>     ^cY#v5n4a08.htm##
01323000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704109200073002001201165#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#25#21#article#232#<p><font face="Verdana
" size="2">Do ponto de vista mec&acirc;nico, o trabalho    exc&ecirc;ntrico de a
lta intensidade durante e ap&oacute;s o exerc&iacute;cio,    em rela&ccedil;&ati
lde;o ao conc&ecirc;ntrico, produz um maior aumento muscular    e plasm&aacute;t
ico dos n&iacute;veis de citocinas implicadas na resposta inflamat&oacute;ria   
 (IL-1, TNF e IL-6), que podem participar da patogenia de um maior grau de les&a
tilde;o    muscular<SUP>4,5</SUP>. Entre os mecanismos respons&aacute;veis pela 
produ&ccedil;&atilde;o    dessas mol&eacute;culas pr&oacute;-inflamat&oacute;ria
s podemos incluir o estresse    gerado em tecidos diretamente relacionados com a
 demanda funcional muscular,    hep&aacute;tica e sist&ecirc;mica<SUP>6</SUP>. O
 exerc&iacute;cio produz reajustes    constantes do organismo para retornar ao e
stado de homeostase. Aumenta o n&iacute;vel    de estresse e conseq&uuml;entemen
te aumenta o n&iacute;vel sangu&iacute;neo    de v&aacute;rios horm&ocirc;nios: 
catecolaminas, horm&ocirc;nio do crescimento,    endorfinas, ACTH e cortisol<SUP
>7</SUP>. </font></p>     ^cY#v5n4a08.htm##
00984000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704075300073002001200826#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#26#22#article#232#<p><font face="Verdana
" size="2">Quando os processos de adapta&ccedil;&atilde;o    org&acirc;nica e mu
scular s&atilde;o insuficientes para satisfazer as demandas,    surge a s&iacute
;ndrome da fadiga. Esta n&atilde;o deve ser considerada somente    como um fator
 negativo, j&aacute; que a fadiga deve ser compreendida como um    sistema de al
erta e um potente fator de mobiliza&ccedil;&atilde;o dos recursos    funcionais,
 o que a torna um poderoso fator de adapta&ccedil;&atilde;o<SUP>1,2</SUP>.    Ap
esar da complexidade fisiopatol&oacute;gica da fadiga e sem esquecer que &eacute
;    um processo cont&iacute;nuo, o m&uacute;sculo &eacute; o elemento central n
a    avalia&ccedil;&atilde;o e na recupera&ccedil;&atilde;o do atleta. </font></
p>     ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#27#23#article#232#<p>&nbsp; </p>     ^cY
#v5n4a08.htm##
00318000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704008700073002001200160#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#28#24#article#232#<p><font face="Verdana
" size="3"><B>II. O TECIDO MUSCULAR </b></font></p> <B>      ^cY#v5n4a08.htm##
00320000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704008900073002001200162#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#29#25#article#232#<p><font face="Verdana
" size="2">II.1. Introdu&ccedil;&atilde;o</font></p> </B>      ^cY#v5n4a08.htm##
01305000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704107400073002001201147#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#30#26#article#232#<p><font face="Verdana
" size="2">O tecido muscular representa em torno de 40 a    45% da massa corpora
l de um indiv&iacute;duo adulto e a sua principal fun&ccedil;&atilde;o    &eacut
e; o movimento. Do ponto de vista metab&oacute;lico, o m&uacute;sculo    &eacute
; o maior dep&oacute;sito de prote&iacute;nas (&#177; 50% do total de    prote&i
acute;nas) e amino&aacute;cidos livres no organismo. Essas prote&iacute;nas    r
epresentam uma fonte de precursores para a s&iacute;ntese de glicose (via glicon
eog&ecirc;nese)    e de amino&aacute;cidos para o anabolismo prot&eacute;ico em 
outros tecidos<SUP>8,9</SUP>.    O m&uacute;sculo &eacute; consumido durante pro
cessos catab&oacute;licos, patol&oacute;gicos    (traumatismos, neoplasias, seps
e, etc.) ou fisiol&oacute;gicos (exerc&iacute;cio    f&iacute;sico intenso), com
 finalidade ben&eacute;fica, j&aacute; que fornece    amino&aacute;cidos para a 
gliconeog&ecirc;nese e aumenta a produ&ccedil;&atilde;o    de citocinas que regu
lam a s&iacute;ntese de prote&iacute;nas da fase aguda<SUP>10</SUP>.    </font><
/p>     ^cY#v5n4a08.htm##
01112000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704088100073002001200954#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#31#27#article#232#<p><font face="Verdana
" size="2">O aumento ou a redu&ccedil;&atilde;o das prote&iacute;nas    muscular
es s&atilde;o determinados pelo equil&iacute;brio entre a s&iacute;ntese    e o 
catabolismo. H&aacute; uma cont&iacute;nua renova&ccedil;&atilde;o das prote&iac
ute;nas    (s&iacute;ntese e degrada&ccedil;&atilde;o) com a finalidade de repar
ar ou se    adaptar aos tecidos. Essa renova&ccedil;&atilde;o muscular est&aacut
e; afetada    por diversas condi&ccedil;&otilde;es fisiol&oacute;gicas como: o j
ejum, a alimenta&ccedil;&atilde;o,    a idade ou o exerc&iacute;cio f&iacute;sic
o<SUP>11-15</SUP> e est&aacute; regulada    pelo sistema neuroend&oacute;crino<S
UP>16-19</SUP>, com o sistema imunol&oacute;gico    participando de forma decisi
va pela sua influ&ecirc;ncia no processo de recupera&ccedil;&atilde;o    do proc
esso inflamat&oacute;rio<SUP>20</SUP>. </font></p>     ^cY#v5n4a08.htm##
00312000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704008100073002001200154#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#32#28#article#232#<p><font face="Verdana
" size="2"><B>II.2. Microestrutura</B> </font></p>     ^cY#v5n4a08.htm##
00851000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704062000073002001200693#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#33#29#article#232#<p><font face="Verdana
" size="2">Embora as fibras esquel&eacute;ticas, lisas e    card&iacute;acas apr
esentem pontos comuns em termos de organiza&ccedil;&atilde;o,    composi&ccedil;
&atilde;o (prote&iacute;nas contr&aacute;teis e regulat&oacute;rias)    e metabo
lismo, h&aacute; grandes diferen&ccedil;as morfol&oacute;gicas, funcionais    e 
nutricionais entre elas. Al&eacute;m disso, temos que levar em conta que a    co
mposi&ccedil;&atilde;o e distribui&ccedil;&atilde;o dos diferentes tipos de    f
ibras musculares n&atilde;o s&atilde;o iguais em todos os m&uacute;sculos do    
indiv&iacute;duo. </font></p>     ^cY#v5n4a08.htm##
00906000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704067500073002001200748#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#34#30#article#232#<p><font face="Verdana
" size="2">Entre as fibras esquel&eacute;ticas h&aacute;    diferen&ccedil;a tan
to em termos de rapidez de resposta (fibras de contra&ccedil;&atilde;o    r&aacu
te;pida e lenta) quanto no metabolismo ("vermelhas", predominantemente    oxidat
ivas; e "brancas", predominantemente glicol&iacute;ticas)<SUP>8,9</SUP>.    Os m
&uacute;sculos esquel&eacute;ticos envolvidos nos movimentos possuem uma    comb
ina&ccedil;&atilde;o desses tipos de fibras, por&eacute;m, como podemos    obser
var na <a href="#tab1">tabela 1</a>, com caracter&iacute;sticas histol&oacute;gi
cas,    histoqu&iacute;micas, metab&oacute;licas e funcionais diferentes.</font>
</p>     ^cY#v5n4a08.htm##
00266000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003500073002001200108#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#35#31#article#232#<p><a name="tab1"></a>
</p>     ^cY#v5n4a08.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#36#32#article#232#<p>&nbsp;</p>     ^cY#
v5n4a08.htm##
00310000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007900073002001200152#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#37#33#article#232#<p align="center"><img
 src="/img/revistas/rbme/v5n4/a08tab01.gif"></p>     ^cY#v5n4a08.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#38#34#article#232#<p>&nbsp;</p>     ^cY#
v5n4a08.htm##
00727000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704049600073002001200569#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#39#35#article#232#<p><font face="Verdana
" size="2">Os diferentes tipos de fibras podem mudar como    reflexo do efeito p
roduzido por diversas situa&ccedil;&otilde;es (exerc&iacute;cio,    hiberna&cced
il;&atilde;o). As fibras r&aacute;pidas s&atilde;o convert&iacute;veis;    por e
xemplo, as fibras glicol&iacute;ticas r&aacute;pidas podem ser convertidas    em
 oxidativas r&aacute;pidas e vice-versa, mas as fibras lentas e r&aacute;pidas  
  n&atilde;o s&atilde;o convert&iacute;veis entre si. </font></p>     ^cY#v5n4a0
8.htm##
00318000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704008700073002001200160#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#40#36#article#232#<p><font face="Verdana
" size="2"><B>II.3. Componente funcional</B> </font></p>     ^cY#v5n4a08.htm##
00685000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704045400073002001200527#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#41#37#article#232#<p><font face="Verdana
" size="2">O m&uacute;sculo, para executar a sua fun&ccedil;&atilde;o,    deve s
e adaptar (plasticidade muscular) quanto ao di&acirc;metro e comprimento    das 
suas fibras, for&ccedil;a, aporte vascular e efici&ecirc;ncia metab&oacute;lica.
    Ainda n&atilde;o s&atilde;o completamente conhecidos detalhadamente os perfi
s    metab&oacute;licos e morfol&oacute;gicos que podem ser alterados com o trei
namento.    </font></p>     ^cY#v5n4a08.htm##
00575000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704034400073002001200417#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#42#38#article#232#<p><font face="Verdana
" size="2">Do ponto de vista funcional, o m&uacute;sculo    est&aacute; constitu
&iacute;do por uma s&eacute;rie de prote&iacute;nas que    interatuam por meio d
e enzimas, que para o seu funcionamento correto necessitam    da presen&ccedil;a
 de minerais (&iacute;ons) (<a href="#tab2">tabela 2</a>).    </font></p>     ^c
Y#v5n4a08.htm##
00266000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003500073002001200108#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#43#39#article#232#<p><a name="tab2"></a>
</p>     ^cY#v5n4a08.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#44#40#article#232#<p>&nbsp;</p>     ^cY#
v5n4a08.htm##
00310000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007900073002001200152#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#45#41#article#232#<p align="center"><img
 src="/img/revistas/rbme/v5n4/a08tab02.gif"></p>     ^cY#v5n4a08.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#46#42#article#232#<p>&nbsp;</p>     ^cY#
v5n4a08.htm##
01294000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704106300073002001201136#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#47#43#article#232#<p><font face="Verdana
" size="2">Quarenta por cento das prote&iacute;nas sol&uacute;veis    de um m&ua
cute;sculo est&atilde;o constitu&iacute;das por enzimas. O conte&uacute;do    e/
ou atividade delas, para a contra&ccedil;&atilde;o muscular e o metabolismo    e
nerg&eacute;tico, varia conforme o tipo de fibra muscular. De uma forma geral,  
  as enzimas interferem no metabolismo dos carboidratos e dos lip&iacute;dios.  
  Desse grupo destacamos: a frutose 1,6-difosfato aldolase, a desidrogenase l&aa
cute;tica    (LDH), a fosfofrutoquinase, a piruvato-quinase, a fosforilase, a gl
icog&ecirc;nio-sintetase,    a hexoquinase, a succinato-desidrogenase e a citrat
o-sintetase. A LDH atua tamb&eacute;m    nas rea&ccedil;&otilde;es para a libera
&ccedil;&atilde;o muscular do &aacute;cido    l&aacute;tico produzido com o exer
c&iacute;cio. H&aacute; outras enzimas que    interferem no metabolismo do ATP c
omo a creatino-quinase (CK). Outras atividades    enzim&aacute;ticas est&atilde;
o fixadas sobre estruturas intracelulares<SUP>9,21</SUP>.    </font></p>     ^cY
#v5n4a08.htm##
01556000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704132500073002001201398#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#48#44#article#232#<p><font face="Verdana
" size="2">H&aacute; prote&iacute;nas, como a mioglobina,    que possuem uma gra
nde afinidade pelo oxig&ecirc;nio, captando-o no n&iacute;vel    extracelular e 
transferindo-o at&eacute; as mitoc&ocirc;ndrias, onde servir&aacute;    para o m
etabolismo oxidativo gerador de ATP. Outras prote&iacute;nas, como a    calmodul
ina, possuem fun&ccedil;&atilde;o reguladora e influenciam no acoplamento    do 
c&aacute;lcio a enzimas e regula os fluxos de c&aacute;lcio entre o exterior    
e o interior das c&eacute;lulas. O complexo calmodulina-c&aacute;lcio estimula  
  o "bombeamento" do c&aacute;lcio sarcoplasm&aacute;tico nas cisternas, influen
ciando    no relaxamento muscular. O c&aacute;lcio em forma ionizada &eacute; in
dispens&aacute;vel    para a contra&ccedil;&atilde;o muscular e durante esse pro
cesso se une &agrave;s    calciprote&iacute;nas (calmodulina, troponina C e parv
albumina). O magn&eacute;sio    ionizado pode substituir o c&aacute;lcio nos s&i
acute;tios espec&iacute;ficos    das calciprote&iacute;nas, influenciando no rel
axamento. Na presen&ccedil;a    de c&aacute;lcio, os &iacute;ons magn&eacute;sio
 s&atilde;o igualmente ativadores    enzim&aacute;ticos, estimulando todas as en
zimas do metabolismo fosforado: ATPases,    mioquinase, fosfatases<SUP>9,21</SUP
>. </font></p>     ^cY#v5n4a08.htm##
00606000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704037500073002001200448#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#49#45#article#232#<p><font face="Verdana
" size="2">Os componentes fosforados desempenham um importante    papel nos fen&
ocirc;menos de contra&ccedil;&atilde;o e relaxamento muscular.    Devemos destac
ar a "moeda energ&eacute;tica" que &eacute; o ATP, que se forma    essencialment
e nas mitoc&ocirc;ndrias, principalmente pelo metabolismo aer&oacute;bico<SUP>9,
21</SUP>.    </font></p>     ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#50#46#article#232#<p>&nbsp; </p>     ^cY
#v5n4a08.htm##
00379000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704014800073002001200221#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#51#47#article#232#<p><font face="Verdana
" size="3"><B>III. FADIGA MUSCULAR E SUA IMPLICA&Ccedil;&Atilde;O    COM O SISTE
MA IMUNOL&Oacute;GICO</B> </font></p>     ^cY#v5n4a08.htm##
01534000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704130300073002001201376#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#52#48#article#232#<p><font face="Verdana
" size="2">A fadiga &eacute; um sintoma complexo de dif&iacute;cil    delimita&c
cedil;&atilde;o. Em um sentido cl&iacute;nico produz a limita&ccedil;&atilde;o  
  para a realiza&ccedil;&atilde;o de atividades f&iacute;sicas habituais ou uma 
   redu&ccedil;&atilde;o na toler&acirc;ncia das demandas. Em rela&ccedil;&atild
e;o    &agrave; Medicina do Esporte, a fadiga &eacute; um evento que freq&uuml;e
ntemente    surge nos atletas ap&oacute;s longos per&iacute;odos de treinamento 
ou durante    as competi&ccedil;&otilde;es. Muitos fatores afetam ou determinam 
o surgimento    da fadiga muscular no atleta, entretanto a sua etiopatogenia ain
da n&atilde;o    est&aacute; claramente estabelecida. Os fatores metab&oacute;li
cos (redu&ccedil;&atilde;o    das reservas de ATP e de fosfocreatina, de glicog&
ecirc;nio muscular, da oferta    de oxig&ecirc;nio, etc.), o ac&uacute;mulo de m
etab&oacute;litos (&aacute;cido    l&aacute;tico, &iacute;ons hidrog&ecirc;nio o
u esc&oacute;rias nitrogenadas),    dist&uacute;rbios hidroeletrol&iacute;ticos,
 desequil&iacute;brios da homeostase    mineral e altera&ccedil;&otilde;es do es
tado funcional do sistema imunol&oacute;gico    contribuem para o estabeleciment
o da fadiga muscular perif&eacute;rica<SUP>8,22-24</SUP>.    </font></p>     ^cY
#v5n4a08.htm##
01362000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704113100073002001201204#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#53#49#article#232#<p><font face="Verdana
" size="2">O surgimento de fadiga produz uma s&eacute;rie    de sinais e sintoma
s caracterizados por uma redu&ccedil;&atilde;o da for&ccedil;a    com hiperexcit
abilidade muscular, altera&ccedil;&otilde;es metab&oacute;licas    e eletrol&iac
ute;ticas, al&eacute;m de altera&ccedil;&otilde;es neuroend&oacute;crinas,    to
dos esse fatores levando a uma redu&ccedil;&atilde;o do desempenho f&iacute;sico
<SUP>    24</SUP>. Nessas condi&ccedil;&otilde;es &eacute; originado um importan
te grau    de estresse f&iacute;sico e ps&iacute;quico, com v&aacute;rias conseq
&uuml;&ecirc;ncias    patol&oacute;gicas. Entre elas, podemos incluir les&otilde
;es musculares importantes    (inflama&ccedil;&atilde;o e dano celular), que se 
tornam mais importantes &agrave;    medida em que a fadiga se prolonga. Ou seja,
 &eacute; produzido um processo    de deteriora&ccedil;&atilde;o do sistema imun
ol&oacute;gico, que cursa com um    controle inadequado da sua fun&ccedil;&atild
e;o com a participa&ccedil;&atilde;o    da patogenia dos fen&ocirc;menos inflama
t&oacute;rios mencionados<SUP>20,25-27</SUP>.    </font></p>     ^cY#v5n4a08.htm
##
01034000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704080300073002001200876#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#54#50#article#232#<p><font face="Verdana
" size="2">No sistema imunol&oacute;gico foram descritas    diversas anomalias r
elacionadas &agrave; fadiga. Entre essas altera&ccedil;&otilde;es    podemos inc
luir as implicadas na regula&ccedil;&atilde;o da produ&ccedil;&atilde;o    das s
ubclasses de imunoglobulinas<SUP>28</SUP>. Nesse sentido, Tarp e Barnes<SUP>29</
SUP>    observaram que quando se aumenta o volume e a intensidade de treinamento
 (135    a 200%) em atletas bem treinados, h&aacute; uma redu&ccedil;&atilde;o d
os n&iacute;veis    salivares de IgA, acompanhada de varia&ccedil;&otilde;es nas
 subpopula&ccedil;&otilde;es    linfocit&aacute;rias. Esses estudos<SUP>28</SUP>
 sugerem que o tratamento com    imunoglobulinas pode ser uma via de solu&ccedil
;&atilde;o para essa s&iacute;ndrome.    </font></p>     ^cY#v5n4a08.htm##
02529000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704229800073002001202371#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#55#51#article#232#<p><font face="Verdana
" size="2">O aumento do volume e da intensidade do treinamento    est&aacute; as
sociado a diversas altera&ccedil;&otilde;es leucocit&aacute;rias    e do tr&aacu
te;fego linfomonocit&aacute;rio. V&aacute;rios autores observaram    uma redu&cc
edil;&atilde;o do n&uacute;mero de linf&oacute;citos CD4 T cooperadores    e aum
ento das c&eacute;lulas NK circulantes<SUP>30,31</SUP>. As anomalias quantitativ
as    na distribui&ccedil;&atilde;o leucocit&aacute;ria s&atilde;o acompanhadas 
por    diferentes altera&ccedil;&otilde;es funcionais. Entre elas temos resposta
s de    ativa&ccedil;&atilde;o e prolifera&ccedil;&atilde;o defeituosas do compa
rtimento    linfocit&aacute;rio T. H&aacute; ainda evid&ecirc;ncia de altera&cce
dil;&otilde;es    na secre&ccedil;&atilde;o de citocinas entre as quais est&atil
de;o inclu&iacute;das    as secretadas pelas c&eacute;lulas acess&oacute;rias e 
por diversas popula&ccedil;&otilde;es    linf&oacute;ides e de forma preferencia
l os linf&oacute;citos T. Essas defici&ecirc;ncias    na regula&ccedil;&atilde;o
 imunol&oacute;gica incluem o aumento da produ&ccedil;&atilde;o    de citocinas 
pr&oacute;-inflamat&oacute;rias. Apesar desses dados, n&atilde;o    est&aacute; 
estabelecido que essas anormalidades desempenhem um papel patog&ecirc;nico    di
reto sobre a fadiga. Para explicar a fadiga mediada por mecanismos imunol&oacute
;gicos,    v&aacute;rios autores apontam anomalias associadas do sistema neuroen
d&oacute;crino    que se associariam de forma direta<SUP>32,33</SUP>. Da mesma f
orma, foi observado    que o exerc&iacute;cio f&iacute;sico provoca agudamente u
m aumento do n&uacute;mero    de leuc&oacute;citos circulantes (leucocitose)<SUP
>33-37</SUP>. O n&iacute;vel    dessas altera&ccedil;&otilde;es em n&uacute;mero
, distribui&ccedil;&atilde;o    e fun&ccedil;&atilde;o dos leuc&oacute;citos e c
&eacute;lulas linfocit&aacute;rias    parece estar relacionado com diversas vari
&aacute;veis entre as quais o grau    de "estresse" experimentado pelo indiv&iac
ute;duo<SUP>8,33,38</SUP>. Esse fen&ocirc;meno    &eacute; proporcional &agrave;
 concentra&ccedil;&atilde;o plasm&aacute;tica    das catecolaminas que aumentam 
com a intensidade e dura&ccedil;&atilde;o do    exerc&iacute;cio f&iacute;sico<S
UP>39,40</SUP>. </font></p>     ^cY#v5n4a08.htm##
00363000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704013200073002001200205#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#56#52#article#232#<p><font face="Verdana
" size="2"><B>III.1. Altera&ccedil;&otilde;es estruturais    no m&uacute;sculo l
esado</B> </font></p>     ^cY#v5n4a08.htm##
01686000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704145500073002001201528#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#57#53#article#232#<p><font face="Verdana
" size="2">As altera&ccedil;&otilde;es da ultra-estrutura    muscular s&atilde;o
 seguidas por uma resposta inflamat&oacute;ria que &eacute;    habitualmente rep
arada. Imediatamente ap&oacute;s o esgotamento devido a um    trabalho muscular 
exc&ecirc;ntrico as micrografias eletr&ocirc;nicas mostram    uma desorganiza&cc
edil;&atilde;o das prote&iacute;nas contr&aacute;teis dentro    das fibras esgot
adas<SUP>24</SUP>. As altera&ccedil;&otilde;es da ultra-estrutura    muscular s&
atilde;o seguidas por uma resposta inflamat&oacute;ria que &eacute;    reparada 
habitualmente ap&oacute;s um per&iacute;odo de adapta&ccedil;&atilde;o    e inte
nsidades de exerc&iacute;cios adequados &agrave;s possibilidades musculares    d
e cada indiv&iacute;duo. Os processos de adapta&ccedil;&atilde;o s&atilde;o    m
ais eficazes quando o m&uacute;sculo j&aacute; sofreu diferentes les&otilde;es, 
   fazendo com que ele se fa&ccedil;a mais resistente &agrave; les&atilde;o devi
do    a um recrutamento mais eficaz de unidades motoras<SUP>41</SUP>. Quando o e
xerc&iacute;cio    se mant&eacute;m n&atilde;o s&atilde;o gerados os est&iacute;
mulos pertinentes    por les&atilde;o das unidades motoras e n&atilde;o se insta
uram as terapias    reparadoras pertinentes com o tempo de atua&ccedil;&atilde;o
 necess&aacute;rio,    desenvolvendo-se les&atilde;o e destrui&ccedil;&atilde;o 
musculares (rabdomi&oacute;lise)<SUP>24,41</SUP>.    </font></p>     ^cY#v5n4a08
.htm##
00934000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704070300073002001200776#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#58#54#article#232#<p><font face="Verdana
" size="2">Inicialmente os focos de les&atilde;o estrutural    se localizam nas 
miofibrilas e no citoesqueleto<SUP>42</SUP>. Este estado de    rabdomi&oacute;li
se &eacute; acompanhado por uma libera&ccedil;&atilde;o de    enzimas musculares
, aumento de mioglobina e de mioglobin&uacute;ria<SUP>24,43</SUP>.    Se houver 
ainda algum grau de desidrata&ccedil;&atilde;o, aumentam o risco e    as conseq&
uuml;&ecirc;ncias da rabdomi&oacute;lise. Al&eacute;m disso, &eacute;    observa
da uma certa desestrutura&ccedil;&atilde;o celular nas fibras lesionadas    com 
uma degrada&ccedil;&atilde;o dos lip&iacute;dios e das prote&iacute;nas    estru
turais<SUP>43</SUP>. </font></p>     ^cY#v5n4a08.htm##
00886000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704065500073002001200728#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#59#55#article#232#<p><font face="Verdana
" size="2">Ap&oacute;s as primeiras 72 horas, ocorre o aparecimento    de hidrox
iprolina excretada e a libera&ccedil;&atilde;o retardada das enzimas    CPK e LD
H, que sugerem uma les&atilde;o tecidual muscular<SUP>24,43</SUP>. O    r&aacute
;pido desenvolvimento da les&atilde;o muscular das fibras e do tecido    conjunt
ivo &eacute; acompanhado por uma disfun&ccedil;&atilde;o dos componentes    intr
acelulares que extravasam para os espa&ccedil;os intersticial e intravascular.  
  Muitas dessas subst&acirc;ncias incluem as prostaglandinas que atraem os neutr
&oacute;filos    e os mon&oacute;citos<SUP>44</SUP>. </font></p>     ^cY#v5n4a08
.htm##
01366000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704113500073002001201208#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#60#56#article#232#<p><font face="Verdana
" size="2">O conhecimento das modifica&ccedil;&otilde;es    do sistema imunol&oa
cute;gico, originadas pela atividade f&iacute;sica cont&iacute;nua    ao longo d
a temporada de competi&ccedil;&atilde;o e ao longo de um exerc&iacute;cio    nas
 suas fases aer&oacute;bica e anaer&oacute;bica, pode permitir a instaura&ccedil
;&atilde;o    de medidas terap&ecirc;uticas que evitem as complica&ccedil;&otild
e;es associadas    &agrave; pr&aacute;tica do esporte de alto n&iacute;vel e fav
ore&ccedil;am a    melhora do desempenho f&iacute;sico dos atletas. Nesse sentid
o, temos observado    em atletas de elite que o treinamento di&aacute;rio de alt
o n&iacute;vel, ao    longo da temporada de competi&ccedil;&atilde;o, provoca im
portantes modifica&ccedil;&otilde;es    no sistema imunol&oacute;gico, tanto em 
condi&ccedil;&otilde;es basais quanto    ap&oacute;s o exerc&iacute;cio m&aacute
;ximo. As altera&ccedil;&otilde;es imunol&oacute;gicas    observadas nos atletas
 parecem estar associadas com redu&ccedil;&otilde;es da    resist&ecirc;ncia f&i
acute;sica e do desempenho<SUP>24,25,36,44,45</SUP>. </font></p>     ^cY#v5n4a08
.htm##
01213000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704098200073002001201055#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#61#57#article#232#<p><font face="Verdana
" size="2">Nossos resultados indicam que a modula&ccedil;&atilde;o    do sistema
 imunol&oacute;gico dos desportistas pode produzir relevantes benef&iacute;cios.
    Esses efeitos terap&ecirc;uticos podem ser explicados pela restaura&ccedil;&
atilde;o    do controle interno do sistema linfomonocit&aacute;rio com equil&iac
ute;brio    do seus mediadores inflamat&oacute;rios, o que permite manter a home
ostase.    Al&eacute;m disso, a normaliza&ccedil;&atilde;o do sistema imunol&oac
ute;gico    pode conseguir a resposta adequada a agentes microbiol&oacute;gicos.
 Nesse sentido,    a instaura&ccedil;&atilde;o de tratamentos com imunomodulador
es (nossa experi&ecirc;ncia    foi conduzida com glicofosfopeptical <I>&#91;Imun
oferon<SUP>&#174;</SUP>&#93;</I>)    pode prevenir e auxiliar na recupera&ccedil
;&atilde;o da inflama&ccedil;&atilde;o    e les&atilde;o tissular originadas pel
o estresse devido ao exerc&iacute;cio    intenso e mantido. </font></p>     ^cY#
v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#62#58#article#232#<p>&nbsp; </p>     ^cY
#v5n4a08.htm##
00360000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704012900073002001200202#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#63#59#article#232#<p><font face="Verdana
" size="3"><B>IV. RESPOSTA IMUNOL&Oacute;GICA &Agrave; INFLAMA&Ccedil;&Atilde;O<
/B>    </font></p>     ^cY#v5n4a08.htm##
02378000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704214700073002001202220#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#64#60#article#232#<p><font face="Verdana
" size="2">O processo inflamat&oacute;rio originado ap&oacute;s    a les&atilde;
o tecidual deve se restaurar eficientemente para recuperar o equil&iacute;brio  
  homeost&aacute;tico. A resposta inflamat&oacute;ria &eacute; um mecanismo impo
rtante    que representa uma intera&ccedil;&atilde;o complexa entre os agentes p
atog&ecirc;nicos,    os componentes parenquimatosos celulares e teciduais, a vas
culariza&ccedil;&atilde;o    e os componentes celulares do sangue e do plasma. T
radicionalmente, a evolu&ccedil;&atilde;o    da resposta inflamat&oacute;ria foi
 observada como uma continua&ccedil;&atilde;o    das etapas iniciais da inflama&
ccedil;&atilde;o aguda at&eacute; uma rea&ccedil;&atilde;o    mantida ou cr&ocir
c;nica seguida por uma repara&ccedil;&atilde;o da les&atilde;o    tecidual. As e
tapas iniciais da resposta inflamat&oacute;ria, o sofrimento celular    at&eacut
e; a les&atilde;o tecidual, se caracterizam pela libera&ccedil;&atilde;o    de m
ediadores vasoativos produzidos pelos mast&oacute;citos tissulares (histamina,  
  leucotrienos, etc.), plaquetas e componentes plasm&aacute;ticos (bradicinina),
    dando lugar &agrave; vasodilata&ccedil;&atilde;o e &agrave; forma&ccedil;&at
ilde;o    de edema. Em seguida, s&atilde;o ativados os sistemas de coagula&ccedi
l;&atilde;o    e de complemento, gerando-se fatores quimiot&aacute;xicos do plas
ma (C5a) e    diversas quimiocinas com capacidade de atra&ccedil;&atilde;o para 
neutr&oacute;filos    e outras c&eacute;lulas inflamat&oacute;rias linfomonocit&
aacute;rias. Essas    mol&eacute;culas recrutam c&eacute;lulas inflamat&oacute;r
ias aos locais onde    h&aacute; inflama&ccedil;&atilde;o e promovem o seu tr&aa
cute;fego hematotissular.    Uma vez presentes nos tecidos, as c&eacute;lulas in
flamat&oacute;rias podem    ser estimuladas a liberar produtos de degranula&cced
il;&atilde;o, inclu&iacute;dos    metab&oacute;litos oxig&ecirc;nio-reativos e p
roteases, assim como mediadores    lip&iacute;dicos biologicamente ativos como o
 leucotrieno B4, o fator ativador    plaquet&aacute;rio e diversas citocinas e q
uimiocinas<SUP>20</SUP>. </font></p>     ^cY#v5n4a08.htm##
00357000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704012600073002001200199#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#65#61#article#232#<p><font face="Verdana
" size="2"><B>IV.1. Participa&ccedil;&atilde;o do sistema    imunol&oacute;gico<
/B> </font></p>     ^cY#v5n4a08.htm##
01372000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704114100073002001201214#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#66#62#article#232#<p><font face="Verdana
" size="2">Nas fases iniciais do processo de inflama&ccedil;&atilde;o    tissula
r, os mon&oacute;citos mobilizados no n&iacute;vel tissular e os sist&ecirc;mico
s    ativados ou recirculantes produzem monocinas, das quais as mais claramente 
implicadas    s&atilde;o o IL-1 e o fator de necrose tumoral (FNT), o IL-6 e o f
ator estimulante    dos hepat&oacute;citos (FEH)<SUP>30,46</SUP>. Logo os n&iacu
te;veis s&eacute;ricos    de cortisol aumentam, chegando a taxas muito elevadas 
em cerca de seis horas;    a quantidade de neutr&oacute;filos circulantes come&c
cedil;a a aumentar e chega    ao m&aacute;ximo dez horas depois. Uma grande quan
tidade de leuc&oacute;citos    se associam fracamente com as c&eacute;lulas endo
teliais que se alinham nos    vasos sangu&iacute;neos; s&atilde;o liberados na c
orrente sangu&iacute;nea em    um processo conhecido como desmargina&ccedil;&ati
lde;o. Al&eacute;m desses efeitos    do cortisol, outra causa de leucocitose &ea
cute; a libera&ccedil;&atilde;o de    neutr&oacute;filos da medula &oacute;ssea 
provocada pela presen&ccedil;a de    IL-1<SUP>47-49</SUP>. </font></p>     ^cY#v
5n4a08.htm##
01015000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704078400073002001200857#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#67#63#article#232#<p><font face="Verdana
" size="2">Seguindo o desenvolvimento da resposta inflamat&oacute;ria,    &eacut
e; produzida uma infiltra&ccedil;&atilde;o de mon&oacute;citos, eosin&oacute;fil
os    e linf&oacute;citos. Como a les&atilde;o inicial &eacute; controlada, se r
eduz    ou &eacute; contida, os neutr&oacute;filos n&atilde;o s&atilde;o mobiliz
ados    durante um tempo prolongado e, ao contr&aacute;rio, acumulam-se c&eacute
;lulas    mononucleadas. Nesse momento da evolu&ccedil;&atilde;o tendem a predom
inar,    no leito tecidual afetado, a infiltra&ccedil;&atilde;o por mon&oacute;c
ito-macr&oacute;fagos,    linf&oacute;citos e c&eacute;lulas plasm&aacute;ticas 
e o tecido adquire a apar&ecirc;ncia    histol&oacute;gica de inflama&ccedil;&at
ilde;o cr&ocirc;nica. </font></p>     ^cY#v5n4a08.htm##
01022000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704079100073002001200864#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#68#64#article#232#<p><font face="Verdana
" size="2">Na inflama&ccedil;&atilde;o cr&ocirc;nica, as    c&eacute;lulas acess
&oacute;rias desempenham dois pap&eacute;is importantes    na resposta imunol&oa
cute;gica: 1) o primeiro &eacute; o de uma c&eacute;lula    fagocit&aacute;ria c
apaz de englobar e degradar microrganismos e restos celulares;    2) o segundo &
eacute; a modula&ccedil;&atilde;o da resposta imunol&oacute;gica    e a fun&cced
il;&atilde;o de c&eacute;lulas T, B e NK atrav&eacute;s da apresenta&ccedil;&ati
lde;o    do ant&iacute;geno e a secre&ccedil;&atilde;o de diversas citocinas. Al
&eacute;m    disso, estas citocinas modulam a fun&ccedil;&atilde;o, n&atilde;o s
omente das    c&eacute;lulas inflamat&oacute;rias, mas tamb&eacute;m das parenqu
imatosas<SUP>20,47</SUP>.    </font></p>     ^cY#v5n4a08.htm##
00639000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704040800073002001200481#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#69#65#article#232#<p><font face="Verdana
" size="2">Desta forma, o processo inflamat&oacute;rio &eacute;    bastante comp
lexo e inclui a participa&ccedil;&atilde;o de numerosos fatores    fisiopatol&oa
cute;gicos: sangu&iacute;neos, imunol&oacute;gicos, tissulares,    metab&oacute;
licos e vasculares<SUP>47</SUP>, que est&atilde;o resumidos na    <a href="/img/
revistas/rbme/v5n4/a08fig01.gif">figura 1</a>.</font></p>     ^cY#v5n4a08.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#70#66#article#232#<p>&nbsp;</p>     ^cY#
v5n4a08.htm##
00399000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704016800073002001200241#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#71#67#article#232#<p><font face="Verdana
" size="3"><B>V. IMPLICA&Ccedil;&Atilde;O DOS IMUNOMODULADORES    NA RESPOSTA IM
UNOL&Oacute;GICA AO EXERC&Iacute;CIO </b></font></p> <B>      ^cY#v5n4a08.htm##
00348000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704011700073002001200190#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#72#68#article#232#<p><font face="Verdana
" size="2">V.1. Imunomoduladores fisiol&oacute;gicos end&oacute;genos</font></p>
 </B>      ^cY#v5n4a08.htm##
01100000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704086900073002001200942#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#73#69#article#232#<p><font face="Verdana
" size="2">Durante o exerc&iacute;cio intenso, ocorrem no    organismo v&aacute;
rias altera&ccedil;&otilde;es metab&oacute;licas e hormonais.    Aumenta a ativi
dade simp&aacute;tica e os n&iacute;veis sangu&iacute;neos de    alguns horm&oci
rc;nios como a adrenalina, noradrenalina, vasopressina, glucagon,    cortisol, h
orm&ocirc;nio do crescimento, ACTH e TSH. Muitas dessas respostas    s&atilde;o 
consideradas como componentes da resposta ao estresse. Como j&aacute;    comenta
mos anteriormente<SUP>33</SUP>, a pr&aacute;tica regular de exerc&iacute;cios   
 produz diversos benef&iacute;cios fisiol&oacute;gicos, constituindo-se em um   
 eficaz mecanismo de imunomodula&ccedil;&atilde;o, j&aacute; que facilita a fun&
ccedil;&atilde;o    imunol&oacute;gica e aumenta a resist&ecirc;ncia &agrave;s i
nfec&ccedil;&otilde;es.    </font></p>     ^cY#v5n4a08.htm##
00668000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704043700073002001200510#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#74#70#article#232#<p><font face="Verdana
" size="2">Nesta revis&atilde;o aprofundamos alguns conceitos    sobre os aspect
os imunomoduladores provocados pela libera&ccedil;&atilde;o hormonal    produzid
a pelo exerc&iacute;cio. Parece claro que as varia&ccedil;&otilde;es    induzida
s pelo exerc&iacute;cio na libera&ccedil;&atilde;o de fatores neuroend&oacute;cr
inos    exerce um efeito sobre a fun&ccedil;&atilde;o linfocit&aacute;ria. </fon
t></p>     ^cY#v5n4a08.htm##
01311000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704108000073002001201153#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#75#71#article#232#<p><font face="Verdana
" size="2">A relev&acirc;ncia biol&oacute;gica dos diferentes    horm&ocirc;nios
 e neurotransmissores na patogenia das altera&ccedil;&otilde;es    do sistema im
unol&oacute;gico &eacute; desconhecida. O efeito imunomodulador    dos glicocort
ic&oacute;ides parece evidente, sem desvalorizar o GH ou os horm&ocirc;nios    t
ireoidianos. O aumento da atividade adren&eacute;rgica induzida pelo exerc&iacut
e;cio    intenso produz um importante aumento das concentra&ccedil;&otilde;es sa
ngu&iacute;neas    das catecolaminas adrenalina e noradrenalina. Os n&iacute;vei
s desses horm&ocirc;nios    no sangue aumentam exponencialmente com a intensidad
e e a dura&ccedil;&atilde;o    do exerc&iacute;cio, retornando rapidamente aos v
alores normais em um curto    per&iacute;odo ap&oacute;s um esfor&ccedil;o inten
so e permanecendo ainda elevado    pelo menos durante 30 minutos ap&oacute;s uma
 atividade moderada. As catecolaminas    tamb&eacute;m alteram o n&uacute;mero e
 a fun&ccedil;&atilde;o dos linf&oacute;citos    circulantes<SUP>50,51</SUP>. </
font></p>     ^cY#v5n4a08.htm##
02135000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704190400073002001201977#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#76#72#article#232#<p><font face="Verdana
" size="2">Por outro lado, a secre&ccedil;&atilde;o adrenocortical    incide sob
re os componentes psicol&oacute;gico, metab&oacute;lico e imunol&oacute;gico    
(atrav&eacute;s das c&eacute;lulas imunocompetentes)<SUP>52,53</SUP>. De fato,  
  demonstrou-se que o n&uacute;mero de linf&oacute;citos circulantes, em algumas
    ocasi&otilde;es, varia inversamente com as altera&ccedil;&otilde;es circadia
nas    de cortisol plasm&aacute;tico. Estas c&eacute;lulas, por sua vez, s&atild
e;o    diretamente afetadas pelo horm&ocirc;nio do crescimento (GH) e pela prola
ctina    (PRL)<SUP>40</SUP>. Nos linf&oacute;citos h&aacute; receptores para o G
H, de    tal forma que quando h&aacute; defici&ecirc;ncia desse horm&ocirc;nio &
eacute;    provocada uma defici&ecirc;ncia do sistema imunol&oacute;gico (por at
rofia do    timo), que &eacute; revers&iacute;vel quando se rep&otilde;e o GH<SU
P>40</SUP>.    A PRL se une a receptores espec&iacute;ficos de diversas popula&c
cedil;&otilde;es    linfocit&aacute;rias e estimula a sua prolifera&ccedil;&atil
de;o<SUP>54</SUP>.    Por outro lado, as citocinas exercem um importante efeito 
neuroimunomodulador,    como &eacute; observado na resposta inflamat&oacute;ria<
SUP>40</SUP>. De fato,    nos pacientes com problemas n&atilde;o end&oacute;crin
os, as citocinas atuam    na ativa&ccedil;&atilde;o do eixo hipot&aacute;lamo-hi
pofis&aacute;rio-adrenal    e provocam inibi&ccedil;&atilde;o dos eixos hip&oacu
te;fise-tireoidiano e hip&oacute;fise-gonadal<SUP>40,55</SUP>.    Os efeitos das
 citocinas sobre as c&eacute;lulas do sistema nervoso central    constituem um c
ontraste. A relev&acirc;ncia dessa atividade &eacute; clara em    diversas fun&c
cedil;&otilde;es concretas, como a regula&ccedil;&atilde;o da    temperatura cor
poral, mas tamb&eacute;m em outras fun&ccedil;&otilde;es abstratas,    como as e
mo&ccedil;&otilde;es. </font></p>     ^cY#v5n4a08.htm##
00549000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704031800073002001200391#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#77#73#article#232#<p><font face="Verdana
" size="2">Outros componentes que influenciam na regula&ccedil;&atilde;o    do s
istema imunol&oacute;gico s&atilde;o as prostaglandinas, fundamentalmente    a E
<SUB>2</SUB> (PGE<SUB>2</SUB>), produzidas e liberadas pelos mon&oacute;citos   
 e neutr&oacute;filos<SUP>30</SUP>. </font></p>     ^cY#v5n4a08.htm##
00339000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704010800073002001200181#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#78#74#article#232#<p><font face="Verdana
" size="2"><B>IV.2. Imunomoduladores farmacol&oacute;gicos</B>    </font></p>   
  ^cY#v5n4a08.htm##
00778000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704054700073002001200620#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#79#75#article#232#<p><font face="Verdana
" size="2">A utiliza&ccedil;&atilde;o de imunomoduladores    na terap&ecirc;utic
a cl&iacute;nica &eacute; um avan&ccedil;o na Medicina do    Esporte. De fato, l
evando em conta que o exerc&iacute;cio provoca um processo    inflamat&oacute;ri
o importante, a princ&iacute;pio os mecanismos terap&ecirc;uticos    utilizados 
para tratar essa situa&ccedil;&atilde;o poderiam ser da mesma natureza    que os
 aplicados nas situa&ccedil;&otilde;es de estresse acompanhadas de um    compone
nte inflamat&oacute;rio. </font></p>     ^cY#v5n4a08.htm##
01423000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704119200073002001201265#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#80#76#article#232#<p><font face="Verdana
" size="2">De todas as subst&acirc;ncias que possuem efeito    imunomodulador, a
lgumas delas, como os cortic&oacute;ides, t&ecirc;m car&aacute;ter    preferenci
almente supressor. Inibem a fun&ccedil;&atilde;o das c&eacute;lulas    acess&oac
ute;rias e dos linf&oacute;citos T cooperadores, com diminui&ccedil;&atilde;o   
 da sua atividade secretor de citocinas. Tamb&eacute;m suprimem a resposta linfo
cit&aacute;ria    ao est&iacute;mulo das citocinas, a libera&ccedil;&otilde;es d
os gr&acirc;nulos    das c&eacute;lulas citot&oacute;xicas e a produ&ccedil;&ati
lde;o de imunoglobulinas<SUP>52,53</SUP>.    Os corticoster&oacute;ides produzem
 uma redu&ccedil;&atilde;o da prolifera&ccedil;&atilde;o    de linf&oacute;citos
, uma redu&ccedil;&atilde;o da produ&ccedil;&atilde;o de    interleucina-2 (IL-2
) e uma diminui&ccedil;&atilde;o da express&atilde;o de    receptores para IL-2<
SUP>53</SUP>. A dexametasona e a prednisolona administradas    <I>in vivo</I> mo
dificam significativamente a capacidade dos linf&oacute;citos    para responder 
a est&iacute;mulos mitog&ecirc;nicos, assim como a produ&ccedil;&atilde;o    de 
imunoglobulinas<SUP>20</SUP>. </font></p>     ^cY#v5n4a08.htm##
01260000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704102900073002001201102#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#81#77#article#232#<p><font face="Verdana
" size="2">Os tratamentos com imunoglobulina humana normal    (possui a mesma a&
ccedil;&atilde;o que a imunoglobulina G) v&ecirc;m sendo utilizados    freq&uuml
;entemente como estimulantes da fun&ccedil;&atilde;o imunol&oacute;gica,    cons
iderando-se essas subst&acirc;ncias como verdadeiros imunomoduladores. A    resi
st&ecirc;ncia &agrave; infec&ccedil;&atilde;o &eacute; devida em parte &agrave; 
   presen&ccedil;a de n&iacute;veis s&eacute;ricos suficientes de imunoglobulina
s    tanto em n&iacute;vel plasm&aacute;tico quanto em n&iacute;vel tissular. A 
resist&ecirc;ncia    &agrave; reinfec&ccedil;&atilde;o &eacute; geralmente atrib
u&iacute;da &agrave;    presen&ccedil;a de n&iacute;veis adequados de ant&iacute
;geno espec&iacute;fico    de imunoglobulinas no soro ou nas secre&ccedil;&otild
e;es respirat&oacute;rias.    As concentra&ccedil;&otilde;es dessas mol&eacute;c
ulas tamb&eacute;m s&atilde;o    essenciais nas mucosas, especialmente os de IgA
 secretor<SUP>56,57</SUP>. </font></p>     ^cY#v5n4a08.htm##
00929000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704069800073002001200771#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#82#78#article#232#<p><font face="Verdana
" size="2">Existe um grupo de f&aacute;rmacos, n&atilde;o    muito grande, que e
xerce um importante efeito imunomodulador com regula&ccedil;&atilde;o    de dive
rsas popula&ccedil;&otilde;es e fun&ccedil;&otilde;es. Essas atividades    s&ati
lde;o de significado complexo, com atividades estimulantes e inibit&oacute;rias 
   em diversas popula&ccedil;&otilde;es e com poss&iacute;vel varia&ccedil;&otil
de;es    de acordo com o estado do sistema imunol&oacute;gico sobre o que atuam 
e o momento    da evolu&ccedil;&atilde;o temporal. Entre eles destacamos o &aacu
te;cido acetilsalic&iacute;lico    e o glicofosfopeptical <I>(Imunoferon<SUP>&#1
74;</SUP>)</I>. </font></p>     ^cY#v5n4a08.htm##
00829000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704059800073002001200671#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#83#79#article#232#<p><font face="Verdana
" size="2">Do nosso ponto de vista, o &aacute;cido acetilsalic&iacute;lico    &e
acute; o imunomodulador mais utilizado e mais conhecido, embora n&atilde;o    se
ja reconhecido como tal. S&atilde;o bem conhecidos os seus efeitos antiinflamat&
oacute;rios,    anti-reum&aacute;ticos, antit&eacute;rmicos e recentemente foram
 descritas as    suas propriedades sobre a modula&ccedil;&atilde;o da fun&ccedil
;&atilde;o linfocit&aacute;ria.    Acredita-se que a sua a&ccedil;&atilde;o seja
 por inibi&ccedil;&atilde;o do    metabolismo de leucotrienos<SUP>58</SUP>. </fo
nt></p>     ^cY#v5n4a08.htm##
00642000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704041100073002001200484#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#84#80#article#232#<p><font face="Verdana
" size="2">O glicofosfopectical &eacute; um imunomodulador    de natureza poliss
ac&aacute;rido/prote&iacute;nica, tamb&eacute;m denominado    como AM3 <I>(Imuno
feron<SUP>&#174;</SUP>)</I>. Esse imunomodulador possui efeitos    biol&oacute;g
icos importantes sobre a resposta imunol&oacute;gica e inflamat&oacute;ria,    c
onforme resumido na <a href="#tab3">tabela 3</a>.</font></p>     ^cY#v5n4a08.htm
##
00266000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003500073002001200108#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#85#81#article#232#<p><a name="tab3"></a>
</p>     ^cY#v5n4a08.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#86#82#article#232#<p>&nbsp;</p>     ^cY#
v5n4a08.htm##
00310000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007900073002001200152#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#87#83#article#232#<p align="center"><img
 src="/img/revistas/rbme/v5n4/a08tab03.gif"></p>     ^cY#v5n4a08.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#88#84#article#232#<p>&nbsp;</p>     ^cY#
v5n4a08.htm##
01293000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704106200073002001201135#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#89#85#article#232#<p><font face="Verdana
" size="2">Em portadores de asma br&ocirc;nquica e em outras    doen&ccedil;as, 
foi comprovado que a administra&ccedil;&atilde;o desse f&aacute;rmaco    &eacute
; capaz de aumentar a fun&ccedil;&atilde;o efetora de c&eacute;lulas    implicad
as na resposta antiinfecciosa. Nesse sentido, o glicofosfopectical aumenta    a 
capacidade funcional das c&eacute;lulas fagocit&aacute;rias, assim como a    ati
vidade dos linf&oacute;citos T e das c&eacute;lulas NK desses pacientes.    Em e
studos realizados em diferentes modelos experimentais e cl&iacute;nicos    foi d
emonstrado que o glicofosfopectical possui um efeito antiinflamat&oacute;rio    
importante, com inibi&ccedil;&atilde;o de citocinas pr&oacute;-inflamat&oacute;r
ias,    como o fator de necrose tumoral alfa. Esta a&ccedil;&atilde;o supressora
 da    inflama&ccedil;&atilde;o do glicofosfopectical parece tamb&eacute;m parti
cipar    no mecanismo de a&ccedil;&atilde;o desse f&aacute;rmaco em diversas sit
ua&ccedil;&otilde;es    patol&oacute;gicas<SUP>59,60</SUP>. </font></p>     ^cY#
v5n4a08.htm##
00905000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704067400073002001200747#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#90#86#article#232#<p><font face="Verdana
" size="2">Baseados no efeito do exerc&iacute;cio sobre    o metabolismo muscula
r e estudando as caracter&iacute;sticas qu&iacute;micas    e aplica&ccedil;&otil
de;es do AM3 em diferentes processos patol&oacute;gicos,    desenvolvemos a sua 
aplica&ccedil;&atilde;o no esporte<SUP>59,61</SUP>. A instaura&ccedil;&atilde;o 
   de tratamentos com AM3 pode prevenir a auxiliar a recupera&ccedil;&atilde;o  
  da inflama&ccedil;&atilde;o e da les&atilde;o tecidual originada pelo estresse
    conseq&uuml;ente ao exerc&iacute;cio intenso e sustentado, sobretudo nos des
portistas    que treinam e competem regularmente ao longo da temporada. </font><
/p>     ^cY#v5n4a08.htm##
00708000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704047700073002001200550#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#91#87#article#232#<p><font face="Verdana
" size="2">Nesse sentido, pudemos comprovar a efic&aacute;cia    do glicofosfope
ctical <I>(Imunoferon<SUP>&#174;</SUP>)</I> sobre diferentes    par&acirc;metros
 implicados no metabolismo muscular e/ou hep&aacute;tico. Em    um estudo duplo 
cego durante 30 dias com glicofosfopectical, apreciamos uma    redu&ccedil;&atil
de;o dos n&iacute;veis s&eacute;ricos das prote&iacute;nas    associadas com a l
es&atilde;o tecidual<SUP>61</SUP>. </font></p>     ^cY#v5n4a08.htm##
00782000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704055100073002001200624#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#92#88#article#232#<p><font face="Verdana
" size="2">O ibuprofeno tem sido utilizado tamb&eacute;m    como imunomodulador,
 como tratamento preventivo para a les&atilde;o muscular    produzida pelo exerc
&iacute;cio f&iacute;sico intenso<SUP>62</SUP>. O mecanismo    do ibuprofeno par
a diminuir a resposta inflamat&oacute;ria &eacute; o bloqueio    da forma&ccedil
;&atilde;o de endoper&oacute;xido e prostaglandinas. Com isso,    se consegue um
a redu&ccedil;&atilde;o do edema e da press&atilde;o intramuscular    provocados
 pela les&atilde;o muscular. </font></p>     ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#93#89#article#232#<p>&nbsp; </p>     ^cY
#v5n4a08.htm##
00309000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007800073002001200151#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#94#90#article#232#<p><font face="Verdana
" size="3"><B>REFER&Ecirc;NCIAS</B> </font></p>     ^cY#v5n4a08.htm##
00383000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069888000200073704013800075002001200213#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#95#91#article#232#1#<p><font
 face="Verdana" size="2">1. Platanov VN. El entrenamiento deportivo. Teoria    y
 metodologia. Barcelona: Paidotribo, 1997.    ^cY#v5n4a08.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002100073002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#96#92#article#232# </font></p>     ^cY#v
5n4a08.htm##
00428000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069888000200073704018300075002001200258#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#97#93#article#232#2#<p><font
 face="Verdana" size="2">2. Grosser M, Bruggemann P, Zintl F. Alto rendimiento  
  deportivo. Planificaci&oacute;n y desarrollo. Barcelona: Martinez Roca S.A.,  
  1989.    ^cY#v5n4a08.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002100073002001200094#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#98#94#article#232# </font></p>     ^cY#v
5n4a08.htm##
00437000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069888000200073704019200075002001200267#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#99#95#article#232#3#<p><font
 face="Verdana" size="2">3. Evans WJ, Meredith CN, Cannon JG. Metabolic    chang
es following eccentric exercise in trained and untrained men. J Appl Physiol    
1986; 61:1864-8.    ^cY#v5n4a08.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704002100074002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#100#96#article#232# </font></p>     ^cY#
v5n4a08.htm##
00414000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070888000200074704016800076002001200244#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#101#97#article#232#4#<p><fon
t face="Verdana" size="2">4. Pedersen BK, Bruunsgaard H. How physical exercise  
  influences the establishment of infections. Sports Med 1995;19:393-400.    ^cY
#v5n4a08.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704002100074002001200095#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#102#98#article#232# </font></p>     ^cY#
v5n4a08.htm##
00486000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070888000200074704024000076002001200316#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#103#99#article#232#5#<p><fon
t face="Verdana" size="2">5. Pizza FX, Mitchell JB, Davis BH, Starling    RD, Ho
ltz RW, Bigelow N. Exercise-induced muscle damage: effect on circulating    leuk
ocyte and lymphocyte subsets. Med Sci Sport Exerc 1995;27:363-70.    ^cY#v5n4a08
.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#104#100#article#232# </font></p>     ^cY
#v5n4a08.htm##
00456000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704020900077002001200286#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#105#101#article#232#6#<p><fo
nt face="Verdana" size="2">6. Kappel M, Tvede N, Galbo H, et al. Evidence    tha
t the effect of physical exercise on NK cell activity is mediated by epinephrine
.    J Appl Physiol 1991;70:2530-4.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#106#102#article#232# </font></p>     ^cY
#v5n4a08.htm##
00416000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704016900077002001200246#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#107#103#article#232#7#<p><fo
nt face="Verdana" size="2">7. Hoffman-Goetz L, Pedersen BK. Exercise and    the 
immune system: a model of the stress response? Immunol Today 1994;15:382-7.    ^
cY#v5n4a08.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#108#104#article#232#    </font></p>     
^cY#v5n4a08.htm##
00387000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704014000077002001200217#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#109#105#article#232#8#<p><fo
nt face="Verdana" size="2">8. C&oacute;rdova A. La fatiga muscular en el    rend
imiento deportivo. Madrid: Ed. Sintesis, 1997.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#110#106#article#232# </font></p>     ^cY
#v5n4a08.htm##
00411000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704016400077002001200241#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#111#107#article#232#9#<p><fo
nt face="Verdana" size="2">9. C&oacute;rdova A. Compendio de fisiolog&iacute;a  
  para ciencias de la salud. Madrid: Interamericana-McGraw-Hill, 1994.    ^cY#v5
n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#112#108#article#232# </font></p>     ^cY
#v5n4a08.htm##
00495000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704024700078002001200325#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#113#109#article#232#10#<p><f
ont face="Verdana" size="2">10. Reeds PJ, Fjeld CR, Jahoor F. Do the differences
    between the amino acid compositions of acute-phase and muscle proteins have 
   a bearing on nitrogen loss in traumatic states? J Nutr 1994;124:906-10.    ^c
Y#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#114#110#article#232# </font></p>     ^cY
#v5n4a08.htm##
00545000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029700078002001200375#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#115#111#article#232#11#<p><f
ont face="Verdana" size="2">11. Cheng KN, Pacy PJ, Dworzak F, Ford GC, Halliday 
   D. Influence of fasting on leucine and muscle protein metabolism across the  
  human forearm determined using L-&#91;l-<SUP>13</SUP>C, <SUP>15</SUP>N&#93;leu
cine    as a tracer. Clin Sci 1987;73:241-6.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#116#112#article#232# </font></p>     ^cY
#v5n4a08.htm##
00396000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704014800078002001200226#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#117#113#article#232#12#<p><f
ont face="Verdana" size="2">12. Rennie MJ. Muscle protein turnover and the    wa
sting to injury and disease. Br Med Bul 1985;41:257-64.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#118#114#article#232# </font></p>     ^cY
#v5n4a08.htm##
00424000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017600078002001200254#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#119#115#article#232#13#<p><f
ont face="Verdana" size="2">13. Rennie MJ, Smith K, Watt PW. Measurement    of h
uman tissue protein synthesis: an optimal approach. Am J Physiol 1994;266:E298-3
07.    ^cY#v5n4a08.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#120#116#article#232#    </font></p>     
^cY#v5n4a08.htm##
00422000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017400078002001200252#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#121#117#article#232#14#<p><f
ont face="Verdana" size="2">14. Welle S, Thornton C, Jozefowicz R, Statt    M. M
yofibrillar protein synthesis in young and old men. Am J Physiol 1993;264:E693-8
.    ^cY#v5n4a08.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#122#118#article#232#    </font></p>     
^cY#v5n4a08.htm##
00472000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704022400078002001200302#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#123#119#article#232#15#<p><f
ont face="Verdana" size="2">15. Yarasheski KE, Zachwieja JJ, Bier DM. Acute    e
ffects of resistance exercise on muscle protein synthesis rate in young and    e
lderly men and women. Am J Physiol 1993;265:E210-4.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#124#120#article#232# </font></p>     ^cY
#v5n4a08.htm##
00372000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704012400078002001200202#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#125#121#article#232#16#<p><f
ont face="Verdana" size="2">16. Florini JR. Hormonal control of muscle growth.  
  Muscle Nerve 1987; 10:577-98.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#126#122#article#232# </font></p>     ^cY
#v5n4a08.htm##
00392000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704014400078002001200222#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#127#123#article#232#17#<p><f
ont face="Verdana" size="2">17. Florini JR, Ewton DZ, McWade FJ. IGFs, muscle   
 growth, and myogenesis. Diabetes Rev 1995;3:73-92.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#128#124#article#232# </font></p>     ^cY
#v5n4a08.htm##
00422000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017400078002001200252#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#129#125#article#232#18#<p><f
ont face="Verdana" size="2">18. Sugden PH, Fuller SJ. Review article. Regulation
    of protein turnover in skeletal and cardiac muscle. Biochem J 1991;273:21-37
.    ^cY#v5n4a08.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#130#126#article#232#    </font></p>     
^cY#v5n4a08.htm##
00404000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015600078002001200234#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#131#127#article#232#19#<p><f
ont face="Verdana" size="2">19. Rooyackers OE, Nair KS. Hormonal regulation    o
f human muscle protein metabolism. Ann Rev Nutr 1997;17:457-85.    ^cY#v5n4a08.h
tm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#132#128#article#232# </font></p>     ^cY
#v5n4a08.htm##
00414000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016600078002001200244#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#133#129#article#232#20#<p><f
ont face="Verdana" size="2">20. Sigal LH, Ron Y. Immunology and inflammation.   
 Basic mechanisms and clinical consequences. New York: McGraw-Hill, 1994.    ^cY
#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#134#130#article#232# </font></p>     ^cY
#v5n4a08.htm##
00436000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704018800078002001200266#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#135#131#article#232#21#<p><f
ont face="Verdana" size="2">21. Saltin B, Gollnick PD. Skeletal muscle adaptabil
ity:    significance for metabolism and performance. Bethesda: Handbook of Physi
ology,    1986.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#136#132#article#232# </font></p>     ^cY
#v5n4a08.htm##
00425000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017700078002001200255#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#137#133#article#232#22#<p><f
ont face="Verdana" size="2">22. Marco JC, Rodriguez H, Navas JF, C&oacute;rdova 
   A. La fatiga psicol&oacute;gica en el deportista. Selecci&oacute;n 1995;4:129
-36.    ^cY#v5n4a08.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#138#134#article#232#    </font></p>     
^cY#v5n4a08.htm##
00435000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704018700078002001200265#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#139#135#article#232#23#<p><f
ont face="Verdana" size="2">23. C&oacute;rdova A, Navas FJ, Seco J. Aspectos    
metab&oacute;licos de la fatiga muscular durante el ejercicio. Arch Med Dep    1
995;48:283-91.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#140#136#article#232# </font></p>     ^cY
#v5n4a08.htm##
00421000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017300078002001200251#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#141#137#article#232#24#<p><f
ont face="Verdana" size="2">24. C&oacute;rdova A, Alvarez-Mon M. Aspectos    fis
iopatol&oacute;gicos del da&ntilde;o y la fatiga muscular. Medicine (en prensa).
    ^cY#v5n4a08.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#142#138#article#232#    </font></p>     
^cY#v5n4a08.htm##
00454000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704020600078002001200284#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#143#139#article#232#25#<p><f
ont face="Verdana" size="2">25. C&oacute;rdova A, Alvarez-Mon M. Behaviour    of
 zinc in physical exercise: a special reference to immunity and fatigue. Neurosc
i    Biobehav Rev 1995;19:439-45.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#144#140#article#232# </font></p>     ^cY
#v5n4a08.htm##
00371000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704012300078002001200201#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#145#141#article#232#26#<p><f
ont face="Verdana" size="2">26. Kuipers H. Exercise-induced muscle damage.    In
t J Sports Med 1994; 15:132-5.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#146#142#article#232# </font></p>     ^cY
#v5n4a08.htm##
00386000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704013800078002001200216#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#147#143#article#232#27#<p><f
ont face="Verdana" size="2">27. Keast D, Cameron K, Morton AR. Exercise and    t
he immune response. Sports Med 1988;5:248-67.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#148#144#article#232# </font></p>     ^cY
#v5n4a08.htm##
00419000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017100078002001200249#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#149#145#article#232#28#<p><f
ont face="Verdana" size="2">28. Nieman DC, Nehlsen-Cannarella SL. The effects   
 of acute and chronic exercise on immunoglobulins. Sports Med 1991;11:183-201.  
  ^cY#v5n4a08.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#150#146#article#232#    </font></p>     
^cY#v5n4a08.htm##
00407000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015900078002001200237#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#151#147#article#232#29#<p><f
ont face="Verdana" size="2">29. Tarp GD, Barnes M. Reduction of saliva immunoglo
bulin    levels by swim training. Eur J Appl Physiol 1990;60:61-4.    ^cY#v5n4a0
8.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#152#148#article#232# </font></p>     ^cY
#v5n4a08.htm##
00424000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017600078002001200254#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#153#149#article#232#30#<p><f
ont face="Verdana" size="2">30. Pedersen BK. Influence of physical activity    o
n the cellular immune system: mechanisms of action. Int J Sports Med 1991;12:S23
-9.    ^cY#v5n4a08.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#154#150#article#232#    </font></p>     
^cY#v5n4a08.htm##
00499000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704025100078002001200329#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#155#151#article#232#31#<p><f
ont face="Verdana" size="2">31. Tvede N, Steensberg J, Baslund B, et al.    Cell
ular immunity in highly-trained elite racing cyclists and controls during    per
iods of training with high and low intensity. Scand J Sports Med 1991;1:163-6.  
  ^cY#v5n4a08.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#156#152#article#232#    </font></p>     
^cY#v5n4a08.htm##
00430000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704018200078002001200260#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#157#153#article#232#32#<p><f
ont face="Verdana" size="2">32. Nieman DC, Simandle S, Henson DA, et al.    Lymp
hocyte proliferative response to 2.5 hours of running. Int J Sports Med    1995;
16:404-8.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#158#154#article#232# </font></p>     ^cY
#v5n4a08.htm##
00479000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704023100078002001200309#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#159#155#article#232#33#<p><f
ont face="Verdana" size="2">33. C&oacute;rdova A, Alvarez-Mon M. El sistema    i
nmune I: conceptos generales, adaptaci&oacute;n al ejercicio f&iacute;sico    e 
implicaciones cl&iacute;nicas. Arch Med Dep 1999;69:47-54.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#160#156#article#232# </font></p>     ^cY
#v5n4a08.htm##
00480000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704023200078002001200310#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#161#157#article#232#34#<p><f
ont face="Verdana" size="2">34. Shinkai S, Shore S, Shek PN, Shephard RJ.    Acu
te exercise and immune function. Relationship between lymphocyte activity    and
 changes in subset counts. Int J Sports Med 1992;13:452-61.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#162#158#article#232# </font></p>     ^cY
#v5n4a08.htm##
00474000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704022600078002001200304#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#163#159#article#232#35#<p><f
ont face="Verdana" size="2">35. C&oacute;rdova A, Martins F, Alvarez-Mon    M. E
ffect of maximal exercise on lymphocytes (CD3, CD19) and serum immunoglobulin   
 levels in elite sportsmen. Physiol Behav (sometido).    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#164#160#article#232# </font></p>     ^cY
#v5n4a08.htm##
00593000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704034500078002001200423#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#165#161#article#232#36#<p><f
ont face="Verdana" size="2">36. C&oacute;rdova A, Sada G, Villarrubia V,    Alva
rez-Mon M. Effects of training on serum zinc in CD+3 and CD+19 lymphocytes    in
 sportsmen along a season. In: Collery Ph, Cobella J, Domingo JL, Etienne    JC,
 Llobet JM, editors. Metal ions in biology and medicine. Paris: John Libbey,    
1996: 667-9.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#166#162#article#232# </font></p>     ^cY
#v5n4a08.htm##
00457000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704020900078002001200287#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#167#163#article#232#37#<p><f
ont face="Verdana" size="2">37. Gray AB, Telford RD, Collins M, Weidemann    MJ.
 The response of leukocyte subsets and plasma hormones to interval exercise.    
Med Sci Sports Exerc 1993;25:1252-8.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#168#164#article#232# </font></p>     ^cY
#v5n4a08.htm##
00452000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704020400078002001200282#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#169#165#article#232#38#<p><f
ont face="Verdana" size="2">38. Keats D, Morton AR. Long-term exercise and    im
mune function. In: Watson RR, Eisinger M, editors. Exercise and disease. Boca   
 Raton: CRC Press, 1993:89-120.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#170#166#article#232# </font></p>     ^cY
#v5n4a08.htm##
00446000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019800078002001200276#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#171#167#article#232#39#<p><f
ont face="Verdana" size="2">39. Laperriere A, Ironson G, Antoni MH, Schneiderman
    N, Klimas N, Fletcher MA. Exercise and psychoneuroimmunology. Med Sci Sports
    Exerc 1994;26:182-90.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#172#168#article#232# </font></p>     ^cY
#v5n4a08.htm##
00374000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704012600078002001200204#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#173#169#article#232#40#<p><f
ont face="Verdana" size="2">40. Payan DG, McGillis JP, Goetz EJ. Neuroimmunology
.    Adv Immunol 1986;39:299-323.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#174#170#article#232# </font></p>     ^cY
#v5n4a08.htm##
00428000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704018000078002001200258#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#175#171#article#232#41#<p><f
ont face="Verdana" size="2">41. Nosaka K, Clarkson PM. Muscle damage following  
  repeated bouts of high force eccentric exercise. Med Sci Sports Exerc 1995;27:
1263-9.    ^cY#v5n4a08.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#176#172#article#232#    </font></p>     
^cY#v5n4a08.htm##
00419000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017100078002001200249#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#177#173#article#232#42#<p><f
ont face="Verdana" size="2">42. Friden J, Lieber RL. Structural and mechanical  
  basis of exercise-induce muscle injury. Med Sci Sports Exerc 1992;24:521-30.  
  ^cY#v5n4a08.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#178#174#article#232#    </font></p>     
^cY#v5n4a08.htm##
00475000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704022700078002001200305#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#179#175#article#232#43#<p><f
ont face="Verdana" size="2">43. Evans WJ, Cannon JG. The metabolic effects    of
 exercise-induced muscle damage. In: Holloszy J. Exercise and sport sciences    
reviews. Baltimore: Williams and Wilkins, 1991:99-125.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#180#176#article#232# </font></p>     ^cY
#v5n4a08.htm##
00396000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704014800078002001200226#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#181#177#article#232#44#<p><f
ont face="Verdana" size="2">44. Tidball JG. Inflammatory cell response to    acu
te muscle injury. Med Sci Sports Exerc 1995;27:1022-32.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#182#178#article#232# </font></p>     ^cY
#v5n4a08.htm##
00459000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704021100078002001200289#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#183#179#article#232#45#<p><f
ont face="Verdana" size="2">45. C&oacute;rdova A, Navas FJ, Escanero JF.    The 
effect of exercise and zinc supplement on the haematological parameters    in ra
ts. Biol Trace Elem Res 1993;39:13-20.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#184#180#article#232# </font></p>     ^cY
#v5n4a08.htm##
00394000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704014600078002001200224#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#185#181#article#232#46#<p><f
ont face="Verdana" size="2">46. Kent TH, Hart MN. Injury, inflammation and    re
pair. Norwalk, Connecticut: Appleton and Lange, 1993.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#186#182#article#232# </font></p>     ^cY
#v5n4a08.htm##
00458000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704021000078002001200288#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#187#183#article#232#47#<p><f
ont face="Verdana" size="2">47. Macityre DL, Reid WD, McKenzie DC. Delayed    mu
scle soreness. The inflammatory response to muscle injury and its clinical    im
plications. Sports Med 1995;20:24-40.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#188#184#article#232# </font></p>     ^cY
#v5n4a08.htm##
00423000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017500078002001200253#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#189#185#article#232#48#<p><f
ont face="Verdana" size="2">48. Gallin JI, Goldstein IM, Snyderman R. Inflammati
on:    basic principles and clinical correlates. New York: Raven Press Ltd., 199
2.    ^cY#v5n4a08.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#190#186#article#232#    </font></p>     
^cY#v5n4a08.htm##
00421000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017300078002001200251#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#191#187#article#232#49#<p><f
ont face="Verdana" size="2">49. Northoff H, Berg A. Immunologic mediators    as 
parameters of the reaction to strenous exercise. Int J Sports Med 1991;12:S9-15.
    ^cY#v5n4a08.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#192#188#article#232#    </font></p>     
^cY#v5n4a08.htm##
00447000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019900078002001200277#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#193#189#article#232#50#<p><f
ont face="Verdana" size="2">50. Shephard RJ, Rhind S, Shek PN. Exercise and    t
he immune system. Natural killer cells, interleukins and related responses.    S
ports Med 1994; 18:341-69.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#194#190#article#232# </font></p>     ^cY
#v5n4a08.htm##
00399000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015100078002001200229#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#195#191#article#232#51#<p><f
ont face="Verdana" size="2">51. Mazzeo RS. The influence of exercise and    agin
g on immune function. Med Sci Sports Exerc 1994;26:586-92.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#196#192#article#232# </font></p>     ^cY
#v5n4a08.htm##
00434000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704018600078002001200264#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#197#193#article#232#52#<p><f
ont face="Verdana" size="2">52. Blalock JE. A molecular basis for bidirectional 
   communication between the immune and neuroendocrine systems. Physiol Rev 1989
;    69:1-32.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#198#194#article#232# </font></p>     ^cY
#v5n4a08.htm##
00415000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016700078002001200245#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#199#195#article#232#53#<p><f
ont face="Verdana" size="2">53. Ferry A, Weill BL, Rieu M. Immunomodulations    
induced in rats by exercise on a treadmill. J Appl Physiol 1990;69:1912-5.    ^c
Y#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#200#196#article#232# </font></p>     ^cY
#v5n4a08.htm##
00446000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019800078002001200276#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#201#197#article#232#54#<p><f
ont face="Verdana" size="2">54. Kelley KW, Arkins S, Li YM. Growth hormone,    p
rolactin, and insulin-like growth factors: new jobs for old players. Brain    Be
hav Immun 1992; 6:317-26.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#202#198#article#232# </font></p>     ^cY
#v5n4a08.htm##
00375000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704012700078002001200205#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#203#199#article#232#55#<p><f
ont face="Verdana" size="2">55. Reighlin S. Neuroendocrine-immune interactions. 
   N Engl J Med 1993; 329:1246-53.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#204#200#article#232# </font></p>     ^cY
#v5n4a08.htm##
00354000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704010600078002001200184#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#205#201#article#232#56#<p><f
ont face="Verdana" size="2">56. Bellanti JA. Immunology III. Philadelphia:    Sa
unders, 1985.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#206#202#article#232# </font></p>     ^cY
#v5n4a08.htm##
00427000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017900078002001200257#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#207#203#article#232#57#<p><f
ont face="Verdana" size="2">57. Carrol MC. The role of complement and complement
    receptors in induction and regulation of immunity. Ann Rev Immunol 1998;16:5
45-68.    ^cY#v5n4a08.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#208#204#article#232#    </font></p>     
^cY#v5n4a08.htm##
00463000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704021500078002001200293#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#209#205#article#232#58#<p><f
ont face="Verdana" size="2">58. Sainte-Laudy J. Importance of in vivo and    in 
vitro studies of leukotrienes. Application to the particular instance of    aspi
rin. Allerg Immunol (Paris) 1997;29:28-35.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#210#206#article#232# </font></p>     ^cY
#v5n4a08.htm##
00568000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704032000078002001200398#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#211#207#article#232#59#<p><f
ont face="Verdana" size="2">59. Villarrubia VG, Moreno Koch MC, Calvo C,    Gonz
&aacute;lez S, Alvarez-Mon M. The immunosenescent phenotype in mice and    human
s can be defined by alterations in the natural immunity reversal by immunomodula
tion    with oral AM3. Immunopharmacol Immunotoxicol 1997;19:53-74.    ^cY#v5n4a
08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#212#208#article#232# </font></p>     ^cY
#v5n4a08.htm##
00452000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704020400078002001200282#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#213#209#article#232#60#<p><f
ont face="Verdana" size="2">60. Alonso JL, Morejon M, Pivel JP. AM3, a new    an
tagonist of lypopolysaccharide (LPS) induced tumor necrosis factor (TNF) product
ion.    Immunobiol 1987;175:F2.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#214#210#article#232# </font></p>     ^cY
#v5n4a08.htm##
00492000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704024400078002001200322#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#215#211#article#232#61#<p><f
ont face="Verdana" size="2">61. C&oacute;rdova A, Villarrubia V, Sada G,    Calv
o CG, Alvarez-Mon M. Immunomodulation for prevention of muscle damage in    athl
etes. International Pre-Olympic Scientific Congress. Texas (USA), 1996.    ^cY#v
5n4a08.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#216#212#article#232#    </font></p>     
^cY#v5n4a08.htm##
00472000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704022400078002001200302#v5n
4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#p#217#213#article#232#62#<p><f
ont face="Verdana" size="2">62. Hasson SM, Daniels JC, Divine JG, et al.    Effe
cts of ibuprofen use on muscle soreness damage, and performance: a preliminary  
  investigation. Med Sci Sports Exerc 1993;25:9-17.    ^cY#v5n4a08.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#218#214#article#232# </font></p>     ^cY
#v5n4a08.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#219#215#article#232#<p>&nbsp;</p>     ^c
Y#v5n4a08.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#220#216#article#232#<p>&nbsp;</p>     ^c
Y#v5n4a08.htm##
00421000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704018800075002001200263#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#221#217#article#232#<p><font face="Verda
na" size="2"><b><a name="send"></a><a href="#topo"><img src="/img/revistas/rbme/
v5n4/seta.gif" border="0"></a>    Endere&ccedil;o para correspond&ecirc;ncia</b>
    ^cY#v5n4a08.htm##
00286000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704005300075002001200128#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#222#218#article#232#<br>   Alfredo C&oac
ute;rdova Mart&iacute;nez    ^cY#v5n4a08.htm##
00275000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704004200075002001200117#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#223#219#article#232#<br>   C/ Nicol&aacu
te;s Rabal, 17    ^cY#v5n4a08.htm##
00273000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704004000075002001200115#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#224#220#article#232#<br>   Area de Fisio
log&iacute;a    ^cY#v5n4a08.htm##
00274000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704004100075002001200116#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#225#221#article#232#<br>   E.U. Fisioter
apia de Soria    ^cY#v5n4a08.htm##
00281000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704004800075002001200123#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#226#222#article#232#<br>   42003 &#150; 
Soria &#150; Espanha    ^cY#v5n4a08.htm##
00326000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704009300075002001200168#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#227#223#article#232#<br>   E-mail: <a hr
ef="mailto:cordova@bio.uva.es">cordova@bio.uva.es</a></font></p>     ^cY#v5n4a08
.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#228#224#article#232#<p>&nbsp;</p>     ^c
Y#v5n4a08.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#229#225#article#232#<p>&nbsp;</p>     ^c
Y#v5n4a08.htm##
00511000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704027800075002001200353#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#230#226#article#232#<p><font face="Verda
na" size="2">Traduzido, com permiss&atilde;o por escrito,    do original: Mart&i
acute;nez AC, Alvarez-Mon M. El sistema inmune (II): Importancia    de los inmun
omoduladores en la recuperaci&oacute;n del deportista. Arch Med    Deporte 1999;
70:155-65.    ^cY#v5n4a08.htm##
00300000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704006700075002001200142#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#231#227#article#232#<br>   </font><font 
face="Verdana" size="2">Traduzido por:     ^cY#v5n4a08.htm##
00275000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704004200075002001200117#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#232#228#article#232#<br>   Jos&eacute; K
awazoe Lazzoli    ^cY#v5n4a08.htm##
00306000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704007300075002001200148#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#233#229#article#232#<br>   Editor-Chefe 
da Revista Brasileira de Medicina do Esporte     ^cY#v5n4a08.htm##
00332000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704009900075002001200174#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#234#230#article#232#<br>   Primeiro-Secr
et&aacute;rio da Sociedade de Medicina Desportiva do Rio de Janeiro        ^cY#v
5n4a08.htm##
00402000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704016900075002001200244#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#235#231#article#232#<br>   Professor do 
Depto. de Morfologia e da Disciplina de Medicina do Exerc&iacute;cio    e do Esp
orte, da Universidade Federal Fluminense, Niter&oacute;i, RJ     ^cY#v5n4a08.htm
##
00353000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704012000075002001200195#v5n4#V:\SciELO\
serial\rbme\v5n4\markup\v5n4a08.htm#S#p#236#232#article#232#<br>   Diretor do er
gocenter &#150; Instituto Petropolitano de Ergometria, Petr&oacute;polis,    RJ 
</font></p>     ^cY#v5n4a08.htm##
00433000000000229000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160020000740180053000940660
01000147062001100157065000900168064000500177865000900182002001200191#v5n4#V:\Sci
ELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#237#1#article#62#1#^rND^sPlatanov^nV
N.#El entrenamiento deportivo. Teoria y metodologia^les#Barcelona#Paidotribo#199
70000#1997#19990800#v5n4a08.htm##
00504000000000253000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160017000740160020000910160
01600111018005900127066001000186062001900196065000900215064000500224865000900229
002001200238#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#238#2#articl
e#62#2#^rND^sGrosser^nM#^rND^sBruggemann^nP#^rND^sZintl^nF.#Alto rendimiento dep
ortivo. Planificación y desarrollo^les#Barcelona#Martinez Roca S.A.#19890000#198
9#19990800#v5n4a08.htm##
00582000000000289000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100016000740100019000900100
01800109012008000127030001500207065000900222064000500231031000300236014000700239
865000900246002001200255035001000267801001500277#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#239#3#article#62#3#^rND^sEvans^nWJ#^rND^sMeredith^nCN#^r
ND^sCannon^nJG.#Metabolic changes following eccentric exercise in trained and un
trained men^len#J Appl Physiol#19860000#1986#61#1864-8#19990800#v5n4a08.htm#0021
-8987#J Appl Physiol##
00540000000000277000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100019000740100022000930120
06900115030001100184065000900195064000500204031000300209014000800212865000900220
002001200229035001000241801001100251#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a08.htm#S#c#240#4#article#62#4#^rND^sPedersen^nBK#^rND^sBruunsgaard^nH.#How phys
ical exercise influences the establishment of infections^len#Sports Med#19950000
#1995#19#393-400#19990800#v5n4a08.htm#0112-1642#Sports Med##
00650000000000313000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100016000740100019000900100
01600109010001900125010001600144010001800160012009100178030002000269710000200289
065000900291064000500300031000300305014000700308865000900315002001200324#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#241#5#article#62#5#^rND^sPizza^n
FX#^rND^sMitchell^nJB#^rND^sDavis^nBH#^rND^sStarling^nRD#^rND^sHoltz^nRW#^rND^sB
igelow^nN.#Exercise-induced muscle damage: effect on circulating leukocyte and l
ymphocyte subsets^len#Med Sci Sport Exerc#2#19950000#1995#27#363-70#19990800#v5n
4a08.htm##
00611000000000301000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100016000740100015000900100
01500105810000700120012009700127030001500224065000900239064000500248031000300253
014000700256865000900263002001200272035001000284801001500294#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a08.htm#S#c#242#6#article#62#6#^rND^sKappel^nM#^rND^sTve
de^nN#^rND^sGalbo^nH#et al.#Evidence that the effect of physical exercise on NK 
cell activity is mediated by epinephrine^len#J Appl Physiol#19910000#1991#70#253
0-4#19990800#v5n4a08.htm#0021-8987#J Appl Physiol##
00545000000000277000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100023000740100020000970120
06800117030001400185065000900199064000500208031000300213014000600216865000900222
002001200231035001000243801001400253#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a08.htm#S#c#243#7#article#62#7#^rND^sHoffman-Goetz^nL#^rND^sPedersen^nBK.#Exerci
se and the immune system: a model of the stress response?^len#Immunol Today#1994
0000#1994#15#382-7#19990800#v5n4a08.htm#0167-5699#Immunol Today##
00428000000000229000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160018000740180051000920660
00700143062001300150065000900163064000500172865000900177002001200186#v5n4#V:\Sci
ELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#244#8#article#62#8#^rND^sCórdova^nA.
#La fatiga muscular en el rendimiento deportivo^les#Madrid#Ed. Sintesis#19970000
#1997#19990800#v5n4a08.htm##
00445000000000229000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160018000740180054000920660
00700146062002700153065000900180064000500189865000900194002001200203#v5n4#V:\Sci
ELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#245#9#article#62#9#^rND^sCórdova^nA.
#Compendio de fisiología para ciencias de la salud^les#Madrid#Interamericana-McG
raw-Hill#19940000#1994#19990800#v5n4a08.htm##
00632000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100016000920100
01700108012014700125030000700272065000900279064000500288031000400293014000700297
865000900304002001200313035001000325801000700335#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#246#10#article#62#10#^rND^sReeds^nPJ#^rND^sFjeld^nCR#^rN
D^sJahoor^nF.#Do the differences between the amino acid compositions of acute-ph
ase and muscle proteins have a bearing on nitrogen loss in traumatic states?^len
#J Nutr#19940000#1994#124#906-10#19990800#v5n4a08.htm#0022-3166#J Nutr##
00686000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100015000920100
01700107010001500124010001900139012014200158030000900300065000900309064000500318
031000300323014000600326865000900332002001200341035001000353801000900363#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#247#11#article#62#11#^rND^sCheng
^nKN#^rND^sPacy^nPJ#^rND^sDworzak^nF#^rND^sFord^nGC#^rND^sHalliday^nD.#Influence
 of fasting on leucine and muscle protein metabolism across the human forearm de
termined using L-[l-13C, 15N]leucine as a tracer^len#Clin Sci#19870000#1987#73#2
41-6#19990800#v5n4a08.htm#0009-9287#Clin Sci##
00472000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760120066000940300
01100160710000200171065000900173064000500182031000300187014000700190865000900197
002001200206#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#248#12#artic
le#62#12#^rND^sRennie^nMJ.#Muscle protein turnover and the wasting to injury and
 disease^len#Br Med Bul#2#19850000#1985#41#257-64#19990800#v5n4a08.htm##
00569000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100015000930100
01600108012007100124030001300195065000900208064000500217031000400222014000900226
865000900235002001200244035001000256801001300266#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#249#13#article#62#13#^rND^sRennie^nMJ#^rND^sSmith^nK#^rN
D^sWatt^nPW.#Measurement of human tissue protein synthesis: an optimal approach^
len#Am J Physiol#19940000#1994#266#E298-307#19990800#v5n4a08.htm#0002-9513#Am J 
Physiol##
00585000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100015000760100018000910100
02000109010001600129012005600145030001300201065000900214064000500223031000400228
020000700232865000900239002001200248035001000260801001300270#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a08.htm#S#c#250#14#article#62#14#^rND^sWelle^nS#^rND^sTh
ornton^nC#^rND^sJozefowicz^nR#^rND^sStatt^nM.#Myofibrillar protein synthesis in 
young and old men^len#Am J Physiol#19930000#1993#264#E693-8#19990800#v5n4a08.htm
#0002-9513#Am J Physiol##
00614000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100021000760100020000970100
01600117012010900133030001300242065000900255064000500264031000400269014000700273
865000900280002001200289035001000301801001300311#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#251#15#article#62#15#^rND^sYarasheski^nKE#^rND^sZachwiej
a^nJJ#^rND^sBier^nDM.#Acute effects of resistance exercise on muscle protein syn
thesis rate in young and elderly men and women^len#Am J Physiol#19930000#1993#26
5#E210-4#19990800#v5n4a08.htm#0002-9513#Am J Physiol##
00480000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760120038000950300
01300133065000900146064000500155031000300160014000700163865000900170002001200179
035001000191801001300201#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#
252#16#article#62#16#^rND^sFlorini^nJR.#Hormonal control of muscle growth^len#Mu
scle Nerve#19870000#1987#10#577-98#19990800#v5n4a08.htm#0148-639X#Muscle nerve##
00504000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100016000940100
01800110012004000128030001300168710000200181065000900183064000500192031000200197
014000600199865000900205002001200214#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a08.htm#S#c#253#17#article#62#17#^rND^sFlorini^nJR#^rND^sEwton^nDZ#^rND^sMcWade^
nFJ.#IGFs, muscle growth, and myogenesis^len#Diabetes Rev#2#19950000#1995#3#73-9
2#19990800#v5n4a08.htm##
00546000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100018000930120
08200111030001000193065000900203064000500212031000400217014000600221865000900227
002001200236035001000248801001000258#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a08.htm#S#c#254#18#article#62#18#^rND^sSugden^nPH#^rND^sFuller^nSJ.#Review artic
le. Regulation of protein turnover in skeletal and cardiac muscle^len#Biochem J#
19910000#1991#273#21-37#19990800#v5n4a08.htm#0264-6021#Biochem J##
00498000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100021000760100016000970120
05900113030001300172710000200185065000900187064000500196031000300201014000700204
865000900211002001200220#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#
255#19#article#62#19#^rND^sRooyackers^nOE#^rND^sNair^nKS.#Hormonal regulation of
 human muscle protein metabolism^len#Ann Rev Nutr#2#19970000#1997#17#457-85#1999
0800#v5n4a08.htm##
00480000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160016000760160014000920180
07600106066000900182062001200191065000900203064000500212865000900217002001200226
#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#256#20#article#62#20#^rN
D^sSigal^nLH#^rND^sRon^nY.#Immunology and inflammation. Basic mechanisms and cli
nical consequences^len#New York#McGraw-Hill#19940000#1994#19990800#v5n4a08.htm##
00499000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160016000760160020000920180
07800112066000900190062002300199065000900222064000500231865000900236002001200245
#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#257#21#article#62#21#^rN
D^sSaltin^nB#^rND^sGollnick^nPD.#Skeletal muscle adaptability: significance for 
metabolism and performance^len#Bethesda#Handbook of Physiology#19860000#1986#199
90800#v5n4a08.htm##
00534000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100019000920100
01600111010001800127012004300145030001000188710000200198065000900200064000500209
031000200214014000700216865000900223002001200232#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#258#22#article#62#22#^rND^sMarco^nJC#^rND^sRodriguez^nH#
^rND^sNavas^nJF#^rND^sCórdova^nA.#La fatiga psicológica en el deportista^les#Sel
ección#2#19950000#1995#4#129-36#19990800#v5n4a08.htm##
00530000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100016000930100
01500109012006800124030001300192710000200205065000900207064000500216031000300221
014000700224865000900231002001200240#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a08.htm#S#c#259#23#article#62#23#^rND^sCórdova^nA#^rND^sNavas^nFJ#^rND^sSeco^nJ.
#Aspectos metabólicos de la fatiga muscular durante el ejercicio^les#Arch Med De
p#2#19950000#1995#48#283-91#19990800#v5n4a08.htm##
00412000000000193000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160017000760160022000930180
08200115865000900197002001200206#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.
htm#S#c#260#24#article#62#24#^rND^sCórdova^nA#^rND^sAlvarez-Mon^nM.#Aspectos fis
iopatológicos del daño y la fatiga muscular. Medicine (en prensa)^les#19990800#v
5n4a08.htm##
00580000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100022000930120
08800115030002200203065000900225064000500234031000300239014000700242865000900249
002001200258035001000270801002200280#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a08.htm#S#c#261#25#article#62#25#^rND^sCórdova^nA#^rND^sAlvarez-Mon^nM.#Behaviou
r of zinc in physical exercise: a special reference to immunity and fatigue^len#
Neurosci Biobehav Rev#19950000#1995#19#439-45#19990800#v5n4a08.htm#0149-7634#Neu
rosci Biobehav Rev##
00483000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760120035000940300
01700129065000900146064000500155031000300160014000600163865000900169002001200178
035001000190801001700200#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#
262#26#article#62#26#^rND^sKuipers^nH.#Exercise-induced muscle damage^len#Int J 
Sports Med#19940000#1994#15#132-5#19990800#v5n4a08.htm#0172-4622#Int J sports Me
d##
00529000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100015000760100017000910100
01800108012003700126030001100163065000900174064000500183031000200188014000700190
865000900197002001200206035001000218801001100228#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#263#27#article#62#27#^rND^sKeast^nD#^rND^sCameron^nK#^rN
D^sMorton^nAR.#Exercise and the immune response^len#Sports Med#19880000#1988#5#2
48-67#19990800#v5n4a08.htm#0112-1642#Sports Med##
00544000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100030000930120
06500123030001100188065000900199064000500208031000300213014000800216865000900224
002001200233035001000245801001100255#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a08.htm#S#c#264#28#article#62#28#^rND^sNieman^nDC#^rND^sNehlsen-Cannarella^nSL.#
The effects of acute and chronic exercise on immunoglobulins^len#Sports Med#1991
0000#1991#11#183-201#19990800#v5n4a08.htm#0112-1642#Sports Med##
00540000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100015000760100017000910120
06300108030001900171065000900190064000500199031000300204014000500207865000900212
002001200221035001000233801001900243#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a08.htm#S#c#265#29#article#62#29#^rND^sTarp^nGD#^rND^sBarnes^nM.#Reduction of sa
liva immunoglobulin levels by swim training^len#Eur J Appl Physiol#19900000#1990
#60#61-4#19990800#v5n4a08.htm#0301-5548#Eur J Appl Physiol##
00537000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100020000760120087000960300
01700183065000900200064000500209031000300214014000600217865000900223002001200232
035001000244801001700254#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#
266#30#article#62#30#^rND^sPedersen^nBK.#Influence of physical activity on the c
ellular immune system: mechanisms of action^len#Int J Sports Med#19910000#1991#1
2#S23-9#19990800#v5n4a08.htm#0172-4622#Int J sports Med##
00618000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100015000760100020000910100
01700111810000600128012013000134030001900264710000200283065000900285064000500294
031000200299014000600301865000900307002001200316#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#267#31#article#62#31#^rND^sTvede^nN#^rND^sSteensberg^nJ#
^rND^sBaslund^nB#et al#Cellular immunity in highly-trained elite racing cyclists
 and controls during periods of training with high and low intensity^len#Scand J
 Sports Med#2#19910000#1991#1#163-6#19990800#v5n4a08.htm##
00586000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100018000930100
01700111810000600128012006200134030001700196065000900213064000500222031000300227
014000600230865000900236002001200245035001000257801001700267#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a08.htm#S#c#268#32#article#62#32#^rND^sNieman^nDC#^rND^s
Simandle^nS#^rND^sHenson^nDA#et al#Lymphocyte proliferative response to 2.5 hour
s of running^len#Int J Sports Med#19950000#1995#16#404-8#19990800#v5n4a08.htm#01
72-4622#Int J sports Med##
00542000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100022000930120
10200115030001300217710000200230065000900232064000500241031000300246014000600249
865000900255002001200264#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#
269#33#article#62#33#^rND^sCórdova^nA#^rND^sAlvarez-Mon^nM.#El sistema inmune I:
 conceptos generales, adaptación al ejercicio físico e implicaciones clínicas^le
s#Arch Med Dep#2#19990000#1999#69#47-54#19990800#v5n4a08.htm##
00644000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100015000930100
01500108010002000123012011000143030001700253065000900270064000500279031000300284
014000700287865000900294002001200303035001000315801001700325#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a08.htm#S#c#270#34#article#62#34#^rND^sShinkai^nS#^rND^s
Shore^nS#^rND^sShek^nPN#^rND^sShephard^nRJ.#Acute exercise and immune function. 
Relationship between lymphocyte activity and changes in subset counts^len#Int J 
Sports Med#19920000#1992#13#452-61#19990800#v5n4a08.htm#0172-4622#Int J sports M
ed##
00505000000000217000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160017000760160017000930160
02200110018010900132062002500241865000900266002001200275#v5n4#V:\SciELO\serial\r
bme\v5n4\markup\v5n4a08.htm#S#c#271#35#article#62#35#^rND^sCórdova^nA#^rND^sMart
ins^nF#^rND^sAlvarez-Mon^nM.#Effect of maximal exercise on lymphocytes (CD3, CD1
9) and serum immunoglobulin levels in elite sportsmen^len#Physiol Behav (sometid
o)#19990800#v5n4a08.htm##
00782000000000349000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100014000930100
02100107010002200128012009600150016001800246016001700264016001800281016001800299
01600170031701800390033406600060037306200120037906500090039106400050040001400060
0405865000900411002001200420#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#
S#c#272#36#article#62#36#^rND^sCórdova^nA#^rND^sSada^nG#^rND^sVillarrubia^nV#^rN
D^sAlvarez-Mon^nM.#Effects of training on serum zinc in CD+3 and CD+19 lymphocyt
es in sportsmen along a season^len#^rED^sCollery^nPh#^rED^sCobella^nJ#^rED^sDomi
ngo^nJL#^rED^sEtienne^nJC#^rED^sLlobet^nJM#Metal ions in biology and medicine^le
n#Paris#John Libbey#19960000#1996#667-9#19990800#v5n4a08.htm##
00625000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100015000760100018000910100
01700109010002100126012007900147030002100226065000900247064000500256031000300261
014000700264865000900271002001200280035001000292801002100302#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a08.htm#S#c#273#37#article#62#37#^rND^sGray^nAB#^rND^sTe
lford^nRD#^rND^sCollins^nM#^rND^sWeidemann^nMJ.#The response of leukocyte subset
s and plasma hormones to interval exercise^len#Med Sci Sports Exerc#19930000#199
3#25#1252-8#19990800#v5n4a08.htm#0195-9131#Med Sci Sports Exerc##
00565000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100015000760100018000910120
04300109016001700152016001800169018002500187066001100212062001000223065000900233
064000500242014000700247865000900254002001200263#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#274#38#article#62#38#^rND^sKeats^nD#^rND^sMorton^nAR.#Lo
ng-term exercise and immune function^len#^rED^sWatson^nRR#^rED^sEisinger^nM#Exer
cise and disease^len#Boca Raton#CRC Press#19930000#1993#89-120#19990800#v5n4a08.
htm##
00650000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100020000760100017000960100
01700113010002200130010001600152010002000168012003900188030002100227065000900248
06400050025703100030026201400070026586500090027200200120028103500100029380100210
0303#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#275#39#article#62#39
#^rND^sLaperriere^nA#^rND^sIronson^nG#^rND^sAntoni^nMH#^rND^sSchneiderman^nN#^rN
D^sKlimas^nN#^rND^sFletcher^nMA.#Exercise and psychoneuroimmunology^len#Med Sci 
Sports Exerc#19940000#1994#26#182-90#19990800#v5n4a08.htm#0195-9131#Med Sci Spor
ts Exerc##
00518000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100019000920100
01700111012002000128030001200148065000900160064000500169031000300174014000800177
865000900185002001200194035001000206801001200216#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#276#40#article#62#40#^rND^sPayan^nDG#^rND^sMcGillis^nJP#
^rND^sGoetz^nEJ.#Neuroimmunology^len#Adv Immunol#19860000#1986#39#299-323#199908
00#v5n4a08.htm#0065-2776#Adv Immunol##
00563000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100020000920120
07600112030002100188065000900209064000500218031000300223014000700226865000900233
002001200242035001000254801002100264#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a08.htm#S#c#277#41#article#62#41#^rND^sNosaka^nK#^rND^sClarkson^nPM.#Muscle dama
ge following repeated bouts of high force eccentric exercise^len#Med Sci Sports 
Exerc#19950000#1995#27#1263-9#19990800#v5n4a08.htm#0195-9131#Med Sci Sports Exer
c##
00554000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100018000920120
06900110030002100179065000900200064000500209031000300214014000700217865000900224
002001200233035001000245801002100255#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a08.htm#S#c#278#42#article#62#42#^rND^sFriden^nJ#^rND^sLieber^nRL.#Structural an
d mechanical basis of exercise-induce muscle injury^len#Med Sci Sports Exerc#199
20000#1992#24#521-30#19990800#v5n4a08.htm#0195-9131#Med Sci Sports Exerc##
00580000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100018000920120
06000110016001900170018004000189066001000229062002100239065000900260064000500269
014000700274865000900281002001200290#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a08.htm#S#c#279#43#article#62#43#^rND^sEvans^nWJ#^rND^sCannon^nJG.#The metabolic
 effects of exercise-induced muscle damage^len#^rND^sHolloszy^nJ.#Exercise and s
port sciences reviews^len#Baltimore#Williams and Wilkins#19910000#1991#99-125#19
990800#v5n4a08.htm##
00513000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760120054000950300
02100149065000900170064000500179031000300184014000800187865000900195002001200204
035001000216801002100226#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#
280#44#article#62#44#^rND^sTidball^nJG.#Inflammatory cell response to acute musc
le injury^len#Med Sci Sports Exerc#19950000#1995#27#1022-32#19990800#v5n4a08.htm
#0195-9131#Med Sci Sports Exerc##
00601000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100016000930100
02000109012008800129030002000217065000900237064000500246031000300251014000600254
865000900260002001200269035001000281801002000291#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#281#45#article#62#45#^rND^sCórdova^nA#^rND^sNavas^nFJ#^r
ND^sEscanero^nJF.#The effect of exercise and zinc supplement on the haematologic
al parameters in rats^len#Biol Trace Elem Res#19930000#1993#39#13-20#19990800#v5
n4a08.htm#0163-4984#Biol Trace Elem Res##
00460000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160015000760160016000910180
03600107066002100143062001900164065000900183064000500192865000900197002001200206
#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#282#46#article#62#46#^rN
D^sKent^nTH#^rND^sHart^nMN.#Injury, inflammation and repair^len#Norwalk^eConnect
icut#Appleton and Lange#19930000#1993#19990800#v5n4a08.htm##
00598000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100015000950100
02000110012010200130030001100232065000900243064000500252031000300257014000600260
865000900266002001200275035001000287801001100297#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#283#47#article#62#47#^rND^sMacityre^nDL#^rND^sReid^nWD#^
rND^sMcKenzie^nDC.#Delayed muscle soreness. The inflammatory response to muscle 
injury and its clinical implications^len#Sports Med#19950000#1995#20#24-40#19990
800#v5n4a08.htm#0112-1642#Sports Med##
00507000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160017000760160020000930160
02000113018005900133066000900192062001700201065000900218064000500227865000900232
002001200241#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#284#48#artic
le#62#48#^rND^sGallin^nJI#^rND^sGoldstein^nIM#^rND^sSnyderman^nR.#Inflammation: 
basic principles and clinical correlates^len#New York#Raven Press Ltd.#19920000#
1992#19990800#v5n4a08.htm##
00552000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100015000940120
07700109030001700186065000900203064000500212031000300217014000600220865000900226
002001200235035001000247801001700257#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4
a08.htm#S#c#285#49#article#62#49#^rND^sNorthoff^nH#^rND^sBerg^nA.#Immunologic me
diators as parameters of the reaction to strenous exercise^len#Int J Sports Med#
19910000#1991#12#S9-15#19990800#v5n4a08.htm#0172-4622#Int J sports Med##
00586000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100015000950100
01600110012009300126030001100219065000900230064000500239031000300244014000700247
865000900254002001200263035001000275801001100285#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#286#50#article#62#50#^rND^sShephard^nRJ#^rND^sRhind^nS#^
rND^sShek^nPN.#Exercise and the immune system. Natural killer cells, interleukin
s and related responses^len#Sports Med#19940000#1994#18#341-69#19990800#v5n4a08.
htm#0112-1642#Sports Med##
00516000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760120059000940300
02100153065000900174064000500183031000300188014000700191865000900198002001200207
035001000219801002100229#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#
287#51#article#62#51#^rND^sMazzeo^nRS.#The influence of exercise and aging on im
mune function^len#Med Sci Sports Exerc#19940000#1994#26#586-92#19990800#v5n4a08.
htm#0195-9131#Med Sci Sports Exerc##
00538000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760120100000950300
01200195065000900207064000500216031000300221014000500224865000900229002001200238
035001000250801001200260#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#
288#52#article#62#52#^rND^sBlalock^nJE.#A molecular basis for bidirectional comm
unication between the immune and neuroendocrine systems^len#Physiol Rev#19890000
#1989#69#1-32#19990800#v5n4a08.htm#0031-9333#Physiol Rev##
00562000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100015000760100016000910100
01500107012006500122030001500187065000900202064000500211031000300216014000700219
865000900226002001200235035001000247801001500257#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#289#53#article#62#53#^rND^sFerry^nA#^rND^sWeill^nBL#^rND
^sRieu^nM.#Immunomodulations induced in rats by exercise on a treadmill^len#J Ap
pl Physiol#19900000#1990#69#1912-5#19990800#v5n4a08.htm#0021-8987#J Appl Physiol
##
00592000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100016000930100
01400109012008900123030001800212065000900230064000500239031000200244014000700246
865000900253002001200262035001000274801001800284#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#290#54#article#62#54#^rND^sKelley^nKW#^rND^sArkins^nS#^r
ND^sLi^nYM.#Growth hormone, prolactin, and insulin-like growth factors: new jobs
 for old players^len#Brain Behav Immun#19920000#1992#6#317-26#19990800#v5n4a08.h
tm#0889-1591#Brain Behav Immun##
00483000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760120039000950300
01300134065000900147064000500156031000400161014000800165865000900173002001200182
035001000194801001300204#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#
291#55#article#62#55#^rND^sReighlin^nS.#Neuroendocrine-immune interactions^len#N
 Engl J Med#19930000#1993#329#1246-53#19990800#v5n4a08.htm#0028-4793#N Engl J Me
d##
00402000000000229000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160020000760180019000960660
01300115062000900128065000900137064000500146865000900151002001200160#v5n4#V:\Sci
ELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#292#56#article#62#56#^rND^sBellanti^
nJA.#Immunology III^len#Philadelphia#Saunders#19850000#1985#19990800#v5n4a08.htm
##
00503000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760120092000940300
01600186710000200202065000900204064000500213031000300218014000700221865000900228
002001200237#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#293#57#artic
le#62#57#^rND^sCarrol^nMC.#The role of complement and complement receptors in in
duction and regulation of immunity^len#Ann Rev Immunol#2#19980000#1998#16#545-68
#19990800#v5n4a08.htm##
00546000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100023000760120114000990300
01500213710000200228066000600230065000900236064000500245031000300250014000600253
865000900259002001200268#v5n4#V:\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#
294#58#article#62#58#^rND^sSainte-Laudy^nJ.#Importance of in vivo and in vitro s
tudies of leukotrienes. Application to the particular instance of aspirin^len#Al
lerg Immunol#2#Paris#19970000#1997#29#28-35#19990800#v5n4a08.htm##
00753000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100022000760100022000980100
01500120010001800135010002200153012015000175030003000325065000900355064000500364
031000300369014000600372865000900378002001200387035001000399801003000409#v5n4#V:
\SciELO\serial\rbme\v5n4\markup\v5n4a08.htm#S#c#295#59#article#62#59#^rND^sVilla
rrubia^nVG#^rND^sMoreno Koch^nMC#^rND^sCalvo^nC#^rND^sGonzález^nS#^rND^sAlvarez-
Mon^nM.#The immunosenescent phenotype in mice and humans can be defined by alter
ations in the natural immunity reversal by immunomodulation with oral AM3^len#Im
munopharmacol Immunotoxicol#19970000#1997#19#53-74#19990800#v5n4a08.htm#0892-397
3#Immunopharmacol Immunotoxicol##
00592000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100017000930100
01700110012010100127030001100228065000900239064000500248031000400253020000300257
865000900260002001200269035001000281801001100291#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#296#60#article#62#60#^rND^sAlonso^nJL#^rND^sMorejon^nM#^
rND^sPivel^nJP.#AM3, a new antagonist of lypopolysaccharide (LPS) induced tumor 
necrosis factor (TNF) production^len#Immunobiol#19870000#1987#175#F2#19990800#v5
n4a08.htm#0171-2985#Immunobiol##
00621000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160017000760160021000930160
01400114016001600128016002200144018006500166053004900231056000900280057000700289
065000900296064000500305865000900310002001200319#v5n4#V:\SciELO\serial\rbme\v5n4
\markup\v5n4a08.htm#S#c#297#61#article#62#61#^rND^sCórdova^nA#^rND^sVillarrubia^
nV#^rND^sSada^nG#^rND^sCalvo^nCG#^rND^sAlvarez-Mon^nM.#Immunomodulation for prev
ention of muscle damage in athletes^len#International Pre-Olympic Scientific Con
gress^i1#Texas^i1#USA^i1#19960000#1996#19990800#v5n4a08.htm##
00632000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100018000930100
01700111810000600128012010100134030002100235065000900256064000500265031000300270
014000500273865000900278002001200287035001000299801002100309#v5n4#V:\SciELO\seri
al\rbme\v5n4\markup\v5n4a08.htm#S#c#298#62#article#62#62#^rND^sHasson^nSM#^rND^s
Daniels^nJC#^rND^sDivine^nJG#et al#Effects of ibuprofen use on muscle soreness d
amage, and performance: a preliminary investigation^len#Med Sci Sports Exerc#199
30000#1993#25#9-17#19990800#v5n4a08.htm#0195-9131#Med Sci Sports Exerc##
